-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RPiv9CFe+7QVyiydeu4xdFfvG9HoG1JnQJYgsAw8n8MbYsKG40hRdWuluFKkWOv2
 m4a+a7bK8gXqY0e3mS/EIw==

<SEC-DOCUMENT>0001047469-06-003960.txt : 20060324
<SEC-HEADER>0001047469-06-003960.hdr.sgml : 20060324
<ACCEPTANCE-DATETIME>20060324150213
ACCESSION NUMBER:		0001047469-06-003960
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20060428
FILED AS OF DATE:		20060324
DATE AS OF CHANGE:		20060324
EFFECTIVENESS DATE:		20060324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABBOTT LABORATORIES
		CENTRAL INDEX KEY:			0000001800
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				360698440
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-02189
		FILM NUMBER:		06708997

	BUSINESS ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		D-322 AP6D
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-3500
		BUSINESS PHONE:		8479376100
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2167434zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=4><B> SCHEDULE 14A</B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>Proxy
Statement Pursuant to Section&nbsp;14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=3><FONT SIZE=2>Filed by the Registrant <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><FONT SIZE=2>Filed by a Party other than the Registrant <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><FONT SIZE=2><BR>
Check the appropriate box:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
Preliminary Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><BR><FONT SIZE=2><B>Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
Definitive Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
Definitive Additional Materials</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
Soliciting Material Pursuant to &sect;240.14a-12</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER"><BR><FONT SIZE=2><B>Abbott Laboratories</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER"><HR NOSHADE><FONT SIZE=2> (Name of Registrant as Specified In Its Charter)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER"><HR NOSHADE><FONT SIZE=2> (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2>Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
No fee required.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(1)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Title of each class of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(2)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Aggregate number of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(3)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(4)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Proposed maximum aggregate value of transaction:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(5)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Total fee paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2><BR>
(1)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2><BR>
Amount Previously Paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(2)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Form, Schedule or Registration Statement No.:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(3)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Filing Party:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>(4)</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Date Filed:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="89%"><BR><FONT SIZE=2><B>Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- ZEQ.=1,SEQ=1,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=362819,FOLIO='blank',FILE='DISK132:[06CHI1.06CHI1111]BA1111A.;3',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER"><FONT SIZE=2><B>
<IMG SRC="g449301.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="891">
  </B></FONT></P>

<!-- ZEQ.=1,SEQ=2,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=20248,FOLIO='blank',FILE='DISK132:[06CHI1.06CHI1111]BC1111A.;1',USER='EYOUNG',CD='22-MAR-2006;15:13' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><B>
<IMG SRC="g519019.jpg" ALT="ABBOTT LABORATORIES LOGO" WIDTH="52" HEIGHT="46">
  </B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Abbott Laboratories<BR>
100 Abbott Park Road<BR>
Abbott Park, Illinois 60064-6400 U.S.A.</B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="87%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TD WIDTH="43%" VALIGN="TOP"><FONT SIZE=2><B>Cover:</B></FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="55%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="43%" VALIGN="TOP"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2><I>Yew Han Yong is an active 3-year-old from Singapore who enjoys preschool. He maintains his energy, thanks in part to Grow, a nutritional supplement for children that delivers important nutrients to
enhance their daily diet.</I></FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=2><I><BR>&nbsp;</I></FONT></TD>
<TD WIDTH="55%" VALIGN="TOP"><FONT SIZE=2><I><BR>
&nbsp;</I></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- ZEQ.=1,SEQ=3,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=357247,FOLIO='blank',FILE='DISK132:[06CHI1.06CHI1111]BE1111A.;7',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<!-- TOC_END -->
<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=5><B>Your Vote<BR>
Is Important  </B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=3><B>Please sign and promptly return your<BR>
proxy in the enclosed envelope or vote<BR>
your shares by telephone or using the Internet.</B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=4><B>Notice of Annual Meeting<BR>
of Shareholders</B></FONT></P>

<P><FONT SIZE=2>The Annual Meeting of the Shareholders of Abbott Laboratories will be held at Abbott's headquarters, 100&nbsp;Abbott Park Road, at the intersection of Route
137 and Waukegan Road, Lake County, Illinois, on Friday, April&nbsp;28, 2006, at 9:00&nbsp;a.m. for the following purposes: </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>To
elect 13 directors to hold office until the next Annual Meeting or until their successors are elected (Item&nbsp;1 on the proxy card),
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>To
ratify the appointment of Deloitte&nbsp;&amp; Touche&nbsp;LLP as auditors of Abbott for 2006 (Item 2 on the proxy card), and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>To
transact such other business as may properly come before the meeting, including consideration of three shareholder proposals, if presented at the meeting (Items&nbsp;3,
4, and 5 on the proxy card). </FONT></DD></DL>

<P><FONT SIZE=2><B>The board of directors recommends that you vote FOR Items&nbsp;1 and 2 on the proxy card.</B></FONT></P>

<P><FONT SIZE=2><B>The board of directors recommends that you vote AGAINST Items&nbsp;3, 4, and 5 on the proxy
card.</B></FONT></P>

<P><FONT SIZE=2>The close of business March&nbsp;1, 2006 has been fixed as the record date for determining the shareholders entitled to receive notice of and to vote at the
Annual Meeting. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>Admission
to the meeting will be by admission card only. If you plan to attend, please complete and return the reservation form on the back cover, and an admission card will be sent to you. Due to
space limitations, reservation forms must be received before April&nbsp;21, 2006. Each admission card, along with photo identification, admits one person. A shareholder may request two admission
cards. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>By
order of the board of directors. </FONT></P>

<P><FONT SIZE=2>LAURA
J. SCHUMACHER<BR></FONT> <FONT SIZE=2><I>Secretary  </I></FONT></P>

<P><FONT SIZE=2>March&nbsp;24, 2006 </FONT></P>

<HR NOSHADE>
<BR>
<!-- ZEQ.=1,SEQ=4,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=30917,FOLIO='blank',FILE='DISK132:[06CHI1.06CHI1111]DE1111A.;12',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<!-- TOC_END -->

<P><FONT SIZE=2><A
NAME="page_dg1111_1_1"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=5><B>Abbott Laboratories  </B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=5><B> Proxy Statement  </B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Solicitation of Proxies  </B></FONT></P>

<P><FONT SIZE=2>
The accompanying proxy is solicited on behalf of the board of directors for use at the Annual Meeting of Shareholders. The meeting will be held on April&nbsp;28, 2006, at Abbott's headquarters, 100
Abbott Park Road, at the intersection of Route&nbsp;137 and Waukegan Road, Lake County, Illinois. This proxy statement and the accompanying proxy card are being mailed to shareholders on or about
March&nbsp;24, 2006. </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Information about the Annual Meeting  </B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Who Can Vote  </B></FONT></P>

<P><FONT SIZE=2>
Shareholders of record at the close of business on March&nbsp;1, 2006 will be entitled to notice of and to vote at the Annual Meeting. As of January&nbsp;31, 2006, Abbott had 1,538,625,812
outstanding common shares, which are Abbott's only outstanding voting securities. All shareholders have cumulative voting rights in the election of directors and one vote per share on all other
matters. </FONT></P>

<P><FONT SIZE=2><B>Cumulative Voting  </B></FONT></P>

<P><FONT SIZE=2>
Cumulative voting allows a shareholder to multiply the number of shares owned by the number of directors to be elected and to cast the total for one nominee or distribute the votes among the nominees,
as the shareholder desires. Nominees who receive the greatest number of votes will be elected. If you wish to cumulate your votes, you must sign and mail in your proxy card or attend the Annual
Meeting. </FONT></P>

<P><FONT SIZE=2><B>Voting by Proxy  </B></FONT></P>

<P><FONT SIZE=2>
All of Abbott's shareholders may vote by mail or at the Annual Meeting. The bylaws provide that a shareholder may authorize no more than two persons as proxies to attend and vote at the meeting. Most
of Abbott's shareholders may also vote their shares by telephone or the Internet. If you vote by telephone or the Internet, you do not need to return your proxy card. The instructions for voting by
telephone or the Internet can be found with your proxy card. </FONT></P>

<P><FONT SIZE=2><B>Revoking a Proxy  </B></FONT></P>


<P><FONT SIZE=2>
You may revoke your proxy by voting in person at the Annual Meeting or, at any time prior to the meeting: </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>by
delivering a written notice to the secretary of Abbott, </FONT></DD></DL>
<HR NOSHADE>

<P><FONT SIZE=2>1</FONT></P>

<!-- ZEQ.=1,SEQ=5,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=631077,FOLIO='1',FILE='DISK132:[06CHI1.06CHI1111]DG1111A.;16',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_dg1111_1_2"> </A>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>by
delivering an authorized proxy with a later date, or
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>by
voting by telephone or the Internet after you have given your proxy. </FONT></DD></DL>

<P><FONT SIZE=2><B>Discretionary Voting Authority  </B></FONT></P>

<P><FONT SIZE=2>
Unless authority is withheld in accordance with the instructions on the proxy, the persons named in the proxy will vote the shares covered by proxies they receive to elect the 13&nbsp;nominees named
in Item&nbsp;1 on the proxy card. Should a nominee become unavailable to serve, the shares will be voted for a substitute designated by the board of directors, or for fewer than 13&nbsp;nominees
if, in the judgment of the proxy holders, such action is necessary or desirable. The persons named in the proxy may also decide to vote shares cumulatively so that one or more of the nominees may
receive fewer votes than the other nominees (or no&nbsp;votes&nbsp;at all), although they have no present intention of doing&nbsp;so. </FONT></P>

<P><FONT SIZE=2>Where
a shareholder has specified a choice for or against the ratification of the appointment of Deloitte&nbsp;&amp; Touche LLP as auditors, or the approval of a shareholder proposal, or where the
shareholder has abstained on these matters, the shares represented by the proxy will be voted (or not voted) as specified. Where no choice has been specified, the proxy will be voted FOR ratification
of Deloitte&nbsp;&amp; Touche&nbsp;LLP as auditors and AGAINST the shareholder proposals. </FONT></P>

<P><FONT SIZE=2>With
the exception of matters omitted from this proxy statement pursuant to the rules of the Securities and Exchange Commission, the board of directors is not aware of any other issue which may
properly be brought before the meeting. If other matters are properly brought before the meeting, the accompanying proxy will be voted in accordance with the judgment of the proxy holders. </FONT></P>

<P><FONT SIZE=2><B>Quorum and Vote Required to Approve Each Item on the Proxy  </B></FONT></P>

<P><FONT SIZE=2>
A majority of the outstanding shares entitled to vote on a matter, represented in person or by proxy, constitutes a quorum for consideration of that matter at the meeting. The affirmative vote of a
majority of the shares represented at the meeting and entitled to vote on a matter shall be the act of the shareholders with respect to that matter. </FONT></P>

<P><FONT SIZE=2><B>Effect of Broker Non-Votes and Abstentions  </B></FONT></P>

<P><FONT SIZE=2>
A proxy submitted by an institution such as a broker or bank that holds shares for the account of a beneficial owner may indicate that all or a portion of the shares represented by that proxy are not
being voted with respect to a particular matter. This could occur, for example, when the broker or bank is not permitted to vote those shares in the absence of instructions from the beneficial owner
of the stock. These "non-voted shares" will be considered shares not present and, therefore, not entitled to vote on that matter, although these shares may be considered present and
entitled to vote for other purposes. Non-voted shares will not affect the determination of the outcome of the vote on any matter to be decided at the meeting. Shares represented by proxies
which are present and entitled to vote on a matter but which have elected to abstain from voting on that matter will have the effect of votes against that matter. </FONT></P>

<P><FONT SIZE=2><B>Inspectors of Election  </B></FONT></P>

<P><FONT SIZE=2>
The inspectors of election and the tabulators of all proxies, ballots, and voting tabulations that identify shareholders are independent and are not Abbott employees. </FONT></P>


<P><FONT SIZE=2><B>Cost of Soliciting Proxies  </B></FONT></P>

<P><FONT SIZE=2>
Abbott will bear the cost of making solicitations from its shareholders and will reimburse banks and brokerage firms for out-of-pocket expenses incurred in connection with this
solicitation. Proxies may be solicited by mail or in person by directors, officers, or employees of Abbott and its subsidiaries. </FONT></P>

<P><FONT SIZE=2>Abbott
has retained Georgeson Shareholder to aid in the solicitation of proxies, at an estimated cost of $17,500 plus reimbursement for reasonable out-of-pocket expenses. </FONT></P>

<P><FONT SIZE=2><B>Abbott Laboratories Stock Retirement Plan  </B></FONT></P>

<P><FONT SIZE=2>
Participants in the Abbott Laboratories Stock Retirement Plan will receive a voting instruction card for their shares held in the Abbott Laboratories Stock Retirement Trust. The Stock Retirement Trust
is administered by both a trustee and three co-trustees. The trustee of the Trust is Putnam Fiduciary Trust Company. The co-trustees are Thomas C. Freyman, Robert E. Funck, and
Stephen R. Fussell, officers of Abbott. The voting power with respect to the shares is held by and shared between the co-trustees and the participants. The co-trustees must
solicit voting instructions from the participants and follow the voting instructions they receive. The co-trustees may use their own discretion with respect to those shares for which no
voting instructions are received. </FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>2</FONT></P>

<!-- ZEQ.=2,SEQ=6,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=723837,FOLIO='2',FILE='DISK132:[06CHI1.06CHI1111]DG1111A.;16',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_dg1111_1_3"> </A>
<BR>

<P><FONT SIZE=2><B>Confidential Voting  </B></FONT></P>

<P><FONT SIZE=2>
It is Abbott's policy that all proxies, ballots, and voting tabulations that reveal how a particular shareholder has voted be kept confidential and not be disclosed, except: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2>&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2>where disclosure may be required by law or regulation,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2><BR>
&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
where disclosure may be necessary in order for Abbott to assert or defend claims,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2><BR>
&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
where a shareholder provides comments with a proxy,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2><BR>
&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
where a shareholder expressly requests disclosure,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2><BR>
&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
to allow the inspectors of election to certify the results of a vote, or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2><BR>
&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
in other limited circumstances, such as a contested election or proxy solicitation not approved and recommended by the board of directors.</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Information Concerning Nominees for Directors (Item 1 on Proxy Card)  </B></FONT></P>

<P><FONT SIZE=2>Thirteen
directors are to be elected to hold office until the next Annual Meeting or until their successors are elected. All of the nominees are currently serving as directors. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>3</FONT></P>

<!-- ZEQ.=3,SEQ=7,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=389619,FOLIO='3',FILE='DISK132:[06CHI1.06CHI1111]DG1111A.;16',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_di1111_1_4"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT SIZE=4><B>Nominees for Election as Directors  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="75%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><BR><FONT SIZE=2><B>
<IMG SRC="g426392.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
 </B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>Roxanne&nbsp;S.
Austin&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;45&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 2000<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Former President and Chief Operating Officer, DIRECTV,&nbsp;Inc., El Segundo, California<BR>
(Digital Satellite Television Service Provider)<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mrs.&nbsp;Austin served as president and chief operating officer of DIRECTV,&nbsp;Inc. from June&nbsp;2001 to December&nbsp;2003. She also served as executive vice president of Hughes Electronics Corporation and as a
member of its executive committee until December&nbsp;2003. From 1997 to June&nbsp;2001, Mrs.&nbsp;Austin was the corporate senior vice president and chief financial officer of Hughes Electronics Corporation. Mrs.&nbsp;Austin served as Hughes
Electronics' vice president, treasurer, chief accounting officer and controller from December&nbsp;1996 to July&nbsp;1997; as its vice president, treasurer, and controller from July&nbsp;1996 to December&nbsp;1996; and as its vice president and
controller from July&nbsp;1993 to July&nbsp;1996. Prior to joining Hughes, Mrs.&nbsp;Austin was a partner at the accounting firm Deloitte&nbsp;&amp; Touche. Mrs.&nbsp;Austin earned her B.B.A. degree in accounting from the University of Texas at San
Antonio. She serves on the board of trustees of the California Science Center. Mrs.&nbsp;Austin serves on the board of directors of Target Corporation.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g173968.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>William M.
Daley&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age
&nbsp;57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 2004<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Chairman of the Midwest, JPMorgan Chase &amp; Co., Chicago, Illinois<BR>
(Banking and Financial Services Company)<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Daley has served as the senior executive of the Midwest region and serves on the JPMorgan Chase&nbsp;&amp; Co. Executive Committee and on its International Council since May&nbsp;2004. He served as President,
SBC Communications,&nbsp;Inc. (diversified telecommunications) from December&nbsp;2001 to May&nbsp;2004. Mr.&nbsp;Daley was vice chairman of Evercore Capital Partners L.P. from January to November&nbsp;2001. From June to December&nbsp;2000,
Mr.&nbsp;Daley served as Chairman of Vice President Albert Gore's 2000 presidential election campaign. Mr.&nbsp;Daley served as the U.S. Secretary of Commerce from January&nbsp;1997 to June&nbsp;2000. Mr.&nbsp;Daley serves on the board of directors
of Boston Properties,&nbsp;Inc., The Boeing Company, The Art Institute of Chicago, Joffrey Ballet of Chicago, Loyola University of Chicago, Northwestern Memorial Hospital, and Northwestern University. He also sits on the Council on Foreign Relations.
Mr.&nbsp;Daley is a graduate of Loyola University in Chicago and of John Marshall Law School.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g243310.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>W. James
Farrell&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age
&nbsp;63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 2006<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Chairman of Illinois Tool Works&nbsp;Inc., Glenview, Illinois<BR>
(Worldwide Manufacturer of Highly Engineered Products and Specialty Systems)<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Farrell has served as the Chairman of Illinois Tool Works&nbsp;Inc. since 1996. Mr.&nbsp;Farrell served as Illinois Tool Works' Chief Executive Officer from 1995 to 2005 and has served on its board of
directors since 1995. He also serves on the board of directors of Allstate Insurance Company, Kraft Foods,&nbsp;Inc. and UAL Corporation.</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>4</FONT></P>

<!-- ZEQ.=1,SEQ=8,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=736234,FOLIO='4',FILE='DISK132:[06CHI1.06CHI1111]DI1111A.;36',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_di1111_1_5"> </A>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g616240.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>H.&nbsp;Laurance
Fuller&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;67&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 1988<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Retired Co-Chairman of the Board, BP Amoco, p.l.c., London, United Kingdom<BR>
(Integrated Petroleum and Chemicals Company)<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Fuller was elected president of Amoco Corporation in 1983 and chairman and chief executive officer in 1991. As the result of the merger of British Petroleum, p.l.c. and Amoco effective December&nbsp;31, 1998,
he became co-chairman of BP Amoco, p.l.c. He retired from that position in April&nbsp;2000. He is a director of Cabot MicroElectronics Corporation, Motorola,&nbsp;Inc., and the Rehabilitation Institute of Chicago, and a trustee of The Orchestral
Association and Cornell University.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g785559.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>Richard&nbsp;A.
Gonzalez&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;52&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 2001<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>President and Chief Operating Officer, Medical Products Group, Abbott Laboratories<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Gonzalez was elected Abbott's president and chief operating officer, medical products group in 2001. He served as executive vice president, medical products from 2000 to 2001, as senior vice president,
hospital products from 1998 to 2000, and as vice president, Abbott HealthSystems division from 1995 to 1998. Mr.&nbsp;Gonzalez joined Abbott in 1977. He received his bachelor's degree in biochemistry from the University of Houston and his master's
degree in biochemistry from the University of Miami.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g509192.jpg" ALT="PHOTO" WIDTH="133" HEIGHT="133">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>Jack M.
Greenberg&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;63&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 2000<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Retired Chairman and Chief Executive Officer, McDonald's Corporation, Oak Brook, Illinois (Developer, Operator, and Franchisor of a Worldwide System of Restaurants)<BR>
<BR> </I></FONT><FONT SIZE=2><B>At the end of 2002, Mr.&nbsp;Greenberg retired as chairman and chief executive officer of McDonald's Corporation. He had served as McDonald's chairman since May&nbsp;1999 and as its chief executive officer since
August&nbsp;1998. Mr.&nbsp;Greenberg served as McDonald's president from August&nbsp;1998 to May&nbsp;1999, and as its vice-chairman from December&nbsp;1991 to 1998. Mr.&nbsp;Greenberg also served as chairman (from October&nbsp;1996) and chief
executive officer (from July&nbsp;1997) of McDonald's USA until August&nbsp;1998. Mr.&nbsp;Greenberg is a graduate of DePaul University's School of Commerce and School of Law. He is a member of the American Institute of Certified Public Accountants,
the Illinois CPA Society, and the Chicago Bar Association. Mr.&nbsp;Greenberg is a director of The Allstate Corporation, First Data Corporation, Hasbro,&nbsp;Inc., Manpower&nbsp;Inc., and Quintiles Transnational Corp. He is also a member of the board
of trustees of DePaul University, the Field Museum, and the Chicago Community Trust.</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>

<P><FONT SIZE=2>5</FONT></P>

<!-- ZEQ.=2,SEQ=9,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=663461,FOLIO='5',FILE='DISK132:[06CHI1.06CHI1111]DI1111A.;36',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_di1111_1_6"> </A>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g916736.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>The Rt.&nbsp;Hon. Lord Owen
CH&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 1996<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Chairman of Global Natural Energy p.l.c., London, United Kingdom<BR>
(Owner and Operator of Gasoline Retailing Sites)<BR>
<BR> </I></FONT><FONT SIZE=2><B>David Owen is a British subject. He has been chairman of Global Natural Energy p.l.c. since 1995. He was a neurologist and Research Fellow on the Medical Unit of St. Thomas' Hospital, London, from 1965 through 1968 and
a member of Parliament for Plymouth in the House of Commons from 1966 until he retired in May of 1992. In 1992, he was created a Life Peer and a Member of the House of Lords. In August of 1992, the European Union appointed him Co-Chairman of the
International Conference on Former Yugoslavia. He stepped down in June of 1995. Lord Owen was Secretary for Foreign and Commonwealth Affairs from 1977 to 1979 and Minister of Health from 1974 to 1976.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g993219.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>Boone
Powell&nbsp;Jr.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;Age&nbsp;69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 1985<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Retired Chairman, Baylor Health Care System, Dallas, Texas<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Powell had been associated with Baylor University Medical Center since 1980 when he was named president and chief executive officer. In August&nbsp;2001, Mr.&nbsp;Powell retired from his position as Chairman
of Baylor Health Care System. Prior to joining Baylor, he was president of Hendrick Medical Center in Abilene, Texas. He is a director of Comerica Bank-Texas, U.S. Oncology, and United Surgical Partners International and a fellow of the American
College of Health Care Executives. Mr.&nbsp;Powell is a graduate of Baylor University. He received a master's degree in hospital administration from the University of California.</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>6</FONT></P>

<!-- ZEQ.=3,SEQ=10,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=399055,FOLIO='6',FILE='DISK132:[06CHI1.06CHI1111]DI1111A.;36',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_di1111_1_7"> </A>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g521797.jpg" ALT="PHOTO" WIDTH="133" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>W.&nbsp;Ann Reynolds,
&nbsp;Ph.D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 1980<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Retired Director, Center for Community Outreach and Development, The University of Alabama at Birmingham, Birmingham, Alabama<BR>
<BR> </I></FONT><FONT SIZE=2><B>At the end of 2003, Dr.&nbsp;Reynolds retired as director, Center for Community Outreach and Development, The University of Alabama at Birmingham. She had served in that position since 2002 and as the university's
president from 1997 to 2002. From 1990 to 1997, Dr.&nbsp;Reynolds served as chancellor of The City University of New York. Prior to that, she served as chancellor of The California State University, chief academic officer of Ohio State University and
associate vice chancellor for research and dean of the graduate college of the University of Illinois Medical Center. She also held appointments as professor of anatomy, research professor of obstetrics and gynecology, and acting associate dean for
academic affairs at the University of Illinois College of Medicine. Dr.&nbsp;Reynolds is a graduate of Emporia State University (Kansas) and holds M.S. and Ph.D. degrees in zoology from the University of Iowa. She is also a director of
Humana&nbsp;Inc., Maytag Corporation, Owens-Corning, Invitrogen, and the Champaign-Urbana News Gazette.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g633815.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>Roy&nbsp;S.
Roberts&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since
1998<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Managing Director, Reliant Equity Investors, Chicago, Illinois (Venture Capital Firm)<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Roberts has served as managing director of Reliant Equity Investors since September&nbsp;2000. Mr.&nbsp;Roberts retired from General Motors in April&nbsp;2000. At the time of his retirement, he was group vice
president for North American Vehicle Sales, Service and Marketing of General Motors Corporation, having been elected to that position in October&nbsp;1998. Prior to that time, he was vice president and general manager in charge of Field Sales,
Service and Parts for the Vehicle Sales, Service and Marketing Group from August&nbsp;1998 to October&nbsp;1998, general manager of the Pontiac-GMC Division from February&nbsp;1996 to October&nbsp;1998, and general manager of the GMC Truck Division
from October&nbsp;1992 to February&nbsp;1996. Mr.&nbsp;Roberts first joined General Motors Corporation in 1977 and became a corporate officer of General Motors Corporation in April&nbsp;1987. Mr.&nbsp;Roberts earned a bachelor's degree from Western
Michigan University. He serves as a director of Burlington Northern Santa Fe Corporation; as Trustee Emeritus at Western Michigan University; as immediate past president and on the National Board of Directors for the Boy Scouts of America; and on the
Board of the Michigan Opera Theatre.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g304005.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>William D.
Smithburg&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 1982<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Retired Chairman, President and Chief Executive Officer, The Quaker Oats Company, Chicago, Illinois (Worldwide Food Manufacturer and Marketer of Beverages and Grain-Based Products)<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Smithburg retired from Quaker Oats in October&nbsp;1997. Mr.&nbsp;Smithburg joined Quaker Oats in 1966 and became president and chief executive officer in 1981, and chairman and chief executive officer in 1983
and also served as president from November&nbsp;1990 to January&nbsp;1993 and again from November&nbsp;1995. Mr.&nbsp;Smithburg was elected to the Quaker board in 1978 and served on its executive committee until he retired. He is a director of
Smurfit-Stone Container Corporation, Northern Trust Corporation, and Corning Incorporated. He is a member of the board of trustees of Northwestern University. Mr.&nbsp;Smithburg earned a B.S. degree from DePaul University and an M.B.A. degree from
Northwestern University.</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>

<P><FONT SIZE=2>7</FONT></P>

<!-- ZEQ.=4,SEQ=11,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=891988,FOLIO='7',FILE='DISK132:[06CHI1.06CHI1111]DI1111A.;36',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_di1111_1_8"> </A>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g583704.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>John&nbsp;R.
Walter&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since
1990<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Retired President and Chief Operating Officer, AT&amp;T Corporation, Basking Ridge, New Jersey (Telecommunications Company); and Former Chairman and Chief Executive Officer, R. R. Donnelley&nbsp;&amp;
Sons Company, Chicago, Illinois (Printing Company)<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;Walter served as president and chief operating officer of AT&amp;T Corporation from October&nbsp;1996 to July&nbsp;1997. Prior to that time, he was chairman, president and chief executive officer of R. R.
Donnelley&nbsp;&amp; Sons Company, a printing company. He was elected chairman of the board and chief executive officer in 1989 and president in 1987. He holds a bachelor's degree from Miami University of Ohio. Mr.&nbsp;Walter serves as a director of
Deere&nbsp;&amp; Company, Manpower&nbsp;Inc., SNP Corporation of Singapore, and VascoData Security International. He is a trustee of Northwestern University and a director of Evanston Northwestern Healthcare and Steppenwolf Theatre.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="22%"><FONT SIZE=2><B><BR>
<BR>
 <IMG SRC="g206804.jpg" ALT="PHOTO" WIDTH="135" HEIGHT="135">
</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="75%"><BR><FONT COLOR="#2B85FF" SIZE=2><B>Miles&nbsp;D.
White&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;Age&nbsp;50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director since 1998<BR>
<BR> </B></FONT><FONT COLOR="#2B85FF" SIZE=2><I>Chairman of the Board and Chief Executive Officer, Abbott Laboratories<BR>
<BR> </I></FONT><FONT SIZE=2><B>Mr.&nbsp;White has served as Abbott's chairman of the board and chief executive officer since 1999. He served as an executive vice president of Abbott from 1998 to 1999, as senior vice president, diagnostics operations
from 1994 to 1998, and as vice president, diagnostics systems operations from 1993 to 1994. Mr.&nbsp;White joined Abbott in 1984. He received both his bachelor's degree in mechanical engineering and M.B.A. degree from Stanford University. He serves
on the board of trustees of The Culver Educational Foundation, The Field Museum in Chicago, and Northwestern University and is chairman of the board of directors of the Federal Reserve Bank of Chicago. He serves as a director of Motorola&nbsp;Inc.
and the Tribune Company.</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>8</FONT></P>

<!-- ZEQ.=5,SEQ=12,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=370349,FOLIO='8',FILE='DISK132:[06CHI1.06CHI1111]DI1111A.;36',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_dk1111_1_9"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>The Board of Directors and its Committees  </B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=2><B>The Board of Directors  </B></FONT></P>

<P><FONT SIZE=2>
The board of directors held eight meetings in 2005. The average attendance of all directors at board and committee meetings in 2005 was 97&nbsp;percent. Abbott encourages its board members to attend
the annual shareholders meeting. Last year, all of Abbott's directors attended the annual shareholders meeting. </FONT></P>

<P><FONT SIZE=2>The
board has determined that each of the following directors, who constitute all eleven of Abbott's non-employee directors, is independent in accordance with the New&nbsp;York Stock
Exchange listing standards: R.&nbsp;S.&nbsp;Austin, W.&nbsp;M.&nbsp;Daley, W.&nbsp;J.&nbsp;Farrell, H.&nbsp;L.&nbsp;Fuller, J.&nbsp;M.&nbsp;Greenberg,
D.&nbsp;A.&nbsp;L.&nbsp;Owen, B.&nbsp;Powell&nbsp;Jr., W.&nbsp;A.&nbsp;Reynolds, R.&nbsp;S.&nbsp;Roberts, W.&nbsp;D.&nbsp;Smithburg, and J.&nbsp;R.&nbsp;Walter. To determine
independence, the board applied the categorical standards found on Exhibit&nbsp;A to this proxy statement. The board also considered whether a director has any other material relationships with
Abbott or its subsidiaries and concluded that none of these directors had a relationship that impaired the director's independence. In making its determination, the board relied on both information
provided by the directors and information developed internally by Abbott. </FONT></P>

<P><FONT SIZE=2>The
chairman of the nominations and governance committee acts as lead director to facilitate communication with the board and preside over regularly conducted executive sessions of the independent
directors or sessions where the
chairman of the board is not present. It has been and continues to be the role of the lead director to review and approve matters, such as agenda items, schedule sufficiency, and, where appropriate,
information provided to other Board members. The lead director is chosen by and from the independent members of the Board of Directors, and serves as the liaison between the chairman and the
independent directors; however, all directors are encouraged to, and in fact do, consult with the chairman on each of the above topics as well. The lead director, and each of the other directors,
communicates regularly with the chairman and chief executive officer regarding appropriate agenda topics and other board related matters.  </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Committees of the Board of Directors  </B></FONT></P>

<P><FONT SIZE=2>The
board of directors has five committees established in Abbott's bylaws: the executive committee, audit committee, compensation committee, nominations and governance committee, and public policy
committee. Each of the members of the audit committee, compensation committee, nominations and governance committee, and public policy committee is independent. </FONT></P>


<P><FONT SIZE=2>The
executive committee, whose members are M.&nbsp;D.&nbsp;White, chairman, H.&nbsp;L.&nbsp;Fuller, J.&nbsp;M.&nbsp;Greenberg, W.&nbsp;A.&nbsp;Reynolds, and
W.&nbsp;D.&nbsp;Smithburg, did not hold any meetings in 2005. This committee may exercise all the authority of the board in the management of Abbott, except for matters expressly reserved by law
for board action. </FONT></P>

<P><FONT SIZE=2>The
audit committee, whose members are J.&nbsp;M.&nbsp;Greenberg, chairman, R.&nbsp;S.&nbsp;Austin, D.&nbsp;A.&nbsp;L.&nbsp;Owen, W.&nbsp;D.&nbsp;Smithburg, and
J.&nbsp;R.&nbsp;Walter, held seven meetings in 2005. The committee is governed by a written charter, a copy of which is attached as Exhibit&nbsp;B to this proxy statement. This committee assists
the board of directors in fulfilling its oversight responsibility with respect to Abbott's accounting and financial reporting practices and the audit process, the quality and integrity of Abbott's
financial statements, the independent auditors' qualifications, independence and performance, the performance of Abbott's internal audit function and internal auditors, and certain areas of legal and
regulatory compliance. Each of the members of the audit committee is financially literate, as required of audit committee members by the New&nbsp;York Stock Exchange. The board of directors has
determined that both J.&nbsp;M.&nbsp;Greenberg, the committee's chairman, and R.&nbsp;S.&nbsp;Austin are "audit committee financial experts." A copy of the report of the audit committee is on
page&nbsp;22. </FONT></P>

<P><FONT SIZE=2>The
compensation committee, whose members are W.&nbsp;D.&nbsp;Smithburg, chairman, W.&nbsp;M.&nbsp;Daley, W.&nbsp;J.&nbsp;Farrell, H.&nbsp;L.&nbsp;Fuller,
J.&nbsp;M.&nbsp;Greenberg, and B.&nbsp;Powell&nbsp;Jr., held two meetings in 2005. The committee is governed by a written charter. This committee assists the board of directors in carrying out
the responsibilities of the board relating to the compensation of Abbott's executive officers and directors by discharging the responsibilities set forth in its charter. A copy of the report of the
compensation committee is on pages&nbsp;13 and&nbsp;14. </FONT></P>

<P><FONT SIZE=2>The
nominations and governance committee, whose members are H. L. Fuller, chairman, W.&nbsp;J.&nbsp;Farrell, D.&nbsp;A.&nbsp;L.&nbsp;Owen, W.&nbsp;A.&nbsp;Reynolds, and
R.&nbsp;S.&nbsp;Roberts, held four meetings in 2005. The committee is governed by a written charter. This committee assists the board of directors in identifying individuals qualified to become
board members and recommends to the board the nominees for election as directors at the next annual meeting of shareholders,
recommends to the board the persons to be elected as executive officers of Abbott, develops and recommends to the board the corporate </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>9 </FONT></P>

<!-- ZEQ.=1,SEQ=13,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=511886,FOLIO='9',FILE='DISK132:[06CHI1.06CHI1111]DK1111A.;13',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_dk1111_1_10"> </A>
<BR>

<P><FONT SIZE=2>
governance guidelines applicable to Abbott, and serves in an advisory capacity to the board and the chairman of the board on matters of organization, management succession plans, major changes in the
organizational structure of Abbott, and the conduct of board activities. The process used by this committee to identify a nominee depends on the qualities being sought. Board members should have
backgrounds that when combined provide a portfolio of experience and knowledge that will serve Abbott's governance and strategic needs. Board candidates will be considered on the basis of a range of
criteria, including broad-based business knowledge and relationships, prominence and excellent reputations in their primary fields of endeavor, as well as a global business perspective and commitment
to good corporate citizenship. Directors should have demonstrated experience and ability that is relevant to the board of directors' oversight role with respect to Abbott's business and affairs. </FONT></P>

<P><FONT SIZE=2>The
public policy committee, whose members are W.&nbsp;A.&nbsp;Reynolds, chair, R.&nbsp;S.&nbsp;Austin, W.&nbsp;M.&nbsp;Daley, B.&nbsp;Powell&nbsp;Jr., R.&nbsp;S.&nbsp;Roberts, and
J.&nbsp;R.&nbsp;Walter, held two meetings in 2005. The committee is governed by a written charter. This committee assists the board of directors in fulfilling its oversight responsibility with
respect to Abbott's public policy, certain areas of legal and regulatory compliance, and governmental affairs and healthcare compliance issues that affect Abbott by discharging the responsibilities
set forth in its charter.  </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Communicating with the Board of Directors  </B></FONT></P>

<P><FONT SIZE=2>You
may communicate with the board of directors by writing a letter to the chairman of the board, to the chairman of the nominations and governance committee, who acts as the lead director at the
meetings of the independent directors, or to the independent directors c/o Abbott Laboratories, 100&nbsp;Abbott Park&nbsp;Road, D-364, AP6D, Abbott Park,
Illinois&nbsp;60064-6400 Attention: corporate secretary. The general counsel and corporate secretary will regularly forward to the addressee all letters other than mass mailings,
advertisements, and other materials not relevant to Abbott's business.  </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Corporate Governance Materials  </B></FONT></P>

<P><FONT SIZE=2>Abbott's
corporate governance guidelines, outline of directorship qualifications, code of business conduct and the charters of Abbott's audit committee, compensation committee, nominations and
governance committee, and public policy committee are all available in the corporate governance section of Abbott's investor relations Web Site
(</FONT><FONT SIZE=2><I>www.abbottinvestor.com</I></FONT><FONT SIZE=2>) or by sending a request for a paper copy to: Abbott Laboratories, 100&nbsp;Abbott Park Road, Dept.&nbsp;383, AP6D2,
Abbott&nbsp;Park, Illinois&nbsp;60064-6400, attn. Investor Relations. </FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>10</FONT></P>

<!-- ZEQ.=2,SEQ=14,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=630384,FOLIO='10',FILE='DISK132:[06CHI1.06CHI1111]DK1111A.;13',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<BR>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_dm1111_1_11"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Compensation of Directors  </B></FONT></P>

<P><FONT SIZE=2>Abbott
employees are not compensated for serving on the board or board committees. Abbott's non-employee directors are compensated for their service under the Abbott Laboratories
Non-Employee Directors' Fee Plan and the Abbott Laboratories 1996 Incentive Stock Program. </FONT></P>

<P><FONT SIZE=2>Under
the Abbott Laboratories Non-Employee Directors' Fee Plan, non-employee directors earn $6,667 for each month of service as director and $1,000 for each month of service as
a chairman of a board committee. In recognition of the increasing demands on the chairman and members of the audit committee, the Board has amended the Plan. Effective as of the 2006 Annual Meeting,
the chairman of the audit committee will receive $1,500 for each month of service as a chairman of that committee and the other members of the audit committee will receive $500 for each month of
service as a committee member. </FONT></P>

<P><FONT SIZE=2>Fees
earned under the Abbott Laboratories Non-Employee Directors' Fee Plan are paid in cash to the director, paid in the form of non-qualified stock options (based on an
independent appraisal of their fair market value), or deferred (as a non-funded obligation of Abbott or paid into a grantor trust established by the director) until payments commence
(generally at age 65 or upon retirement from the board of directors). The director may elect to have deferred fees credited to either a guaranteed interest account at the prime rate plus
2.25&nbsp;percent or to a stock equivalent account that earns the same return as if the fees were invested in Abbott stock. If necessary, Abbott contributes funds to a director's trust so that as of
year-end the stock equivalent account balance (net of taxes) is not less than seventy-five percent of the value of Abbott common stock. Abbott pays the director for any tax
owed on the income earned by the trust or any supplemental contribution to the trust by Abbott. </FONT></P>

<P><FONT SIZE=2>The
Abbott Laboratories 1996 Incentive Stock Program provides that each non-employee director elected to the board of directors at the annual shareholder meeting receives restricted stock
units covering a number of Abbott common shares having a fair market value on the date of the award closest to, but not exceeding $90,000. In 2005, this was 1,889 shares. The non-employee
directors receive cash payments equal to the dividends paid on the Abbott shares covered by the units. Upon termination, retirement from the board, death, or a change in control of Abbott, a
non-employee director will receive one Abbott common share for each restricted stock unit. </FONT></P>

<P><FONT SIZE=2>Abbott's
non-employee directors are eligible to participate in Abbott's charitable matching grant program, which matches the director's contributions (up to $25,000 annually) to IRS
recognized charities. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>11</FONT></P>

<!-- ZEQ.=1,SEQ=15,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=997959,FOLIO='11',FILE='DISK132:[06CHI1.06CHI1111]DM1111A.;8',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_do1111_1_12"> </A> </FONT></P>

<HR NOSHADE SIZE=8>


<P><FONT COLOR="#2B85FF" SIZE=2><B>Security Ownership of Executive Officers and Directors  </B></FONT></P>

<P><FONT SIZE=2>The
table below reflects the number of common shares beneficially owned by each director, by the chief executive officer and the four other most highly paid executive officers (the "named officers"),
and by all directors and executive officers of Abbott as a group as of February&nbsp;7, 2006. It also reflects the number of stock equivalent units and restricted stock units held by
non-employee directors under the Abbott Laboratories Non-Employee Directors' Fee&nbsp;Plan. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH COLSPAN=5 ALIGN="CENTER"><HR NOSHADE></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH WIDTH="70%" ALIGN="LEFT"><FONT SIZE=1>Name</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="14%" ALIGN="CENTER"><FONT SIZE=1>Shares<BR>
Beneficially<BR>
Owned,<BR>
Excluding<BR>
Options (1)(2)(3)</FONT><BR></TH>
<TH WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="9%" ALIGN="CENTER"><FONT SIZE=1>Stock<BR>
Equivalent<BR>
Units</FONT><BR></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=5 ALIGN="CENTER"><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Roxanne S. Austin</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>8,733</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>William M. Daley</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>5,389</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>2,124</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>William G. Dempsey</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>134,642</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>W. James Farrell</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>1,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Thomas C. Freyman</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>211,515</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>H. Laurance Fuller</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>36,523</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>46,412</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Richard A. Gonzalez</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>328,909</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Jack M. Greenberg</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>8,733</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Jeffrey M. Leiden, M.D. Ph.D.</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>309,980</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>The Lord Owen CH</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>16,338</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>5,896</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Boone Powell Jr.</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>35,116</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>79,177</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>W. Ann Reynolds, Ph.D.</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>37,250</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>73,364</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Roy S. Roberts</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>13,381</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>1,395</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>William D. Smithburg</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>55,205</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>112,346</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>John R. Walter</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>29,465</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>29,909</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>Miles D. White</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>655,887</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="70%"><FONT SIZE=1>All directors and executive officers as a group&nbsp;(4)(5)</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="14%" ALIGN="RIGHT"><FONT SIZE=1>2,638,248</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>350,623</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>The
table excludes unexercised option shares which are exercisable within 60&nbsp;days after February&nbsp;7, 2006, as follows: R.&nbsp;S.&nbsp;Austin,&nbsp;6,668;
W.&nbsp;G.&nbsp;Dempsey, 623,460; T.&nbsp;C.&nbsp;Freyman, 478,098; H.&nbsp;L.&nbsp;Fuller,&nbsp;56,440; R.&nbsp;A.&nbsp;Gonzalez, 1,799,062;
J.&nbsp;M.&nbsp;Greenberg,&nbsp;16,857; J.&nbsp;M.&nbsp;Leiden,&nbsp;1,587,319; D.&nbsp;A.&nbsp;L.&nbsp;Owen,&nbsp;31,243; W.&nbsp;A.&nbsp;Reynolds,&nbsp;51,372;
R.&nbsp;S.&nbsp;Roberts,&nbsp;35,660; W.&nbsp;D.&nbsp;Smithburg,&nbsp;35,324; J.&nbsp;R.&nbsp;Walter, 45,860; M.&nbsp;D.&nbsp;White,&nbsp;3,604,969; and all directors and
executive officers as a group, 10,580,610.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>The
table includes the shares held in the officers' accounts in the Abbott Laboratories Stock Retirement Trust as follows: W.&nbsp;G.&nbsp;Dempsey,&nbsp;10,310;
T.&nbsp;C.&nbsp;Freyman,&nbsp;17,895; R.&nbsp;A.&nbsp;Gonzalez,&nbsp;17,381; J.&nbsp;M.&nbsp;Leiden,&nbsp;631; M.&nbsp;D.&nbsp;White,&nbsp;15,699; and, all executive officers
as a group, 128,916. Each officer has shared voting power and sole investment power with respect to the shares held in his account.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>The
table includes restricted stock units held by the non-employee directors and payable in stock upon their retirement from the board, as follows:
R.&nbsp;S.&nbsp;Austin,&nbsp;1,889; W.&nbsp;M.&nbsp;Daley,&nbsp;1,889; H.&nbsp;L.&nbsp;Fuller,&nbsp;1,889; J.&nbsp;M.&nbsp;Greenberg,&nbsp;1,889;
D.&nbsp;A.&nbsp;L.&nbsp;Owen,&nbsp;1,889; B.&nbsp;Powell&nbsp;Jr.,&nbsp;1,889; W.&nbsp;A.&nbsp;Reynolds,&nbsp;1,889; R.&nbsp;S.&nbsp;Roberts,&nbsp;1,889;
W.&nbsp;D.&nbsp;Smithburg,&nbsp;1,889; and J.&nbsp;R.&nbsp;Walter,&nbsp;1,889; and all directors as a group,&nbsp;18,890.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD><FONT SIZE=2>T.
C. Freyman and certain other executive officers of Abbott are fiduciaries of several employee benefit trusts maintained by Abbott. As such, they have shared voting and/or
investment power with respect to the common shares held by those trusts. The table does not include the shares held by the trusts. As of February&nbsp;7, 2006, these trusts owned a total of
61,532,697 (4.0%) of the outstanding shares of Abbott.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD><FONT SIZE=2>Excluding
the shared voting and/or investment power over the shares held by the trusts described in footnote 4, the directors and executive officers as a group together own
beneficially less than one percent of the outstanding shares of Abbott. </FONT>
<BR><BR>
</DD></DL>
<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>12</FONT></P>

<!-- ZEQ.=1,SEQ=16,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=590717,FOLIO='12',FILE='DISK132:[06CHI1.06CHI1111]DO1111A.;66',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_dq1111_1_13"> </A> </FONT></P>

<HR NOSHADE SIZE=6>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Executive Compensation  </B></FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Report of the Compensation Committee  </B></FONT></P>

<P><FONT SIZE=2>
The Compensation Committee of the Board of Directors is composed entirely of directors who have never been employees of the corporation and who satisfy the independence requirements of the New York
Stock Exchange, Rule&nbsp;16b-3 of the Securities Exchange Act of 1934, as amended, and Section 162(m) of the Internal Revenue Code of 1986, as amended. The committee is responsible for oversight of
the Company's executive officer and director compensation policies and programs, setting its executive officer compensation philosophy and specifically, reviewing, setting and administering the
compensation of Abbott's Chief Executive Officer, and other executive officers and directors. The Committee reviews relative health care and select high performing company market data provided by an
independent outside consultant when considering programs that govern director and executive officer annual compensation, long-term incentives and stock ownership programs. </FONT></P>

<P><FONT SIZE=2>The
foundation of the executive compensation program is based on principles designed to help align the corporation's business strategy, values and management initiatives with shareholder interests.
The Committee annually reviews and approves corporate goals and objectives relevant to the compensation of the Chief Executive Officer and other executive officers. The Committee evaluates performance
in light of those goals and objectives as well as performance against certain non-financial goals including development of management talent and other strategic business objectives. </FONT></P>

<P><FONT SIZE=2>The
Committee sets the Chief Executive Officer's and other executive officers' compensation based on that evaluation, advice from the Committee's independent compensation consultant, performance
relative to its health care and high performing company peer groups and shareholder return. </FONT></P>

<P><FONT SIZE=2>The
Company's compensation program: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2>&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2>Integrates compensation programs which link total shareholder return with both the corporation's annual and long-term strategic planning and measurement processes.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2><BR>
&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
Supports a performance-oriented environment that rewards actual performance that is related to both goals and performance of the corporation as compared to that of industry performance levels.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="3%"><FONT SIZE=2><BR>
&#149;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="95%"><FONT SIZE=2><BR>
Helps attract and retain key executives who are critical to the long-term success of the corporation.</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2>The key components of the Company's total compensation program are base salary, annual incentive awards, and long-term incentive awards comprised of various forms of equity
awards. These components are administered with the goal of providing total compensation that is competitive in the marketplace, recognizes meaningful differences in individual performance, and varies
the opportunity based on individual and corporate performance. In determining the long-term incentive component of the Chief Executive Officer's and other executive officers' compensation, the
Committee considers the Company's performance and relative shareholder return, the component mix and value of similar incentive awards to executives at comparable companies, and the awards given to
the Chief Executive Officer and other executive officers in past years. </FONT></P>

<P><FONT SIZE=2>The
marketplace is defined by comparing the corporation's pay practices to a group of twenty-four major corporations with similar characteristics, including ten within the health care industry and
eight which are also included in the Standard and Poor's Health Care-500. A select group of high performing non-health care companies, who are defined as having a five year compounded return on equity
(ROE) of 18% or higher and chosen for size and comparability to the corporation, is used as a secondary source of comparison. Using compensation survey data from the comparison groups, a range for
total compensation and each of its elements - base, annual incentive and long-term equity-based compensation - is established. The intent is to deliver competitive total compensation that varies with
the corporation's relative performance. To achieve this objective, a substantial portion of executive pay is delivered through performance-related variable compensation programs, which are based upon
achievement of specific corporate and individual performance goals. Each year the Committee reviews the elements of executive compensation to ensure that the total compensation program, and each of
its elements, meets the overall objectives discussed above. </FONT></P>

<P><FONT SIZE=2>In
2005, total compensation was paid to executives based on individual performance and on the extent to which the business plans for the corporation and their areas of responsibility were achieved or
exceeded. Specifically, for 2005 the Company met or exceeded all of its financial goals and delivered five-year total shareholder returns that were superior to the average of the companies in Abbott's
health care peer group. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>13</FONT></P>

<!-- ZEQ.=1,SEQ=17,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=772092,FOLIO='13',FILE='DISK132:[06CHI1.06CHI1111]DQ1111A.;37',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<A NAME="page_dq1111_1_14"> </A>
<BR>

<P><FONT SIZE=2>The
Abbott Performance Incentive Plan (PIP), which limits participation to Senior Officers of Abbott and its subsidiaries and complies with the performance requirements of Section 162(m) of the
Internal Revenue Code of 1986; and the Management Incentive Plan (MIP), in which the other officers of the Company participate, are annual incentive plans designed to reward executives when the
Company achieves certain financial objectives and when each executive's area of responsibility meets its predetermined goals. These goals include specific financial targets related to
consolidated net earnings, profitability, total sales and earnings per share. While many aspects of performance can be measured in these financial terms, the Committee also evaluates the success of
the management team in areas of performance that cannot be measured by traditional accounting tools, including the development and execution of strategic plans, the development of management and
employees, including Abbott's diversity initiative and the exercise of leadership within the industry and in the communities that Abbott serves. All of these factors are collectively taken into
account by management and the Committee when determining the appropriate level of annual incentive awards. </FONT></P>

<P><FONT SIZE=2>Each
year, individual base award allocations establish the maximum annual bonus awards for PIP participants as a percentage of consolidated net earnings. Actual awards paid to PIP participants have
historically been below their maximums. </FONT></P>

<P><FONT SIZE=2>Each
year, individual incentive targets are established for MIP participants based on competitive survey data from the group of companies discussed above. Under the MIP, 40% of a participant's target
incentive award is attributable to corporate performance relative to its Earnings Per Share target. The remainder of the incentive award is based on the Committee's overall assessment of each
participant's achievement of the predetermined financial and strategic performance goals discussed above. As noted above, awards are paid at levels commensurate with Company and individual performance
and relative to peer group companies. </FONT></P>

<P><FONT SIZE=2>For
2005, the corporation achieved or exceeded its predetermined financial goals. As a result, each PIP participant's final award allocation and each MIP participant's incentive award were based on
the corporation's financial goal achievement and the committee's overall assessment of each participant's achievement of the predetermined goals discussed above. </FONT></P>

<P><FONT SIZE=2>To
motivate and reward its executives and managers and to directly align key employee and shareholder interests, the corporation has provided long-term incentives in the form of equity participation
for many years. Grants of stock options, replacement stock options, restricted stock units and restricted stock awards are important parts of this relationship. To ensure this objective is achieved,
executives follow fixed stock ownership guidelines. </FONT></P>

<P><FONT SIZE=2>Targeted
ranges and form of equity awards are determined taking into account competitive practice among the comparison companies noted above. Equity participation targets are set based on established
salary ranges and may vary based on each executive's performance as determined by the Committee. As noted above, the target ranges and mix of equity awards are established such that equity awards are
appropriately delivered and scaled to the performance of the company within its peer group. Based on its analysis of the competitive equity marketplace and upon the recommendation of its independent
compensation consultant, the Committee has determined that the annual equity award should consist of both stock options and restricted stock awards. For 2005, the equity award component mix was 70%
stock options and 30% restricted stock. </FONT></P>

<P><FONT SIZE=2>The
Committee also believes it is critical to periodically award restricted stock as a vehicle to retain key management talent. These stock awards are generally restricted for a 5-year period. The
last such retention award was in 2002. </FONT></P>

<P><FONT SIZE=2>Mr.&nbsp;White
met or exceeded all strategic and financial goals for 2005. The Company's performance for 2005 as described above and as reflected in the Corporation's financial statements included
strong growth in sales, earnings, stock price performance and shareholder returns that were superior to the average of the companies in Abbott's health care peer group. Therefore, in
February&nbsp;2006, the Committee awarded Mr.&nbsp;White a bonus of $2,650,000. </FONT></P>

<P><FONT SIZE=2>Other
2005 compensation, recommended and approved as appropriate by the Committee and Board of Directors in February&nbsp;2005, included a base salary increase of 3.5% to $1,614,600, a 440,800 share
stock option grant and a 63,800 share restricted stock award. </FONT></P>

<P><FONT SIZE=2>It
is the Committee's policy to establish and maintain compensation programs for executive officers, which operate, in the best interests of the corporation and its stockholders in achieving the
corporation's long-term business objectives. To that end, the committee continues to assess the impact of the Omnibus Budget Reconciliation Act of 1993 on its executive compensation strategy and takes
action to assure that appropriate levels of deductibility are maintained. </FONT></P>

<P><FONT SIZE=2><I><U>Compensation Committee</U>  </I></FONT></P>

<P><FONT SIZE=2>W.&nbsp;D.&nbsp;Smithburg, chairman, W.&nbsp;M.&nbsp;Daley, W.&nbsp;J.&nbsp;Farrell, H.&nbsp;L.&nbsp;Fuller, J.&nbsp;M.&nbsp;Greenberg, and B.&nbsp;Powell
Jr. </FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>14</FONT></P>

<!-- ZEQ.=2,SEQ=18,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=732479,FOLIO='14',FILE='DISK132:[06CHI1.06CHI1111]DQ1111A.;37',USER='ABLIJDE',CD='20-MAR-2006;19:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->


<P><FONT SIZE=2><A
NAME="page_ds1111_1_15"> </A> </FONT></P>

<HR NOSHADE>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Summary Compensation Table  </B></FONT></P>

<P><FONT SIZE=2>
The following table summarizes compensation earned in 2005, 2004 and 2003 by the named officers. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="17%" ALIGN="LEFT"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="4%" ALIGN="LEFT"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER"><FONT SIZE=1>Annual Compensation<BR></FONT>
<HR NOSHADE></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=4 ALIGN="CENTER"><FONT SIZE=1>Long-term Compensation</FONT><HR NOSHADE></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH WIDTH="17%" ALIGN="LEFT"><FONT SIZE=1>Name and<BR>
Principal Position</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="4%" ALIGN="CENTER"><FONT SIZE=1>Year</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1>Salary ($)(1)</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1>Bonus ($)</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1>Other<BR>
Annual<BR>
Compens-<BR>
ation ($)(2)</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1>Restricted<BR>
Stock<BR>
Award(s) ($)(3)</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="9%" ALIGN="CENTER"><FONT SIZE=1>Securities<BR>
Underlying<BR>
Options/<BR>
SARs (#)(4)</FONT><BR></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1>All Other<BR>
Compensa-<BR>
tion ($)(5)</FONT><BR></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=20 ALIGN="CENTER"><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="17%"><FONT SIZE=1>Miles D. White<BR>
Chairman of the Board,<BR>
Chief Executive Officer<BR>
and Director</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>2005<BR>
<BR>
2004<BR>
<BR>
2003</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$<BR><BR><BR><BR></FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,605,990<BR>
<BR>
1,551,846<BR>
<BR>
1,564,961</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$<BR><BR><BR><BR></FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,650,000<BR>
<BR>
2,700,000<BR>
<BR>
1,750,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$<BR><BR><BR><BR></FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>439,387<BR>
<BR>
87,817<BR>
<BR>
84,122</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$<BR><BR><BR><BR></FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>2,960,320<BR>
<BR>
2,401,300<BR>
<BR>
0</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>440,800<BR>
224,097<BR>
404,340<BR>
<BR>
675,674</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=1><BR>(6)<BR><BR><BR></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$<BR><BR><BR><BR></FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>80,300<BR>
<BR>
77,592<BR>
<BR>
78,248</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=20><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="17%"><FONT SIZE=1>Jeffrey M. Leiden, M.D., Ph.D.<BR>
President and Chief<BR>
Operating Officer,<BR>
Pharmaceutical Products<BR>
Group and Director</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>2005<BR>
<BR>
2004<BR>
<BR>
2003</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>905,943<BR>
<BR>
875,385<BR>
<BR>
882,692</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,000,000<BR>
<BR>
1,100,000<BR>
<BR>
970,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>319,449<BR>
<BR>
64,752<BR>
<BR>
70,602</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>2,152,960<BR>
<BR>
1,746,400<BR>
<BR>
0</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>313,200<BR>
19,944<BR>
287,294<BR>
26,124<BR>
478,824</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=1><BR>(6)<BR><BR>(6)<BR></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>45,297<BR>
<BR>
43,769<BR>
<BR>
44,135</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=20><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="17%"><FONT SIZE=1>Richard A. Gonzalez<BR>
President and Chief<BR>
Operating Officer,<BR>
Medical Products Group<BR>
and Director</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>2005<BR>
<BR>
2004<BR>
<BR>
2003</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>905,943<BR>
<BR>
875,385<BR>
<BR>
882,692</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,050,000<BR>
<BR>
1,100,000<BR>
<BR>
885,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>174,218<BR>
<BR>
53,334<BR>
<BR>
50,866</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>2,152,960<BR>
<BR>
1,746,400<BR>
<BR>
0</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>313,200<BR>
41,540<BR>
287,294<BR>
<BR>
478,824<BR>
25,298</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=1><BR>(6)<BR><BR><BR><BR>(6)</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>45,297<BR>
<BR>
43,769<BR>
<BR>
44,135</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=20><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="17%"><FONT SIZE=1>Thomas C. Freyman<BR>
Executive Vice President,<BR>
Finance and Chief Financial<BR>
Officer</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>2005<BR>
<BR>
2004<BR>
<BR>
2003</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>730,288<BR>
<BR>
617,308<BR>
<BR>
585,577</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>825,000<BR>
<BR>
685,000<BR>
<BR>
589,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>19,041<BR>
<BR>
8,318<BR>
<BR>
8,027</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>431,520<BR>
<BR>
349,280<BR>
<BR>
0</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>63,800<BR>
29,290<BR>
58,522<BR>
58,107<BR>
106,404</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=1><BR>(6)<BR><BR>(6)<BR></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>36,514<BR>
<BR>
30,866<BR>
<BR>
29,279</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=20><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="17%"><FONT SIZE=1>William G. Dempsey<BR>
Senior Vice President,<BR>
Pharmaceutical Operations</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>2005<BR>
<BR>
2004<BR>
<BR>
2003</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>591,930<BR>
<BR>
565,769<BR>
<BR>
534,808</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>613,000<BR>
<BR>
567,500<BR>
<BR>
540,500</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>251,112<BR>
<BR>
84,594<BR>
<BR>
73,790</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>431,520<BR>
<BR>
349,280<BR>
<BR>
0</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>63,800<BR>
51,687<BR>
58,522<BR>
35,729<BR>
106,404<BR>
55,556</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=1><BR>(6)<BR><BR>(6)<BR><BR>(6)</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=1>29,597<BR>
<BR>
28,289<BR>
<BR>
26,740</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=20><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>Abbott's
U.S. salaried employees are paid on a bi-weekly pay period schedule. In typical years, such as 2005 and 2004, this results in 26 pay periods. In 2003, the
calendar included an extra pay period for Abbott's U.S. salaried employees resulting in salaries approximately 3.8% higher than a typical year having 26 pay periods.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>These
amounts are paid pursuant to the terms of Abbott Laboratories' deferred compensation arrangements in connection with compensation the officer has earned and elected to have
contributed to such individual trusts as have been established under these arrangements.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>The
number and value of Abbott restricted shares held as of December&nbsp;31, 2005, respectively, were as follows:<BR>
M. D.&nbsp;White - 358,800/$14,147,484;<BR>
J. M. Leiden - 231,400/$9,124,102;<BR>
R. A. Gonzalez - 231,400/$9,124,102;<BR>
T. C. Freyman - 52,300/$2,062,189; and<BR>
W. G. Dempsey - 42,300/$1,667,889. </FONT></DD></DL>
<UL>

<P><FONT SIZE=2>As
the result of the spin-off of Hospira,&nbsp;Inc. to shareholders on April&nbsp;30, 2004, the named officers, along with all other Abbott shareholders, received a special dividend
distribution in the form of shares of Hospira,&nbsp;Inc. The number and value of Hospira restricted shares held as of December&nbsp;31, 2005, respectively, were as follows:<BR>
M. D.&nbsp;White - 29,500/$1,262,010;<BR>
J. M. Leiden - 18,500/$791,430;<BR>
R. A.&nbsp;Gonzalez - 18,500/$791,430;<BR>
T. C. Freyman - 4,300/$183,954; and<BR>
W. G. Dempsey - 3,300/$141,174. </FONT></P>

<P><FONT SIZE=2>These
Hospira shares are subject to the same restrictions as the related Abbott restricted shares held by the officer. The officers receive any dividends paid on these Abbott and Hospira restricted
shares. </FONT></P>

</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD><FONT SIZE=2>The
number of securities that were outstanding on April&nbsp;30, 2004 has been adjusted to reflect the spin-off of Hospira,&nbsp;Inc. on April&nbsp;30, 2004.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD><FONT SIZE=2>These
amounts are employer contributions made to the Stock Retirement Plan and made or accrued with respect to the 401(k) Supplemental Plan.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD><FONT SIZE=2>These
options are replacement stock options. They are described in the table captioned "Options Granted in Last Fiscal Year" on page&nbsp;16. </FONT></DD></DL>
<HR NOSHADE>

<P><FONT SIZE=2>15</FONT></P>

<!-- ZEQ.=1,SEQ=19,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=646524,FOLIO='15',FILE='DISK132:[06CHI1.06CHI1111]DS1111A.;47',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_du1111_1_16"> </A> </FONT></P>

<HR NOSHADE>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Stock Options  </B></FONT></P>

<P><FONT SIZE=2>
The following tables summarize the named officers' stock option activity during 2005. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B><U>Options Granted in Last Fiscal Year</U></B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="LEFT"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=10 ALIGN="CENTER"><FONT SIZE=1><BR>
Individual Grants<BR></FONT>
<HR NOSHADE></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="LEFT"><FONT SIZE=1>Name</FONT><BR></TH>
<TH WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="16%" ALIGN="CENTER"><FONT SIZE=1>Number of Securities<BR>
Underlying Options/<BR>
SARs Granted<BR>
(#)</FONT><BR></TH>
<TH WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="15%" ALIGN="CENTER"><FONT SIZE=1>% of Total Options/<BR>
SARs Granted to<BR>
Employees in<BR>
Fiscal Year</FONT><BR></TH>
<TH WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1>Exercise or<BR>
Base<BR>
Price ($/Sh.)</FONT><BR></TH>
<TH WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="7%" ALIGN="CENTER"><FONT SIZE=1>Expiration<BR>
Date</FONT><BR></TH>
<TH WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="13%" ALIGN="CENTER"><FONT SIZE=1>Grant Date<BR>
Present Value(3)</FONT><BR></TH>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=13><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>Miles D. White</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>440,800</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(1)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>1.7</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.34</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/17/15</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>$5,364,536</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="2%"><FONT SIZE=0>&nbsp;</FONT></TD>
<TD WIDTH="18%"><FONT SIZE=1>Replacement Options:</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>224,097</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.9</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>44.60</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/10/10</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>1,129,449</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=13><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>Jeffrey M. Leiden, M.D., Ph.D.</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>313,200</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(1)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>1.2</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.34</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/17/15</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>3,811,644</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="2%"><FONT SIZE=0>&nbsp;</FONT></TD>
<TD WIDTH="18%"><FONT SIZE=1>Replacement Options:</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>19,944</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.1</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>48.45</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/13/13</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>217,190</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=13><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>Richard A. Gonzalez</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>313,200</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(1)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>1.2</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.34</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/17/15</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>3,811,644</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="2%"><FONT SIZE=0>&nbsp;</FONT></TD>
<TD WIDTH="18%"><FONT SIZE=1>Replacement Options:</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>2,142</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.0</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.65</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/13/07</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>7,390</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>2,142</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.0</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.65</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/10/10</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>17,821</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>37,256</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.1</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.65</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/13/13</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>399,757</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=13><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>Thomas C. Freyman</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>63,800</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(1)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.2</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.34</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/17/15</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>776,446</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="2%"><FONT SIZE=0>&nbsp;</FONT></TD>
<TD WIDTH="18%"><FONT SIZE=1>Replacement Options:</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>29,290</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.1</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.65</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/13/13</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>314,282</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=13><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>William G. Dempsey</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>63,800</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(1)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.2</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>46.34</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/17/15</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>776,446</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="2%"><FONT SIZE=0>&nbsp;</FONT></TD>
<TD WIDTH="18%"><FONT SIZE=1>Replacement Options:</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>28,771</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.1</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>48.29</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/13/13</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>316,481</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="16%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>22,916</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>(2)</FONT></TD>
<TD WIDTH="15%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>0.1</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>%</FONT></TD>
<TD WIDTH="2%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>48.67</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=1>02/13/07</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="13%" ALIGN="RIGHT" VALIGN="TOP"><FONT SIZE=1>79,060</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=13><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>One-third
of the shares covered by these options are exercisable after one year; two-thirds after two years; and all after three years.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>These
options contain a replacement feature. When the option's exercise price is paid (or, in the case of a non-qualified stock option, when the option's exercise price or
the withholding taxes resulting on exercise of that option are paid) with shares of Abbott's common stock, a replacement option is granted for the number of shares used to make that payment. The
replacement option has an exercise price equal to the fair market value of Abbott's common stock on the date the replacement option is granted, is exercisable in full six months after the date of
grant, and has a term expiring on the expiration date of the original option.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>These
values were determined as of the option's grant date using a Black-Scholes stock option valuation model. For options, other than replacement options, the model uses the
following assumptions: expected volatility of 29% (based on the historic volatility of Abbott stock over a period equal to the option's expected life), dividend yield of 2.2%, risk-free
interest of 3.8% (based on the rates for zero-coupon U.S. government issues with a remaining term equal to the option's expected life), and option life of 5.4&nbsp;years. For replacement options,
the model uses the following assumptions: expected volatility ranging between 16% and 28%, dividend yield ranging between 2.3% and 2.5%, risk-free interest ranging between 3.3% and 4.0%,
and an option life equal to 54% of the option's remaining term. </FONT></DD></DL>
<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>16</FONT></P>

<!-- ZEQ.=1,SEQ=20,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=428347,FOLIO='16',FILE='DISK132:[06CHI1.06CHI1111]DU1111A.;52',USER='FSTREET',CD='23-MAR-2006;22:49' -->
<A NAME="page_du1111_1_17"> </A>
<UL>
<P ALIGN="CENTER"><FONT SIZE=2><B><U>Aggregated Option/SAR Exercises in Last Fiscal Year and Year-End Option/SAR Values</U></B></FONT></P>

</UL>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="19%" ALIGN="LEFT"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH WIDTH="12%" ALIGN="LEFT"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="17%" ALIGN="CENTER"><FONT SIZE=1>Number of Securities<BR>
Underlying Unexercised<BR>
Options/SARs at<BR>
Fiscal Year End (#)</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1>Value of Unexercised<BR>
In-the-Money Options/<BR>
SARs at<BR>
Fiscal Year End ($)</FONT><BR></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH WIDTH="19%" ALIGN="LEFT"><BR><FONT SIZE=1>Name</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=1><BR>&nbsp;</FONT></TH>
<TH WIDTH="12%" ALIGN="CENTER"><FONT SIZE=1><BR>
Shares Acquired<BR>
on Exercise (#)</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=1><BR>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1><BR>
Value<BR>
Realized ($)(1)</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=1><BR>&nbsp;</FONT></TH>
<TH WIDTH="17%" ALIGN="CENTER"><FONT SIZE=1><BR>
Exercisable/Unexercisable</FONT><BR></TH>
<TH WIDTH="5%"><FONT SIZE=1><BR>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=1><BR>
Exercisable/Unexercisable</FONT><BR></TH>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=11><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="19%"><FONT SIZE=1>Miles D. White</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>319,358</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=1>3,466,323</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>3,098,030&nbsp;/&nbsp;935,585</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>3,974,775&nbsp;/&nbsp;$1,396,080</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=11><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="19%"><FONT SIZE=1>Jeffrey M. Leiden, M.D., Ph.D.</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>24,629</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=1>374,819</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>1,311,090&nbsp;/&nbsp;664,337</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>1,641,470&nbsp;/&nbsp;989,346</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=11><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="19%"><FONT SIZE=1>Richard A. Gonzalez</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>62,474</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=1>789,456</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>1,455,688&nbsp;/&nbsp;664,337</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>1,729,022&nbsp;/&nbsp;989,346</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=11><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="19%"><FONT SIZE=1>Thomas C. Freyman</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>51,362</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=1>550,291</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>425,081&nbsp;/&nbsp;138,281</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>0&nbsp;/&nbsp;219,846</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=11><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="19%"><FONT SIZE=1>William G. Dempsey</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1>79,025</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=1>830,775</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>547,219&nbsp;/&nbsp;138,281</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="RIGHT"><FONT SIZE=1>20,906&nbsp;/&nbsp;219,846</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=11><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD><FONT SIZE=1>Value
realized is based on the fair market value of Abbott's common shares on the respective dates of exercise, minus the applicable exercise price, and does not necessarily indicate
that the named officer sold shares on that date, at that price, or at all. </FONT></DD></DL>
<HR NOSHADE>

<P><FONT SIZE=2>17</FONT></P>

<!-- ZEQ.=2,SEQ=21,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=873222,FOLIO='17',FILE='DISK132:[06CHI1.06CHI1111]DU1111A.;52',USER='FSTREET',CD='23-MAR-2006;22:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_dw1111_1_18"> </A> </FONT></P>

<HR NOSHADE>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Pension and Retirement Arrangements  </B></FONT></P>

<P><FONT SIZE=2>
Abbott and certain subsidiaries maintain a defined benefit pension plan known as the Abbott Laboratories Annuity Retirement Plan covering most employees in the United States, age&nbsp;21 or older.
Pension benefits are generally based on service and eligible earnings for the 60&nbsp;consecutive months within the final 120&nbsp;months of employment for which eligible earnings were highest.
Pension benefits are partially offset for Social Security benefits. </FONT></P>

<P><FONT SIZE=2>The
following table shows the estimated annual benefits payable to employees upon normal retirement. The amounts shown are computed on a straight life annuity basis without giving effect to Social
Security offsets and include supplemental benefits under a nonqualified supplemental pension plan. </FONT></P>

<P ALIGN="CENTER"><FONT COLOR="#2B85FF" SIZE=2>Pension Plan Table</FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="RIGHT"><HR NOSHADE></TH>
<TH WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER"><FONT SIZE=1>Years of Service</FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%"><FONT SIZE=1>Remuneration</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=1>15</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=1>20</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=1>25</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=1>30</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=1>35</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=2 ALIGN="CENTER"><HR NOSHADE></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=14 ALIGN="RIGHT"><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;500,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>168,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>225,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>262,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>277,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>$</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>277,500</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;750,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>253,125</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>337,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>393,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>416,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>416,250</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>1,000,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>337,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>450,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>525,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>555,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>555,000</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>1,250,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>421,875</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>562,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>656,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>693,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>693,750</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>1,500,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>506,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>675,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>787,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>832,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>832,500</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>1,750,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>590,625</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>787,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>918,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>971,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>971,250</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>2,000,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>675,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>900,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,050,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,110,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,110,000</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>2,250,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>759,375</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,012,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,181,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,248,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,248,750</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>2,500,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>843,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,125,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,312,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,387,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,387,500</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>2,750,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>928,125</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,237,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,443,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,526,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,526,250</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>3,000,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,012,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,350,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,575,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,665,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,665,000</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>3,250,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,096,875</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,462,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,706,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,803,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,803,750</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>3,500,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,181,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,575,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,837,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,942,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,942,500</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>3,750,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,265,625</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,687,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,968,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,081,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,081,250</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>4,000,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,350,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,800,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,100,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,220,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,220,000</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>4,250,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,434,375</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,912,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,231,250</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,358,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,358,750</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1>4,500,000</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>1,518,750</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,025,000</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,362,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,497,500</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="RIGHT"><FONT SIZE=1>2,497,500</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=2 ALIGN="CENTER"><HR NOSHADE></TD>
<TD WIDTH="4%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=14 ALIGN="RIGHT"><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2>The compensation considered in determining the pensions payable to the named officers is the compensation shown in the "Salary" and "Bonus" columns of the
Summary Compensation Table on page&nbsp;15. Pensions accrued under the Annuity Retirement Plan are funded through the Abbott Laboratories Annuity Retirement Trust, established on behalf of all
participants in that plan. </FONT></P>

<P><FONT SIZE=2>The
Annuity Retirement Plan, which covers most Abbott employees in the United States, age&nbsp;21 or older, provides early retirement benefits to all plan participants who reach certain age and
service thresholds. Messrs.&nbsp;White, Gonzalez, Freyman, and Dempsey have reached these age and service thresholds and the corresponding accrued pension benefits provided under the nonqualified
supplemental pension plan have increased accordingly. In addition, the nonqualified supplemental pension plan previously provided that pensions accrued under the plan with present values exceeding
$100,000 were funded through individual trusts established on behalf of the officers who participate in the
plan. In 2005, to conform to the distribution requirements of Internal Revenue Code Section&nbsp;409A and its proposed regulations, the plan was amended to eliminate this funding threshold. Vested
plan benefits accrued through December&nbsp;31, 2005, to the extent not previously funded, were distributed to the participants' individual trusts and included in the participants' income in 2005.
During 2005, the following amounts, less applicable tax withholdings, were deposited in such individual trusts established on behalf of the named officers:
M.&nbsp;D.&nbsp;White,&nbsp;$9,520,948; J.&nbsp;M.&nbsp;Leiden,&nbsp;$693,585; R.&nbsp;A.&nbsp;Gonzalez,&nbsp;$4,988,792; T.&nbsp;C. Freyman, $2,937,223; and W.&nbsp;G. Dempsey,
$1,008,852. As of December&nbsp;31, 2005, the years of service credited under the plan for the named officers were as follows: M.&nbsp;D. White - 21; J.&nbsp;M.&nbsp;Leiden - 5;
R.&nbsp;A.&nbsp;Gonzalez - 25; T.&nbsp;C. Freyman - 26; and W.&nbsp;G.&nbsp;Dempsey - 23. </FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>18</FONT></P>

<!-- ZEQ.=1,SEQ=22,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=920899,FOLIO='18',FILE='DISK132:[06CHI1.06CHI1111]DW1111A.;30',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<A NAME="page_dw1111_1_19"> </A>
<HR NOSHADE>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Key Employee Retention  </B></FONT></P>

<P><FONT SIZE=2>
Abbott has change in control arrangements with its management team, in the form of change in control agreements for Abbott officers and a change in control plan for other key management personnel. The
agreements with the named officers are described below. </FONT></P>

<P><FONT SIZE=2>The
agreements with the named officers continue in effect until December&nbsp;31, 2008, and at the end of each year will automatically be extended through the third year thereafter unless Abbott
notifies the officer that the agreement will not be extended. The agreements also automatically extend for two years following any change in control (as defined in the agreements) that occurs while
they are in effect. The agreements provide that if the officer is terminated other than for specified reasons or if the officer elects to terminate employment under certain circumstances during a
potential change in control (as defined in the agreements) or within two years following a change in control of Abbott (including termination by the officer for any reason during the
thirty-day window period which begins six months after the date of a change in control), the officer is entitled to receive a lump sum payment equal to three times the officer's annual
salary and bonus (assuming for this purpose that all target performance goals have been achieved or, if higher, based on the average bonus for the last three years), plus any unpaid bonus owing for
any completed performance period and the pro rata bonus for any current bonus period (based on the highest of the bonus assuming achievement of target performance, the average bonus for the past three
years, or in the case of the unpaid bonus for any completed performance period, the actual bonus earned). The officer will also receive up to three years of additional employee benefits (including
outplacement services and tax and financial counseling for three years and the value of three more years of pension accruals), payment of any excise taxes and other related taxes and payments for
which the officer is responsible as a result of the agreement, and reimbursement of certain legal, tax and audit fees. The agreements also limit the conduct for which awards under Abbott's stock
incentive programs can be terminated and generally permit options to remain exercisable for the remainder of their term. Independent compensation consultants confirm that the level of payments
provided under the agreements is consistent with current market practice. </FONT></P>

<HR NOSHADE>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Related Transactions  </B></FONT></P>

<P><FONT SIZE=2>
In 2005, Abbott entered time-sharing lease agreements with those of its officers who were required by Abbott policy to use corporate aircraft for all air travel when practicable. Under
these agreements for non-business related flights, Abbott leases the aircraft and provides a qualified flight crew to the officer pursuant to federal aviation regulations, and the officer
reimburses Abbott for its cost of the flight, up to the higher of the cost of first-class airfare or the amount calculated for personal use of aircraft under Department of Treasury regulations. The
following amounts were reimbursed by the officers to Abbott under their agreements for flights in 2005: M.&nbsp;D.&nbsp;White,&nbsp;$61,892; J.&nbsp;M.&nbsp;Leiden,&nbsp;$73,061; and
R.&nbsp;A.&nbsp;Gonzalez,&nbsp;$68,257. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>19</FONT></P>

<!-- ZEQ.=2,SEQ=23,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=130108,FOLIO='19',FILE='DISK132:[06CHI1.06CHI1111]DW1111A.;30',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<A NAME="page_dw1111_1_20"> </A>
<HR NOSHADE>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Performance Graph  </B></FONT></P>

<P><FONT SIZE=2>
The following graph compares the change in Abbott's cumulative total shareholder return on its common shares with the Standard&nbsp;&amp; Poor's 500 Index and the Standard&nbsp;&amp; Poor's 500 Health
Care Index. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>
<IMG SRC="g733421.jpg" ALT="PERFORMANCE CHART" WIDTH="670" HEIGHT="462">
  </B></FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>20</FONT></P>

<!-- ZEQ.=3,SEQ=24,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=426727,FOLIO='20',FILE='DISK132:[06CHI1.06CHI1111]DW1111A.;30',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_dy1111_1_21"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Ratification of Deloitte&nbsp;&amp; Touche LLP as Auditors (Item 2 on Proxy Card)  </B></FONT></P>


<P><FONT SIZE=2>Abbott's
bylaws provide that the audit committee shall appoint annually a firm of independent registered public accountants to serve as auditors. In October&nbsp;2005, the audit committee appointed
Deloitte&nbsp;&amp; Touche LLP to act as auditors for 2006. Deloitte&nbsp;&amp; Touche LLP has served as Abbott's auditors since 2002. </FONT></P>

<P><FONT SIZE=2>Although
the audit committee has sole authority to appoint auditors, it would like to know the opinion of the shareholders regarding its appointment of Deloitte&nbsp;&amp; Touche LLP as auditors for
2006. For this reason, shareholders are being asked to ratify this appointment. If the shareholders do not ratify the appointment of Deloitte&nbsp;&amp; Touche LLP as auditors for 2006, the audit
committee will take that fact into consideration, but may, nevertheless, continue to retain Deloitte&nbsp;&amp; Touche LLP. </FONT></P>

<P><FONT SIZE=3><B>The board of directors recommends a vote FOR ratification of the appointment of Deloitte&nbsp;&amp; Touche LLP as auditors for 2006.  </B></FONT></P>

<P><FONT SIZE=2>Representatives of Deloitte&nbsp;&amp; Touche LLP are expected to be present at the Annual Meeting and will be given the opportunity to make a statement if they
desire to do so. They will also be available to respond to appropriate questions. </FONT></P>

<P><FONT SIZE=2><B>Audit Fees and Non-Audit Fees  </B></FONT></P>

<P><FONT SIZE=2>
The following table presents fees for professional audit services by Deloitte&nbsp;&amp; Touche LLP, the member firms of Deloitte Touche Tohmatsu, and their respective affiliates ("the Deloitte
Entities") for the audit of Abbott's annual financial statements for the years ended December&nbsp;31, 2005 and December&nbsp;31, 2004, and fees billed for other services rendered by the Deloitte
Entities during these periods. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="69%" ALIGN="LEFT"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=2>2005</FONT><HR NOSHADE></TH>
<TH WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER"><FONT SIZE=2>2004</FONT><HR NOSHADE></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="69%"><FONT SIZE=2>Audit fees:(1)</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>$</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>11,875,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>$</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>11,257,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="69%"><FONT SIZE=2>Audit related fees:(2)</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>143,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>98,000</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="69%"><FONT SIZE=2>Tax fees:(3)</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>2,563,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>2,588,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="69%"><FONT SIZE=2>All other fees:(4)</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>&#151;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="69%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=2 ALIGN="RIGHT"><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=2 ALIGN="RIGHT"><HR NOSHADE></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="69%"><FONT SIZE=2>Total</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>$</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>14,581,000</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>$</FONT></TD>
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>13,943,000</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>The
Deloitte Entities billed or will bill Abbott for professional services rendered for: the audit of Abbott's annual financial statements, the review of Abbott's financial statements
included in Abbott's quarterly reports, and the audits of Abbott's internal control over financial reporting and management's assessment thereof, statutory and subsidiary audits, the review of
documents filed with the Securities and Exchange Commission, and certain accounting consultations in connection with the audits.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>Audit
related fees include: accounting consultations and audits in connection with proposed acquisitions and divestitures, and consultations related to Abbott's internal control over
financial reporting.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>Tax
fees consist principally of professional services rendered by the Deloitte Entities for tax compliance and tax planning and advice including assistance with tax audits and
appeals, and tax advice related to mergers and acquisitions.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD><FONT SIZE=2>No
fees for other service were incurred in 2005 or 2004. </FONT></DD></DL>


<P><FONT SIZE=2><B>Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of the Independent Auditor  </B></FONT></P>

<P><FONT SIZE=2>
The audit committee has established policies and procedures to pre-approve all audit and permissible non-audit services performed by the Deloitte Entities. </FONT></P>

<P><FONT SIZE=2>Prior
to engagement of the independent registered public accounting firm for the next year's audit, management will submit a schedule of all proposed services expected to be rendered during that year
for each of four categories of services to the audit committee for approval. </FONT></P>

<P><FONT SIZE=2>Prior
to engagement, the audit committee pre-approves these services by category of service. The fees are budgeted and the audit committee requires the independent registered public
accounting firm and management to report actual fees versus the budget periodically by category of service. During the year, circumstances may arise when it may become necessary to engage the
independent registered public accounting firm for additional services not contemplated in the original pre-approval. In those instances, the audit committee requires specific
pre-approval before engaging the independent registered public accounting firm. </FONT></P>

<P><FONT SIZE=2>The
audit committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated must report any pre-approval decisions to
the audit committee at its next scheduled meeting. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>21</FONT></P>

<!-- ZEQ.=1,SEQ=25,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=748746,FOLIO='21',FILE='DISK132:[06CHI1.06CHI1111]DY1111A.;28',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<A NAME="page_dy1111_1_22"> </A>
<BR><BR>
<HR NOSHADE>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Report of the Audit Committee  </B></FONT></P>

<P><FONT SIZE=2>Management
is responsible for Abbott's internal controls and the financial reporting process. The independent registered public accounting firm is responsible for performing an audit of the
consolidated financial statements and expressing an opinion on the conformity of those financial statements with accounting principles generally accepted in the United States of America, as well as
expressing an opinion on (i)&nbsp;management's assessment of the effectiveness of internal control over financial reporting and (ii)&nbsp;the effectiveness of internal control over financial
reporting. The audit committee reviews these processes on behalf of the board of directors. In this context, the committee has reviewed and discussed the audited financial statements contained in the
2005 Annual Report on Form 10-K with Abbott's management and its independent registered public accounting firm. </FONT></P>


<P><FONT SIZE=2>The
committee has discussed with the independent registered public accounting firm the matters required to be discussed by the Statement on Auditing Standards No. 61 </FONT> <FONT SIZE=2><I>(Communication with Audit Committees)</I></FONT><FONT SIZE=2>,
as amended. </FONT></P>

<P><FONT SIZE=2>The
committee has received the written disclosures and the letter from the independent registered public accounting firm required by Independence Standards Board Standard No. 1 </FONT> <FONT SIZE=2><I>(Independence Discussions with Audit Committees)
</I></FONT><FONT SIZE=2>, as amended, and has discussed with the independent registered public accounting firm their
independence. The committee has also considered whether the provision of the services described on page&nbsp;21 under the captions "Audit Fees and Non-Audit Fees" is compatible with maintaining the
independence of the independent registered public accounting firm. </FONT></P>

<P><FONT SIZE=2>Based
on the review and discussions referred to above, the committee recommended to the Board of Directors that the audited financial statements be included in Abbott's Annual Report on Form 10-K for
the year ended December&nbsp;31, 2005 filed with the Securities and Exchange Commission. </FONT></P>

<P><FONT SIZE=2><I><U>Audit Committee</U>  </I></FONT></P>

<P><FONT SIZE=2>
J.&nbsp;M. Greenberg, chairman, R.&nbsp;S. Austin, D.&nbsp;A.&nbsp;L. Owen, W.&nbsp;D.&nbsp;Smithburg and J.&nbsp;R. Walter </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance  </B></FONT></P>

<P><FONT SIZE=2>Abbott
believes that during 2005 its officers and directors complied with all filing requirements under Section&nbsp;16(a) of the Securities Exchange Act of 1934.  </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Shareholder Proposals  </B></FONT></P>

<P><FONT SIZE=2>Three
shareholder proposals have been received. Abbott is advised that the proposals will be presented for action at the Annual Meeting. The proposed resolutions and the statements made in support
thereof are presented below. </FONT></P>

<P><FONT SIZE=3><B>The board of directors recommends that you vote AGAINST the proposals.  </B></FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>22</FONT></P>

<!-- ZEQ.=2,SEQ=26,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=556,FOLIO='22',FILE='DISK132:[06CHI1.06CHI1111]DY1111A.;28',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<BR><BR>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_ea1111_1_23"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Shareholder Proposal on Pay-for-Superior-Performance (Item&nbsp;3 on Proxy Card)  </B></FONT></P>


<P><FONT SIZE=2>The
United Brotherhood of Carpenters Pension Fund, 101&nbsp;Constitution Avenue,&nbsp;N.W., Washington, D.C.&nbsp;20001, owner of 25,400 Abbott common shares, has informed Abbott that it intends
to present the following proposal at the meeting: </FONT></P>

<P><FONT SIZE=2><I>Resolved:</I></FONT><FONT SIZE=2> That the shareholders of Abbott Laboratories ("Company") request that the Board of Director's Executive Compensation Committee establish a
pay-for-superior-performance standard in the Company's executive compensation plan for senior executives ("Plan"), by incorporating the following principles into the Plan: </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>1.</FONT></DT><DD><FONT SIZE=2>The
annual incentive component of the Company's Plan should utilize financial performance criteria that can be benchmarked against peer group performance, and provide that no annual
bonus be awarded based on financial performance criteria unless the Company exceeds the median or mean performance of a disclosed group of peer companies on the selected financial criteria;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>2.</FONT></DT><DD><FONT SIZE=2>The
long-term equity compensation component of the Company's Plan should utilize financial and/or stock price performance criteria that can be benchmarked against peer
group performance, and any options, restricted
shares, or other equity compensation used should be structured so that compensation is received only when Company performance exceeds the median or mean performance of the peer group companies on the
selected financial and stock price performance criteria; and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>3.</FONT></DT><DD><FONT SIZE=2>Plan
disclosure should allow shareholders to monitor the correlation between pay and performance established in the Plan. </FONT></DD></DL>
<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Proponent's Statement in Support of Shareholder Proposal  </B></FONT></P>

<P><FONT SIZE=2>We
feel it is imperative that executive compensation plans for senior executives be designed and implemented to promote long-term corporate value. A critical design feature of a
well-conceived executive compensation plan is a close correlation between the level of pay and the level of corporate performance. We believe the failure to tie executive compensation to
superior corporate performance has fueled the escalation of executive compensation and detracted from the goal of enhancing long-term corporate value. The median increase in CEO total
compensation between 2003 and 2004 was 30.15% for S&amp;P 500 companies, twice the previous year increase of 15.04% according to The Corporate Library's CEO Pay Survey. </FONT></P>

<P><FONT SIZE=2>The
pay-for-performance concept has received considerable attention, yet most executive compensation plans are designed to award significant amounts of compensation for average
or below average peer group performance. Two common and related executive compensation practices have combined to produce pay-for-average-performance and escalating executive
compensation. </FONT></P>

<P><FONT SIZE=2>First,
senior executive total compensation levels are targeted at peer group median levels. Second, the performance criteria and benchmarks in the incentive compensation portions of the plans, which
typically deliver the vast majority of total compensation, are calibrated to deliver a significant portion of the targeted amount. The formula combines generous total compensation targets with less
than demanding performance criteria and benchmarks. </FONT></P>

<P><FONT SIZE=2>We
believe the Company's Plan fails to promote the pay-for-superior-performance principle. Our Proposal offers a straightforward solution: The Compensation Committee should
establish and disclose meaningful performance criteria on which to base annual and long-term incentive senior executive compensation and then set and disclose performance benchmarks to
provide for awards or payouts only when the Company exceeds peer group performance. We believe a plan to reward only superior corporate performance will help moderate executive compensation and focus
senior executives on building sustainable long-term corporate value. </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Board of Directors' Statement in Opposition to the Shareholder Proposal on
Pay-for-Superior-Performance (Item&nbsp;3 on Proxy Card)  </B></FONT></P>

<P><FONT SIZE=2>The
Company supports performance-based compensation for employees. This concept is embedded in the Company's current compensation programs, consisting of fixed-price fair market value stock options
and various performance-based incentive plans. In 2005, over 75% of the total compensation for Section&nbsp;(16)(b) Reporting Officers was performance based in the form of bonuses and
long-term incentive compensation. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>23</FONT></P>

<!-- ZEQ.=1,SEQ=27,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=822417,FOLIO='23',FILE='DISK132:[06CHI1.06CHI1111]EA1111A.;26',USER='GLOPEZA',CD='23-MAR-2006;15:50' -->
<A NAME="page_ea1111_1_24"> </A>

<P><FONT SIZE=2>Fixed-priced
stock options are inherently performance-based, because the exercise or grant price equals the market price of Abbott common stock on the date of grant. Option holders realize no economic
benefit unless Abbott's stock price increases in value subsequent to the grant date. This benefits all shareholders. Similarly, annual awards under the Company's various incentive plans reward
participants only when the Company achieves certain financial objectives, and when pre-defined goals or objectives are met. </FONT></P>

<P><FONT SIZE=2>In
February 2006, further refinements were made to the Company's long-standing performance-based compensation policies, including the adoption of performance requirements for the vesting
of restricted stock awards to officers of the Company. </FONT></P>

<P><FONT SIZE=2>The
board opposes the specific proposals recommended by the proponent. It is in the best interest of shareholders to preserve the flexibility and discretion of the Compensation Committee to design
compensation programs that meet the need to attract and retain critical personnel and to incent those employees to meet the overall objectives of the shareholders. The Company's longstanding
performance-based compensation programs, along with the addition of performance shares in 2006, more than meet the objectives of the proponent's proposal. </FONT></P>


<P><FONT SIZE=3><B>The board of directors recommends that you vote AGAINST the proposal.  </B></FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>24</FONT></P>

<!-- ZEQ.=2,SEQ=28,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=867120,FOLIO='24',FILE='DISK132:[06CHI1.06CHI1111]EA1111A.;26',USER='GLOPEZA',CD='23-MAR-2006;15:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_ee1111_1_25"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Shareholder Proposal on Corporate Political Contributions (Item&nbsp;4 on Proxy Card)  </B></FONT></P>


<P><FONT SIZE=2>Mercy
Investment Program, 205 Avenue&nbsp;C, #10E, New&nbsp;York, New&nbsp;York 10009, owner of 5,450 Abbott common shares, and three other proponents have informed Abbott that they intend to
present the following proposal at the meeting. Abbott will provide the proponents' names and addresses to any shareholder who requests that information and, if provided by the proponent to Abbott, the
number of Abbott common shares held by that proponent. </FONT></P>

<P><FONT SIZE=2><I>Resolved:</I></FONT><FONT SIZE=2> that the shareholders of Abbott Laboratories ("Company") hereby request that our Company provide a report, updated semi-annually,
disclosing our Company's: </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>1.</FONT></DT><DD><FONT SIZE=2>Policies
and procedures for political contributions, both direct and indirect, made with corporate funds.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>2.</FONT></DT><DD><FONT SIZE=2>Monetary
and non-monetary contributions to political candidates, political parties, political committees and other political entities organized and operating under
26&nbsp;USC Sec.&nbsp;527 of the Internal Revenue Code including the following:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>a.</FONT></DT><DD><FONT SIZE=2>An
accounting of our Company's funds contributed to any of the persons or organizations described above;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>b.</FONT></DT><DD><FONT SIZE=2>Identification
of the person or persons in our Company who participated in making the decisions to contribute.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>c.</FONT></DT><DD><FONT SIZE=2>The
internal guidelines or policies, if any, governing our Company's political contributions. </FONT></DD></DL>
</DD></DL>

<P><FONT SIZE=2>This
report shall be presented to the Board of Directors' audit committee or other relevant oversight committee and posted on our Company's website to reduce costs to shareholders. </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Proponent's Statement in Support of Shareholder Proposal  </B></FONT></P>


<P><FONT SIZE=2><I>Supporting Statement</I></FONT></P>

<P><FONT SIZE=2>As
long-term shareholders of Abbott Laboratories, we support policies that apply transparency and accountability to corporate political giving. In our view, such disclosure is consistent
with public policy in regard to public company disclosure. </FONT></P>

<P><FONT SIZE=2>Company
executives exercise wide discretion over the use of corporate resources for political purposes. In 2003-04, the last fully reported election cycle, Abbott contributed at least
$46,000. (The Center for Public Integrity: </FONT><FONT SIZE=2><I>http://www.publicintegrity.org/527/db.aspx?act=main</I></FONT><FONT SIZE=2>) </FONT></P>

<P><FONT SIZE=2>Relying
only on the limited data available from the Federal Election Commission and the Internal Revenue Service, the Center for Public Integrity, a leading campaign finance watchdog organization,
provides an incomplete picture of our Company's political donations. Complete disclosure by our Company is necessary for our Company's Board and shareholders to be able to fully evaluate the political
use of corporate assets. </FONT></P>

<P><FONT SIZE=2>Although
the Bi-Partisan Campaign Reform Act of 2002 prohibits corporate contributions to political parties at the federal level, it allows companies to contribute to independent political
committees, also known as 527s. </FONT></P>

<P><FONT SIZE=2>Absent
a system of accountability, corporate executives will be free to use a company's assets for political objectives that are not shared by and may be inimical to the interests of the company and
its shareholders. There is currently no single source of information that provides the information sought by this resolution. That is why we urge your support for this critical governance reform. </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Board of Directors' Statement in Opposition to the Shareholder Proposal on Corporate
Political Contributions (Item&nbsp;4 on Proxy Card)  </B></FONT></P>

<P><FONT SIZE=2>The
Company's political contributions are reported to the public through official state and federal government Web sites. In the year 2005, Abbott contributed approximately $277,175 to political
candidates, committees or parties. Further, the Company's political contributions, made with corporate funds, will be published in an annual report available on its corporate Web site, </FONT> <FONT SIZE=2><I>www.abbott.com</I></FONT><FONT SIZE=2>.
Abbott's report will cover 2005 corporate contributions to political candidates, political parties, political committees and
organizations operating under 26&nbsp;USC Sec.&nbsp;527 of the Internal Revenue Code. Thus, the proponent's proposal is unnecessary. </FONT></P>

<P><FONT SIZE=2>The
Company's support of political candidates is bipartisan and based upon clear criteria: policy positions that reflect Abbott's interests; representation of geographic areas where Abbott employees
and facilities are located; relevant legislative committee assignments; ability to be elected and need for financial assistance. The Company's participation in the political process on issues of
importance to both patients and to the Company's long-term success is appropriate. </FONT></P>

<P><FONT SIZE=3><B>The board of directors recommends that you vote AGAINST the proposal.  </B></FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>25</FONT></P>

<!-- ZEQ.=1,SEQ=29,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=549593,FOLIO='25',FILE='DISK132:[06CHI1.06CHI1111]EE1111A.;28',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_ek1111_1_26"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Shareholder Proposal on the Roles of Chair and CEO (Item&nbsp;5 on Proxy Card)  </B></FONT></P>


<P><FONT SIZE=2>Catholic
Healthcare West, 185&nbsp;Berry Street, Suite&nbsp;300, San Francisco, California 94107-1739, owner of 400 Abbott common shares, and five other proponents have informed Abbott
that they intend to present the following proposal at the meeting. Abbott will provide the proponents' names and addresses to any shareholder who requests that information and, if provided by the
proponent to Abbott, the number of Abbott common shares held by that proponent. </FONT></P>

<P><FONT SIZE=2><I>Resolved</I></FONT><FONT SIZE=2>: The Shareholders of Abbott Laboratories (the "Company") request the Board of Directors establish a policy of, whenever possible, separating
the roles of Chairman and Chief Executive Officer, so that an independent director who has not served as an executive officer of the Company serves as Chair of the Board of Directors. </FONT></P>


<P><FONT SIZE=2>This
proposal shall not apply to the extent that complying would necessarily breach any contractual obligations in effect at the time of the 2006 shareholder meeting.  </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Proponent's Statement in Support of Shareholder Proposal  </B></FONT></P>

<P><FONT SIZE=2>We
believe in the principle of the separation of the roles of Chairman and Chief Executive Officer. This is a basic element of sound corporate governance practice. In addition, the lack of access to
medicines has created a leadership crisis at our company which a separation of the Chair and CEO would begin to address. </FONT></P>

<P><FONT SIZE=2>We
believe an independent Board Chair&#151;separated from the CEO&#151;is the preferable form of corporate governance. The primary purpose of the Board of Directors is to protect
shareholder's interests by providing independent oversight of management and the CEO. The Board gives strategic direction and guidance to our Company. </FONT></P>

<P><FONT SIZE=2>The
Board will likely accomplish both roles more effectively by separating the roles of Chair and CEO. An independent Chair will enhance investor confidence in our Company and strengthen the integrity
of the Board of Directors. </FONT></P>

<P><FONT SIZE=2>A
number of respected institutions recommend such separation. CalPER's Corporate Core Principles and Guidelines state: "the independence of a majority of the Board is not enough" and that "the
leadership of the board must embrace independence, and it must ultimately change the way in which directors interact with management." </FONT></P>

<P><FONT SIZE=2>An
independent board structure will also help the board address complex policy issues facing our company, foremost among them the crisis in access to pharmaceutical products. </FONT></P>

<P><FONT SIZE=2>Millions
of Americans and others around the world have limited or no access to our company's life-saving medicines. We believe an independent Chair and vigorous Board will bring greater
focus to this ethical imperative, and be better able to forge solutions for shareholders and patients to address this crisis. </FONT></P>


<P><FONT SIZE=2>The
current business model of the pharmaceutical sector is undergoing significant challenges. The industry has generated substantial revenue from American purchasers, who pay higher prices for
medicines than those in other developed countries. Pressure on drug pricing and dependence on this business model may impact our company's long-term value. We believe independent Board
leadership will better position our company to respond to these enduring challenges. </FONT></P>

<P><FONT SIZE=2>A
similar resolution voted on in 2005 was supported by 17.60% of shareholders. </FONT></P>

<P><FONT SIZE=2>In
order to ensure that our Board can provide the proper strategic direction for our Company with independence and accountability, we urge a vote FOR this resolution.  </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Board of Directors' Statement in Opposition to the Shareholder Proposal on the Roles of Chair
and CEO (Item&nbsp;5 on Proxy Card)  </B></FONT></P>

<P><FONT SIZE=2>The
stated premise of the shareholder proponents' proposal that "the lack of access to medicines has created a leadership crisis at our Company" is false. There is no leadership crisis at the Company,
nor is there any connection between the policy issues relating to access to medicines and the Company's governance structure. The Company's governance profile is strong, as explained more fully below. </FONT></P>


<P><FONT SIZE=2>The
Company is committed to expanding access to medicines through a variety of measures, which include both Company-sponsored and industry-sponsored programs to deliver needed medicines to patients
and through advocacy to help patients. The board is aware of and supports the Company's many efforts in addressing the need for access to medicines. The assertion that a governance change would better
address the access issue is unfounded. </FONT></P>

<P><FONT SIZE=2>Abbott's
governance profile ensures that the appropriate level of oversight and independence is applied to all </FONT></P>

<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>26</FONT></P>

<!-- ZEQ.=1,SEQ=30,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=803766,FOLIO='26',FILE='DISK132:[06CHI1.06CHI1111]EK1111A.;56',USER='GLOPEZA',CD='23-MAR-2006;15:51' -->
<A NAME="page_ek1111_1_27"> </A>
<BR>

<P><FONT SIZE=2>
board decisions. Independent directors comprise over three-quarters of the board. The membership of each of the key committees, including Audit, Compensation, Nominations and Governance and Public
Policy consists of only independent directors. A Lead Director has been designated by and from the independent board members. The Lead Director facilitates communications with the board and presides
over regularly conducted executive sessions and sessions where the chairman is not present. </FONT></P>

<P><FONT SIZE=2>As
noted on page&nbsp;9 of this Proxy Statement, it has been and continues to be the role of the Lead Director to review and approve matters, such as agenda items, schedule sufficiency, and, where
appropriate, information provided to other board members. </FONT></P>

<P><FONT SIZE=2>The
Company also has established independence standards, governance guidelines and a published procedure enabling shareholders and other third parties to communicate directly with board members. This
information is posted and available on the Company Web site, </FONT><FONT SIZE=2><I>www.abbott.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P><FONT SIZE=2>There
is no reason to alter the current governance profile of the Company. The current structure, in which the offices of chairman and chief executive officer are held by one individual, supports the
board's exercise of its oversight responsibilities and is in the best interests of the Company and its shareholders. </FONT></P>

<P><FONT SIZE=4><B>The board of directors recommends that you vote AGAINST the proposal.  </B></FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Other Matters  </B></FONT></P>

<P><FONT SIZE=2>
As described more fully in the 2005 proxy statement, Abbott settled three sets of shareholder derivative actions during 2005. As required by its articles of incorporation, Abbott advanced defense
costs on behalf of the present and former directors named in these suits. </FONT></P>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Date for Receipt of Shareholder Proposals for the 2007 Annual Meeting Proxy Statement  </B></FONT></P>

<P><FONT SIZE=2>
Shareholder proposals for presentation at the 2007 Annual Meeting must be received by Abbott no later than November&nbsp;16, 2006 and must otherwise comply with the applicable requirements of the
Securities and Exchange Commission to be considered for inclusion in the proxy statement and proxy for the 2007 meeting. </FONT></P>

<HR NOSHADE>

<P><FONT SIZE=2>27</FONT></P>

<!-- ZEQ.=2,SEQ=31,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=381897,FOLIO='27',FILE='DISK132:[06CHI1.06CHI1111]EK1111A.;56',USER='GLOPEZA',CD='23-MAR-2006;15:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_eo1111_1_28"> </A> </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>Procedure for Recommendation and Nomination of Directors and Transaction of Business at Annual Meeting  </B></FONT></P>


<P><FONT SIZE=2>A
shareholder may recommend persons as potential nominees for director by submitting the names of such persons in writing to the chairman of the nominations and governance committee or the secretary
of Abbott. Recommendations should be accompanied by a statement of qualifications and confirmation of the person's willingness to serve. A nominee who is recommended by a shareholder following these
procedures will receive the same consideration as other comparably qualified nominees. </FONT></P>

<P><FONT SIZE=2>A
shareholder entitled to vote for the election of directors at an Annual Meeting and who is a shareholder of record on: </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>the
record date for that Annual Meeting,
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>the
date the shareholder provides timely notice to Abbott, and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>the
date of the Annual Meeting, </FONT></DD></DL>
<BR>

<P><FONT SIZE=2>may
directly nominate persons for director by providing proper timely written notice to the secretary of Abbott. </FONT></P>

<P><FONT SIZE=2>That
notice must include the name, age, business address, residence address and principal occupation or employment of the nominee, the class and number of shares of Abbott owned by the nominee and any
other information relating to the nominee that is required to be disclosed in solicitations for proxies pursuant to the Securities Exchange Act. In addition, the notice must include the name and
record address of the nominating shareholder and the class and number of shares of Abbott owned by the nominating shareholder. </FONT></P>

<P><FONT SIZE=2>A
shareholder of record on the record date for an Annual Meeting of Shareholders, the date the shareholder provides timely notice to Abbott and on the date of the Annual Meeting of Shareholders may
properly bring business before the Annual Meeting by providing timely written notice to the secretary of Abbott. For each matter the shareholder proposes to bring before the Annual Meeting, the notice
must include a brief description of the business to be discussed, the reasons for conducting such business at the Annual Meeting, the name and record address of the shareholder proposing such
business, the class and number of shares of Abbott owned by the shareholder and any material interest of the shareholder in such business. </FONT></P>

<P><FONT SIZE=2>To
be timely, written notice either to directly nominate persons for director or to bring business properly before the Annual Meeting must be received at Abbott's principal executive offices not less
than ninety days and not more than one hundred twenty days prior to the anniversary date of the preceding Annual Meeting. If the Annual Meeting is called for a date that is not within twenty five days
before or after such anniversary date, notice by the shareholder must be received not later than the close of business on the tenth day following the day on which such notice of the date of the Annual
Meeting was mailed or made public in a press release or in a filing with the Securities and Exchange Commission, whichever occurs first. </FONT></P>

<HR NOSHADE SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>General  </B></FONT></P>

<P><FONT SIZE=2>It
is important that proxies be returned promptly. Shareholders are urged, regardless of the number of shares owned, to vote their shares. Most of Abbott's shareholders may vote their shares by
telephone or the Internet. Shareholders who wish to vote by mail should sign and return their proxy card in the enclosed business reply envelope. Shareholders who vote by telephone or the Internet do
not need to return their proxy card. </FONT></P>

<P><FONT SIZE=2>The
Annual Meeting will be held at Abbott's headquarters, 100&nbsp;Abbott Park Road, located at the intersection of Route&nbsp;137 and Waukegan Road, Lake County, Illinois. Admission to the
meeting will be by admission card only. A shareholder planning to attend the meeting should promptly complete and return the reservation form. Reservation forms must be received before
April&nbsp;21, 2006. An admission card admits only one person. </FONT></P>

<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>

<P><FONT SIZE=2>By
order of the board of directors. </FONT></P>

<P><FONT SIZE=2>LAURA&nbsp;J.
SCHUMACHER<BR></FONT> <FONT SIZE=2>SECRETARY </FONT></P>

</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>28</FONT></P>

<!-- ZEQ.=1,SEQ=32,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=257458,FOLIO='28',FILE='DISK132:[06CHI1.06CHI1111]EO1111A.;13',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="page_ha1111_1_1"> </A> </FONT> <FONT SIZE=2><B>EXHIBIT&nbsp;A  </B></FONT></P>

<HR NOSHADE ALIGN="LEFT" WIDTH="261" SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>DIRECTOR INDEPENDENCE STANDARD  </B></FONT></P>

<P><FONT SIZE=2>No
director qualifies as "independent" unless the Board affirmatively determines that the director has no material relationship with Abbott or its subsidiaries (either directly or as a partner,
shareholder or officer of an organization that has a relationship with Abbott or any of its subsidiaries). In making this determination, the Board shall consider all relevant facts and circumstances,
including the following standards: </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>A
director is not independent if the director is, or has been within the last three years, an employee of Abbott or its subsidiaries, or an immediate family member is, or
has been within the last three years, an executive officer of Abbott or its subsidiaries.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>A
director is not independent if the director has received, or has an immediate family member who has received, during any twelve-month period within the last three years,
more than $100,000 in direct compensation from Abbott or its subsidiaries, other than director and committee fees and pension or other forms of deferred compensation for prior service (provided such
compensation is not contingent in any way on continued service), and
other than amounts received by an immediate family member for service as an employee (other than an executive officer).
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>A
director is not independent if (A)&nbsp;the director or an immediate family member is a current partner of a firm that is Abbott's internal or external auditor;
(B)&nbsp;the director is a current employee of such a firm; (C)&nbsp;the director has an immediate family member who is a current employee of such a firm and who participates in the firm's audit,
assurance or tax compliance (but not tax planning) practice; or (D)&nbsp;the director or an immediate family member was within the last three years (but is no longer) a partner or employee of such a
firm and personally worked on Abbott or its subsidiaries' audit within that time.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>A
director is not independent if the director or an immediate family member is, or has been within the last three years, employed as an executive officer of another company
where any of the present executive officers of Abbott or its subsidiaries at the same time serves or served on that company's compensation committee.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>A
director is not independent if the director is a current employee, or an immediate family member is a current executive officer, of a company that has made payments to, or
received payments from, Abbott or its subsidiaries for property or services in an amount which, in any of the last three fiscal years, exceeds the greater of $1&nbsp;million, or 2% of such other
company's consolidated gross revenues.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>A
director is not independent if the director is an executive officer of a charitable organization that received charitable contributions (other than matching contributions)
from Abbott and its subsidiaries in the preceding fiscal year that are in excess of the greater of $1&nbsp;million or 2% of such charitable organization's consolidated gross revenues. </FONT></DD></DL>
<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>A-1</FONT></P>

<!-- ZEQ.=1,SEQ=33,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=968276,FOLIO='A-1',FILE='DISK132:[06CHI1.06CHI1111]HA1111A.;31',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="page_hc1111_1_1"> </A> </FONT> <FONT SIZE=2><B>EXHIBIT&nbsp;B  </B></FONT></P>

<HR NOSHADE ALIGN="LEFT" WIDTH="261" SIZE=8>

<P><FONT COLOR="#2B85FF" SIZE=2><B>AUDIT COMMITTEE CHARTER  </B></FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>1.</FONT></DT><DD><FONT SIZE=2><I><U>Purpose</U></I></FONT><FONT SIZE=2>. The Audit Committee of the Board of Directors shall assist the Board in fulfilling its oversight
responsibility with respect to:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Abbott's
accounting and financial reporting practices and the audit process;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>the
quality and integrity of Abbott's financial statements;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>the
independent auditors' qualifications, independence, and performance;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>the
performance of Abbott's internal audit function and internal auditors; and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>legal
and regulatory compliance (recognizing that other board committees assist the Board of Directors in reviewing certain areas of legal and regulatory compliance); </FONT></DD></DL>
</DD></DL>
<UL>

<P><FONT SIZE=2>and
shall prepare the report required by the rules of the Securities and Exchange Commission to be included in Abbott's annual proxy statement. </FONT></P>

</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>2.</FONT></DT><DD><FONT SIZE=2><I><U>Organization</U></I></FONT><FONT SIZE=2>. The Audit Committee shall be composed of at least three (3) directors. Each member must
satisfy the independence and financial literacy requirements of the New York Stock Exchange, Section&nbsp;10A of the Securities Exchange Act of 1934, the rules under Section&nbsp;10A (which rules
shall be deemed included in any reference in this charter to Section&nbsp;10A of the Exchange Act), and this charter, as such requirements are interpreted by the Board in its business judgment. At
least one member of the Audit Committee shall have accounting or related financial management expertise. Director's fees are the only compensation an Audit Committee member may receive from Abbott. No
member of the Audit Committee may serve simultaneously on the audit committee of more than three public companies. Abbott's Board shall appoint, and may remove, members of the Audit Committee and the
Committee's Chairman, acting on the recommendation of Abbott's Nominations and Governance Committee.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>3.</FONT></DT><DD><FONT SIZE=2><I><U>Authority and Responsibilities</U></I></FONT><FONT SIZE=2>. The Audit Committee is directly responsible for the appointment,
termination, compensation, and oversight of the work of Abbott's independent auditors (including the resolution of disagreements between management and the independent auditors regarding financial
reporting) for the purpose of preparing or issuing an audit report or related work. It shall report regularly to the Board. </FONT></DD></DL>
<UL>

<P><FONT SIZE=2>Abbott's
independent auditors shall report directly to the Audit Committee. Abbott's internal auditors shall be ultimately accountable to the Audit Committee and the Board of Directors. The Audit
Committee shall preapprove all permissible non-audit services and all audit, review or attest engagements required under the securities laws to be rendered by the independent auditors.
Alternatively, Abbott may enter into engagements to render such services pursuant to pre-approval policies and procedures established by the Audit Committee; provided, that such polices
and procedures are detailed as to the particular service, the Audit Committee is informed of each service and such policies and procedures do not include the delegation of Audit Committee
responsibilities under the Exchange Act to management. Moreover, the pre-approval requirement for permissible non-audit services shall be waived under certain circumstances
described in Section&nbsp;10A of the Exchange Act. </FONT></P>

<P><FONT SIZE=2>The
Audit Committee may, to the extent it deems necessary or appropriate, conduct or authorize investigations into any matter within the scope of its authority and may retain legal counsel,
accountants and others to assist it in the conduct of its responsibilities, including investigations. The Audit Committee shall receive appropriate funding, as determined by the Audit Committee, from
Abbott for payment of (a)&nbsp;compensation to the independent auditor employed
by Abbott for the purpose of rendering or issuing an audit report or performing other audit, review or attest services for Abbott, (b)&nbsp;compensation to any special legal, accounting or other
consultants employed by the Audit Committee and (c)&nbsp;ordinary administrative expenses of the Audit Committee that are necessary or appropriate in carrying out its duties. The Audit Committee may
consult with management and may delegate any of its responsibilities and duties to one or more members of the Audit Committee, except to the extent such delegation would be inconsistent with the
requirements of the Exchange Act or the listing rules of the New York Stock Exchange. </FONT></P>

</UL>
<HR NOSHADE>

<P><FONT SIZE=2>B-1</FONT></P>

<!-- ZEQ.=1,SEQ=34,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=466233,FOLIO='B-1',FILE='DISK132:[06CHI1.06CHI1111]HC1111A.;25',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<A NAME="page_hc1111_1_2"> </A>
<UL>
<BR>
</UL>

<P><FONT SIZE=2>The
Audit Committee shall: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Prepare
the report required by the rules of the Securities and Exchange Commission to be included in Abbott's annual proxy statement.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Meet
separately, periodically, with Abbott's independent auditors, with Abbott's management and with Abbott's internal auditors.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>At
least annually, evaluate the qualifications, performance, and independence of Abbott's independent auditors and appoint a firm of independent public accountants to act as
Abbott's independent auditors. This evaluation shall include the review and evaluation of the lead partner of Abbott's independent auditors and take into account the opinions of Abbott's management
and internal auditors. In connection with this evaluation and appointment, the Audit Committee shall obtain and review a report by Abbott's then current independent auditors describing:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>the
independent auditors' internal quality-control procedures;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>any
material issues raised by the most recent internal quality-control review, or peer review, of the independent auditors, or by any inquiry or investigation by
governmental or professional authorities, within the preceding five years, respecting one or more independent audits carried out by the independent auditors, and any steps taken to deal with any such
issues; and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>all
relationships between the independent auditors and Abbott. </FONT></DD></DL>
</DD></DL>

<P><FONT SIZE=2>The
Audit Committee shall discuss with the independent auditors any relationships disclosed in that report and shall, if necessary, take appropriate action to ensure the auditors' independence. </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Oversee
compliance of Abbott's rotation policy for the partners and employees of its independent auditors with the requirements of Section&nbsp;10A of the Exchange Act.
The Audit Committee shall consider the regular rotation of Abbott's independent auditors and report its conclusions to the Board.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Meet
to review and discuss with management and the independent auditors:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>the
annual audited financial statements and quarterly financial statements, including Abbott's specific disclosures under Management's Discussion and Analysis of Financial
Condition and Results of Operations (that is, under the section captioned "Financial Review") and the matters required to be discussed pursuant to Statement on Auditing Standards No.&nbsp;61, before
their incorporation into Abbott's filings with the Securities and Exchange Commission;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>the
scope, procedures and fees for the proposed audit for the current year and, at its conclusion, review that audit including any comments or recommendations by the
independent auditors;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>earnings
releases (paying particular attention to any use of "pro-forma" or "adjusted" non-GAAP information), as well as financial information and
earnings guidance provided to analysts and rating agencies (this may be done generally and need not occur in advance of each earnings release or each instance in which Abbott may provide earnings
guidance);
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>the
responsibilities, budget and staffing of Abbott's internal audit function;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>major
issues regarding accounting principles and financial statement presentations, including significant changes in Abbott's selection or application of accounting
principles and major issues as to the adequacy of Abbott's internal controls and any special audit steps adopted in light of material control deficiencies;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>analyses
prepared by management or Abbott's independent auditors setting forth significant financial reporting issues and judgments made in connection with the preparation
of financial statements, including analyses of the effects of alternative GAAP methods on the financial statements; and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>the
effect of regulatory and accounting initiatives, as well as off-balance sheet structures (if any), on Abbott's financial statements. </FONT></DD></DL>
</DD></DL>
</UL>
<HR NOSHADE>
<P ALIGN="RIGHT"><FONT SIZE=2>B-2</FONT></P>

<!-- ZEQ.=2,SEQ=35,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=1045205,FOLIO='B-2',FILE='DISK132:[06CHI1.06CHI1111]HC1111A.;25',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<A NAME="page_hc1111_1_3"> </A>
<UL>
<UL>
</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Review
and discuss with Abbott's independent auditors:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>any
problems or difficulties encountered in the course of the audit work, including any restrictions on the scope of the independent auditors' activities or on access to
requested information and management's response, and any significant disagreements with management;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>any
report by the independent auditors required by Section&nbsp;10A of the Exchange Act including any report relating to critical accounting policies and practices to be
used in connection with the audit of Abbott, all alternative treatments of financial information within generally accepted accounting principles that have been discussed with management, the
ramifications of the use of those alternative disclosures and treatments, and the treatment preferred by the independent auditors, and other material written communications between the independent
auditors and management; and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>any
information obtained from the independent auditors with respect to illegal acts in accordance with Section&nbsp;10A.
<BR><BR></FONT></DD></DL>
</DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Review
and discuss with Abbott's internal auditors the internal audit function, the department's authority and responsibilities, budget, staffing, independence, and
reporting obligations, the proposed audit plan for the coming year, the coordination of that proposed audit plan with Abbott's independent auditors, the results of the internal audit and a specific
review of any significant issues.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Review
and discuss (with management, the internal auditors and the independent auditors, as appropriate) Abbott's major financial risk exposures and the steps management has
taken to monitor and control those exposures, including Abbott's risk assessment and risk management policies.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Adopt
guidelines governing the hiring of employees or former employees of the independent auditors who were engaged on Abbott's account in compliance with Section&nbsp;10A
of the Exchange Act.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Establish
procedures for:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>the
receipt, retention and treatment of complaints received by Abbott regarding accounting, internal accounting controls or auditing matters, and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#150;</FONT></DT><DD><FONT SIZE=2>the
confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters.
<BR><BR></FONT></DD></DL>
</DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Review
any disclosures made to the Audit Committee by Abbott's chief executive officer or chief financial officer relating to their certification obligations under
Rule&nbsp;13a-14 under the Exchange Act.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD><FONT SIZE=2>Review
with the independent auditors, internal auditors and financial management, the adequacy, effectiveness and quality of the Corporation's accounting and financial
reporting principles, policies, procedures and controls, and elicit from them any recommendations for improvements.
<BR><BR></FONT></DD></DL>
</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>4.</FONT></DT><DD><FONT SIZE=2><I><U>Annual Performance Evaluation</U></I></FONT><FONT SIZE=2>. The Audit Committee shall review and assess the adequacy of its charter
annually and recommend any proposed changes to the Board for approval. It also shall conduct an annual evaluation of the Audit Committee's performance. </FONT></DD></DL>
<HR NOSHADE>

<P><FONT SIZE=2>B-3</FONT></P>

<!-- ZEQ.=3,SEQ=36,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=550145,FOLIO='B-3',FILE='DISK132:[06CHI1.06CHI1111]HC1111A.;25',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><B>
<IMG SRC="g519019.jpg" ALT="logo" WIDTH="52" HEIGHT="46">
  </B></FONT></P>


<P><FONT COLOR="#2B85FF" SIZE=2><B>Abbott Laboratories<BR>
100 Abbott Park Road<BR>
Abbott Park, Illinois 60064-6400 U.S.A.</B></FONT></P>

<P><FONT SIZE=4><B> Notice of Annual Meeting<BR>
of Shareholders<BR>
and Proxy Statement  </B></FONT></P>

<P><FONT SIZE=4><B> Meeting Date<BR>
April&nbsp;28, 2006  </B></FONT></P>

<HR NOSHADE ALIGN="LEFT" WIDTH="300">

<P><FONT SIZE=2><B>YOUR VOTE IS IMPORTANT! <BR>  </B></FONT><FONT SIZE=2>Please sign and promptly return your proxy <BR>
in the enclosed envelope or vote your <BR>
shares by telephone or using the Internet. </FONT></P>

<HR NOSHADE ALIGN="LEFT" WIDTH="300">
<HR NOSHADE>

<P><FONT SIZE=2><B> Reservation Form for Annual Meeting  </B></FONT></P>

<P><FONT SIZE=2>I am a shareholder of Abbott Laboratories and plan to attend the Annual <BR>
Meeting to be held at Abbott's headquarters, 100 Abbott Park Road, <BR>
located at the intersection of Route 137 and Waukegan Road, Lake <BR>
County, Illinois at 9:00 a.m. on Friday, April 28, 2006. </FONT></P>

<P><FONT SIZE=2>Please
send me an admission card for each of the following persons. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="29%"><FONT SIZE=2>Name</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="29%"><FONT SIZE=2>Name</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="RIGHT"><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="RIGHT"><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER"><FONT SIZE=1>Please print name of shareholder</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER"><FONT SIZE=1>Please print name of guest</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="29%"><BR><FONT SIZE=2>Address</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="29%"><FONT SIZE=2><BR>
Address</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="RIGHT"><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="RIGHT"><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="29%"><FONT SIZE=2><BR>
City</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="29%"><FONT SIZE=2><BR>
City</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="RIGHT"><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="RIGHT"><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="29%"><FONT SIZE=2><BR>
State</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
Zip Code</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="29%"><FONT SIZE=2><BR>
State</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
Zip Code</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="29%" ALIGN="RIGHT"><HR NOSHADE></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="RIGHT"><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="29%" ALIGN="RIGHT"><HR NOSHADE></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="RIGHT"><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><FONT SIZE=2><BR>
Phone Number (<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>)
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
Phone Number (<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>)
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="29%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="29%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="19%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<HR NOSHADE>

<P><FONT SIZE=2><B>If you plan to attend the meeting, please complete and return the Reservation Form directly to Abbott Laboratories, Annual Meeting Ticket Requests,
D-0383 AP6D, 100&nbsp;Abbott Park Road, Abbott Park, Illinois 60064-6048. Due to space limitations, Reservation Forms must be received before April&nbsp;21, 2006. An
admission card, along with a form of photo identification, admits one person. A shareholder may request two admission cards.<BR>
<BR>
To avoid a delay in the receipt of your admission card, do not return this form with your proxy card or mail it in the enclosed business envelope.</B></FONT></P>

<HR NOSHADE>
<P ALIGN="CENTER"><FONT SIZE=2><B>
<IMG SRC="g674535.jpg" ALT="logo" WIDTH="144" HEIGHT="87">
  </B></FONT></P>

<!-- ZEQ.=1,SEQ=37,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=303400,FOLIO='blank',FILE='DISK132:[06CHI1.06CHI1111]HO1111A.;4',USER='ABLIJDE',CD='20-MAR-2006;19:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER"><FONT SIZE=2><B>PROXY  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=3><B>ABBOTT LABORATORIES  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned, revoking previous proxies, acknowledges receipt of the Notice and Proxy Statement dated March&nbsp;24, 2006, in connection with the Annual
Meeting of Shareholders of Abbott Laboratories to be held at 9:00&nbsp;a.m. on April&nbsp;28, 2006, at the corporation's headquarters, and hereby appoints MILES&nbsp;D. WHITE and LAURA&nbsp;J.
SCHUMACHER, or either of them, proxy for the undersigned, with power of substitution, to represent and vote all shares of the undersigned upon all matters properly coming before the Annual Meeting or
any adjournments thereof. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the undersigned is a participant in the Abbott Laboratories Stock Retirement Plan, then this card also instructs the plan's co-trustees to vote as specified at the 2006 Annual Meeting
of Shareholders, and any adjournments thereof, all shares of Abbott Laboratories held in the undersigned's plan account upon the matters indicated and in their discretion upon such other matters as
may properly come before the meeting. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="92%"><FONT SIZE=2><B>INSTRUCTIONS: This proxy when properly executed will be voted in the manner directed herein by the undersigned shareholder. If no direction is made, this proxy will be voted FOR Items&nbsp;1 and 2 and AGAINST
Items&nbsp;3, 4 and 5 and in accordance with the judgment of the proxy holders on any other matters that are properly brought before the meeting.</B></FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2><BR>
SEE REVERSE SIDE</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="65%" ALIGN="CENTER"><BR><FONT SIZE=2><B>(Important&#151;Please sign and date on other side.)</B></FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><BR><FONT SIZE=2>SEE REVERSE SIDE</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=38,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=299337,FOLIO='blank',FILE='DISK133:[06CHI2.06CHI1112]MA1112A.;30',USER='GLOPEZA',CD='23-MAR-2006;17:10' -->
<P ALIGN="CENTER"><FONT SIZE=3><B>ABBOTT LABORATORIES  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=1><B>&nbsp;&nbsp;&nbsp;<BR>
Your vote is important. Please vote immediately.  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="35%" ALIGN="CENTER"><FONT SIZE=2><B>Vote-by-Internet</B></FONT></TD>
<TD WIDTH="7%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="50%" ALIGN="CENTER"><FONT SIZE=2><B>Vote-by-Telephone</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><BR><FONT SIZE=2>1.</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="35%"><FONT SIZE=2><BR>
Log on to the internet and go to<BR>
http://www.eproxyvote.com/abt</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><BR><FONT SIZE=2> OR</FONT></TD>
<TD WIDTH="2%"><BR><FONT SIZE=2>1.</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
Call toll-free 1-877-779-8683 (within the U.S. and Canada) or 1-201-536-8073 (outside the U.S. and Canada).</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2><BR>
2.</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="35%"><FONT SIZE=2><BR>
Follow the easy steps outlined on the secured internet site.</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2><BR>
2.</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
Follow the easy recorded instructions.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3><BR><FONT SIZE=2><B>Your vote is important!</B></FONT></TD>
<TD WIDTH="7%"><FONT SIZE=2><B><BR>
&nbsp;</B></FONT></TD>
<TD COLSPAN=2><FONT SIZE=2><B><BR>
Your vote is important!</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=4><FONT SIZE=1><B>Go to http://www.eproxyvote.com/abt by 11:59 p.m. 4/27/06</B></FONT></TD>
<TD COLSPAN=2><FONT SIZE=1><B>Call 1-877-PRX-VOTE bv 11:59 p.m. 4/27/06</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=3><B>Do not return your Proxy Card if you are voting by Telephone or Internet.  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=1>DETACH HERE </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="5%"><FONT SIZE=5><B><FONT FACE="WINGDINGS">&#253;</FONT></B></FONT></TD>
<TD WIDTH="48%"><FONT SIZE=1><B>Please mark<BR>
votes as in<BR>
this example.</B></FONT></TD>
<TD WIDTH="48%" ALIGN="RIGHT"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER"><BR><FONT SIZE=1><B>The Board of Directors recommends that you vote FOR Items 1 and 2.</B></FONT></TD>
<TD WIDTH="12%"><FONT SIZE=1><B><BR>
&nbsp;</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><BR><FONT SIZE=1>1.</FONT></TD>
<TD WIDTH="75%"><FONT SIZE=1><BR>
Election of 13 Directors.</FONT></TD>
<TD WIDTH="11%" ALIGN="CENTER"><BR><FONT SIZE=1>FOR</FONT></TD>
<TD WIDTH="12%" ALIGN="CENTER"><BR><FONT SIZE=1>WITHHELD</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="75%"><FONT SIZE=1><B>Nominees:</B></FONT><FONT SIZE=1> (01) R.S. Austin, (02)&nbsp;W.M.&nbsp;Daley, (03)&nbsp;W.J.&nbsp;Farrell, (04)&nbsp;H.L.&nbsp;Fuller, (05)&nbsp;R.A.&nbsp;Gonzalez,</FONT></TD>
<TD WIDTH="11%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="12%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="75%"><FONT SIZE=1>(06)&nbsp;J.M.&nbsp;Greenberg, (07)&nbsp;D.A.L.&nbsp;Owen, (08)&nbsp;B.&nbsp;Powell&nbsp;Jr., (09)&nbsp;W.A.&nbsp;Reynolds, (10)&nbsp;R.S.&nbsp;Roberts, (11)&nbsp;W.D.&nbsp;Smithburg, (12)&nbsp;J.R.&nbsp;Walter, and
(13)&nbsp;M.D.&nbsp;White</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="12%"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=1><BR>
For, except vote withheld from the above nominee(s).</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="88%"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE ALIGN=LEFT WIDTH="30%"></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD WIDTH="72%"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><BR><FONT SIZE=1>FOR</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><BR><FONT SIZE=1>AGAINST</FONT></TD>
<TD WIDTH="9%" ALIGN="CENTER"><BR><FONT SIZE=1>ABSTAIN</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>2.</FONT></TD>
<TD WIDTH="72%"><FONT SIZE=1>Ratification of Deloitte &amp; Touche LLP as auditors.</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="9%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER"><BR><FONT SIZE=1><B>The Board of Directors recommends that you vote AGAINST Items&nbsp;3, 4 and&nbsp;5.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><BR><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="72%"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=1><BR>
FOR</FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1><BR>
AGAINST</FONT></TD>
<TD WIDTH="9%" ALIGN="CENTER"><FONT SIZE=1><BR>
ABSTAIN</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1>3.</FONT></TD>
<TD WIDTH="72%"><FONT SIZE=1>Shareholder Proposal&#151;Pay-for-Superior-Performance</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="9%" ALIGN="CENTER"><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1><BR>
4.</FONT></TD>
<TD WIDTH="72%"><FONT SIZE=1><BR>
Shareholder Proposal&#151;Political Contributions</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><BR><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><BR><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="9%" ALIGN="CENTER"><BR><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=1><BR>
5.</FONT></TD>
<TD WIDTH="72%"><FONT SIZE=1><BR>
Shareholder Proposal&#151;The Roles of Chair and CEO</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><BR><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="10%" ALIGN="CENTER"><BR><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="9%" ALIGN="CENTER"><BR><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="40%"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD WIDTH="12%" ALIGN="CENTER"><FONT SIZE=1><BR>
MARK HERE<BR>
FOR ADDRESS<BR>
CHANGE AND<BR>
NOTE AT LEFT</FONT></TD>
<TD WIDTH="7%" ALIGN="CENTER"><BR><FONT SIZE=3><B><FONT FACE="WINGDINGS">&#111;</FONT></B></FONT></TD>
<TD WIDTH="40%"><BR><FONT SIZE=1>Each joint tenant should sign; executors, administrators, trustees, etc. should give full title and, where more than one is named, a majority should sign. </FONT><FONT SIZE=1><B>Please read other side before
signing.</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="9%"><FONT SIZE=1><BR>
Signature:</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD WIDTH="17%"><FONT SIZE=1><BR>
&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1><BR>
Date:</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=1><BR>
&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1><BR>
Signature:</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD WIDTH="17%"><FONT SIZE=1><BR>
&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
<TD WIDTH="2%"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1><BR>
Date:</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=1><BR>
&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="9%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="17%" ALIGN="CENTER"><FONT SIZE=1>(If held jointly)<BR></FONT>
</TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=39,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1",CHK=981836,FOLIO='blank',FILE='DISK133:[06CHI2.06CHI1112]MA1112A.;30',USER='GLOPEZA',CD='23-MAR-2006;17:10' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<!-- SEQ=,FILE='QUICKLINK',USER=SLYUBOM,SEQ=,EFW="2167434",CP="ABBOTT LABORATORIES",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g449301.jpg
<DESCRIPTION>G449301.JPG
<TEXT>
begin 644 g449301.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`O1$E32S$S,CI;,#9#2$DQ+C`V0TA)
M,3$Q,2Y/5510551=,3$Q,5]/1D,N15!3_]L`0P`'!08&!@4'!@8&"`@'"0L2
M#`L*"@L7$!$-$AL7'!P:%QH9'2$J)!T?*"`9&B4R)2@L+2\P+QTC-#@T+C<J
M+B\N_]L`0P$("`@+"@L6#`P6+AX:'BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN_\``$0@#>P*L`P$B``(1`0,1
M`?_$`!P```$%`0$!``````````````,!`@0%!@`'"/_$`$H0``$#`@0#!00&
M"`0%`P4!`0$``@,$$042(3$305$&(C)A<10S@9$'(T)2H;$5)#1B<I+!T35#
MD^$6)5-4@D1C\1=SHK+PXE7_Q``4`0$`````````````````````_\0`%!$!
M`````````````````````/_:``P#`0`"$0,1`#\`J9">_J=U7PDY]SNI[_M^
MJ@1>,^J":TGJ4>`FYU*CA'@W*"4">I2,)ON5S=ES-T#I";;E0WDW.JEOV4-^
MY0,)/4KKGJ5Q7'9!$JG';,46CN(]RH]4=5(IO<@^2`L9.NI7$G.#<KF>%<4`
MYG$\R@DFVY1)"A[H!DD#<KFDWW*YRYFZ`[2<NY2`F^Y2M\*0;H)]"3G)N=E$
MK'$RNU.ZET0\1\E`JSWG>J",2;[E-N2=RN2#Q!!,879=RG$GJ4UOA2GD@=<V
MW*GT1.4ZE0.2L*(=Q`/$G'A[JLS')N?FK'%/`%5GP`(',<;C4J6XGA[E1&;A
M2G^[01+F^Y1XR;;E1PI$>R`US;<H#R>I1N2"_=`.Y#MRI$9-[7*CG=2(M2@/
M5$Y1J4VD)S;E+5>$)*3=`.I)XQU*>XD-!N4.H]\41WA03NSSS^D1<G9;V0WB
M8O/,$=EQ!ERO0;W@84`P3?=3*0GO&ZAA3*/[2#18-L583'OJCHZQM-=IT1)\
M587=TE!;,U**00-U0,Q0AV@)13B<CA9L;B@F8D[ZHZJ1A,C!`V[N2SU7532-
ML6$#S74CZH,^J_%!H*V:,NMFYH\,L+(]PLM(*I[^]>Z.RFK7CWA066)U3"P@
M%1\-K611`%W-5U12SM%WFZ-14!F9F)T06CL2BS'O!1*RNB>-':IIPYH-BHU3
M1M8.Z4"1UKFL(S+J>KD;,7BY7141,>8H^'4P,S@[<(#.Q28D`1E(:^K=X6%2
MW4K&R"ZDQQ,&P""H-37'8+GQXK)$XM=9JOV0L)%U9-B9P2,HL@\J?Q6U+A*3
MGOK=2[FVZ)CC&LQ:4-%MD/D@@U)/52*(FU[J/5*11>%!.;>VZF41[Y4(;J91
M>,H+["HFRS@N%[+0!C1LU4F#>_5X@[2V@7+ER#E6!H;BN@W:K-5LNF*QGJU!
M9*+,Q\<G'B%_O-4I=ZH!03,F;=IU&X*;6_LLG\*'40OCDXU/J?M-ZJ!78F!$
M8W,<QQ%K$(+##OV2/T1Y9,C=-2=`%5X94R&)K&L+K!63(W%V>0Z].B#HHR#Q
M)-7'ET15RY!7XC^T4W\2L!L%78A^TT_JK$;!!\P2;O\`50(?>'U4^3=_JH5.
M+S`#F4$D(\&Y02+.(18=[()(\*5FZX'NKF;H.DV45VY4N7917<R@&FN3BF/V
M00:G5P"FQ"T.J@RZR!3V^["!S19J0^$IY\(0W;%`%R9S3G)HW0#>N:N>=4K=
MT!A:R0>)+R7-W03J3PN5=4GO.5A3:,?JJZHW*",E9XPNTLEC\:"6+V7'DNY+
MD#N2LJ(?5JMY*SHQ]6@B8H=@JQ^S0K'$C=RK7[A`2/=29/`%&CW"DR>!!$"D
M1[*.$>/9`;D@/W1_LH#_`!(&.W"D1;H!W"/%R0&JM&A=2<TE3L$ZDV*"//[X
MHI\(0I_>E&^R@ZC=DK(W>:]!IG9Z9B\Y!M,PCJM]AC\U(WT02U,H^:A*;1;E
M!:4U,)W:BZE'#8P=DN$C5RLY/%\$%?#01`^!3&4D3?LA$C&J*0$%=B$$8A/=
M")A4+#"-`NQ)OU!1L(T@:@#61-C<'`*32OB>!8)U4WB`A4WUM+.3KD*"RQ!K
M>&;`(.%#ZK0;$H<M5')`07"]DN%R-;%XN:`U2<I)YJ%E=*[:X4FH<)9;-U4F
M*-K6VMJ@"R,-BV0*"WM,GHI[@"PJ#0M_67H)DH#I0#T1&LLAS`\4$=$9A)&J
M`D=\P5FWW158R]QT5FWW)0><=H/\8D]`@<AZ*1VA_P`8?Z!1SX4$&IW4BBV0
M*E'H=D$X*90^,J&+J;0^,H-#@WOE>*DP;WRNT'+ERY!P5;4Z8E">H5FJNM>T
M5T!)M9!9KD@((N-DJ#E$Q"".6G>7-%P+[*6A57[/)Z(`86P"E80!<A3%$PL_
MJK%+0<N4&?$J>"0QN/>'DH[L:A%\K7'X("UW[53^JL1992IKG3SM>T$95.9B
MDP8!P2?-!\^R;R*)0B]6T>94N7_,]5&PP7KHQ^\@DSC+.X)8?$GUX#:MP38/
M$@D_93F)I(LG1H$EV4=RD2(#D`2AR;(K@@RFP00W^]`4\BS&JN8;R_%63OLA
M`^V@0'J0[11WE`)^Z:-TKM2D"`3MT]FZ&X]ZR*SD@(5S5Q%@N9N@F0&T3E6U
M![Q5BS2)RK9_%=`%/B\2:!=.C&J"4E&Z1<-T#E:4VD7P58K.'2%!`Q#Q*L<>
M\K/$-U5\P@D1[A2)?`@,\01IO`@BA'CV0`CQ[(#_`&5&=X@I(\*C.\2!';H\
M6X0';H\2`E1L$^E\)0Y^2+3>`H(LQ^M/JCC91YO>E2F"X!01Y+AS2MU@IO2,
M]%AIO$`MK@/[(ST06BF46Y4-NZFT6Y0:#"=RK&4]X*NPG<]%82GO(.9KZIYS
M(;#JB%X`01<1OP"BX/K`U#KY&\$BX3L'D:(1J-T$V4:[<T-].V9MBGRS,#CW
M@G0R-=J$&=Q##'LN^-Y;Y)V&02&*Q/-7->?JRHN%6R.]4!8(1&[7=2BP'FA3
MN#"7*`[$@QQ:2@L7M&1RKZ`?K,B"_%&%I%Q=0H*XLF>X:@H-%,0'A*'"VZH)
M<1>YX(!3?;Y=LKD&E8]MP+A6+'-$.ZQ`KIQJ&E%_2E=PW!D1<$%;VA(.+N(/
M(*.?`%&GFDGJW22"SME)/A""#4J10[?!`J4:@\T%@%+H?&0H@4NA]X4%U15+
M::8%VQ5H[%J-HN9!?HJBGIQ4R!I-AS5LW"*(;QW0!=CM*#W0]Q\@@NQTGW=,
M\JR9A](W:$(S8(6^&-OR04;L4KY!W::RK)IJF6<&0$/&RV0C8/LA4]?#&VNA
MLW<H(L(Q9S`&$!MD.9V)P/!FE.6_):=H`:`!LH.,-!I;VU!W02Z=Q,#"=20F
MU7N)/X4M-[EGHNJ?<2>B`&&?LK5,ZJ%A7[*U3>J"E92LGQ&7,-`59"CIQM&U
M1:33$9_@K((*.HHXF5\;0``[DKAD,8:!E'R4&MTKX5:#9!\O2_;]5'PO]OB_
MB4B7=Z!AG[?%_$@F8E^V.OT3(/$B8I^V.]$.#Q()">Q,3V[(&NW07(KMTQR`
M#E%G*E/42;6Y01X!]:%87O(%!IA>53A[ZWF@))S44G52Y.?HH9W*!IW7!(=T
MIT"".[QHT>MD(VS(T:`CES%SBNC023[HJMF/>*L#X+*NEU==`SD42+<(9\D2
M(602%PT7#9=S0/&X5HSW056-PK2/P!!7XE_158\05IBF_P`%5L-W()3/$"BS
M^!#9N$2?PH(P1HT$(T?)`?[*CGQ*1]E1CXO@@1VZ/%R0';A&BW"!\NI1Z?P;
M($N]T>#W:"'*?K2ID6K?@H4OO2IU-X4$:H%GA;;`Q:D9Z+%51^M"V^"#]49Z
M(+`;J;0^(J&-U,H3WB@MZ.K9`2'&R?4XI&7Z.^2CPTGM#T<X4P'9`#]*@;`H
M4N(2O!#0Y64.&QYM6A3!11`>%!F):F=[+$$!%I7U8;:&Y5W6T<?`-@NPB)F0
MBW-!33NQ$#,ZZO<&<]T(+R2;(U=&P1GNC1"PGP$!!(KO`[T4/"_`X#JI=;?A
MN4/"]`[U02*PG*5304QGE<2+JXK?`2HF$&\DE^J`#\+MF-DV@I`9BT@:*_D(
MRN5=26%4^W1`\T<;7"X'R3Q31#[(^2+-XQZ)0@1E)&3>P^2LHJ.'@GNC;HHD
M>X5G%[E!YUC\+8<4+6@`$()\`4OM/_BP]%$'@""#4(U#L@U.Y1Z#9!/"ET/O
M%$"ET/O$&BPFPG"O%185[\*]0<N7+D'*JKA^OP*U597?M\'Q0684'%_V7_R4
MY0L6_9O_`"""53VX#/1-J/<O]$L'N6>B6?W+_1!$PK]E'JIR@X3^S?$J>.:"
MLI_\1F5DJRG_`,2F5F@K:[2NISZJS&RK*_\`:J<^:L@=-T'R_*1W]1N@8:1[
M?%J/$O2I*>G[WZO%_($*DIJ?VEEJ>$:_<"##XD1[6=1LAPD7W"]$K*>GX^L$
M6WW`FQT]/F_9XOY`@PS2+[CYI]Q;<+>"F@O?@1?R!*:>"WN(OY`@\^)%]PFN
M(ZA>A"GI_P#H1?R!-?3P6]Q%_($'F\I'4*',X`;CYKTU]/3V_9XOY`@24U,1
M^SP_Z80>;4=C+<$*:T@SWN-UO:>FIKW]GA_D"-'34YD_9XOY`@P$KAKJ%#)%
MSJ/FO2Y*>G_[>+^0(1IJ;_MX?Y`@\VN+[CYI7D`;CYKT9M-3?]O#_(%SJ:FM
M^SP_R!!YD",VX1X[=0O0Q2TU_P!GA_TPB-IJ;_MX?],(/.B1?<)[%Z$:6F(L
M::$C^`*MKL!IIFN?2@0R[@#PGX<D&4>;,5=(>\59U4<D!?%*PLD;H6GDJU]B
M24#`+HL>Z&W=%C0&7#=($HW0$9X@K./8*L9X@K2`7`05V+:.*JXO>*TQ;Q*K
MB\?Q02V;HD_A0V>-$G\*",-T6/DA!%BY()'V2H_VE(^R5'^T@:[<(T2"_=&B
MW0/D4B+W849^ZDQZ1BZ"#+[PJ?3[*!)[PJPIMCZ((E4?KAZK<8)^QL]%AJO2
M8+<X'^QL]$%B`IE#XBH8NI=#XR@T.%"[B58S:.5=A1[Q5A.>^$",W13F0HS9
MR.3H@C5E^`2@X/X#ZJ16'Z@^BCX/J'>J"77#N%1<)V/JG]H7.BPBOFC<6O93
MRN:1N"&$@KS7LGVAQ"'_`(<P_%:J5U7K4R2#>LIC3N>'>9#A8CJ`>:#T^L]V
M[T4/"CW7^JR]3VHQ:HPQDKZ&CIW8EAD]=A[V3.>6!C0ZTFF]G`@MTOH56X+V
MFK*2#BU41J*M^&T+VMXI$;Y9I"QI(MW=2"X_#H@]!K+Y2HF%6,DENJH\6[08
MI1"*@JJ&B_2DU4^!G!E?+#E;'G+B&@O:;:92+\]DVA[0>S=F*OM!4T,L3H(G
M/?3$V.8.RV!/(FVIY'5!LI=G*OI!:J>L?VJ[0=H(<(QG#WPTE'BD$%/.)J6=
MSFB*63)H2+AX.G0@W"G=J<0EP7!91',^.KF,=)%*W,]S'N-B\6!)R@.=MR0:
MZ87>+)S6FR\_P;M36NPS#:&`MQ#$/TD_#'SU1=%G`:Y[)G"U^\P-)%NJFL[6
M8O,*:FI\,HO;705DDW$G>(V.IWY2&V%R'<NB#<Q@A6<7NEYQ_P`;O.%8EB,6
M'MRTF&TE<QCY#=QFOW#II;KS5H.U]0SM%3X<VDIY:"6O_1_%C>\O;)D+B2<N
M30BQ;<E!"[4BV*M]/ZJ&/`%F\4KZV?L+#B$E7*:UU#(XU&;OYL[@'7ZA459C
M6)OHL)H8ZF1E;254;,1>TV+AQ6QM!\GYLWH$&SJ=RC4.RR[^T4DM7([V!WL`
MFFA$C0[.TQWNXW&6Q+2+`W&BC-[08I+@U;-!2MIY#1^U03=ZS1<=TW&KK&X(
MN"@]!"ET/O%C)L8K:7$:FG%.R6I,U'3Y73.$372,<20+7`%OBI.%=HL2JJZ'
M"X*&D&)&>HCD+Y7"$-ARW+3;,2<PL.6MT'IF$GZ\*\7GN!]IC_P@[M/448:Y
ML3WFGCDN"X2%@&;H2!JHO:[M'VD@PK%<)='2T6+PBDD%123O+>#--PSE);=K
MP01Z&X0>F+ED>V_Z4CPC"Z'#JLMJI:EC)(658AGJV-:2^.*5WVM+WT)`.RS-
M)B^+LJ,'P_#:VNDJV8O-3S4F*NRNA!IR]L<CVYN(T:.#AJ;@<D'JBK*[2OI_
M0K&5';^M&!TU?3X=2&I%+/555.Z61Q:V)Y8[+D:="6FSG6"A]HNV-?%4UU7#
MA3#14,=-WC*>(^2=C7,;8"P`+M3\D'J0V4'%W`4WQ"\SJ>UW::>IP>ECH?9Z
MQN*<![27LAJ6F%[A?,`ZP.X(O<)#VRQG%VTE+38;3,KWQ3RRMEF<(FB*3AD-
M(%S=VU]AN@]7IR#"P@WT75+@V!USR7DE+VQQ33$**%TC*REH64U+-)9C)9I'
MMN3R&FI&]@FS=I>T5'68O35S&35DF*14<,3'/?#$33AY(L"ZU@3EM>Y0>GX1
M*PPY;ZW5@^1C6DDVL%Y3A6.XW75M!14N&1PS30SS3\>4L#&Q/:UQ;I<YLPM>
MWG9679G$<6QBIEI<1BCHZC@"H93YGB0-S6-\P`<!IWF$C5!JHJN-N(R$['FK
M;VJ&UR\?-9B*AD?4\-QU&Y5HW!6$=YYN@2IJ635D080;'=7(\(]%70X5#&\/
M!-PK)HT`0>3O^TA4O[2SU4>3%<.[WZY%\T&DQ7#75+`*V(G-U06U8?KTUFZB
M5N)X>VH(-7&#;JFQXKAU_P!LB^:"S:N=LH;<4P[_`+N/YI'8IA__`'<?S03!
MJD=LHC<4P^W[7'\TCL3P[7];B^:`TGA4=^C4&3%<.`UK(OFHDN,88-/;8?F@
MM*8:(L?B*KJ;%<-+;BLBVZHL6*8<2?UR+YH)<FR$H\N*X;_WD7S0?TMAO_>Q
M?-!-"1ZK9L=PJ(=ZNA'J42/%L,E8'-K8B/5!,;NB-V5;^E<-#OVV+YJ;33PS
MLS02LD;U:;H"IS=TU.8-4%!VOI&NIF5C19S"&/\`,'98=W1>B]I1?!:J_0'\
M0O.G(%:BL0FA%8@($YJ1O5*U`]GB"M:8=T*J:+N"MZ<68$%7BWC*K(O>*RQ7
MWI5='XD$IGB3Y_"AQ[HD_A01ANBQ\D((L:"1]DJ/]HJ1]DJ,/$4"/W1HD%^Z
M-$@<_=2F^`*,[Q!2AX`@KY/>%6%+LH#_`'A4^E\)00ZSWP6ZP0?J3/186K]\
M%N\$_86>B"P"E47C<HH4NB\90:#"KYBK":V8*!A?C/HI\PNX(.C/>1K!1XV]
MY'(-MT`JP`P&Y47!W-`<+\U+J6.=$0-UG6MKH)'\-EQ?J@T.)&*6GEAD`='(
MTL<T\P18CY*FPN@PL2T,AHXC)0`MI76UA!;E('E;11*A]>YMWBP3*..H>3D<
M04$]F"X!AYJ)*+#H873,=&ZUR,A-RT`FS6D[@6"KL.PC`H*>:E&'Q&%T#:9S
M'$D&($N:W4[`DD=%*EIJL,)=(2@4U+)*2+GS0#J<-P)M![!'AS!!Q>-H]V?B
M??SWS9K:7OMHC88R@@I'8>*6(4988^"6W86G<$<[HTF&O#2<Q3:*B,CR'<D#
M8\+[.4U%444.'PM@J,IE:7.<7Y3=H)))L+"PO8*73-IZO$H:J2,/EIG.?$\[
ML<18D>=C9$_1;0[74(T-.RF<7-'J@ZHPK#GXFW$9*1CJL/;+Q3>^=K2UKO4-
M)'H4K,(PN.03QT4;9`V5F87VE-Y!_P"1U*.V02.&JD6[MT%/+V5[.U386U&$
MP/;#`VG8TEP`C;X6D`Z@<K[*R'97L]+5_I)^%Q>U\<5(D#W"TH^V`#8.ZD#7
MG=28AS6=[<XE4TK\.I*>HK*5L\<S^-"]S&%[0,K"6,<XN-[AHL#8W05?:7#J
M&%S,+BIF-H1&6"$7RY222/F2JZ?#L)`FGJ*>!KJB2(R/<;9WL(X=SU!M99K$
ML2QO$(#7SUE:V>+"::=K6,R!TYS9[MMKJ-6H.+SSSSST]745GM3<4I^#2-8>
M$:</80_06/,EU]#H@N\0IL%H:PU\[::GGD<X\21^4%Q'>(!-KD;D:HN#X5@Q
MIY?9Z6!\%3'PWEKLS7,^Z#?1OD-%6]K:>>HQK!!3MBS"2<YIHC(QO<YC\D&@
MPZMHJ_#L/BKIF1U4E545)IF"-N:S2UHWR-O_`%0:Z/"<-8YKFTK,S71N#B23
M>,$,-R>0)0*SL[!7.C-,*:%S9WU#VS0F1KWN%B[1P<#IR-CL0L[A>)5+WTIJ
MJ_$?:'13NQ6)T9#::S38L&7ND&P;:^8(F%U_:(8/7U=7+5,Q"B,55'$Y@:):
M1NIN!IG<W-FYAP"#TGLI@U)A^#0X(\-J*9D;HY!(P!L@<277;L!WCIR"D81A
MW8F:GK</PLX=4LSL?5,CJ>*X%A!9F.8FS2--;"RJNS,\V(=F:BOJHZB;V^*>
M9E.PAL@B<'9(V]#DM;S*RN%115)&'X5*<0B;@M3`V48<ZEJZ`9&Y8GO`#7EQ
M&6UKW%T'K6+87AF.48IL2IHZJG+A(VY\+ALYK@;@^8*C8?V?P&A$#*.AA8ZD
MF=.PYBY[)7-REY)))<6FUSR7EM=C6(479/"8L)KL3CGIL&9-#F+QQ9AHY@8(
MR7EI;8M<0`+;[J;456)TE?VMK<,GJ_:*J2@G)(?E%,]C!)*SNGPZBX!+1RT0
M;VH[']F:F***;!X'1QMD8UN9P!:]Q<YIL>\"XDV-Q<J7'V?P6.CJ:)N'0FGJ
M8V1S1ONX2-8W*T&YY-`"PN&U./X@_"J1V+UQH)ZRK8*BGSM>86P7:#(]@+@'
MWL^POMJH=#B?;.+"8JJ"HKJNOJL`EJ3'/'<-J&2-:W*VPL[*7=WF1L@]$H^S
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MI*<8CAL4%158A5/PPX-4O@<7OAC;&,P?;NY2V0NO:U_-!O\`L[0]GH*AM+21
MT0K:2%\0A8\&2.)[@7`MO>Q(!).ZD]GL+[,T,]2<!CI!+']3*()N)P1>^2US
MD%]<HL%YQA<,DCQA^'TTC.TD-9B4M1*(2TY'LD#"9+6(<719=>7DKOZ+@&5,
M,,$8D9%A,4=5(ZB]G=3SAVL)-AG^T3>Y!%[]Y!MV`#$W?PJS58W_`!)WHK-!
MR4)$H0?,$F[_`%4?#S^O1_Q(\FF?U4>@_;H_XD$[$C>K)\D*$ZHF(?M1]$*+
M=!*:4A)7#9(XH'M2/NN:4K]D$&I-@JU^ZG5A)-@H,VE@@GTND)]$>GO8J/%I
M`I$!M'=`*<J.38(\RBO.A*")B,9DAN$;#7.%/8\DI.9ED:!H#+60"J)<I4_`
M:J2GK(I6G=P:X=057U$6<J10,<R>$?OM_-!Z7F`*<UXYH3P<WQ2/!MH@B=HR
M'8-5`?='YA>>.8>2WN.DC!JKGW1^86!,I:;(%:QR(QI7,)<RZ"Z8L*"6!HE`
MU0\_<#@ALG^LRE!-C;>0*X@;W`J%[RW4)S,0D;W;H'XJ/K'*OB\:E22F9Q+M
MRA,8T2;H"Q[IT_A7-`!72FXL@C(L29E18]$!CX2HS?$5)-LJC@&Y0-?NC1(+
M@;HT:!Q/>"E'PA1P+N"DOT`05[_>'U5A3Z,*KW>/XJPIO"4$*L]ZMQ@#KT;/
M18BL'UJV?9P_JD?H@N!NI=#[PJ+S4JBUD*#0X6/K"%82FS@J[#7M;(;FRG3O
M#G``ZH',.J*2;($7=<I!.B#FD62B-NY"5I;9.&J")61LX9-@HN%-&=^G-3JP
M?5E0\*\;_5!*JVCAG15^&>*2_56-;K&[T4#"]7O]4$JI(RE1\+-YI+*54M[I
M4;"VVGD`06,NKK746H'=LIDK3>X42<$BQ01Z=O>4S4*-"T@W4P:C5`D9L==E
M).(0PQEN>Q]575<XC9E!3J'#Q/&Z675Q'-!E,<JVU>(!S3<-TNF`GAC4[(N/
M4K*;$`U@`S;V0V^[""%4\T^A3*KFB4""R:3U*Z2AI,2A=1UT(FIWV+HW$@.M
MUM^2YNZE4GO0@MZ-A#F-B`:&V``T``5VV6>,7D&9O.RK,-`X[?57N^AV0(U^
M<9FN-O5.N>I40YZ=Y-KQN_!26D.%VZA`NO5=\5RY`MSU*A8K?V5VO13%"Q7]
MD<@D4I/L[+'DGR$\-VIV0Z,WIV'R1)/=N]$$/"2>$\7.A*G@D[E5^$^!_P#$
M5/UY(*QA'Z3=Z*S*JV?XF[T5H@[XI0D2V0?,$F[_`%4C!<'K:JICF:P1Q%UP
M]^E_0<U:X#AK:A\E54,S1-=9C3LX]?@M)3>_;_$$%!7=G)G5&;VJ,:?=*9'V
M;F!UJX_Y"M36>^MY)@W09]O9V7_NH_Y2N/9R4G]KC_E*TC5Q-D&=9V;E_P"[
MC_D*5_9R6W[7'_*5I&'1*Y!BZKLU,3^V1C_P*A.[*RN>+UL?\A6RJ#W@@@=\
M(*'_`(9D$('MC/Y"C1=FY!';VMG\A6B?X0$1G@"#*3=F9#I[8S^0J,[LO*1;
MVQG\A6OEW0''1!E6]EI-![:S_3/]U4RQ>SSRPY@XQN+;];+T!NX6$Q<6KZHC
M_JN_-!&=O=$I_P!IA_C;^:$#<(D'[5#_`!M_-!Z.=RN<`G#Q+G#F@K<<`_0]
M5I]D?F%YO5:2:+T?'?\`"*K^$?F%YO4GOZ]4$RE%XTV2!KG>26D/=LC;E`G"
M'#L-E"$)$U[JP<;-4;[8*`YCS-0'4YW4MNH"XH(C8G!197/;,+*S)L"H$P!?
M>R"8RY:"F2W`T1(?=A*^UD$8NL!HG`FUT6PZ)P8"-D`!(>92AZ)PVC9)D%[H
M&@W.J=FMLER).&4'"0WNB<<D:E"X9ND,9"!21>ZD13Y`;:J*6.2278R]M4!I
MGAY)YJXP;&64K1')L-K+,1R.=)8@H[02_9!OHL;I)#;.WYJRPW$J9\Q#9&_-
M>3E[FU676REQR2,=F9(YIZ@H/;:.6*5]VR#YJ4^3A2`Y]"O#HL9Q&G><E2Z_
MFIA[38JYH:Z;-YE![G3SQ/M=XNI8#2+@KYZD[1XNR1O#J2/1::C[>UM/2!LT
M9?(`-1S0>Q!HL$\!>8T/TBQ%H]IB<P^0N%;0]O\`"7>*<#U%D&PK!]6?10\*
M\;_59^;MMA,D1+:EGS28+VHPY\C[SL%SS*#6UELAMT5=AOC>?-"JL=P\QFT\
M9TY%1,+Q:C)D(F;OU07U0[N$*+A=^/(HU7BU"&F\[0?5)@E=!++(62-(07DK
MB"HDY[J++-'G\04>=['-T(0-A><RDRO`9O95\<C&/U(23U3+VS!`K872R!SB
M2.2T=",M/;R6>%;&U@RV4N'&(61N#GM;H@S_`&J_Q&,^1_-0AX`EQJL965S7
M,-VCFD9X!Z((53N42@W0ZG<I]!N@LVE2J/WH44%2*3WH0:'#R!.TD\U>K*.<
M]I:8P2;J<R7%G-LV,6\T%Z;$:A18)6,E=%F]%6.;C#@;D-]`JZ.GQ"2I(+B'
M=0@UUVV\03<[.;E2-PZN<.]5.`]4\81,?%5//Q06YEB&[Q\U6XM5Q>SN8UP)
M*8,%'VIWG_R*AU^%"%F=CB1YE!/H,0A$`:\@6ZE$J<2IQ&[(]I/JHM#A43X@
M^36XZHTV$T_#.1NMD$+#\1$+G9SH22IKL7AL<I-_)1L,HHWR.SMOE-M5;"CI
M[6X3?D@SWMSO:C,+V5A^EGVTC>?@F&CB;7AF46WLKAL,;=F-^2"H.)U)\,#D
MGZ0K3_DE7>5GW0ERMZ!!Y#30-IJ=D#=F"WJEI_?M]45V[D&#2=OJ@/5>^31N
MGU.LOP66J^T,S9W-I8X^&TV#GBY=YH-4-DA*R3>T-?\`=@_D_P!TA[05]]H/
MY/\`=!L6)SUD8\?KK;0_R?[I*CM#7-83:'^3_=!?O[TMKIG^;99"/M'B)<YQ
M$'\G^Z%#VEQ)]0X$06'_`+?^Z#=OY!&B\"Q$G:+$0=H/]/\`W4B+M!B&340_
MR?[H-1.=4$[!9*J[28BTZ"#_`$_]U&=VEQ+EP/\`3_W0;9OB`6&QD?KU5_\`
M==^:>SM+B68>X_T_]U'J)75#WRR6S/.8V'-!';X0BT^M3#_&W\T,6O9%IQ^L
MP_QM_-!Z/S^*<=DG,E=?1!6X]_A%5_"/S"\UJQWUZ5C_`/A%5_"/S"\UJO'\
M4$JE/=LI`W4:EV4L($D\*CD:W1Y=@@E!)BV2N3(=D0H!N/=41^I4F391W;()
M$'A3I=D.GVLB3;(&-.J*-D!NZ,-D'%,S:IYV07(#--TY"C1CL@82+I4(GOHG
M)`H390+;)[4*4\D`6L;FNI+`+7L@!'9L@!)$.+FLBM8%SO$GH#,H8G6<XZE)
M/0QM;F:X:*72,,C0`C5-*6Q$H,X^'O`W4CA%S+`+G^.RL\+IFRG5!5>S.RV`
M*'[-)?9:R2B8P@(HHXC;NA!CN`\?92"-^X!^"V<M'"V,W`56QU/%(00"$%):
M8?:>/B4L<]1%?),]OH595<\;^ZQH`4$BYV0--95<ZAY]2K_LQB=3#49.(3FZ
MK.N;JK'!S:LA_B"#U>`5,S6N+SJ$9T%1;O2&RL<+8TTL>G)2)V`,V04K*21Y
MMG0YJ1[7CO$BZMH!W]D:>',+@:H(46%M<T$DJ;!@D+F%SAFTT!3(*K*1&_0J
M]HCFAN.B#SO%Z-M'7!C=G:A*SP!3NU?^(1^A4)O@""#5;I]!NFU2?0;H+)JD
MTOO0H[5(I?>!!>T#0Z9H(YK0``*@PWW[?5:#S.R!KB&MN=E'@8TO=+:U]EQ!
MGDM?N-_%20```-@@Y<N7(.43$]:1REJ)B7[(]`^A_9H_1'?X'>B!0_LT?HCN
M'=/H@KL+]Y+_`!*R5;AGO9OXE9(*Z3_$F>BL572_XDP^2LCN@1*$B4(/)7;N
M0HO?-]49WB<@1>^'J@/5>(_PE>;\_BO1ZK<_PE>;N0$:NOJD9LD![R"3'LHN
M(/L`U26[*OK#FFL@X-R09NJB4EC*\CJI=0ZT.51*$=YQ\T$J0W*E1>!17:N"
MDP^!!!J_&5%*D59^L4=VZ!S/$%/)T"@,\84Y^C19`,[W1Z1UZB'^-OYH1&9J
M6D!%5"/WV_F@]-ZI"E2%!6X__A%5_"/S"\UJ]_BO2L?_`,'JOX1^87FU7O\`
M%!(I/"%+LH='LIH0,EV"$B3(9V0'@3W(<"(Y`"3=!<$1WB3'("4Z+/X4&+0H
MTW@0`;NCC91X]U)Y($=LH[MU(.R`[=`^%&.R%#9%.R",X]]';L@?;1V[('#F
M@R;HPYH#]T"(L?A""4:/8(.?NG#9(]<W9!;X.+DJPQ*S:=Q5=A!#2;E2,7G'
M!L"@H(FF2HRC75:3#(FPD9A;59RCD;%-G<I\N*D/M&-$%Y72L80XNT4*7%(X
MVC*;E5,E5+4>(Z*.YJ";58E+,+`D!0=7:FY*<&I;(&@73V-N0$@1(=7A!'G;
M9UD>@)$["-[A#JA]8NIG%DK3YH/=L"S.P^$G?*%,F%VFZKNS<V?#(7?NA6$[
MCE0"B;9RF-L1JH,+^\IM]+A!`KJ8EN9@U"G8371M@+)3E<-P4HL19R08;',T
MO&A\D&8[2S,FKX\AO:ZBM\`28Q2&DKPTN)!U%TK?`$$*J"=0;IM5NG4&Z"T"
MD4OO`HXV4BF]X$%Q3/<R0.;U5TPSS``@M;S*J,.`,X!VNM%IR%D",:&-RA*N
M7(.7+ER#E%Q+]D>I2B8F?U1Z!U!^S1^BD.\#O11L/-Z5BDOT8Z_1!6X9[Z;^
M)6:JL-</:)A?[2M4%=-_B,?HK'F553RL&(,-^2LPYIU!0.2A-S#J$X(/)G>)
MR#'[X>J,[Q.0&>^'J@/5;G^$KS9R](J=W?PE>;G=`H-D@OF2A</$@D#1JA.:
M7374HGNH=@UI<@AUKK-(0Z+8E)4G,"2G48[A*`WVE*BT:5#^VI;/=GT05E0;
MRE")ULB3>\*$?$@<T]\*>-6A5X\04T$AH0.T"?3_`+5#_&W\TPZBZ=2G]9A_
MC;^:#TH<UQ7#FN*"MQ__``>J_A'YA>;5/B7I':#_``>J_A'YA><3\T!J+935
M"H=U-YH!2[IIV3IMTQVR`U/L$1Z'3;(CSH4$5QU76NN)[Q7!`K-'(TW@01NC
MR#ZM!%9XE)4:,]Y24''9`<C\D%VZ!\:*=D.-/Y%!&^VCMV0!?B%';L@>$%_B
M1AL@G=`P[(T7A""]%C(`"![ES4V1UBFM==R"7'.80;(%14/DT<D>+A#+=$`P
M"4@;WD\)4!XAHG."2(Z)ST#5RY<@X)\/C"8E8;&Z!E5XUT'C:DF.8W71Z."#
MVGLHX.PR'73*%<SB[398'LO72LI&,&H`6NPVJ=42ECAL@D0BSK%3;#*@R1AL
M@\T>W=L@YH!U5C1^[*K6@W5A2>[*#%]JS_S&/T*AL]V%,[5_XA'\5$9[L((-
M5NEP_P`22J74'B06H1Z;W@0!>R/3>\""\P[]H;ZK1+.X=I4-]5HD'+ERY!RB
MUU6*2/.X7OT4I56-@.;&VW,(`G&7GP0./P4*OQ*>5N0Q.8#U5_201-B;W&[=
M%'Q6",TY=E`(05-#5U;&98HRX!'GJL0,9)A`"L<)B8*8.MK93)6M<P@M%K(,
MK2OJ>*3$.\=[J>78H1R`\@I&&,9QY>Z-'*VT')!DG-J'3V?XU8QTE>6BTI1I
MVM_2#``K;9!G9V5<$C<\I(NK^G<3"PG>RAXL!D'J%+@]RST0>5N\90&>]'JB
MY@_OM-P[4(3?>CU02)]7Z[66%Q#"ZJEE<&Q/DB)[KV"^GGT6ZG\80R@\^]GJ
M/^A+_(4K8)[^YE_D*]`!/4IUSU*#!<":VL,G\A0*B*8,L(9/Y2O1;GJFON1N
M4'E53%,UGN9=?W"CTT,HB]S)_(5Z',27`7*,PG+N4'F_"ES^Z?\`RE21'((C
M]6_^4K?7-]RBD]PZH/)WQR<1WU;_`.4IG#DS>[?_`"E>H'Q%-.Z#S$,?G'<?
M_*5/X;RT=QVWW2M^-U(![J#S=H?L6N^15C@^'3559&[(X1,<'.<18:<O5;;G
ML$\;('!<N"XH*SM!_@]5_"/S"\YGYKT3M&X-P>I_>L/Q"\[FYH"T7-3E!HME
M.0!E3''1$EV0CL@D4Z>_FFT^P3G\T$1WB3DTGO)R#AX@CR>[0!N$>3W:"-'X
ME(4:/Q*0@7DA%%Y(3MT#V)Y\)36I3X2@`/&49NR"/&4=HT0.'A0.91]FJ/=`
MT[IS;W";;O)X'>"!TG)<P:I9>21NX0%.P0W[(A&B&_F@&-TXCFFC=/*`D117
M;(,11CL@8%RY<@Y.B;<IIV1(-"@#.,KK)&;A.J3=Z:S0A!ZCV*IF28>'$"ZT
M5!$(JT@<PLWV'K(HZ#(X]X+24DS)*XENP""SF!SM1!LH]35Q0N;F(!0QBM.!
MJ]OS03`I]*+,*H'8S2M'O&_-(SM)1M#@9F@VZH*GM5^WQ_%1&>Z"%BM>VNK&
MO806CFB,]V$$.J24'B2U7-)0>)!;-V1J;W@06[(U/[P(+NA(%0WU6C&WDLM"
MXM?<(>(8S4TH`8T&_4H-;<=0DN.J\_E[28AR+1\%#D[28GR>WY(/3"YH^T%4
M8O*PE@S"X*\]E[18J?\`U%O_`!5GA=7/5$.GD+R@WU/41&)O>"BXI51>SN:'
M`E8W&:NHAC^JF<S7DH&&U4\THXLKW^I0>@8;51LIPUQMIS1YJ^G:QUG@GU60
MQ%[FTQRN(TY+.TLTCIP'2..O,H/0*&K9'+(\VLXJ7)C-&S0RLOZK.#]F'HLG
M4._6G7/-!OW5S):ELK""&H\O:&BA`$D@!LJ##-(/@J+&W?7A!L9L7BKW-$)N
M+J6W$^$T,=J0LG@.P5I/[PH,%@%:V6)U(]WUD7AONYO^RLF^]'JL(9'Q5/$C
M<6O:;APY*VH^TH$C65<!+KV+X^?P0:V?QA#=LJR;'\/S"YE_D0G]H,.'.7_3
M06X3E2CM#AW67_33O^(<.ZR_Z:"X2/\`"54CM!AW67^1,F[0X<UNIE_D03':
MO4D>%9QO:7#"_P`4W^FI8[0X=;_._D06XW3W>[5&WM#AQ/\`G?R)\G:+#FQW
M/&_D03^J0[JF_P")<-_][_3_`-TT]I,-ZS?R?[H+H>)21LLV.TF&Y@/KO]/_
M`'4L=HL/L/?'_P`/]T%RG-5&>T6'@[3?R?[I[.T6'])OY/\`=!=KBJ?_`(AH
M+:"8_P#A_NJZN[122,,=)$8KZ9W&[OAT0-[5US7Y:*)U\AS26Z\@LE+LIDA)
MN2;GS4247"`E'LIJA4BF<D`Y.2$=D:39!*"3#X4K]BDA\*639!$^TB!#^TB(
M$/B".[W:`=PCG6/X(([-T8;(+=T8;(%0SNGE-0."5WA*1NR5VQ0``[R.W9!;
MNCM0*?"5'4EP[A0(P2;#>Z!MM?-.'B:B\%P[R7(&.U(`!W0-D;LD:W51J_$Z
M>%V2/ZUXWL=`JUV+SA]P8[>6R#1%O=0'BVAT]54MQF5P`[@]%W'XA)>Z[K;E
M!:`<QJEL>B@139&C.Y^UP.J.VL8;-L=>=D$F/0H]NZHT9<=3921X4#%RXKD'
M%.CZII3F'1`*3=<U=)NN&R"]P>5[#9KW`'H5O^S;R9-3<V7G&&..8+T/LV2'
MW\D"]J'$&.SC\UGLQM<D_-7W::Y='94&5QY%`.0Z%1CXE+=%(X:-*`8)`[PH
M)U)N%=M]VJ.E!#@"KQGNP@@U)U74'B7522@\:"X&R-3^\""-D6#W@06L>X5/
MC9L6^JM0[)NJS$V"?+;D@H9#=1I2+*V-%=#.'W04$I6CP$W#5'.%-*L,/@]G
M(`V0`[0&S/BH>#ZR!7%?`VH`!3*.B;"\$6T0'Q0_JKO19NC/UX]5HL7+13.S
M&VBS=`Z(U``=S0:^_P"J#T60J#^MN]5K2?U/3HLC4.R51+F.`ON0@UF&?LWP
M5#C+)'5&C25<X;*S@#7DBR-AD==Q%T$/`6N:!F%E:S-O(2$*%K&>!%<X7U0>
M*2^]=ZJ%_P"H'JITWC=ZJ$?V@>J"94>\"!*=`CU'O`H\WA"!H*(A-3[H'A!J
M3=MD3-H@/[Q).R"'&+2*>=`H<7>F/DI;O"@8SQ)U0?JDV-=5$9`@B)KDX)IW
M0)&>^%8`[>BKF'ZP*Q&P]$"D7*Y@2.W3VH"!(0E"XH!2:A1I!H5(DV4=^@*!
MU*=PIBATW53$#)-D!VZD/V0.:"1%X4Z38I(_"NDV010>]9$YI@WLG'=`CMPI
M'^6H[MPI`]V@`W=%"$-"B-0*4R^J>FH'#9<[PE*-ESA<(`L&JDL:A&T;<[S8
M*%/B#;6C/S""SE>QK+YVV41U7''L6%P\U1U-8;DM\5];'14]17ND+@<S7<B@
MT<N-.#M'$&]B5!JZ^66S1<DF^NRH6S#4ROS'EIS2BIE&I<<O,C6Z"=)4%A/$
M[F;G8)K6QRD'B-]5'DE:1Q!8#KEW^"C6A<20\QG>UM$$Q\-0UY#7@CEINCTK
MZAA#1+Z@JOAJ)X2-<["=CK='CK)7R90P&^O0A!?TE1,"ULA('4;*:T0/#GMD
M(?U!_-4-/.3>SL_7R5K"YKH\T8(/GL@L*.?.[AO<+];:W4\9VFQ`/F%609)0
M`&ALS>9W4F*=['EM[#FTH)5EQ7.<.Z=KBZ3=!R46LD2A`Q^R1NR<\:)@V076
M!@.F`<MYA[N"06ZW6([-0&:J8/)>@4U(8Y`T[%`&K>V<C.0+*/D@;N0K2HP\
MO<TM_$IWZ&X@Z?%!49H!L0A2F)PLQI)\@K^#`HV&[M5>4&$P-8>XV]M[(/.F
M$<4"UB%;L]V$3M%2LIZYF06S=$-GNP@@U6ZZ@\26I&J;0>-!<#9%@]X$%NR-
M![P(+&1I<RPW2,PFJE%P;#T4B`7D8/,+3,&5H`0988#4G>0!$'9^7G,M,N09
ML=GW<YC\U"JL,=2R`9B6E;%5.-`$1_Q!!$I\%9*P/D)1)<$C:PN8YUPKF`6B
M8/)$.Q0>;]H**6W#!=J%0X?A<D-0'$DK=8\`);JCXP#A;=!?853MG#(W"ZLJ
MO!*.6$MX0)]%`P:7(6N*T#JB(,N'#T08%U*:>:2)@L&FP07-ES*TK[BKD-M"
M5"(+G()%$':9BI4D9+M`@4X((OU4]P`*#PV7WA]5"=[\>JFR^-WJH3O?A!+G
M\80)O"C2F[@@S^$(!M2W30E)"!'GES7/LV$D[I6BYU3:L@1V01J47>2I4FC4
M"C&A*/+X4#8^294G8)\6R%4GO(`IKDY-=N@8SWH5D=`%6Q>^"LG<D'.3HTA2
MQZ("A(4X)#L@"_9`D&A1W;(+[6*!:92U$IE+0-?L@D:HS]D'F@.S9=)LN;LD
MDV01VC4HG-,9S3N:#CN$<>!1W;A2&^`(`<T1NR&19R(W9`J3FG+D"M%TR:=D
M5VW!?R!75$P@A+[7/)4SZN0L)>+@^2!:VKE>-"+=`JP3O?,(`V[WG1!KJMK(
MW".XS<RA8,29):E[M0+!!)K<S7")C0YPWOM\%7RP?5E[C?AGO^=^05NYG#:)
MGF[WZCR'(*!)"9HFMB<2PR9G':Z"-44P.4M(!RW<!R/0*$RY<6!U@[=64K"U
MS8VZ.T)/,*"]I,I([KB;VZ(!ASF'RZ%'%G@%T5A:V9@T1X([N<Q[0;:`D;J5
M'!8`,N,W+D@C1TP(#@_X@Z?)/J*-Y8V:$YG7U%]0CMA&K<M]-19/:]T/=!S#
MIY((U-(9']]N20;$Z9O]U=TS'.NZ*0-D;JYO(J$*:&=PR7+]]7V^2G!E@V1I
MRO:,OQ\T%C%)"\ALS1$\^"0;`J=)"V5K9'#OVL7,YCJH#'-?#WVECSN".:GT
M+N#4,@<"&O`(UV0,`+Z01ORORV>QS3R3V2-<`!OS1ZFDM+(T=QSB7M<-O15P
M>TY)0[+F-CTN@FE=R21V<.?Q2E`CO"$+DCY28[H')!I^RDF2LC*]'8;SQ]%Y
MIV<(;+$XKTBE=FDB/F@M)`!E-D9C@0.2%*-&^J(P()#;*;2>`J"T:74ZE/<*
M#%]K3^O1#U4-GNPIG:S]NB]2H<?NT$*IW3:#QIU3NFT'C07`V18/&/5":BP^
M\""XIO>L]5IF^$+,TWO&>JTS?"$"KERY!RJ<9/>B'FK95&,GZR(?O(+.#W3/
M1$.Q*'![IGH@U\_!B(&KCR04&.-#Y``52FG:'#R5G5<1Q+WJ&3J@NL%8QPLY
M6M53,+--"J*@D,;<P75N-F,9+:H&U<8<'"^H*J2_AORNY)T5<Y\KL_VM4S$&
MES<[2@E02!SA;>ZL';CT5%AI.<7/-7Q&WH@\+F\;O50G^^"G3#ON]5!>/K4$
MF3<>B%/X0B..R%/L$`@D*4:+D#F%1ZHWTNC$V:2HTNK;H"TOA3Y3<)E,.XG2
M(%9L$&<]]&CV"CR^)`Q-<G)K]D`X_>CU5H?"U53/>#U5L1W&H$*<Q-*<Q`0+
MCLE"1VR`+]D%VQ1G;%!*!8!8J6HT2DH&NV0N:*Y#YH"MV22>%*-DV7PH`L&Z
M<-US-ES-R@YVX1V>!`?NCL\"`+O$GMV2/W2MV0.7#=<E:+E`*NCO3YB-`LI6
MS<-K[.M8==UI<7J#%"8FD!Y'7<+"XA(3(6$6Z^:"+(]TCBYQN5.PLDN+.5]?
M2RKP+E6V&0Y"7N'+YH+*K<V1S9)"&Q,V`YI*<-J'-RBS2ZP*A5+LY+<_=9II
MS2P3EC'``@1FPL@LZFE:T@M-SY*L%&72WUU<"XJ2:E^5K3<>:D02!Y\.I0-?
M1'B9FC6R.8"`'92U_16U/#=^=PM8:WY!27QL?)W1<H,Z('B0'(=KD>2&VG[^
M:QMU\UK10`09\HS'2]D6#"1)`692,PN"@S/LT<C`XM[XWY7]$6!C0TM(+M;7
M(5V_!Y&`]W4;CR49^$N:2'`V'S!0"C;E&7>(ZBYN6'^H4][7&D<`WOQNNVQU
MZJK+):22Y.@W!V(5I3R-$&8.[A(+0>0YA!;.<UY#9`-6M</0_P"ZSD]*UA+)
M`<H)R&]K$%6.*RN;+2O:XY'L,9/0C9!GC)ANX7<QV87&]P@%3&[$]W--C[K1
M86N-NA3G%`=@'LSE#Y%20\MA+5''-!>X&[+D]5Z-ADF9T>J\PPR3(!ZK?X3-
M9C7#6R#7R@%H2QBRJ75[K`92GLQ%XVC<4%RT&RFTI`8=0LXZNJ#M"Y(*RN`.
M2$GU*"!VL(-;%8]5$B]V%&Q.:>6L'';E(.@4B+6-!#JMRF4'O$2JW0Z+WB"X
M:C0^,>J"U&A\;4%O`0U["3S6DCD8Y@(<+666>TEH#=U-@HZ]S`1,6BR"_P`S
M?O!=G9]X*E]@KN=45WZ.K/\`NB@N.(SFX*EQ>>,RQV.SDXX74G>J<JNMI)89
M@'/S`[70:6FJ8C"TYM@H%14QR3^*X"!!A<CHLQE<-.14(4,K:DL<XV0&Q"2-
MS0UI%U691NI=92.@;G#C\57AY)`03H7@1EI4*I@$K[H[6DQW"@3U)B=9`1M,
MT$$<E)<P/9E*KVUKG=T;ITLSXVEVNB"9#$V-V@5@)1875-15#ICJK%P(-D'B
M\I)>[U4*3WJF/\;_`%4.4?6(#=$.?8)X.R'/R0#7)%SMD#)3R0IM&!/.KDRI
M.H"`\&C$DBZ'P)'[H'-.BCO\14ANRC.W0<ANW3SLADH&Q^]"M3X0JIGO1ZJV
M/@"!I3F)J>W<("!([9*$A0"=L4%R,4,[H.BW4A`9N4=`CD,;HCDWF@>-DV4]
MT)P39-D#&;)&;E*/"4C-R@Y^Z,SPH+MT9GA0,<E:D>E:@<GL&J8B,TN4&>QW
M61UI-//59&H<72$EQ*TG:"JSR.`;J.8YK,./?)0$B9<&_BN+?-63Y00ZVA&I
ML.5E7:1N#7$YK7)Z'DIM/(PW80;N8;D^2"-G^N%@0+_FK.GIR6VZDDJ!11\2
MI(/>(<-3S6I@@:&`9=T%6^(!EQ_\JUP>B+B'D'R"5U+Q)6C+H"M!01,B:&BP
MZ(.]GLQN8:$Z^?DIV'4)EG?*\%K6@6OS/-3:6"-S@7&Y5S!#$UHN+\T%:VFX
MC@"VS;]T+0##&B!N9MP!R3*:+-)F-@.0M^*T,36N8&DZ(,^S#\[&EX[S38/'
M,>:BUF%AKPX-%B-@MBV)IL`T94*HIXW-LT`?T086KP.*=C@&W:=CT6?K,(J*
M&S'1YH7:"W)>K04K"X7UZ^:L78=!)'D=$US2=;M0>&U<+F&GCD`S!P(\PI]5
M%Q1W!:^7?T_V5KVXPUU)*V5K0!&X#3I=54+W/@=F.SKCT00I(A&0TZ`[>2`[
MIS5MBC1P!L`'7'Q"J$!0+QE`'-';[LH`W*"QP]N8+>=GQG#6GHL%A[\MUO.R
MKLTC$&CJ(61@'1$IS%ILHN.R\*,6-M531U+B?$4&P8Z+396-(R-S#I=8NEJG
M"2SG'YK3X9-G:2@SG:IC&5D9:+7*BQ>["/VF?GK6#D%'C]T$$2JW0Z+WB)5;
MH=#[SXH+EJ-#XP@A&B\807$6KF^JTD0LQMNBS4'B9ZA::/P!`Y<N7(.5/C8%
MXC;[2N%48YM'_$$%G3D<%G2RAU\65PF8+V4NEUIV'R"(YH<+'9!FJ^?BPD75
M,T`$J_Q>G;%=[1HL\Y[>(;$:H+"`#@E4>(`&?*KRGUA-E`EI"^I#W;(`4E+:
MSW#X)N(SL#>'I=3:R9L,)`WM992LF>Z3F;H+W"G-+M.JNW@7^"S>!7)%^JTD
MAL[X(/$Y/>.]5#E]ZIDOO7>JAR^-`\)DW).&J;-R0"&VZ:\Z)R9(@2,:W09]
M9`%(9LH\EC*@D1Z,":[Q)[=&IAW0.V:5'.Z.?`5'0<A.14,H&Q:RM]5;/\(5
M3%I,WU5L[8(&\T]J8GM0$"0I0N=L@"4,[HA3"@Y@U1^2"W=&Y($=NFIS@FH'
MA-DV3@FR(!\ES.:[DN8@5VZ,SPH+MT5E\J!CM4K5SMUS4#D1G,(:>PZH,QC5
M.(GW`<7DF[G++FW%^.ZW&.1\21HO;NDW*R,T??:R-MM3<H`3!TD@<;6//D5*
M93D1F5N^4$'\T%\0(LP$D;*=3G]5`)%V.RVMI9`:BC;Q\S=CJM`QU@`J:@8,
MVG)6\8S()D3A?;4JQ@=<#DH,,!(#A=3Z>,FVB"XHGVW5Q`^X5330N`!L590`
MBR"VIC>QZ*WI^]875)3FP!!YJTII-6E!;MN`FNNN;*T#=#?/&W5SP$!819X/
M*ZLX3<!9X8Q0M=E$E]==$:#':4N#6W(&Y')!&[<X:*N@<0.];>R\J@O!G@>#
M9DA83;J%[?424^*8?)[/*USK:MOJ/@O'\?A=3UCMQQ+W'1P0=7-_40QP!+'9
M0?14BMYW&?#.*':G*2.ALJ?F@,T=PA``U*.T]TH'VD$NCYK>]CS>1@6"HSJM
MUV,/U[0@N.U!/#98VN530O:U@NY7':FPB83U61EF.PN@N89@9-"M1A53E803
MR6"I)7"0&Q5]'5.8P$('XS()*UI")'[I5<DADF!*LX_=H(E3K=#H?>?%/J=T
M.B/UOQ07(1H?$$%NZ/%XAZH+>G\;5IH_`%F:?QM6EC\#;('KERY!RJ<<'U;3
MYA6RJL;<."!?6Z"?1_LS/0(RC4+P:=H!Y!2"0$%;C0!@=Z+".S&8@'FMQC$@
M,3A?DL1J*@^J"]HM(=578G6\%UANI]*3[.2LUC4P%5E*#G3.G.9W-17PYGW*
ME4\+WL!:$]U-,=!H@DX2P-<+=5>2#O;<E2X;%)&X%VUU=.-S<(/$Y?>.]5#G
M'?4V7WCO50Y_&$"M3)]PGM3)]P@&AO.J>XV3$"\E'9K*C'9"B\902N2$=T2^
MB'S0*[P("/)HU`0<=D,HB&[F@&-'@^:N&ZL!5.39X]5<1^["!IW1&[(9W1&(
M'A<Y*$CD`7)J<Y-N@Y%&R$BC9!QV2)4G-`Y-D3@F2%`P[+H]ESO"N9L$"N16
M>%"<BL\*!'+F[+G+FE`J<U-2A!%QAA=2%[&W<!;X+%/=8$:_[KT,`2,<PG1P
MLL%B].::L?`/OV^""+2/<'Y3N3<'S4EK2TZ:V)!'5#@:+EP&SK7^"F4\?=L=
M3N@E8>"22K>$6>%%P^`M:20CS.<WP;H+N">%@#20YW0<E,AQ&%@L&`GR5%A\
M!>X%Y.JUV&T%/E!>T$^:`$.)S.=HP9/165-6ASKN&GHK*'#J-PN`T>B9/AL;
M`2P@#R0)'*+M(.G16E)(;&XT6>#C')DOS5YAP+B!N@F2S.RV!LJ^1\CR6G8J
MTG@+&9K+-XGB4%'&^:9XCB9NXZ!!:,PYLX%^Z/)6M+001&PU7F3>WDLD$L^&
MX753T\)L^:UFM]5983V[=-.(*F`PR_\`3D=E<?2^A0>K45$QKA(WQ'<C19'Z
M0,);'(*QK;L>-?(]5I,!Q6*K8VP<UW-KA8HW;&G]H[/U#F@$QC./1!XW2=^&
M2$N`NSEY*JYK3=G,#K\6<_@1M:`+%SS8>BHL3H*O"Z^6BK8C',PZCD1R(/,(
M&#PE`^TI#!=I4<^)!,HA=RV79>;@RYN6RQ=*ZQ6Q[)MXLQ:@T&*N;6,:S>RK
M!A\?,!3<8/LCFD<U#%3W04!(Z*)AT`19&-#+`(,=1<C5/DE[J""0!*%:Q>["
MJG$&5JM8O=A!$J4&C]Z?5'J4"C][\4%RU'B\0]4`(T/B""S+G-:"W=3*>OJ[
M961$^JC,%P`KFB8S335!'X^(N&D/XI#)B9VB'S5T``$J"CS8H?L!5^("M)'&
M&GDM8JW&&CV<FVMD%13.K!$.&=$.6MK&'O.LKNA;&*=M^BIL6#"^[3:Q0=)*
M^6*[C?14;HG"<FRN6'ZD>BK72L$A%@@FP:4[ECL?)%:TCJME!K$Y9''F7JFH
M+S"`'4[3;6R)4U,4#K.LDP,?5`>2K>TC"'L()&J"TIYV3&S`I9S`V5)@NF6Z
MOW@`CT0>*R^]/JH=1XPI<VDA]5$J/$$"M3)]PB,0JGQ!`)VNR0Z+DCB@0^$H
M4(U3WZ1KH!W;H"G9,&Z4I`@Z39!19-D)!QV0RB'9"<@9]L>JN8S]6%2GQCU5
MU'[L>B!AW1&H9W1&('A<[9*$CMB@$Y,3RFE`@W11LA@:H@V0<D"<D0*$Q^Z>
M$Q^Z!K_"N9LD?LG,V0<[=%9X4)^Z(SPH$*0)7)&H')4B5`2,ZK(=HHVMQ*3>
MYLY:QIU5/CU"*R1CHW'.T6*#+4MR)'.T!.BLZ0@EH08\/FB<6O!(Y%2J>%[7
M:M*"[A`;$+)K&YW_`!3F>Z"=3L+G@!!943`P74#&>TCZ,NAIG7D`V&I'F>BL
MH:!\S<KYGY>;6Z7^*L,-[/X=!=[J-DA.Y<+H,)AO:/%JRO$$V,>Q1D$B1S<S
M;\AHM90XWC.'BC?BKXYJ2JN(IF[&QMNM13T>#QD._0T1>/W%<0"-T7#;AL(B
M`M9[-`/1!F,1D?'4ML+!VH6FP";-EZZ*GKJ</J&Z`!@L+<@K7!F9)!KI=!J*
MB,.C]0O-^V/9UV*,B@=/P86$N/.[O3T7I@-V-4:JHH*EA9-$'M/5!Y7@G8B@
M@9)%+BU1PI#=[&NRM*V,?9KLS*]KJJ(UD@``,KKV]%/;@%`UUVL</+,K&CP^
M&$C)&!YH'X5@V'4I9[&R2$,\(#R1\BM)-$)J*6)WA>P@J%3QAH&BL0?JR#T0
M8?%75>%88T89:%C"`]P&I66[:RNQ#"<*Q*1HXX<Z%[AS%KA>AU4M-B&&U,,0
MO=A(OU"\\[76@[/8=3$6>Z8OMY`(,G&;-/H@GQ(L>@^"$?$@D4WBLMKV)_;"
M/)8JF\:V78H_\Q^""][7#*(R/O*@D>1%?R6C[7-S1Q_Q+/S,/L^W)!"IZAQF
ML.JLYW.X8(.JH:>[:FWFKU[@81=`&`DR"ZNXO`%20>\5W%X`@C5*#2>]^*-4
M[(-)[WXH+@(\6X]4!J-%X@@MX?$U:&E8`P+/0[M5W#-E8+H)ZY1VS@Z([3<7
M0*J[&/<'T5BJ[%_<&_1!#II"V'4:65%5U'$J','(J^ARB`7/)96OD8,0RM(U
M07#1]0/14,U_:3;JK^'6F"H9]*CXH+>DOP"LOCKP*IMRM12F].0L7VF>65C+
M]4&GP,@L%NB@]IW!N0G[RD=GG9HFD=%4]MI3'&QW[P03L$<'6/FM!)XO@LIV
M8ESM:;K5R;CT0>)S^\=ZJ+/NI<_C/JHD^Z!6(51X@BQH4Q[X0"]4S<I[DQ`V
M;1J=#X$R<Z)T/A0.<D"5R:W1`DG)#3Y#LF(..R$4]_),*`1/?'JKN+W85(?&
MKN(?5`(&'Q(K4([HC4!`D<E"1R`12`:IQW2(&G=$&R84\;(%7+ER#@F/W1$-
MZ!DGA2LV"23PI6;!`K]T2/PH;]T1GA0(Y($KDT('#=.36I;H%5?-(_,0#;75
M3R5650+90X;$V*`KS&0`\:]0N?%D(O;S1)&,CBXA`+N5U$BF=(W(X]X'YA!*
M<!DLGT9L[U0^5DL)RNN@UF%N9<`A:Z@9$X-LT66"PR4YQ=;;"Y>ZWF@T$5-$
M0.X/DF5K0R(@*5"^S-%4X_B$='2R2.(N`=$&:KZAD4CF[N\E.P>;/;U6?PRJ
M953.DF`)=J3T5LRKI6&])/$X@V(:X&R#>T,?$C#G>%)4'A/(#38+/TF-&&"[
MY@QHU).@"91=N,)K:DT8<]SMA(8R&N]"@LQ5Q/>0#8JRI)&NYK'8]'40.]L@
M8[+N1Y)^"8T)0&YM>=T&_B(T4L@6:J6FJP]C3HK1LN9H/)!F\(A?%45$;_"T
MN"\]^D"H+^T!HP;1TL;6@#J1<G\5ZZ^CRS.?$+,D=F=U7B/:V43=J<4D!N..
M6CT%@@KF?T0G:.4F!F;DH\@L\A`>E%Y%L.QNF*MMT6/I/>K8=D3EQ5@\D&G[
M5MO$P_O*D?'>#3HKKM;?V=A'WE0MD^IUOL@K(X?UBX"LY(W&(*)$2)@>2L97
M`1C7D@APM(>+J[B]V%3L-Y?)7$7NP@C5)0J/WJ)4H=)[WXH+@!%B\00@=$6+
MQ!!;PGPJZC`,85+%]E6S9`V*]T!<C;A2F/`%E5\??5!GK'1M+K[(+W.U5>+2
MM,1;S5!+CX;>[K%178K[2=]$%E45'!IK]`L;%-+4XB9'--KZ$K1RSLD9E<=P
MHT4$#77%KH+F#]E'HJ.=CO:";<U:,D+8[<D(AKC<C5`6D]R5D>U%/(^I:YC;
MA:R-V4&VRC5$<4KAG`N$$?LZTMC8#IHJWMI323PMR-OW@M!3M9&1D75+62Z2
M#1!G>S5/)"T!PLM:\7MZ*#$V*.V6RG\1A`UY(/$9_&[U46?DI51XW>JC3\D'
M1[H,VKT5B'+XD`7)HU("4[KFC4(!5&X"(P6:$*H\81XS=@"!KD@W2N7!`Q^Z
M8G/W34#7)A3W;IA0"=XQZJZA]T%2?;!\U>0^Z"!CMT5J$[=$:@($AV2A(4`S
MND2G=(@Y.":G\@@Y<N2H$Y(9W14([A`U^R<S9->G,0*[=.9X4UVZ<SPH.<D&
MZ<D:W5`@O=.U3K`:DIKI(QS"`;KJ-,TO:=/-300X7&R1V0"Q&Z"MJR]T#2W4
M#=1HI.$Z-Y;W;]XJQ,=KEI^!YICH6F$YVBW)`I(S`C8[)[1I=`C`#6M&S=E)
M8.Z@ET4A;(-5LL*GM;58N$:@K3X0=6Z%!MH*D"(DFP63[29ZUKA?NF]E954K
MVQM:-`=U3556QQ#;H,W#0U3874YD+HG:6(U]+HN']F0V8.IV&-]]'-T5H:J)
MAN3KT4JEQ8AV9@`MU06='@SQ9M5+Q.=G#0K04N#T<3VRFFC+QJ#8:*@@QUKA
M]8&YODI3>U%'%H^<7"#3U4;)8G-<`05YYC=*[#JGVJG!#;]\!7KNUV&#NR5#
M`=]2LWB^/4]>3'3#B-+LCG<@@T^!8AQX6&^X6SHI,T8NO-^R\3HXFYEZ#0&S
M0+H)F*U\>'X74U<KPUL49<">O+\5\]O>^:=\TA)>]Q<;]2O1?I4KYFBBPYC[
M1/:9)&]2#HO.F"R"53D!1IO>$HK$&3Q(#4QL]7^$5?LM<R6]EGZ?QJPV<#=!
MM*W%8ZMHC)YJ,Y[`SR67CED-0`'$W6B;3R24X/4(&&J@:>5T*:L8\`-*IJ^F
MJ&/)`/P3J&CF>0YY=H@O:75P/57<?NPJ:G9DR@E7,1^K01JC="I3]<BU'-!I
MO>_%!<!&BW""TZ(L1[P]4%Q%LU6#P3$;*OCT#59L>TML2$$5K#;7=0\0=:)R
MMW-%M"J7%3]6ZR#"U\QXI%^:Z&H<QNCD&OC>9''S49KBT6.B"Q=7R`[J=AU2
M^60`G19QS[E7.#>]"#8AOU`)WLJYLIS%O0JT;;V9M^BJ-.(ZQYH+2F&9A)59
M6N+)K"ZM:+W95;7@<<(#T!+K728IF8T9;[\D^@`S-1L4:"P^H05#"]POK\T,
MU,C3;53XFC*H<K+/*#S&H\;O51I]@I4WB=ZJ+-L$",V0ICWD6-!G\2`1W3F)
MB<-D$>?5X1H]`@OUD1FBP0<Y(%QW2C9`-^Z:E<;E(@:[=,*>Y,.R`/VF^JO(
MO=-5&?$WU5W#[H(&NW1&ICMT]J`@7'9<-EQV0#<FISDU!R=R2<@EY(%YI4@2
MH$.R'S3SLF?:0-D2L2/W3XQ=!S@;I[=ES@GL9<(&.(8PN/(75&_%YL[@T`#J
MK?$'AE(\6U*QQ=8V*"X-?)(-7I&U)'VKJL8]H%DQTNNA0:"&L+1KJGFL#CJL
MWQG#9R<VH>/M(-**EG,HT<L,@#"\#U6:%4X<TX56FJ#0U`@@:UHE:7N.@!4A
MC+M&BRWM#20>8V6IPJ9E3`T`C,.2`\((<%J,&`);=4`B(=LK;#WF,BW)!H<<
MBE]D#X2+C1>:8G78A1SF&2GRF^CCL0O4F3B2D(=S"H:F"*H#HY`"X;%!AV5+
MI:5L[ZIK;N#2UNAWLM#AV!LGQ&.F?7C*YF<$/%RA5%%%$^TE/&ZQOJU3:5U"
M^1KIHLCVC+<`C1!>X=V6PV*O>RKJG2-T+1GY*V/9_#^"^".(-)=Q(YI+9<H*
MKF34(A#XZ@-E:+"PV"ETE73EH#8GSRVL'2$V'P01:S"Z/$F.A]G#,\@<]P`%
M\NP!Z7U0\0P"EH:`LI8[-9J/,]5H:&!Q>'FQ=;D-`I59"U\):X7N@RN`//#%
MPMKA[B;+,P4S8'EK!I=1>T^.MP^@?04T@-9,+.L?=L.Y]2@S/;/$F8IC\\T1
M!ABM$P]0.?SNJ,;K@/)*-T#VG6R%)XD4;H4GB0%I_>!6#P;A5]+K*U73V=YE
MP@?AU*75#7%;BE@9P`"!LJ:A@8UK7VULKH.^K#6H*^IHF/DV!07T_!9H+*UR
M9.\]`J',D%AR04\=^(+JXB]V%6O`$HLK*+P!!&J$"F]]\4>HW0*?WOQ07#=D
M:+Q!!;L$6,ZA!<LU:U&ENQEVE!B\+5)G]T4"TTV9MBJW%00QY&UD\O+1<(KK
M5$)&A-D&*>^(R%KMU$K:89<[?P0<>8^AK"#<"^B?1UK)6!CG(*O:0A7>#'ZT
M*!70AI+V_,(V!RAU0`"@WMS[*WT5#&_ZYVO-7E[TC5GHC]>_U0:.@-V.]%`K
M_?#T4Z@\!*KL2?:<!!*H/&U2,3\!]0HV'F[F(V*NLSXA`"$7:H\K>^4>G=W4
M*0G.4'E,OB=ZJ+,;`*5+XG>JBS>$(&L0)_$CLT0)O$@$$\=4Q*39I0!'O4:^
MB!%JXE&0(NOHN*X[(!G=(E.Z0[(&.3>24I.2`!\8]5>0^Z'HJ0^-OJKR+W80
M-=NGM0W;V1`.:!X2G9-:G'9`-R:G.34"E*-DA2C9`H2I$J!I3/M)[DSF@:]$
M;HTGH+H;N2,P7C/H@IY<9+)',X>QMJE&/91[I4M6W]:E_B*&&H-7@6,TM1B3
M(JV(<-^@OM=;YV!X&^(3.@CRVO>P7BI:6D.;<$:@K24V/5D]$*1\Q&46OS0:
M-S>S4E<ZFBIV%S3;92W=FZ"35E"TW\EYV7/IZP21N(L;W7HF"X^^:CL'`RM&
MW5!65?8F29V:"F#`JJI[%5T+2]S@&A:BH[18]&WNX?(&]2W14U?C^,54?#<U
MK`=^J#(8CATM%JYP<T;JK951Y[&]EKXF2S!\=4-'#0K'8I1&CJ'-URWT03(G
M":9D<0NYS@!9;/**=S'1``L%M.85)V.P=Q'M\C+N</JF^75:E^'S6N0@FT$L
M-4RXL'#=IW"G-:6'19YL$T+P]I<QPV<%9T^(D`-J6V_?;L@T%+5AK2QXN"%7
MU3A%-F8>Z4P2,D;FC<'#J"A2M<[;7R03&M95,`<+E/BPO70V4&FD=$\7Y+1T
M=0QX%B+H`18418@D*XP[#Q<9LUT>*6,#O$(\%7$#8%!:TM*V,"R;6QAK2?)/
MIZAN6U[`"]RO.^VW;!TDKL.PF49`"))V]>C?[H"8_P!H8:%TE/2VDJSI?=L?
MKU/DL0YTDLCI97E\CC=SG'4E`B;N;DD]5(:$'62<TXIO-`:-F9!J!E?92:8Z
MZH-9[Q`E+[YJT#P"8]5G8#:1I\U>9CFC]4&MI([PM5C`&APNH%`_]7%U+#D!
M*\9V`,*@/@(&A4S-YA-=J@J'-M*+JSB]V$-U.'&]D5K<C;((U1NH\'O/BCU'
M-`@]X@MV[!%C\2`S9&8;%!<QNLQIY(\\S'1D`J`V8<.UT,O'5`:]^:?`]K'$
M$[J+G"[,$%9VBPUF(.8;:CF%30]GQ&;@E:O,+I<X04CL(#HLIU0:+!A33%[0
MM#G"[,"@>P@PM:3L%7MHFM>YX&Y4[,.J[,$#J8AC2$"J@;+('=$7,.J6X0-I
MFB)PT1:K+,W+OK=,77"#HF-:-`%QA!)-DH*<'H/&I/$[U4:7927$%SO51IM`
M@:Q1YO>%2&;J--[PH&!=)X2E&@3)3W2@9!K=%0:8G6Z,=4")#LNW7'9`,[KC
MLN.ZX[(!E-.R<4T[(!-%Y&^JO(_=A4C?>M]5=L'U80,.Z*TZ(+MT5FR!P3CL
MFC=*4#')J>Y,0<G#9-.RY`\&ZY<-DJ!KDSFGN31;J@8Y&9X#Z(+MT9ON7>B#
M)5-C52?Q%-L`NE-JB3^)(\W"!3ELAL>8Y`6II*;>VJ"X#140&5H!L-4W#ZJ6
MBJFR,)L"HN%UH@EX;[%CM"%+JX.&_,/`_4%![O@7:3#,4[/EKXF<=C+$'F5X
M_B3WNKIR.Z,YL!R43`\4=A]1D<X\-VAU4S&8LC_:H3>)^OH4$+VMI/#<[O<D
M"2C_`$E411O;W0;N-N2N>RG9"MQZO%1-'(RC;L=B_P!/):^M[(?H4F1CS-`\
MZN&IC/0^2"OPFE`:`UH#0+`#D%9".2,ZMNU66'X<X1$M`(T.963J`.;MMOH@
MHVTT4XV'H5!J\$?8OA'P5_)1NC==H(1Z=^N5X^:#SRIH*B%V>-SX9!LYJ%%C
M-;2/$=?3<5NPECTNO2ZG#8*EI!:+JEJL`:>[8.;S!""JI*^@J6B\@83R=H59
M00M.L4S#\5'E[,N\5&TO'.,^(>G51(Z$QNRN!:X;@Z607S1(T6.OQ4FBIY7/
M:Z]@54TE(7/'/U*U=-`YL4>P`0/EG%)&QKP'&3NY7:@A8_MCV09'"_&,%A/"
M;K44S=>'^\W]WJ.2U.)VDKXF`W,;?#YJUPF1].6A^OK^(]$'AL!N`I`6K^D'
MLP,'J1BM`S_EM4[5H_R7]/0\ED6/N$#TWFNS+B4$BG\2%6^-(R3(;A-E=Q"@
M2+QA7(V8?-4T>CQZJX:X68/-!KL/),`4M0L.<.`/12\P0/!3KH8<.J<'-ZH'
MW2%)F'5=?1!%GYH$/O/BC5&Z!![SXH+:/8(@*&S9$"`H77/5(-EUQU0.O9)<
MI+CJNN.J!UUUTW,.JZXZH'@I4RXZKLWF@)=*AAXYV2YQU0/2I@<.J7.WJ@==
M*$S.WJES-ZA`1*$+..J<'MMN@\=>;2.]4*;4(\C3G=ZH$OA0-8HTOO"I+%&D
M]X2@:A3;(J#+L@Z&P'P1"F1>$%/*!``$VY3B+IO5`P$W2FR0>)([=`T[ICCT
M3G)CD#8]96J\;X`J.+WS?57C?`$`G;HK/"A.W18]D#@E7+B@:4WFGE#0*?))
MR7+D#FKB5S1HNL@$]U@@&0A2'M"&&A`+B$E36N'`?ULHQ:+J0T`0/]$&0D'Z
MQ)?[R5VR;(ZU3)_$ND)(T0"<X!#:^YM9(YKN6Z07O<H"90#F"MJ&J;-#[/+J
M0.Z52.)T`YKU'Z.OH\DKRW%<;C=%2M&9D#C8N\W=!Y(,_@79+&NT$I.'P6A:
M;.GD-F#^_P`%['@/83#Z"GB96R.JZAHUS;`^3=A\5IZ.&*C@92TC&QQ-&CFM
MM\AR"F0QV'F@'1X93TT)CC`:UVI`.I]2B/I(@+9-+*2&D;V*>T#EIY(*?]%4
MK'7A9DUS%HVOZ+GTMSJVRMG1WU`0G"VA""@J:('6VRK*FAMWF@K7OC:ZP.RB
MS4PL;"X09:*5\;@V3EL58-8R9H*/4T#7C:Q4!K9:22S@<J"93T[<XY%3ZC"*
M+$&6J6VEM9LK1J/7JHL1$C0]IW4^DF?F(M>P09NIPE^&SMB?E=F%VD<PID=@
MP7`L`KN1I=8SL;(SG?7_`.%7UU$]T#S1/S&U^&='?#J@Q3,0:[M#*Z]X\Y;8
M'HMQ1,;,SC,87BUF@+/=GNR](YS<2K'.<7DN:P&WS6R:[A-:R!C6,&EAH@5E
M`*VCFH*^'/32MRO:[IY>8ZKP/&\-=A&,UN&N)=[/*6M)YMW!^2]]:]][YBO&
MOI`?')VOQ!S'9C=@=_%E%T&;L4A!3UQ0-:PE<]I;NI$+;E-JFV*`+#JIX<ZS
M57MW5HQA+6H+^@FD$(]%)$SREPVE<:<&W)3!2'[H00^-(!S2>T2*8ZE-O"HT
ML18;$(`BJD$@!5O"XNCN51.%I6J\@/U80"GYH$'O/BC3E`A/UGQ06[-D1NX0
MF;!%&Z"4Z`NCN%5RND8X@K34;0Z*QZ*KKJ<!Y-D%297]$G&>I7LY.P7>R.^Z
M@B\9W1=QW*2:1V]EWLKNB",)GKN.]2/9'=$[V1W1!&$[UW'>I/L;NB[V1WW4
M$;CO2\9ZDBD=]U+[([[J"+QWA+QGJ5[&[[JX4CNB"-QGIPG?92/8W=$HI']$
M'EKSWG>JCS;%2'>)WJHTNQ0,C0)?&4:-1W^,H&E"E'=3R=;)LEKA`D1L`B)C
M=PG$V"!">23E==H2D*`9W7+CN5R!IV0SKJB'9#<@2$7F:KQOA"I(/?-5V/#\
M$`G;HD:&[=/8@(E2+N2#BAIY33N@0[)`G'9-"`@V7+N2Y`QR8G.2!`P[HX]R
MX>2!]I'_`,A_H@R4F7C2=<RX$$)'MO/(3]XI"`Q`UPMR0A&^5[8XF%\CCE:U
MHN2>B<]Y(T7H'T=X%(ZV(%F6I>X-B)%\C>;@.J"V[!]@'QR-K,0C8^HT(:[5
ML/P^T[\E[)!1/CAR/\#;96\_BJZH@.#8?11T^I!)D<[4N<=R5>T]0Q\+)!JV
M0=T_T01VCNV(N=D9FEDZ2(ZN:FQBX026@$)V4$6*$UP`%S9&;J-4#<I&VH32
MW/MNBG1-(012TM2`;V'P4IP!&J&6:((LD39&FVAZ'=5]73AS2UVA'-6I;KKH
MX;%,J(3,P`6$@-QT*#-P"2!_A.0E64)OF(TOHI/L;PVTH-OR18:,-9R\[(`6
M<V-S6W<3U*9`)`YI=9H!WNICX"T:*OJ'N:2U!:.I&-C;%&+!@T/5180YY-^J
MM**6.JHX)XKY7,%KJ(R/+42,;N7:!!`Q>OI<'PZ6NJI`UC`<H)U>[DT?%>#5
M55+75D]9.;RS/+W6VN5[?VS[(,[14D9CJI(:J`'A`N^K/J/ZKQ7$\-KL(JW4
MF(4[H91J+ZAPZ@\P@CI%P-UP02*8V*2M-[)L1L=$E220$`&[JWC?:-O55#=U
M/:\Y`@W&%27IFW%]%8<0=++/X5.[V=MAR5AQW(+)CFN=8A0\0:!J$)D[@X%)
M4REXU05KQ]8U7%.?J@J:0_6!7%/[L(!SZH$/O/BCS[($'O"@M6;!';N@,V",
MU!H*#W2AXH0"5+P\_5?!0L7YH*Z&:[[*9G"J6.+'G1']I*"=G%[)<[5`]ION
MD]H]$%@)&GDNSMZ*O]INN]H06(>U=G"@>T)?:"@G<1J7.WHH'M!7"I(Z(+`/
M:5V8*![25PJ2@L,S>B4/:J_VDWV3A4?_`-9!Y1N]WJ@S"P*(3:1WJA3FX)0#
MC4:3QDJ1'L5&E\3D#&B[KIK_`!V1(]!="O>1`X:%*2++G;IJ!>20[)>20H!K
MER0H&NV0RB.YH:!U/[X*Z/A5+2B\X5V=D`3NGL3#NGL0$7+ER!"D*<4B!O),
M&Z);R3;:H'C9*N`-DMD`G)H"(YIZ)+(`$=Y2#^SO]$(VS:D(KWL$#^\-D&1D
M][)8ZYBF97N.RDN;'&Y[WD:FZO\``<*9-$,1K8S[,#>.,CWGF?+\T`^R_9B?
M$YXII6EM+FYFQD]/+S7NG9#"H87NECC`8PY1T)YE4.!4$D5(*R4?K-2!PF6L
M(V<K#S7H>%TK:2A9$-P-4%;VF(,<0_>"3L_.'4[J9^I8;6\DS'AG:W]TJNPV
M;V>O:X^%XL4&TC[H#";CD4WA`%PY.3`XL:UQ\!_!28R'A!"GC<:<_>:=%%BK
M70R!K]6'FK1PW'54>(MRF]K:H+]CFO:',-P5Q"J,)J<KN"\]T[*ZL@$;A<"G
MD)KA;4($<S,-K%,R6%G"X1&GJGZ$:H`!KR"RXL=B=U'A<Z-W#>IV6VJ%/")!
M<:.'-`5F5XMR5/BE,6NSM'=NIT$AC?DDT/5)B-Q%?<(*?LA++'68CATCB8VN
M$L(/('<?-:#A`5S7WT<"JG!8VBK,P;9S@1?R5X6M=*V2^K019`]5':/`:+M!
M0.I*MMG#6.4#O1NZC^RMUR#YNQ[!J_`Z]]'71D'4L>/#(WJ%7`A?1V/X'08]
M0NI*Z._-D@\49Z@KPCM+V=K^SM:8*IN>%Q^JG`[KQ_0^2"#3MS!=5LL`EI76
M"ZK==H00F[JV@BSL"J!NKBEERL;\$&OPJD_5QIR4[V3R0,+J![.-#LIW'""*
MZF(V"AS0R#DK?B@A,<6.&H09R1I$@N%;TY^K'HEEIVN-Q9.:S*+(`3[($!^L
M*-4;($/O/B@MF>$(C2;H3?"$\%!H<-]V/1#KXB]VR!15(C8!Y(SZD.-T%<ZD
MN=DTTGDI_%:NXK$$`4GDN-(3R4_BM7<5J"O]C\DOL:G\5J[BM00/9"E%(I_$
M:EXC;(('LGD4HI/)3N(WHEXC$%>:3JE]D\E8<1B[BM05_LGDG-I+#93^(U*)
M&>2#P]_C=ZH4FR*?&[U09-D#&;%19/&>A4EFQ45WC*![0`U1VVXA1B=T!OC*
M`KDU<N0<D)%M5Q*9(\`;H$7(8>D<\G:Z!7$W3#LFD2$Z-)2\"<ZY"@)2GZ\*
M[Y*FIZ:5KPYPT5F'&P%B@XI[4(YN02@2C8()-M%P"B/]HY?@AEM0=WE!/L$A
M<P;N"KBQY\3TPM`W=^*"P,T0/B0S51C;55SW,;S0'3L&R"V->QOV2ANQ'HU5
M1J6E,?,+(+%]=(>B`ZLD<;9E7NDN0&FY*D,IYVMSY+WV023*^UW.LJVNQ-D3
M2UKLSNET&LAQ&<EOA9ZIN%8#+75\=.7$-.KW6V:-T%AV8PF7&ZDU-8XLH(G6
M<!H7G[H_JO3L,I#B%9!2M;EIF$9P-@!R59'3LI8(J.DCRQL`:QHY^JV^`T;:
M.A#B1Q'-U(ZG=!H<*B]JK^):T<>@'1:=QLU5?9Z%L='F^T2<WJK.3PH*/%`'
MY@J*1I#KCD5H*T7<X*FE;9Z#3X5.*BC:U_2Q4Q@,<EAT^:JL)[K%;7#FB^X0
M$>JS$HP^%_4"ZG%]FBZK<4G:(W-!UMR05E.\V8[H5IX)LS1<K)TCKQ#U5]3/
M(8U!;+K(,4G)&&NR!A:-PD">;IKAT0*+I">8*1IY)'CYH$>QDHLX:]0@3Z0%
MDHTMNC@V0JK6%XYD%`"@CR2M:WDTZJT(4'#022\C4-`4]!PT7+ER#E"Q3#*/
M%:&6BKH1)#(+:[M/4="IJ1Q#6EQ-@$'@/:3LW6=G*PQ3`OI7D\&;DX=#YJBG
M/=7N_;1@K>S&(,R`AD?$;<:@C6Z\'E(+;((S594Q[H5:-U84Y&4(-GAGN!Z*
M:%7X6YO`&HV4X/;?<("@V3D+.WJE#Q;=`1-<=$W,WJE)N$$:=`A]X4:=`@/U
MB"U9X0G\DQNK0G(#1'S*+<H,>R+<(%OT*ZYZI+A=<=4"W77*2XZKKA`ZYY+@
M3U2:+D#LQZKLQZIMTJ!USU2AWFF)4#P[S2AU^J&#9.0/N>J4$]4T;)0@\>=X
MW>JCR&UU'DJ)S([*T;]$,QU<FYL/1`9KM[J.]X#CJ$5E!.=_S1&88^]W%!#+
MK@VU0XVON3E5PS#1S)1F4+1N+H*4->>27AR'_97[:*.X[JD"A:1HU!FA3O/5
M28\/SC4*]%(-B$_V;*@I&X:P<D1N'M!\(^2N6Q-`N;+BUM]$%4VB:#X444PV
MRJ>7-"&Z0`W01_96V\*::9@V",Z7R07R^2!O#8U)9HZ)I>3<%#XG4H".(MLH
MTIL$XR!1:E_F@A5,Y:5`?4N<=T>J(M<JHFF#-24$HR.YE1II@TWNHTE3IW7*
M))+FW-T$I]8!U2&M!ZJO7(+"GJ2:AFMQ=:<RD1BW18ECBU[7#<&ZU5'(9H,S
MC;1`LDSM=5KL"I#28=[3(/KYM2.C>BS6&4OMF(PP6):77=Z!>A%H+FL#18#7
MT0'P>%CYFSS;7[H(6WIH.'PR6]U@M\>:R=$&FHIH0/%(/P6YG:UE*3LXMU06
M>!&]&]W(O)4^;PJ!@`(H6#GNI\_AL@J*KO$JIG%BK:?Q%5T[;G1!;86<T05F
MT@:%5>#VX)OR4N2JIVO#2\7)0$F<`">7JJ#%WED9/-RMZN8,:7-L;<RLS7RO
MF>`XW)-[(#4-^`V^Y*O8B1&WT5-3-LUC1R5IF`TN@FQR*;#(-+JF;*`=2CLJ
M+'=!<G79,(0*>H:\@$J24`G"QNG#O-]$YPN$P=TZH$L5'JR6MU4LZ*%B5^&'
M!!(P]OU%^JDDGH@4@+:6(]0C@A`EUUUW6R1`MR@U3M`SKJBJ+*<TCCTT0"J:
M45M#54A-A-$YE_4+YRJHW4\\L#Q9T;BP_`V7TQ3;$KQ7Z3L(;AV.FIB;:&L'
M$%M@[F@Q(W4N(V:H;3JIL3;QA!HL-E?P1931*]#PBE)IPK'V1!$$STAF>I9I
M2$":(L0`]I>'@<E:0N+HP2J:0?6-5O3^Z"!D^Q4>#WBD5'-1H?>(+9A.4)[4
M-GA"(U!)$3BS,`HCI'--K'17E$P/A%^BKJZG`D)`00>.5WM!2F$W2&%W1!WM
M)ZI/:DAA=T2&`]"@?[45WM13.">B3@.Z%`7VI+[4@\!W0KN"[H4!O:O-+[6?
M-`,+NA7<%W0H)'M?JN%7ZH'!=T*[A'H4$@55^:<*JRB\)W1.;$;;%!B#1M#W
M&PW16TS0-;*41WG7ZIJ`1A`.C4_A-Z!.N=4VY*!PC8.029&WY),X!LN+VVWL
M@[*+WNES6YH)D'(H9D%R"4$ASVD;H1DN+(#YVMV-T!TQN2-+H))D.:UT-SR.
M:AOEYYD+B_O%!*?(>J&9-=U$=*.1)372/YH)3IM4)\I.ME&<]QU3#(>902'2
M'+="XETPRMM917SM8[4H)ES8ZA19WVNF"I:05%FG[Q')`*I==I`5'6'8\U.K
MJG(TVW5+)(Z1UR4#GD9=$,FZY<@Y<N7(%:+N`\UI8K11-#>BS<>LC!YA:=S1
MD:`+DZ`(-%V4B[DE66G,\Y6'R6RIF6:,WB.NJJ<"I1#2P1VU:+?%7M@UI/-H
MT06/9R`U&---NY"PN/J=%J,4?E8(^I5;V(@_5*NL<-9)`P>@']RK2ICXLKCR
M`07&#V;$&CD-E.GV57ASLDH;Y*SF\%T%3.+N)4*9ESH5.F41S3R0+3->:1P:
M3XA?T4B.&.P+F`^:?1`"%X=L3JFU3Q#'PV'4]>B"-B$_<LPZ754QO$FN>2-,
MXOT&J=%&&#S*`\.^8<E)?(+ZE1V]UFG-=)<V0/?(1LD;*\G38IK6D@7"-&P7
M0.;(\#,TD$*[PVIX\5G'O!5`8-N2F4(,;BX<R@M[ZI"+C1"#[IPDL@>-18J/
M6B].X=$5K];IM2,T+P-R$#Z0_JD7\**-=`@T-G445NB*TG5I.MT`X9+DM)3S
MKJ-5'\-0;=4=G@'S0.(-E%RDN=ZJ6"@/=JY`Z/NBRRGTD82<3[-R21,S5%*>
M*RVY',?):IFH)*<YK7M<QXNUP((ZA!\M,-RI\+OJ[)_:/#G81C]=AY!#8I3D
MOS:=0?D@PGZO1!M\%DM3#FK(2E4^!ZTP5H@D,?<@$*-7@6N`B1GO#5#K_"$%
M/)XVJWI_=A5$OC"MJ;W80-GV*C0>\4FHYA1H?>$(+2/PA/"8RP:$X&Z#085K
M&/1"Q%H!)*-A/NQZ(&+$:H*V.1N>QLI8+-]%61>,J9R0'NSR2?5^2#=(@/\`
M5^2[ZOR0%R`WU=^26T?D@)4![1^2[+'Y((*ZZ`^5G0)0V/H$%<$!PR/R3@R/
MH$`'1*#YH/.I)P'N]4,SV"KI)3Q'7ZH;IO.Z"R,_FFFIL-U6\0N&F@2%P&[D
M$YU2;[ICJ@V4/.WJF/?;F@D.J2#>Z8ZI<YQ(!0,S1J2ANEZ%`=TCSY(9>3?O
M**Z9VNJ&R1QO<V02A(+VO=,=*`=E'=:]\UDU[BYIR\D$ITNF@2&9Q')0XW.O
MJ=%TTC2;-.J`KY7'[0LA.E`V-T(#S37.:#9`\RDF]U'E=F*21^EP4$O)W0/S
M6YH$[]+W3))HQ>\@NJZHJKW:RY'5`.KE+WVY!1UQ).ZY!RY<N0=R7+ER!6>-
MOJ%ML!IC65L0^S'WG%8EOB'JO5>R%$8*$22MM++WMMAR0:>E9D:UH!L$M7)D
MC<!JBPG*#F^"@51+WA@W<;(/3.SD!I>S=(TBSGMXA^.J/&!F/F58TT+&T4$!
M'@C:WY!0Y*=S'G(=^2!("!.TJX/>BU5&T%K[D'=7-.[-'8\P@@SVN5&.JESQ
M.#B"HY80=D!J5MXWM"JZR;BS..IMW6^BL3<4TQ!L0P[*HC,;&!\CLS^7D@>V
M/*+E*#<^2&Z0O(UT16M)V&B!=>6Q3V@FU^B?&S:X1XV:V\D`V-YHS66^*(UE
MQE(1!&4`VMS`W4F'N,`3&M#0;[+LR`X>04X..Z`";)PTV0&SE%8_,`T^BC@&
MVJ<QIN/)!)PX6I0WHXHQ`S:H-">[*.CRI#@+W01Y1WW6Z(HN`T>2',"'BPO=
M$O<Z7^*!U[`E1@"?BBSNM%<<S9)3Z@GH@5NR5($J#Q[Z8*$,QNCK&"QFA+7'
MJ6G^Q6+AA<6;A;SZ>C-#A^$5433E;*]CG>HT7BK,9J1H'H/6,'>V*`->X75F
M)&G8KQC]/UC+6D4BF[55K'`.=IZH/9(B"\`)*[PK"X=VN@+1Q'AI\RK0]J:*
M5EC*/F@G2^,>JM:;W866=CM`YP/%;\U908_AS6`&9OS06LX4>$=\J%+CF'NV
MF;\TR'%Z'-[YJ#1,.B>%$IZNGE`R2-.G52VZH+_"C]6/1!Q;8HN%>`(.*[%!
M41>\*EJ'"?K%+0<N7+KH.777)$"KDB6Z!0N2)4#DJ:"E0*G!-3@$'C<A)D?<
MZ72"1M\H&O5=*\<5P`Y\T![@#YGH@*]YYN"$XV(.I3`7.)LU-XK0XL>@>9'N
MT`LF9SK?5!=4QMN`5&?4D>$V03'RBUMBDC=Q-,RJG53+G,\7]5+9*UD`>/$[
M9`29^3<J*Z9QV*!7U;6-:YS22>2@MJII#]73O=\$%JZH=HE%0ZVPU4!L6(R#
MW+6CS1!151'UDH`\D$MDP:27(,E1&'7+V_-)[#&UH<^1SCZKA3Q-.C!\4#?;
M(P+-!)0G3S/-FQ@>J-(U@UO9,=)"T:FY0"=%4N&KP!Y)KJ9V7O/>?BC-J6[,
M84[-4/T;'OY((1@8T7<VP\U"K#&'`1VLKB6AJ7M[QRCS4)V'1,!=),19!5+D
M680M-HRYWFA(.7+ER#ERY<@M>S=!^D<5BB=[MG??Z#DO8J-F5K=K<O)8OL+A
M_"H^.]OUE1J/X1LMW%'D8T..W-`Z5V6,H&%QFJQFCA^]*T?C=)5/T.JG=B8^
M+VEI;BX9F=\@@]7(L;(#M9$9P=<>:!(2V0:>2`9CN;A2::[6CR0]+^AU1V^%
M`61H>V_-0WM4UAT220APNT((+&Y@]G4$*A]EF#K$+192QXN.:X-C<2;`ZH*>
M*E)M<*4R!RL,K1R"6S1L@B",WV1!'<AR*2W1-<[F@X;62EW3=,O8727+M@@5
MQ)\DYE^>JYK#S10U`EN:>UH3FMT3VM0-&B>+:676`32;'1`_#W7GJF]'`_@I
MC@3LJO#WC])5#1]I@*M"ZP0,=N+C9./DDWUW"2,WW0"J3W6CS20$ACK[%-JC
MWV`=$]C3E;I9`0;)0D.@2LU%T&&^F7#_`&[L)5/:V[Z9[9A\#8_FOEX1R-OW
M'?)?9O:&E;68#B%*YMQ)`X6/HOFME+$+`QCY(,&X.YM*X,>=FGY+?'#J=VIC
M'R7##Z<;1A!A!%.=FN1HZ2K>-B%NZ?#/:)1%!#F<>0"V>%]@A)3YZHEKSR')
M!XJ**MZE&9A]6=WD+VW_`(`AY/<H&(]D*6AA,CY77'(E!Y.,/G!&:5WS5MAV
M`RU,,D@F=W=!JKVFPM]75BGIVE[B;!>B1]F(L*[/O<XGBY2XGSL@\/HL4JZ"
MKRF9Q8UUC\UZ[@U='4TC'YP7$#FO%:DM$DES<YCKUU5[V2Q2>*JCI\QRWV0>
M^X5[MOHAXKL5V!G-31GJ$F*;'U04T7C*F*)%XRI:#DB5(@Y<N7(.7)%R!4J1
M*$"A+NFI0@<$X)H3AL@\)J*I@D<;DZJ/)B`:`;V5=)1XK-*_PL;?FB-P&5X'
M&J#;G9`LV+-%QQ-5!?B5QW;DD\E;QX#0L(SASSZJ?%1TL&D=,SXA!E>+7RD"
M*GD(]"I,>$XQ4"[FF-IZE:@R.;H&M:/(+N,`#>0E!C,3PRHPV2(SN#LYT5G"
M\R0LOO9`[0U+IS$TDD-=I=$IC]0U!)B8)'@%@(ZE6>1K&"U@%6PO:QI)=8J5
M!&*V7A&H$8`OKS0.?4Q-8==5#DJVD@#JC/9AT1(,CI'#<!<Z>!K08:*Y'-R"
M/(Z>2W#C)]$K*"MD%W#*/-*[$:FQ:QC(_0*+-5U3_%.;=`@E^P1QD<>I;Z71
M6_HY@)9&Z2VY`573`SU3&F[A?FM!B,\=%0&GAB;G?NZR"`ZNIVBT5.+^B"^N
MF=X0&A0FOL$CW]W1`ZHEFE[IF<%3U&9LA:9"\=;J142$GG<*"=T'+E*I6,;=
M[W-VT"C/\1]4"+ERY!R+20NJ:J&!HN9'AJ$M+V'H#58NV4^"$7VYE!Z%AD($
M?":RT;6Y6D<K*Y8Q_"CX@()T/FGTD3(Z5W=%\PLI-5W:6)A(S#5!2U=FM(WU
MLM-]%\7$Q&KJ"-&1Y!\=UD:^3OFQW==>A_1A`&8;--S>\H-NX`M!\U':T/!O
MU1I+Y;#9`BN+ZH"<-ID/S11"+:%"O=UU(:[39`SA/!T*49FFQ"*':)VA"`98
MR3Q:'JLW)4F"OGCO<->0M)*>'&YX^R"5Y]/5.EFDE=?,YUR0@T@JVVOF2BK:
M6^(+,&I=M<IOM)MN@TYJ0?M"ZYLP<X-)68%2[D4>.L>"-;V0;40AP!\DX0CD
M+*NPK$&S1!I-G#E=6S7`\T`Q&GA@3B;+KA`E@`D)7.>`$%SB4"O?TW0R]S1>
MUT]L9.I1Q$W+9!3X=46QD`Z!S2U:$DD7MJLY-$(*]DG1X*TFN4O&K3J"@2/4
M%-8+%+%S7'2YY!!`JY+U%N0"DPR&1HN56N#GR.=U*/`71NU&Z"<XZ@)[=-$)
MNNJ*W9`Y[<['-.Q!"^>*_!\1AK:B-L&C9'`?-?1+;W7G?:.2"EQ>H:\Y22'?
M-!YH,+Q/_H+CAF)6TA"V[:^E(\8375])>V8%!6=GZR3#&_6T1<[J`M*WM0YP
MTI7CX*J?649%KH,==1M?ESH+6?M'6%IR4C_+14LD=;C%2T5;BR,GPJT96T;F
M@<1J+#-1F5A$K=#U0:?`<!H<,IP]C!FM<N*P_P!*':R*"GDP^FDO(18V.RN>
MV7:R+#<,$%*\.F>W2QV7S[C^(MEDDDDE+YI"2=4%49L[W&^A*M^S1OB<1'59
MV#5MUH>S'^)1>H0?1W9_]DB_A3L4V/JF]G_V2+T3L4U!04T?C*EJ(SQE2^2!
M%RY<@Y(N7(.7!<NN@5<%RY`JY<%R!XLG#9,3FG1!XK--&U[KNYH!K8VG2Q1Y
M<%F:]SJF>.(7^TY,93X/`ZTM8V5WW6"Z",ZMN>ZT%()ZF0_5Q./P4I^)X;#W
M:.@?*\<WBP0),7Q)X^JC@IV^2`L.'8C4&YC+1U*#BE%44$;722-<'<@=4$S5
M<Y(J,1D]&&P51'45-%5N$^::%YL"XW00<3D+G,OUNK&E<W@,/DJS%'ATPL--
MPIM*[ZF/36R"3+(V-N8Z@:E65/688_#I)XQ>J/<#>GFJ*MN87`&UU'PPG)(/
M,(+9LK2+&P/D$-T[K>/0(!EI2PQAQ;,/Q0VO:"W,+BZ"TCHIJFCFK&`!L>XY
ME5+GN*L!B'M+33PNX);H6@^-54\,\$@SM+03H@FT9JH(GU$<8(;S*6>JFGUD
M=?HK5TT$/9Z:(`":394N%,=5EK+7MN@-24D]4"8F'*-RFRTTK9!&WO'H%H^+
M3T=#PH91F=N!N%'PQKZ?BUI8'M`MJ@S==224\>>0:NY%57-6N.5;ZBHN77'0
M<E5(#:&.S1<C4H3W9G7M92\,@;43.:]^5H:3NHDC<KW-O>QM=`>BIQ4S",O#
M0M1%V7A#,SGW/*Y6=PI@,X>2.Z0M7.97N:1(0+<B@!_P]$P7`:5I^R.'BG,A
M:P`N<`L[B`J(6QEDI-QU6PP6MP_#*.'V^J:V6P+F@$E!H9&%A;&/"A5SNZ/1
M4U;VOPL/^HCGE_\`$-_-5=5VJDF;EAH0.A>^_P"2"55$F0J^P7Z0!@#G8<[#
M&S0LM=[),KKVU\E@)\4KIG$]R,'[@49C7%Q>ZY<=23S0>ZT7TE]G*GNSBJI2
M?OQYA\PKJB[3=GZO2#%Z4NZ.?E/XKYX##R3FM-]D'TY#)',`8I62?P.!4ENE
MALOF6"6IA<'0S21GJQY;^2NZ#M+VBHR.#B=5;H]^<?B@^@=$X+R+#_I#QR,M
M%7305+1N<I8X_$+789V\P:J(;5B6BD/_`%1=OS"#3XB_+0U!Z,/Y+SC+(PD7
MNMWB-3!58/-+2SLEC<W1['7!6)D=9^I&VR`8:3;5%;`3Y)\):XVN-D9CVM>`
M3L@6&B#P=;%!EII(3J%:T;@26W]%/=`V1NH!09RGJ'P2!S21U"UF&UHGC:;Z
M\PJ"MH"V[F"X0*"9]-.`20$&VSIS>\H4,H?&'`H\,N5Z`SF%<V.Q1PYKAHNL
M@8T`+@=4MDEM4%=7-^M!(5CA<@DIRPG5ILA5D8?%F&X0\)=EF>S[PN@GQ]V1
MS2DEOPB.93I6V>)!Z%#F<=&C?=`%L;&C9/L-[;)&M._-$#4#"Z_HBQ'1=E'1
M$8!9`H*\U[?PM_3+793=T0TZKTS0+S_Z4YHZ&FP^OD;W3(8G.Z7%P@QL=*UV
M^@Z*2VBBL+-OYID%?320"2(AQ\E#JL4<+W(`03*B.FB9=S03ZK.5\\3+EHM\
M4LU9-/H`0W[Q4*2-KC8$O<@CB6IE/=>YC.MTCJ_V,V9.]\G2]U*?3.='9SLH
MZ#=#I\,9Q`0RYZE!5U3Z_$[NF>6BUAKJL[B&!5$8=*R[N>IW7IL.'QM;WE"K
MHVZPM:+'R0>4P:`M(L5?]F?\2C]0A8]AXHY\[?"XIW9D_P#,HQYH/I'L_P#L
MD1\D3$]B@]GOV.+^%/Q0]TH*B/QE2^2A1F\A4N^B!R0I+KKH%27777$A!UTJ
M:$NX0*E30E"!4J1*$"W3ALF)XV0>!0U-'38FR6OXE8PDW8]VBFNQ&@I,2-11
MTC&12_9Z+-U@A?,U\SBT,?J1T4KAMD9=ASL#N[KN$!,1J7.F<]@#6.)T"C-F
M<5&$QBJ70/-XY-6^137/R7N@GB8VU"B5TF=L0N1WPA>T-MS0I9!*8[?>0,K\
M@R`&[M;J?2B\$?HJB?WKAT*MZ3W$=^B!M99L9)-A91L.-HWGS1*]WU0',H-`
M?JWCS0$JJ>6WM3&'(TZV"D4V'U520^/W9UO97F'XADI33"FC<U[<I<[DH`96
ML+J6)X#>1""VIL,PV&%LE9*WB,[W=.Y574U9Q3%&TG#$;1HSS4:5E=#&WVF)
MS`[PN/VD)T,P?!.PVE:=+()F/QOI7,A<W3DJNBD]F>6W(>_PD*RK9JBL=PY(
MBY[1J5#[G"OE^LC-QY()4DKHK1OB(D_>YHXJ9FT[HW&S'JMDKWU3V2S1'-L"
MT(U5*\TX:6%M]KH(%30SM@=5NUCS:*`KF=\[<-X<[OJSX0%3(.!(V)'HN7+D
M!::7@RAY;F`W"T])CV'-RB:!XMSW63`N;!6.'X?+/,WB,.3F@U51CF!S!K;.
MTV*;/BN%51TG#''?-L2@?HBCX>K`/@AG!:-PN!9`5T`;9[7-=&=G--PC1M:H
M;<(IXSFC>YI'0J6(W,'B#K("Y&IP:+V0!+R*()!U026^*UM.JE11@D*`'D:@
MH\518V)L@MX*9KR%<TE#";!P!\U04]4+C74*WI:O:Y"#24E#2-&L;3\%8,IZ
M:UN"PCS"HZ6LZE6D-2"-P@L:=K88Y&0@1LD\36BP*@3L>'$.;Z%';,#K=&!:
MX:G5!"BUU!L4<@N<"=T2.",.&N5I.O-6D-%`YH<'9D%;#*Z-]]=%H*"5L\1*
M![-"T:,"+"!'>UA=!)DC!5754;7DN%FGT5B)ASMZJ/-*"XV*`E#=D`:XBX4A
MS[&X<%#8\$)Q.B"SBFN-T=DPNJB)V@U4D2AH))V06?$;N39!?41@Z."QV)XQ
M/-(Z.%^2(&VFY46'$IF=TG-ZH-_'+'(,N;=0X7MAKQKHLS#7R@.D;(&\KE/;
M7R$FSVDG=Q0;MKVO;IJ"H\PRRWOI94^&54N3*YP)]58SSM8'2RN#6-&I*`K7
M:(@=94\.(MG<>"!EY7&Z-4XG2T<'%K)!$+VOO<H++,GLZK,Q=K,)EJ&P0/D>
M]QL.Y8*R_21M=L?S06ZQWTKX><1[#8@UHN^'+,W_`,2I&+=JZ+"83+7U4$#1
MR<=?DO-\?^E3]+TM3A>#4I>R9I8Z:06%N=@@S.`&6+#FLRFYUN4:9T>>\KL[
MONA-IWU4E,R'*U@`U(160M9L,SNJ!"9)V@%HC8.2)$QHLV-MW=5(AH9IW#-H
MU645/!2LOH7!!$@H2YH=($5S8HMK73YZHVMLTJM=,USBTGXH),\P8R_,[*LG
MD+R+-U75#F9/>;*(ZNIV6(>"1YH*'M@PM8PNZJJ[-$'$HC^\G]JL3;5S")CK
MY3J@=FC_`,QB_B"#Z4[/']2B]$[%C9J'V>_8HO1+BY[J"GB/UA4P'15\9[ZF
MWT"!]UUTRZ6_F@>"NNF7"[,@>-4J9=*"@==.0\P2YP@(N3,[1]H*'B&(14D+
MGEXN!U03W.:WQ$!#]I@&A>/FO,L7[73/E<RGU`YJF_3V(N)<9`/@@JL5IJ6+
M$9XJ:7BP7T)&ZB$B-HC8,K!R"E8FR?C23.%KNULA8=AE;BSY64K;\-N9WH@J
MJP9AF:#F;J++38!0T&*2MAQ;-1-R?5OM8O*LH^RGL6$-Q>HGC=8ZLZ*#VAQQ
MF,45'%%$V.6'NAS>:`3.R+_;XWU4V3#7291-Y7W0.U>$46%5T4%%4":$&X>$
M^+M#5U&%NP>:^6/1O7YJGJ7G)`)27V=8700:\,!;DC(/,]5.I3^K,OT4&O+7
M92#S.BDTU_9HT"5KLK18#91Z,@0RDFVH1JA@D>UIO:QU4>!I--*1MF""0VH>
MUUV$E3\#GXN($5;K#[)=H%6PTQ,D36DDDW6LK:")N"PRM9>:]SE&H01NU%;/
M-+%2/E8Z.,=S*IN$X>Q](97N!RMN"L=+,TNNYQ<^]E:,Q.J@^I&81AM_5!>8
M?B\>&FH,U,V82-L"1J%2TH9-5/+P&M<2;*`VK,M2,VHO>RU6%3X.ZEGK*D99
M&"PCZH(-.RBI9K22`M&HT4*MKZ:JJA&X90T]TVT0)2^IF?)&S*TFX'1`GI2Y
MKN)9K@+@H"5U9")&Q9<S0-?)4SR"]Q;M?1(=3J;KD'+ERY!(HPTO.;>VBU&#
M0ES,Q<2LP6&$1N)RFURKC":TLT83;H@T[XH]!U"5U.T1VN4)M9'-"+&T@ZI'
M5S&V:\W(Y($]G'4IT=.#?4HD5733Z-=E/4I6R921FS#J@A2LC:^SBC34+@T.
MA=F%O"=TLTS8R0^*]^:FAUXVD<P@IB7QG+(TM/FNSGDKZ,0S-R31A[?/D@56
M#6;Q*68%OW'[CXH*Z.8@J?3U5K:JM,;FNLX$'S7#,W9!J*:LTW5I3UUK`'=8
MF*<L.ZGQ5OG9!N(:X.L+A6$%4T[E8."N(U!5E38@+BY0;>.=IYJ5#*0;M=E6
M3I\0!MK=6,-:"+YD&@GJ*K)]4`\GYK/S8S60R%LF9A'(BRG4];?FII-+6,X=
M3"R0<KC4?%!31XZX^,_BID&+QNMF<%&KNR?$!?AM1:^O#D.WH50RX3CU,_+[
M#,\=6=X(-W!6Q/%VN!*G,FC>T6(7F[)\1IW6EHZAA'6,J?38S)&0'7'4.%D&
M[+@!H4&JE+:5[@=2+!4=+B[)-"=U<.89Z:-YN(W"X*#-3]PFXV4=]4(A>8!M
M]0P#6RM,3B=%2R5,(;E#2X.=MHL"R6LKIC-/+EB)T:!JY!J8L1AE=E%]-F`:
M*RB<7,[C=.JI,.B:+`6'57]/(T"UD$B%L['-D$H:`?O'9-K:D8G6RT\->]T8
M=W1L$0@2-MLL^_L[7QUQJ*"H#&O==S)#I?J$%O+B#<(:3+)9K38N/,^2D8?7
MR8[%+FCM&TC+?FJ3M'V9Q/$&05$58TNA'>C<+-=YCS1L`DD@>V@I9#EL./)S
M)Z!!/J<(?$X5,3!G9WA;FO,>T_;SM%+42T5.YM$QA+3PQ=Q^*]SIX6%MVD]"
M"OG_`.D*F;0=K*R"PRN(>+>8N@RSV5%9(9:NHDD>[4ND=<_BM#V9AIZ=[VO<
M"X[*G86.<`X6".,E+,R6)]R#=!OV0$C-)H#L`CLA8+%P#1^:;0U,4E!#4.(+
MGA,G=G#B'ZCD@LFSLR\-EA8*!.^\I:QUSYJ+3S/+P[G:UDV1IXQD=((QZH.J
MWNL+D9F\E6559'3Q.DJ'A@'50,:QVEHG.RO,DGEJL1B&)U6)R@2.LV^C0@L,
M2Q>:MJ.%1N(C.YV46ND--"UC7DO=OJK3",&E?025$8S.&JS%0][YG&2^8&UC
MR0,U)N3JKOLQKB,?\05&KOLO_B#/X@@^E>SO[#%Z)<8/=3>SG[!%Z+L8\*"D
MC/UBFC8*"PCB%2P;`("+DR_1=?5`KG!HN2H<V(0Q_:%T#&ZK@4SG`V-EYK-C
MDCY79B2+H/09L::-C\E$DQMQV+EC8L7C([UT<8G"4&D?C,W+,@G&:@\G?-4S
M:^)W-2&5$1%]$$]V+51ULZWJLSCN,U$]XBX@'?56=770,B(!%UE*EQDD+R@$
M'@#S1XHJA[<S6:73,/IS/49?LA;&FC@BA:RPT04+8)W856MEGA/#?>WVG!56
M$XW/@E8<FC)6%KCZH]3#EGG)T<U]KW4>I9$,S7-#QR)Y(#LQ6JK(YZ268\`F
M]BJNFA>TNCX6C'7#K\D]Q9&TAK[W'1&IY'`/'WFW"!H8X2<0.#6_:%E!K79W
M1%N@#D620Z\E#<XR,:`->):Y0,K".[8W-RI=,3[+&H%0TM-BZ^JG4_=IXS=`
ML\V0!K0+D'50F%PI'&_=SC12)VYK/M8!`BN:61H:2<PV"#0]FZ5U6\/+-!H$
M7&,8J8*I]+`S+$T9;V47!\8=A](Y@R@VMKNJVKQ&6H81U.Y01:5O&K&!W-UR
MMG!AL6(SMBC+6M`L2LM@;(S5YYO"W<JZDEIX9Y744C@QPU-T$G#L#A&-<*^=
MK";E.[0TE&RHRTA:+FSK;*KPNKK*%TN0EW$V)W4:*.J<\B:Y!<2"@MZID--$
MQD9%LMR0J#%)B<H:XV*DXBQU*T%CC(T[^2:UW$I,[HA;J4%*`3L+KBIL4D?&
M>_1H`T"A'<H.Y+ERY!-KIF2LBRVOEU1,+E:PD'=5R)#)PWW07[:F%KP9)0W5
M2:NIH2P&)XS=;K*.)+B2D0:>DJ8'-+72`&W5'?*&Q![);_%9%+F-K7-D&I?5
M2/8WZQJT--=]'$[F6KS4.<-G$?%;_LQ)Q\(A!-W-NT_-!.C<6N4UTQX>_)`D
MAMR0G.L"$`'.#S8@%)'3,D=9KLI2.&I*Z%UI`@4T%07Y8F<4\LNY^"COBDB<
M62-<QPW:X6*M!(8W@AUG;@@JUQ'$!6T,<DF5SQHZX099I<!8(C)Y&G=3Q!3S
M"[1E/DHLT!C=EW\R@D4]>6D7)5I3XC>P+EG',(Y$)H>YAT)0;>FK_P!Y7-)6
M\[KSN"L+=R5;TE>3;OH/2*6N.6X*EPUKKCHL12XDUS0,VBM:>N!`(<@UPK'%
MMKW"=QH9?>11OOH<S05G8JO<$H@J>CD%R[#,(GN31L83S9W2I,-&(:1](R5T
ME.X&P/B9?H>:HFUI'VD=F)<.QS(*CM%,*>,8:0[NL%R=BT+&&4<32UKZ`<EZ
M;5##<;I#35[-_"]IRN;Y@KSSM!V6Q/"2ZII;UM"->)&.\P?O-_J$$RDG%B2;
M%7-))G=E!^*P5+B`=H'+2895@"][70;2!K,O=O=2VES`"1H>JKL,J8L@S&SK
M*Q>[,RX00L<KLM"(*:_M$G=TY*EPF%U*PFQ#@;N+N95?C^)OP[%*=SA:*1I;
M?SNKBHJX:S"XYV/:Q@`N`=0>:#045>PED5VB1YV)7EGTO81/38U#BI;GI)VY
M<X^RX<BK_LA1U=?6S8I6.+0YQ$3>C>2V.+8:S%,&J<*J6AW'C(83R=R/S0?-
MSY6N:[(W0)T;F.`N4)L,M-/+3RM+7QN+'#S!LI3H82!>["@U'9^.H?">\TPM
M&FJ++Q^\[7?=0NRK'ODD:V4F)FI')#QOM'3TSI(V$$M-@T=4#<4Q>/"8^('Y
MICH&K'5_:+$:QSLTF0'DU0JR2JKZAU1(TDNY=$QE'._9EO5!'>]SW%SW$D\R
MI.'@.J+'>VB*,,G/-J)!AL[9&NS`$=$%]@^)U%!G@-C$X=%FL5<U]?,]@L";
MJ]BI7GQ.NG-HHP7%S02>=D&45OV;=;$8]?M!6+<,B>[1@N?)76$X)%3O%0]M
MB-@@]J[,O::&(`ZV3\8\*H^Q=5Q"Z(&X;HKS&/"@H6>,J6-@HC/&I0V"!;KK
MIM_--+M"4&8[7U&2G>V_)><!MS=:_ME49G%E]RLI&$"</R3F,%TYVR:QI+KH
M"SY8V=TZJ,RIF.@)^:=6$@6&R!3.&870&^L<>^24DIL+*9=EKZ*%.1J>2"X[
M,TG&;)(>6@4J:4Q321N=JUUE0X9BTU!G8P`M<@U%8^>=\K@07%`-TLOM\O%N
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MV5EC4XJ7L%V11,%AYH*Q\]/&<D,!/1Q33,Y["TLL?)`GK*6"Q`,A"K*C%)Y"
M>&!&W\4$Z4@-+9'-##OJH-35T[:?@17<%6R2/D<7/<7'S31KL$''?1<G%CP+
MEI`\TU!RY<N0<N7)\,9ED;&"`7&VJ!61R2,+FL)#=RAK5X)AL<A=3&2Y.IU5
M'C5*RCQ"6!FS4$!<N7(.6P[#S@\2E)V<'#XK'JS[.U1I<5A=>P=W3_1!ZA4Q
MAFBK9([N*N&EM3"U[=^:`ZF-R@JA"22$TP'-S5RVD-KH<L0;H!<V053HB6M(
MY%$(>V!S3>Q5[%A;WQQES2!:Y\T&MI`QA`&B"AI92UV4JPD8)HO-5TD61][*
M?2O[H"!E/*UC^%.P.;S!"L_T%2UK.)22F%Q^R1F;_=0JB%L@TT/(I*&OFH9`
MV0G+?=!'KL%KZ.[GQ\1@^W'J%`:]S3H5Z#35]/4,!S"YW5;B/9^&I>Z:C>UK
MSKEY'^R#-P5;F_:*M:7$G"PO=4DD#XI71R-+9&FS@>13FN<PZ'1!M*7$`X6+
ME8,JFD"Q6&AJG-(N5:TU:2!<W"#5L?<Z%+4EL4.=S@W3<FRK*6IN1W@5>BFH
M\3HWT=;"V6)XU!TMZ'D@IJ>NLXCB7MT*OL.Q5S``77'FL1VAP:IP`BJHWRST
M5[/:XYG1^=^80\/Q=LK&N;*US?(H&=MJ6CH<5BGH@(Q4M+C&-@X;D?-1\/GT
MO<K-=LL4DK>T=.V-WU=.T,L.IU*MZ!QR@W0;;#JLM+225?-KSEU/PNLA1O.4
M*T9*6BU]+(#8I1PXHWAS-N+W46J@`ABPZG%F[.(Z(U15-IJ9\[CHT75K1.P^
MII63M^RVY:-R>J"5AA;31LAN&Y1:ROJ:4RD/;LQ9"(U$]5D![U]P-@M%1/\`
M9XWL>1E'XH/"_I(I/T7VNKFM/<E?QV^CM;?-4,M4V6)A`.FBM^WF*-QSM+7U
M+;<)CN#'YM;I=9C"0]U5DWC8ZY!0:VEF?A&%N>#>:<:`<EFFT3I9'22:N<;D
ME6]0]]5*"[PM%@$YC6,&FZ"+%1,:.]8)_":#9J,XN/),S@;;H!EF4IS&"Z>0
M#SU18V`#4H%C9:Y7"-SWY6`DE2J>%\[LD0N5=T]+!0,#Y`#*@C46'"E8)IR+
M]$.IJ'22!K-&I]34R5#M=!R"%P@P!SD&P["&U2\+6XQ;(L9V#?FK9++8XP>[
M9!0L/?*E7T"AL\94DG0(.)0Y76C<?)*2HU8^T#CY(/.^T\IDK;7V)50Q2L9?
MGKGJ$38('N?9)&\ER6.DJIQF9&;=4U]-5P7S1.]0@ZK[P4*,/!V1@\DV<"CD
ML`%@@"Y[FC0(/$?)W+*3<'HIE'2YCGL$$"G@,<@<]MPICC!F.@4^6'2V4(+:
M0&YMS039J.BJ3[4^:^I!:3M91Y*C#W@1-I(^$=,UM4";B0N<UA!-R22/R42-
MSI7.'#L`=7%`VK,M&YQHY'<-NI9R(5;*YI:YWV7=ZRN&4M3(YPX;\CP0--U#
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M5C8;=M/$&A!!INS<;&YZF4`C<70*EU#2`AC6W'DF5-;/)F<YYUY*BF<YTA)*
M`E54.G?<Z-Y!`7+@"38`D^2#ERF08?42V.7*.I5E#A4,=C*[,4%"N!(-P;%:
M?)3QC*U@^204<$N\;1=!2T%=+1S<1KG:^:7$)/:)>-<N>[4FROJ;"J34.`]2
MI(IZ6%N4-!L@QS8I7&PC=\D<44A;<N:WR*U)93VN6"W0*-+3QRZ-:;%!F)(^
M&ZQ(/HF`D$$;C4+5-PJE+>\T9NJ!4X/`!=GX(--@6(YZ:*8&[7#O#SYK74IC
MG:T@[KS?`FFESTSC=KC=OJM+15DE,X:D@<D&PGILL0(&Z&S#VMC!>.\YVUEV
M'XG'4QM:[<<BK&21A`<=@;$H+>HH0V)F5HRY0-O)4%=1W:[1;"AGCK(A&#<\
M-KAZ646NH^Z3E0>85E&6N.BB-86E;&MH7O<0V,GT"A?H'$)O=4<I'4BR#/W-
MD&9H>VS@M7%V1Q9_BC9&/WG?V4D=BJ@"\M4ST:U!YV7U%.X\-Q^:FT^-S1D-
ME<X#J%M).R<,?CO)ZJ+48%!$PVA;_*@R6(5L54]LP>#);*[J>B&TAPW5Q/AF
M8.X3&7V\*S59%5X:XF5I=%?Q@;>J"?EL!9.;(YO-1J>I9*S,T@H[6E^J"SI*
MTL<`7+5X7B#1E[ZP[8G7!`5MAKI&/`&W/5!OGSLJ(LALX'0W5'-V=PIG$>R!
MC7$$BPM91?TDV(M;G%U&Q;%*D1<)C,K)!;BD[>2#SF&B!K72!MP'GXZK21-(
ML6C3\D:&ARD`#SNIT=*0-D"4TA%KJTA>=[Z*O;3/!N`I]%!(YX;8H'U;>/3.
M8?"1JHN&RUT4A]B:!$W1TCAMZ>:U4/9VIKJ60M:\-:TFPT+CT"@8;)2MPYT;
M&M'#NTE[@+'GOS06&&%M*UKRX%^[R>:SO;3M3^C:>6.!_P"NS-+86`^`'3.?
MZ)F+X_1X33%L=1'559'=8PW#?4KS&N?+6RS5,[R^:0YG.*`]#@TLT`EXH.;4
MJV;V8J**@=6LLXNU("IL,K)6,$3;V'FM-AF.N-'-1RZV&ET%&QKKVM=20QC&
MYGH#YP''*+()F<X]4!7OSZ#0=4)S6M.ANGM#B-4QPL;W0=HT7YJ30TD];*&1
M@Y;ZNZ(F&X9/B$@-LD0.KB-UHW204,'L]*T7MJY!T;(,-AX<=G2G<JNFE?(^
M[B25SW%SNI*/#!]IVZ!:>`WS."BX@\`Y0X7Z*?//PX2`LP9'OF<YSKH-[]'E
MS62$^2VV,>%8GZ/1^MO^"VN+@EJ#/`VDWLCE[;;A1Y8W7N`4!V=!,<\=0H&*
M29:9VO),<9/-5N,2O%,0;H,+6NS5<I\T$G8KI'7E>3U3)38(/0\";`:-KLH)
ML.2G/HX*@>`!4G9N7-1CT5W33N:[1!3XAV<9(26QCX:%9VN[/U,>L9<`.1"]
M)94L(LX)[FP3#8%!XZ^DJXG@.A=\%>T?<BU&O0A;J3"J=YN&`%1*C!VD6#1\
MD&7S`_91&%EO"K&;"7M)M<(#</F%]D&6J:LSYFN<0P'0A2L-88:=U4YH>TG0
M%5^(0NGJ728>PNN;.8T'?JIK*#$74L<5?4,I(&B]BX7*!M;BE1,]LCIVQAF@
M:W908:JMDJ"^&:25Y\KV4POP&D!#6NJY1S=LH\N.U`!920Q4[/W6ZH+"'":F
MH;QL3D9$TZB^A78G/0TT/L]+/Q1L>BS535SRZRSO>[S*!$72O#;$A`F)G,V-
MU@-]E(HQ^K,-[)N)P2%L+6L)WY(L3#'`QIY('O#G1W`3&TU1,;-:3\%H>SU)
M33Q.=4$`-ZJWDK,-HA:-K7'R"#.TO9VHF8'27`\U;4V$X=2"\[@7#J4"LQJH
MG861_5L\E3O+WDN=(3ZE!H)\6I:;N4[`;<U4U6*U$[CWLH\E!RWUW79"?)`N
M<DW<2;H$AN=`C.:TZ:WZ!$&'U-P7MRM.H*"ME$EB`+*&:6:1_=:2M/'0Q,L7
MDN/FI`A:/`Q!FH<*>=976'0*;%#%3M`9%<]5<<!SM7"P3V1PQZD7*"IO.1HV
MR3AR'5Q*MG/8XZ#X67&`.UV""K#<IO9/S.&JL70Q@V`U2-@83=Q0062/U`2'
M->Y*L3%"-`0F/A'P00FZ&Y*7.>1LC&`'9--,3L@%Q'$^(KC*1I=/]ED)3A2E
MNY013(]KVO;N#=:"%[9HFR-^T%42TUQH%(PU[HG&)Y[KMO5!;P3/C>"UQ!"T
M%#B#9(RR34D6UZ\EG+:W18WEA!')!ML/J*B2F$U*\MFI``0.;2;_`)W6CH\7
MDDC:ZK@!ONX+`X/B)I:ADY&9A.61O5NQ_NO0O8&-8)([R1$`CTY(+""LIW^%
MH;\%+$@<`;BRJ(Z,-CSL)L.JG4Y(:+H)!?\`)-)'.PNF.OJHO$+3D=M?3R0'
M>QK]#:Z@UE"'QNL!LI`E((N="I+")&:(,&^GX$SF/;ST4\X-3UM/JT.#A8@\
MT7&F!E2';"ZL<(&4!M[C<60>9XUV&K:%YJ<(?W";F)_]"J1C\1IW\.HI<CAU
M!7T+P&O8+@6]%6UN!4M3XXFW]$'DM$U[QFX0)\BIDV'U=4P-9,Z(#8,%A\5N
MO^$XFNNSN^84F'!'PD7(>WS"#SJ&&:DRQU\1R_9E:-/BKV*D@JJ3(QS7W"V)
MH(G,+)(18BQ!"HZK`N#(9*,EHWL$&0EIJJ@F;&-8[_:Y(T%:QSLLD+QT(6J;
M`*F/@U4=G<G65/4X)+#*2UA<WEY("T@IR]CI&2921<@;!;.DPZDA#)(;2`BX
M=99+#\/J<S6C8\EN*"G+6F,`[7^*"SH#E&B\N^E_LG%#?M+21O#)'#VJ-I[H
M=R?;\UZA1M((5A5TD%=0ST52P.AFC+'@]"$'R$#Q#HT^@1V1R$91$[5:?'L"
MKNSE9+#54CVPAY$<Q;W7CD;JK-3F(%P$&6GCKJ>J<(8S8]5;X;35+FOEE%G'
MDK<S0@9M"[T0VN<\.L;!!'CH"]A<YUK)K8&LN+ZKB^1MV@E+%')*\-#27'D$
M'!NA)<K'"L%-1^L55V0C4`G=6-!@X@M4UH`L.ZQ+6UKI3E;W8V[-"`E15,CC
M]GIADC&E^JK7/+G91J2ELZ0V;JB,8V,;Z\R@Z)F74ZDHG&([C4&9_=.0\MT*
MC<[AN+AK?1`6H(#>^=U4.`#KCHK2:GDE;FY!5,MVRAM^2#<]@7M;5/)ZA>A3
MB.3<A>6]D7N;5NR^2W)J'\T$U]-$>BCOI(M5%-0_JANG?U02#11+/]IZ6..E
M=;HK7VA_59OM75/-,1<[%!YT_P`;O5*^Q:FE-<ZP0:_LN[]5LKR`]\K-=EY?
MJ;>:T4!NXE!,OJB,<0HK)0Y]@I`*"3'.\<[A&]H!T<`H8-E38M6R02M#>90:
M@.B?H0$PPQW.BHZ'$>,X,.ZN&$VW0>85N/U.9\-+%'2Q7MH-51SSR3/+I9'R
MN/,E+)')),[*UQ-U*I\*J9B+M-CT05MS:P2MAEE($;2M52]G&-[TVG/4JQRX
M91L&;*XCD$&4I<#J9B,PT*T.']GH8`'S$`!-GQ_(W+2Q-;;FJBIQ2LF\4AR]
M$&HE_1=*PA[6R$BW592K;&YSC$VS2=/)-XQ+.\^Y2-F%M+%`]CI&,R,<0.:9
M?6YU3.(X[);_`!/D@XR`NRC=):U[E$BII7'1H:#S*FQ4<33=Y+B@@L:YQ`8V
M]U*91/.KW6"EET<1[K0AB<O)N;!`L<$$6H%RGOD+S8G;;R4?B-.IO==Q6702
M6Y`>^=4KY8VZ-0F-?(=&D#JB<!D9N\YCT0,,CY=&71F06U<[X)`[70!H76/5
M`0B)HT%RAYC;5);6P2@`'O&Z!N7,>:=PP>:,TL+;CY(;W-<;#9`T1@=$O"+M
M+KFEG0^J4NMX;_%`G":TV.J7A'?DD:23<I^<Y4"!HL4S(=[:),QO<HK'N-@0
M@"1JFE@O<;HKFV<==$K6,.F9`^&<`AC]#U/-3`S-LJQ\0<""[;9.I:MT3N%,
M=.106]*")PTFP=H5Z'V2Q5\M/)13.[T+;M)Z<Q\%YY3N)D:]H#M5<T-744E4
MVIB`:YH&8$;H/3*5PX;FFQ%T1KVCNCDH^%QBHI3)%?(X![+[Y3_;92!"\.RN
MW"#B3XKIKHFO.N_(HI8`"?P3&N;<A`II18"UQR2QP<.^4V16R<CN-BD,C1S"
M"A[04[C`90-DG9R0R-8#:X4S&)V&BE9O<*#V6:<I/F@UT>@LC"Q"C!VE[HK'
M<T!L@*[AMMLE8X$)^Z`$D(<-@57U-'(.]'KY%6R<&@Z(,P!"]Q9(S(\;@H[J
M>-\):TV(&CNBMZW#(:MEG!S7#PO;H0LO5U.(8-,(JZ#C4Q-FSQBWS'5!=8;$
MR1FK6ME;H0!OYA7<$65HL-%F:.N@=()8Y/@0M+253)F--P">?(H"B$!^9HT1
MR;)KB04K>\=4`:VFIZF`P5<#)H'BSF/;<%>6]K/HL,A=6=FY&-!U-+*>?[I_
MH5ZU,V[+)L)([I0?)]33U5#6/I:R!\,\9L]CQ8@IY?E8<GR7TUC?9S!<=9;$
MJ&.5X%A(-'CT(U7F?:7Z+7TC34X+.^6$&[X9=7-'4'F@\OIX9JB01QLS/)Y+
M5T5)3X3`):@A]01HT<EUJ3!HS'``^H/B>>2JJBI?*\O>224$BJK99GESG?!1
M6M=*>Z+#F2DC8Z4W=HP<^JDN<QK+"S6#\4"6#&V'S2"":8$@98QU30[B/`V&
MP5K6O934.8D-:!J@J1'>01_-$F8V)S6M((\E7?I!HM+&,S3T1J>9TT;Y';[H
M#U%7D@<UN]EG@\NEN[4E2IY7`ON=+*$'?6!!L>R5C4N^"VK]EA^Q^M4_U"W+
MT`2ANW1'(;D`G:$V68[6'Z@^BT[MUE.UKOJB+\D&)/A"L,.HXY7`R[*`!<@*
M:XNCB&4ZH+^,4](VT=O@I=!.UX)6,]ID:=2Y2Z+$G0`@H-.*D-J#KJK&"H:X
M:E8)V(O=.7W(1AC3XR-[(/06N!57B=,9'AXY*CI.T`.[K'S5Y!B$<[-2#Z((
MN'M,=0TVTNKYSWWTV4.-T)((.JEM>PC<(,TZ##J-SR]P<ZZAS8U&SNTT8TYV
M5',7NE?=Q.O5-:SS02JC$*F8F\CM>BA$/<;DE%(#-A\4!\H;J2@4M'/1,E#!
M8!VB<PND=9K"2?)28<,ED?>9V5MMD%4YSR;<D6.&5VK8R?-7L6'PQG:YZE2>
M$T-UL`@I:>A>X_6$^BL&4[(AL`CL`OH#ZI7-:=]4`2YK0>:&Y]^2D%D=MK)K
M8G/T8PVZH(W$`W;\TF?,;-B)/D%9QX>S>4_!%=P8A9H:/S05L=(YPO)W`CL;
M2PDBV<]2G/>YP('AZH+@UNQ!/D@.Z0/'=%@A.!OL3YIEBX7<;!*)BT6O=`[1
MHUW29@`;N^"9WWWU0PPM)OJ4!1(ZW=%O-<2X#,ZUD)SI.34X!SK9]/)`]A#M
M1>W-$#F,._S3#F#=1;R0[G-=!+8YCSK8!*\QG0$*)WD,M<"=;();;#5=GOR0
M6AP&X*7.\<D#G2$:`)K2X[FR3,YW)*UKW;!`UP</"ZZX&2WA4AD))U("4MC&
M@-SY(`M!.I"%41YQ<;A2'-TU('DAEI<-#IU0+0S20QM()T/R6XP>>+%(G196
M<3(;]5B6,`C`'(J1AM7)0UL=1']DZB^XZ(/3>SE55TL[L/>_),T7B)/,?9]'
M#\5NXY!4TS)FM%G"_F#T7F=1*:NG@KZ0.8]K=;'E_<+3=GL98^*.=TF9LQ#)
MVC_+DV#K=#^:#0O8V1MVZ.YJJG$L1N&EW57+VN:\NU%NG--<QKK.N@HFU!.C
MK@(K7DWZ64RJI8G'-:SO)0)1PV$C2R"MQ.3N6UU4[L^S)`2.JIZM[I)+;J\P
MD!K0V_+9!=$]W3=$C.R!IFZ:(C2&[W026G5&:?-0R2'"RD1NM:Z`Z(RP]$,:
MHC=-"@D-((0*NGBFC+7M#V'0M(3F.(-D<6=K9!D*W"C3NSPGZKI;9.H9G16:
M=EJW1,>TAPT/)5\V$1OUCD+#YA`RFKV.<YC)6N+/$V]RU6L$\;VBQ`<>2P7:
M;LGC]15TV(8!B$-+5QL+),Q($K=P".:BX;4_2'03MBQ7`(ZZ#G-22M#A\S9!
MZ8Y#(L54T.,QO#65D,M,[8MF;E+3T/\`=7%@X!S;%IV(0(':H@U"8`G"W)!Y
M1](W9J,XFVKH\L7%9F>VVCCS(6#.$5(89B!)$W?+R7OW:+#?TE0%L>D\?>83
MS\EYL6BE!B?;,39P/)!AG.;E`.C>05,RH?/5OB<=&G0+6X[@DY<ZJH'"3F8N
M8]%BL-CF;BDO&C<TC<$(+02&.8%QLT+L>J^-AQ9U')1\9F:&6;H;H;Z*IJ,,
M,S6DAHN4$?")VPX;("W,[DK/#W13TMFFS[ZJIPB!PC+7@Y2>2L:CAT@S0'Q;
MA`E;3LBC=9V8D*H:.^+JRE9*V(R.=?,%6D=X%!L^Q<;GU+\HO8A;M\$OW"L1
MV#D#*B2XYKT-U4WFTH*UT,H^P4)T4GW"K7VF+F"E]H@ZH*-T3[:L=\ECNV+7
M-9J"%Z9Q8''<+"=OC&8792"4'GT6K@I51R"B0Z2!3)>2",Y@ML@Y;G96!C&6
MZZ.$$7*"#PM-DQT8.X4Z0!KK():"4$0Q::!2H*F6!NYT4B.GN-D&>*QRD()D
M&*R`"]RCMQF07`NJH,`"<Q@(.B#I?>N(V!U0)9F-)UU1'PN?(_.XC72R<RC:
M`#^:"('R2FP%AU*E0PTS!>4F1W0;(XIF!$;`#RL@YE2R)MF1AOH$.>IE<T.8
MZQYW1?9V9M2?@EX++;_!!!$M4[_,L%(8^01V+[GDGEC-FC5=PAFU('D$#N.X
M`7-SY)S97N-R,OJD<QHTC;8]4!T-N\23Y()S'Q@7/>*<^N#0`#:W(*K<''PW
M0<C]W7*"R?7DFQU0S4Q7!<22H/"D)T&B<*:6^U@@FNJ6'2U@5W'B`TWYJ&:9
MXU.OJDX3A]E!)=*Q^N<KA-#>U]E&X3N324GLSMRT_)!+-0R]F$%.#R=7.:`D
MBBB#=0`5'DIW/DN;D>103XG,<+%P10Z)FKG#R%U7<(-%RURBR@YN[=!;.DB+
MLQ=LN?)3$`--E5!I<+7L41D3MSJ@M(RS[Z:Z%SW`MU4(9@="19.SO&IE`MYH
M)G"<T]ZZXBP41U4_;.7)&U$@Y!!-:+;@V1..&`@,LJ]]5/??1-]HD=Y^@03"
M[/WG/^"2YO8=T*)GD.X"?Q)"-`@.\M`TU<D`D.KG6"!Q9&Z%H2B260Z1V]$$
MQ@LU)8)[39C0=[)I.M@@T&#5\C&-B,EF6T"G050PVI]ICM)3R`MFC#K$M/\`
M7F%EH7EKA8V4BJ.0-=<FYUU0>QX)BTDS74LT@E?&T.CE'^9&=CZC8JR,_>ML
MT\UYAV1Q5\%1%3&W$B)=`+:N!\3/EJ/->I!L-3!'/#8QO%_1`"5SP+:'HJJN
MD<UKK;%6=20QEMK=5!GA,D3VVUMH@S\<C7R9GWTY*]HIV9`\7L-+JAP^`C$7
MT\H-W-):3S5SAM+)!-<W="YI#FG[/F@MY#+D;(P7MT4R)S7Y;M.H0:2+*&QO
M?8D7%^:BU^/X'A`SU^)TD!&CHWR#,#Z#5!;LA<;!'9";AKC9>=8A]+&#Q`LP
M[#ZNLE;X7@<-A^)U_!92O^DGM?79F4L5/11G8LCS/`]3_9![U'$T`EV@',[*
M/4XQ@M&2VJQ6CA<-VOF:"/Q7S34S=H<1)=78K62WUL^9UOE>R''A.;5[P7'<
MGF@^@:OZ0.Q],#?%XY3TA8YQ_)4U7]+?9R!UJ:GK*D=0P,_->0,PK2V:Z>,'
M>=@2/1!ZFWZ8L().?"*T-MH0YI4"J^F0&,BAP$\3D9IM!\`%AF8";,N-^JL8
M,$@CL7-!^""54?21VTKGGV7V:E8=A'`#;XNNJJ:N[25TG$KL?K\W1LI:/D%H
M(:6&-MFQM'P0ZBFC<+VL>H08^J=CE-4>TMQ2LE/,OD+OS6A[/?25CV%,$$W#
MJ8@?#*-1\0A.`:XL<`;*HQ6CB+2^-MCN@]X[)]ML+[0Q-:/J*K9T3CS\BM9:
MR^/X:B6EG$D4CXY&ZAS38A>K=B/I2J@XTG:$<6%I#14M%G-'F.:#VH%>8=N*
M<08\2QI`E8'^5]BO1Z*MHZ^G94453'/$X7#F.NL_VUPM]5#%71#,8`0\?N]4
M&$C+@T:V(4>NPZEKFESFB.>VDC=_BIQ83RLFY'#870>5=I\,K\/D'&871%W=
MD:-"EH\9J88A1,`+'=0O57PMDC,<T;9(W;M<+A9;$^R4;9S5X<VW6+^R#+<6
M2"HCC`%GCFDK&B[F[\U)]E>Z=_M#"Q[-`'!1Y:=V5SKW0%I@^K@$0&ME#K*1
M]-+D?T4VAXL3"YHLX(&(3NF<TNW"#0]BA]>_U"WCPO/.R=5'3SOSFURMF<5I
MC]H()A0G$WW47](TQ_S`N%93G:0()!<;ZE8[MGK$=5JO:8#_`)@63[7OC?"<
MKKH,2S1X4UXT:5!9?,"K!Q`C"#B[31$:2!LH^<'0*5$06ZH!\(2'5(8`':*0
MVP7&UP4'1@M.NR+)#'*.2;(\9;(4;B';H`53!%HT73(6YF75JV.-[;O&JYL3
M!<`:700G0@/<?-$:Q@;=R2:8\1WAM=-XPZ!!Q<+W;&4PY[$[6ZE.?*2/%;T0
MNZ=2X_-`F8EUKDGR3\CW`7NE%AX2BM>/M$N]0@8V%Q&@_%<8@-#8$=$]SVV-
MB!=,O8WN@X@-[SB;>B8Z6P[H'J0N=,7=T"_P3)+Z9C:W1`YK[[N&ODE(OW6B
M_P`$,.8W6]SY)WM(:=$#S$YP^[;IS3&N`!`.OFN=5..C1IZ)K=3>UR@<'9G9
M6MN>J0@C2QOY)V:9GA;8>02.EMJX!MT'$$ZYR`F/<;Y;YAU3L]^EDUSH]M$`
M2S,ZR[A$'1Y1,S`.\+=+)G$CL>J!'9QH'GSNG,!ZW/HA%P(V*5KR&V:4!<CM
MW-U]%QSVL-$T/<`"7C7JG9V.O;5`PL>;W=\ES8'G[#G>NB[B.URD-'5/;.18
M%]T',C-K&"YZW2"%[=7:!.=/>]G`)IF;:Q?=`4P-)W/HFNB#=+ZIG%=<$&R8
M9@#>USU026T[W6RN];KC#8VS`D*/QI#I>P2&5XV==`?4#W0/FAME!>`+MUV"
M1LCW"Q<24-T@8X9M""@L72W=;X)6[I[J;,T2,-P1="`<PZA`<`$73Y7%T0!W
M"&R0$6*XD\D#HYI(Y&.9(6O:;M<-P5ZIV'QKVR,1O>&N<ZQ;R#^=O([KR1Y.
MZN.S-2^"LSM,@'VG,-B.A'H@]AQAW<,1<6EQL#;0%0*&HK+<*6-I>+@D'1P`
MW']D`8S$ZCJ'5]3'Q:<#/(1E#V'9Q\[K!8_](H94/BP"-LK<V=LTC"&M)%C8
M<P@]!Q&2FI6FHJI8V-CM(,Q#0YIWUZK-U_TA4<#LF#TLE5*S-9SSD8]IY=2O
M,ZK$ZS%9Q-B=6^I=R:X]UOH-@BF$0N@FC!,?)P^R4%KB7:?M-BT9CEKO9:,W
M+8J?NV\LVZB4V%PF\SV9G'4N?JXE!#Y9P^HIF!KF&TK+7`_>`Z=5*IYYI&M<
M1ZVV""1%%&&V#`.E@BAK+;:H#+M!!ZW1;]W1`]A!(;H%(:UH-[J&-"#HI4+K
M\[H+2`1EMP!='!:T<E7PREI!!]0I@L1>]K\B@G.L7,MT1`WYH+#8M'DI`Z[(
M.LF/9?2Z621K&H37N=H-/)!65D!:YSAKZ*')'+(S+P'$>BT@IVDYI"&CSW2/
MGI*9I-Q8<R4&(FP0R9I&W!WL56&+)-)&PZ`@./P6@Q;&6YI12MSO-_19QSN%
M&V(GOC61QYN.Z#:8'C$E`UG`F?&1;5CK+TG#.WM!/3NIL6:6DMRE[=0X6YA?
M/[L8IJ7N<7,>C=5'?V@J9.[!`[U*#U.JQJ!DTC879H@XACK6N.2B2=HHF`DD
M-MU*\T9-C-22`[*#T"/%@=?4&\LDAOYH-S-VO@C^VW3S48]N8QX&D^@5+2=E
M#<%[7$^JNJ3L]3Q6+HKD(&'M5159RU=#F/WK6*>VEHJYI-!*0[?AO_H59Q4%
M$T6-*T^=D1F&T0D:YK70OY.;L@S,EXRZ)XRENAOR51*YID+1R6^Q7"'XA2.D
MCRFI;L1IG"\]<R2*H?'*TMD;H0>2#5=C\.96SO+N1LMH_LVP[$+*]@Y1'*^Y
MW*]"]M;U""@?V:Z%"/9MXV(6D]M;S(7>VL\D&6=V=G&SBLSVHPB:GB+W$V`U
M7J(JX^H60[<S1OHY,IW:4'D[797:J80]S+\E"!NK6D>QT98>B"(R5H\0U1HY
MX[Z:(DU/&>6ZB&D-]+_!!-$C2;YD_,"18JK?',TZ)!).S<$H+*H)&R:QUP%$
M]K('>"D1543@@G1.NTI!*;GU3898R"`0GAC3<C75!0255I7#-SZIS:KJY198
M+S/]4@@L-T$_VIA%KB_JNXU]057BG=>]T3@N`W03#.=!=.%00-U!R.'-<X.)
MW03VRN>0&G4JT@PZ:1@>7_@L\TR,L6JQI,4FC;:1YL@M8FQ0/RRV)3WQT\WV
M0%7Q5<<\F8E6<3`X`M00JC#CE+HKJK>)8GV>P@^:U]+$7/#;+L9P82P$VRN\
MD&2$PYD:<DYM3;;0J%)$^&8Q.T(1`UW(()+ZE[S:]@@E_>UL4PM<2`4]K&DV
M)0<7N.QLF@V/?)NB\&,:<0W]$D@C8-RX^:!I(/VR4)[FC35*[O[6"9D(W/R0
M*UP%N5TZX)T)0LKR=+(C&/YW*!26[$@I27#1N@0G1ESC<;\U*8QI%G$(`=YU
MP2FBX-BZ_D%)=&!HT[I/9RT9B@%J=M4YK1N0GD6:DUZ_!`A-]@4N@3K6;K:_
M1,-W>00(3<Z)0--2NN&Z-2&XU)U0.S.MO8(;R3L;I'.N4US@`@M<)Q%D=J:<
MZ?9)6F;A_'B;)&`6G8KS>4F]P3<<UZ%V'Q@.PUM+4`O<''*[R0.=A+[^["&[
M"I!J&&RVL#.*7.8P=UN;U"D53L*H*>&IQ"IA@C-G.,AM;TZE!A/T/,6Y^&<M
M[*/B_"[/!TLTC6R#PQ\Y-.2=VA^D2E93R4F"PN?+GO[0]HRCT'/XKS7$*^LQ
M&H-16U$DTI^T\W0&Q'%JW$*ATM1,X@G2,$Y6CI9"BFJ'O#8]2HT;<SPVX%^J
MN:2!E.+OLX=1N@;")VV+ME?8?.YS!3S268[3=0#40926EIY$%`%<R.6Q'S07
MKY'T<D0B?L_?[PY@J4)8X#GB<#3RDZ_==]TJ)!-3XA3Y'M^L'0KJ<OIIA1U`
M!A>#G;UZ$>:"69N\-+Z?-&9(>E@5&LV-_!+KV%XW_?:I$;7N.3AO_E*`I((S
M`)S)`TZ'=-;'(YW<C>?(`I[:68GO-#/XC9!)A^\;ZJ?3.)-B18[%5S82RPDJ
M8P!M8%/XU-'O.]WI8707Q.1C'%P%A8H,U>0W+$S,0J-V)TK>Z&.=;>YW0G8S
ME%HVAJ"^H7SR%[ZNT;!R"ZJQ*2,%M'3.=T("K\(QNG,I94G,'<SR6HA,$K`6
M97-.UD&+J9\:FO=KF-&NBAP05-1*3-(]QZ$Z+T)T#"""T$%9^JI#33<6(:$[
M(*>6!M-2UNK631QE[7.Z+#>UTTK_`*Z1S@?->@]H:*;$<.F?0@.G+`U[-LS1
MJ;>:\T%)J6N99U[$$6L@NJ2?"F?88?@KREQ'#([6AC_E6+_1CW:LS#T2C#*I
MIN"\CIJ@]$9CU`QO<ACOZ)3VE@&S&!8*GP6HF9G;,2.8!U".W`J@;N)'F4&W
M':B$6U;\TX=K(1]D?-8QF`S7U?8(K,$?<!S\H.SCS0;./M93&P<T*='C\,C6
M'(`SF[^RP\5$RG)86$NY..J)$XQ.<Q[B>B#U&DK(I;.8X6W!'Y*O[18%#BC3
M4TX#*H#?[RR%'6U;>[&76ZE:W!\2D>P,G'>&QN@I.S3)*>IEBE:6O:ZQ!Y+6
MNE/5=+103/-5&T-FMJ1]I1770&,IZIIE=]Y1G$H;G'J@F<=P^TLWVKF<ZF=<
M\BK0O==9WM,]QA</)!D&]4]LIC-[H3':623'2R"WA?Q6Z&Z(TV-D+#HW&',B
M/O?9!(:QI-S9(]D>P`0.*;636RY3<G1!U3`S+HU1V4F<:"WHI3ZF-UAHI%*Z
M-PMH@JW021[$I6&<"URKF2)AV(2,IP0@S,IM,_U79ET@O*_U3;60/!OHGH82
MYD#G&X3-BNNE-B;H%N4CAF"<W5.R]$`&9HS<+2X!5M>[)+R6>D[K;E0A521R
M9HR=.B#U*-S&RM>P:*R<]LL5W%9/`L0;548!(S`6*FLJG1D@DVZ(*;M+19)>
M/$"J>-[LHL;Z:WW6KKWMJ('`G6RPTCGQS.:#J#9!9YCEUL$"5S&WM>Z#105]
M=*(:.GFJ9#]F)I<?P6LPOZ/>T%:&OJ1'0L._'-W#_P`0@R1GLF"<.YV/0KU[
M#OHXP6G#75TT]8\;@G(R_H-?Q6EAP+!*>(11X51MCZ<('\T'@`D'_P`)[#<Z
M+V_$>R'9ROC+#AT<#^4E/W'#^A6*Q'Z.<1A<78=60U$?)LOU;_3H@QC6G<E/
M:>FOP4NNP+&\/N:O#*F-@^V&9F_,*NXI#3W]?5`=S6'<$>B"X"]F@E":]SS<
MNT\TYCSGWL$!`T[V-DF<DV)^"(UQ=J0+="$^P<-;-`YH!,[[K?\`\$YYC9HT
M7)YISBP,(!`]!NAMM8-W/4H&Y!NYUST2:\RG.>`2,H36!\SPR-CGR'9K!<_(
M(&6MSU3'7&Y5_0=D.T^(6,&#U#&'[<XX;?\`\EJ:#Z*,2E&:OQ2G@O\`9B:9
M#\]`@\R<XCFF$DKV1WT14F0\/'9Q)R+Z=I;^!67QOZ,NTE`'24L3,2A`O>F-
MGC_P.OR0>>2D`%:CL?E$#I2X`L?<F^P6=K*.H@F?!-%)%*PV<R1I:YOJ"IF!
MU@P\3B>G=*QXT`=:Q0:S%NV5:QCJ?"J=F?(&.F<+@`=!S6`QNJQ"LEX^)5LL
M\Q.SSMZ#D%-Q'$ZVHS-I:04[/O`W<1ZJA='.XESF/)YDH!+DI:X6N"+]4B"R
MHZ;B4Q?&P.?T*0PU]\H8^W3=1::KFIC]4ZPZ%7-#BG<S5,^9W)@[H^)05\>'
MXE,2(X)'$]`K:E[.53FCVVIB@!Y7S.4N/$I)^Y&[3H"F5'MC@2T'1!/@HL/H
M+.;++*_JXV'R"D?I*(.S,B@<ZVA<P$CYK.DU6HD8X@\T)['C[1'J@U#,<GSA
MCLK.F4``%$DQ>JL&R&7*.=U14X$]/F!N]FCASMU4RFD<UN7B`CH4%R[$W2-B
MF+CED[KK'0.']U)AF8]Q#SJ>:I*>6GS/@D.2*;NN(^P>3D:-[FDLD(XD9RN^
M""VJJ+B-#FN.4C<*KEIGQNW)')6>'UN4Y''0]5:"""I8[*0'6N@R_L]QE:->
MJ,S#'2B[GG;T5W)A[HW$Y=.H36=UPON@HWX&^^9N8'K=3L/CQ&E/=D=8;75W
M#*UUQILGG4W&OD@M</G=4P`R"TG,6W3:Q@(S;*'2O<R8&YL0I]19\6;D4%79
MK).(SN.O\"JO'L&IYH_TE'&&R7'%`V/FI4[CGL3L59T0;5TLU*?\R,M08V"D
MA'12Q!`"``-52"5\3W1O<06DM(4IDKG-[DFO1!*J*4,<9:4B.;_\7>1"CTV(
MB5YA?#DG:;.:38>J=%52`Y9FV(_%1\0BCJ6B6-P94L'==M\"@NQ`"QKBX:[=
M%QI'R@MRV'FJC#L5+*>[P"YNC@>11'=H-+VU063L++@`=2.:5F",.K[755^G
MI2TEILF_IJI=]LH+T84]OAD:+<D:*&2$W)%_)9O]*U#AXRC18A*;9G$_%!MZ
M&JL0"=$2=MGFVRS5!5$N!ONM1;B0L<@B/""Y2W1E!?$Y!%<L]VE%X'6Z+1OC
M<JG%:9TD9!')!YTR2VA2.DS."LZK!I\Q<UO-18<)K73M:8]+[H-+A48]A:ZW
M)1GN%W`C6ZU-)AH@PP9M"&K'53LLSVWV)0%$(>+H;H'&XZ+H)BUMKHS9NJ"O
MR$/LE.>-P+20I1LZ0+JEK0`4`Q42VU*?'62!I&FZ8P`BR>RG)!]4%5)[Q_JD
MNFR/'%?KS2@ML@Y<N)')*SS0(1=<V]TXA-O9`46LN+K(1DL$$R%YTV0/ED+^
MZ`5%R6T4MC=$CFB]T#\'K'4E6&$V:X[+25-6!9P*R$S0QXD&X*G,J73-:VZ"
MV96.>_*20#HMW@'8[LT8V5M?Q*VH?WN&76;_`"MU/Q7G;&6`<O8>QKP["(K`
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M==2SP/\`NR,(_'91F.EJ'AD37R..S&"Y_!?3KL.IY(S#.QLT9&K'M!!^!3J'
M#</P]N2BHJ>G;_[48;^2#P+"^QG:;$LIBPR2*,_YE0>&W\=5JZ#Z*:YX!Q#%
M8(AS;!&7GYFP7K]O(E+8]$&&H/HT[-TI:Z=D]7(.<TFG\HT6GHL)I<.:!AU/
M34XZ-A#?Q&JLR/4IV4=$$1TI9K.PAOWV]YO]PCMRD`M(+3L1J"GZ#;=!=3V<
M70%T3SOE\)]1L@*&ZZIX"CLJ.&0RK:(W'0/&K'?'E\5+#>:"G[0=G,([0TYA
MQ.D:^2UF3L%I(_1W]"O&NTOT;8Q@@?4TI_25&#XHF'.P?O,_J%]`7L+)@<0Z
M_-!\ER.(<6EMCM;HF$:;`^B^CNT_87`>T)?/+![)6N'[3`+$GJYNSOS7C7:C
ML3C79MSI)H?:*&_=JH1=EOWANT^J#)M@XQ`+6_).=11M[I8"?1&#AFU'R3N*
MUI[HL4%7-A+=7-<X'HJZHI)H=7-N#S"U+2TB[M2N#8W"[FE!E:6HDIY`]M].
M2V6%8I3U36M<0'VMJJVJHJ:8V$!:[J-+*!)A4L3A)32ZCD4&X%-'(38:'50:
MW#6F^4*IPO&*JD>V"N8X,Y.Y+7POBGC#VN#@>B#$N;+A]2)!?*=#Z*Q<S4/8
M;LDU;JK3$Z`2Q.`U(V5/1!S0^BE%G#6,_P!$#'QO=ON-5.<WCTK*L:30@,F'
MWF\G?#8J!*Z1KR"=M+)]-5OIYVN?K&>Z]IV(.X03&.<RQZ*QI*Y\8)#K@BQ5
M88'Q3NIQ)F86YXG?>8=DQA>,P=HX:(-K2XHU_":XB]['T4J6"&H:3"0';VZK
M"Q5+VS,&NFJMZ7$'L?HX"^R"V=%)$\W!LI$#[D7.Z;38A'4-#9[.LI#J=KFW
MA[PY`(#6'=VN%.CL^,LZA533(V4-.A/56--H#J;E!18BQT4Q`/.X4S`)R*@:
M6`3<6#7D@[_FAX4,DK3YZH,OCL3(L?KZ?06F)'H=?ZJ.(B#I<$[$(_;^,P]I
M7RV(;-&QP(]+?T533UKP&QONX`WN@LB'.:<S=0G,CXC;$97?FF-G9)J/E=.+
MW<M4$66B$,IG(+HW>\:$?V!\GNXFM9R)*D13A_=<W4[^:;'4R4TWL_\`E.U8
M3R\D`VX41JYP*?\`H\,-T<UES8G5=Q[VNY`$THLAF/)KT4P2-)MHG!C';V0.
MPYYX@TV6VC)93L\UDZ*"/B@M=<]%L2T9&]`$$=SRF%Q*,YB$6@(!.?Y*!6'N
M[*Q<VZA5;="@IW.MNU`,[&/S9-0IKV7W426&_)!)J,6/LF3;2RQDLN:5SCS-
MU:XB2R,C8*C:;GS02FO%U(:00H#@X)S7N:-T$N]GA=.;V"CMDYE*^2Z`L1.<
M*PB/=59"^[KE3V$$;H,5/).V9XL?$G-J7ANK2K>6)IE?H-TPP-Z!!5>V$'5I
M16US1O=332QG=H3?8H;:M"`#:UA.^GFBMJ&.V(*:[#H3L4!]!E-VO(0&),KK
M-.@Z(XBR-T*'!'PH][E'9?F4"M-FV2.3@-$UPL@CU('!<DPEV<B_).J?=.0\
M&]Y8]4&E<P9`O3>P\O\`RQ@L=`O-'Z,"]'[!ZX<W=!JR\[N=\`NS@;`E%9$2
M1ECUZV4AM-(X<AZH(EY#LT#U2][G(!Z*>RA%P9)"?(:!2&4L$?A8/D@JFL>[
M1C7N\[64AE).[<!GXJS#`-F@)X!05;,)I\V9[07?>'=/S"FLIHF[`#X*0&I4
M#&M`V">&WZ!<"+]4X$<M$"!O*Z=8#6R2]ST2D#G^:!21R27)^R4MCULNN!N=
M4#;.NNMUU*4NTT!]4W7J@=>P2Y@F6OU3Q8;H%RAPL6!P.X(T*"6S4Y)A:'1<
MXB[4?PG^B/<<BD^"!L<S)<P8[5OB:18M]0B`7"%+$V2Q=H\>%XT+5V::(?6C
MB-^^P:_$?V0'U*[*'M+'@.8X6<UPN".A"1CVO:',<'-ZA-=,&:#5!@NU_P!&
MF&8A!)5X&R*AKAKPMH9?+]T^FB\V;]'G:PM+QAC0>AG9?\U[\][GF[B?1*W7
M^R#YUJ>QG:FD8Y\V"5>0;NC:'C\"51GB-=E.9KAH1L0OJV,EFNQ6=[5X;V9J
M*:2MQJAC(8.]/$TB3YMU/Q0?.[6R/(#2;>J.(RWQ@D]%?8C/@<\KJ;`<-EAC
MS7,\[RZ0@=!]D=>:IZNN@IXWQQV<XBV9!`KIX887%^4/\_R59@6,R4,^1[B8
M''8\E7XC4.FDRW):-=5#0>MT\L53`)(W!P<+W42MHF.L\"SFZ@A8[L[C+Z.1
MM/*Z\3B`+\EO8Y&3QW:;M.R"FJJ8O:96LOIJ1U4!S&.&HL=K+2L:UCRUP[KE
M55]`3(YT>E]4#&/$M"`W6HI3G;;<L^T/ZH\#63QYVM;?JJR(RT=1'.6W`T<.
MJ,U[</KC&W6GF'$CN>1Y?#9!)=3DRN<.0`"&^-[-0=E.BD:Z/,-G&Z(6M<2,
MHOY((4<TC>\+_-6M%B4C""'&W.ZKQ`<Q`VY)P:T.L;W\D&IIL2BE[LFI\^2G
MMDC<+L<%B!,&6=Q+/!M8<U:4L]0XCZHL!&[SE_#=!;U43I#9[+A+1PN8^QU'
M)RCMJY`QCG2M(!RD,:3;XE3(WN+VC,\-=>VH%B@H?I.IW?H6DQ-K`7P2<*2_
MW3M^*\W@Q.,6$D9%N87L/::DDQ3LEB%'$TNF+.(T./-IO;Y!>#G=!I(L2I1;
M+.&^3A93H\2IC8\=G\RQJY!N#64KBUS9F-(YAVZFMD@K8#PG@RL[PU7G2M.S
M]2^#$&922':$(-H1%E:YNKB-0F9"3<MT2^T0P@YF=X.T46JQ*-@))`\D$HG*
M.2AU-:V'3-=W15TF(2U!RQ-(NC4U&7'BS&Y06.`SU<V*P$:1EVH\EZDX=QOH
ML-V?I1&^.6UC(;,'ES6]F99H`Y:((CD-URC%NNJ0M%D$<J+4"ZGN85%G:@K'
M,/1`?'Y*>6E#>Q!0XE1NEC.4:K*S4M1!(;M)"]%='HH<U'')?,T(,/',#H[0
M^:,0UPT*OJG!HW[!5DV#S,\!(""((S;=#M<V3Y:>KCTRW'DHG$?&[OL(02FM
M(.BEQ9LN_-0A4LR\KH\-0,FZ"'*;2O\`5(UUTDWO7^J&7:V0$+M4K22F6%EP
M-D#G:(9U"5VJ8-&H.:[DBA":+A/&Q0/OI9-W7--DET`J@'A.]$+!_>7\T2=Q
M#'>B#A!M(?5!JI-6#T7J7T:1M?AH)%SJO+#[MJ]7^BTC]'$>90;ML8`L&@)P
M8`+73M.J37D$'90EY+M>J[3XH$N/-+<]$J1!POS*5<N0<N767(%`OY+K7YK@
M;%(@>&BW5=H.B:E%N80(=UVJ=IR77`0-%QSLG`#FN.NP7:H'\@NO;F$,'7O&
MZ7,.B`@.O5<YX;MNHCZN$.,?$N\?9;J?P0W/G=?*QL;?O2'7Y!`^>,/<7L>^
M,GQ<,Y;^OFH;G2"[8:F25W3*'`>I4.?%\,9(8G53ZN<?Y4(S:]--%"K,0Q/A
M9WFEP:D_ZE0\9[>0Y(-")13TXEKIHF=7GNM_%5<O:.%[S%AE++6R=6C*SYK+
M#$L"XH-,RNQ^L)T=8B,'U=_0*VB9VHQ`!D;(,)IC]F)O>MZE!,G=C;V<7$*V
M##Z<_9:0W3U.JD89BN'.>(::I?.X"QDRFQ_NJP8#A%/*'8A625E3N0]Y>;^F
MJGMJ::EC/LM*V%C=W$`?B@SG:[!.V6(2/_1LF$04S@1FB'"D<#R<XB_R7BO:
M/"J[!ZJ6DQ-H8\-NUS#=KO0\U]%&6>JM)&#("=QM\SI\KK-]M^Q[.T6&R<$C
M])QM+HP'%US]TD[`^0"#YQ<2XW.Y7*QKL)J\-DDCQ."2GD;_`);AJ3_95R#E
MJNS6+N;:GF?MM=95.BD='('M-B$'JX<V5@>T[)Y:'1[:K.=G<2;,S@O=WN2T
M49L=3<>2"%4TS)+M(/>Z=5`JJ)[\->+$RTI,D9YEO,?U5U41$M[AUY%16F1D
MC7/<&M.A!&_5!`IP\T[2PZ6OKL0I3:AC',%OK2;91J2HGLK8Y)Z4/?*(S=C"
M<HRG4>918WYZ<-86QO!`RL%D$B5\ID876B:><AU^02RQM:YKW\22Y%[=T?+=
M(0983>/*6G6^_FC!K`'1R2YM-".9Y($C(BD<QF5@(N"P:_/=$:9.-&]H)>!:
M[CN4I-F@MC&8#=`,LCM2;>006\+KMD+Y`S,[5JL(#`6"SRYP-]]UEFN=S:;\
MRIE)5/C>.]8`[%!M:0QBQ:2+F^J\.[982[!^T%72C6%SN)$[JQVH_M\%[102
MLF9=IL5EOI*PEU9A]/B$3<SJ4EDIYY#L?@?S0>2L8YY`:+DJ3#1/>1?0*=`V
M-@N;:)TM4&`\,7*!L>&QV[P*,'T="X2BSI!L`JRHJJB3NEQ`VL%-;0.;!&_(
M2[,-T!I<1GF.1K;7U)LE@HIIWYI+D'JK2@%.20^/O#=6@X36W9:R"#3T3(6!
MU@%.H:4U=0&;1MU>>@4>23,<HUNKP1^PX>R,6XLW><>=D%G@D0J,2A:P68TV
M:/);J>D/19?L'3<6OS$7#1=>BR4]^2#+/I#="=3.Z+3FE%_"F&D'W4&6=3N4
M2>%W1;!U&W[JC34(/V4&-="X<DPQNZ+6.PT'[*&<,)^R@RI9RLAN9Y+5G"B;
M]U"=A!/V$&6,80W0@\EJ3@[C]E#.#/\`NH,E)2L<-6!0Y\+AD!NT+;'!I/N)
MAP63_IGY(/.:C`8W7R@A0A@<K20'&R]2_0DA^P?DE;@3[:QE!XE+K*_7FF'3
M6ZZ47E?ZKK#9`0/!%@E0MMDX.*!^EDUVQ79@FN?I8(%BV2O=;9-9>VB5XT0(
M'WW1`04-C`40"PL@#*.XX^2!A-^,?5'DV<A84WZUQ'5!J#[H%>H_180:%P(U
M#BO+O\H+TSZ+">!(W31Q0>E`^5EUP$F_,E(!<H%OZI=4J0D=4';KDE^B47YE
M!QT2W2);H.7)N8);]$"K@D]4NB#M%R1!=50M=DS%S_NL%R@.ETW48R5+](H0
MP'[4A_HD-*9-9Y7R_N^%OR"`CZF$'+Q`YWW6"Y_!.$SSX8'^IL%"J,2PV@&1
M\T;7;".,7<?@%6UF.U38S)#2QTL/_7K7Y!\MT%W/[:YAX'L[''8ON[\EB>T4
MV(Q$QUO:>E@N-(*>-Q>[X#5`J<?=67BAEK<3D)MDIF\"'XNW*'#A?:F=KO9F
MT&#0G<QQYY3_`.9U04!Q[&,-E:"^1M,39DM7%D+AZ;JRAQV&MM%(<3QAUKB.
M+ZN&_0DZJ%B792GA<^:MQY]76VN&93(XG\2@X!C=9!*ZDC9#3N'A>6Y2".1Y
M:^:#44]-VJJF9:2&BP.EM_E-S26_B*2/LS@L53QL4KIL2J[W.9Q>;^G)38:J
M;$H6.O/59AJUO<9\]!^)4G@OIF_K4]/1P_\`398_B=/P0$BJ(Z6(BBH(:9H^
MU(1I\O[A#]KFJS;BU%3?=L(R,^)T!^::T4KG!U/13U<G*6<V8/B[^@4UD6(5
M!^MJF4[.3:9NO\QU^00-%/)3L)EEI:"$]!F>?GI^!388HGNSTU%/4OY3U1(;
MZ@'7Y!6-)A])`[B!A?+SDD)<X_$HE=7TM'$73SQQG8!SK$_#=!#9!/.ZU7.2
M&[QQ=QOI?<H\\L5/`YL89%&P7<20UK1U)4>GJXZMI=&YY:1:XT^-EYWVR[#]
MML:>^2/&XL0I&DNCI1]18=`WPD_%!E/I:QK`L7?3-PZNDJ:JG<0YS66BRG>S
MMR;CI9>:JPQ?"L1PJHX&)4<]-+]V6,M_^5`:,S@+7N;('3BTKA:R8I-1"XF2
M5K3D#K$J,@DX?4/IZECV]5Z!%4.DA:]E[V!7F[39P/0K=X-*9Z5K0=0-$%W'
M5,=$"[0I71,ET)!53('!P[W/0702ZM+B8P\BZ"RQ.*)C:>K`+G0G(\#FT[?(
MJO=B$37G@Q@=Z]RCP03R!PJ91D<+.!V"#/AX#<V6]M"0@62:20EPEWY!*WCY
M0X`@C8G11VB6+1K;`'=$:Z5PL7(+"FE!]X_7R4QK(SX0"Y4L9#7`ZW4^"HR\
MP`@E.A=?DA.@+77YHS:F]LUM45DD;C:]_+F@L,(G+':J_J*>.MHYZ5X[D\;F
M:^8T_%9>%H8\%INM#0S7#1=!XO44<M+524L[;21.+'#S"8Z``7LMI](%$(<:
M95-%FU+`X_Q#0K,O8,IZH*:)C'S-#SKFV6IL&1PM+1;,LN[NUD5OO+20O+Y(
M6';5!)B9'G>\#=,<ZQ-MKKFL+'$7T32/F@FX/3^T5C=+M!N2K3$)1-56:>ZW
M0!)A<9IZ!TYMG?H/1,IFYYBX[(/1/HZ@RMFD.^@"W;F\EDNPC0**^Q))6O=<
MH!%@2&,(BY`+A#HF/A"D)"+H(O!'1=P!T4G*NL@C<`=%WLXZ*3;JNL@B^SMZ
M+O9V]%*LNL@C>SLZ!=[.SH%)RKLH01O9V=`G"!G0?)'LNL$'R5)[U_JF$ZV3
MI/?/]4S[2!P\TNFX32;)H<[-L@<1<I'"PNN))U2.)*`L1%K)UKH,-P=5("!H
M-N24FP7'9#<X[60,EU:4#"R1.1?FC.)(*CX8?UIR#5CW87I/T6O&64'[R\W8
M/JP5Z)]%KK23-_>0>I`GD%UBN!`WT29AUT0+8)4W-?8)1<\T"I,P791>YU*X
MD!`ER3HE(/,H<D\<?B<`?5!]H>_W4+G#J[0()5K%<][6B[G!H\S90I'2AI=+
M4,B;Y?W*IJS'\"H3WZEM1-R9']8Y!?NJ6'W8?)_`-/FFYJE^P9$//O%98]I,
M3JVG]&X0YD?*6I=E`\[*FK\0J7NR8EC[B3_Z:@9<^EP@W%958=2-S5]>P>3Y
M+?@%!':.B>>'AM)4U9ZQ1Y6_,K)X?3R2/OAG9YSG_P#7KWW^-E:.PG&*AO\`
MS/'&4T/_`$:49!^&J"QJ\9KF,S3S4&&-_P#>DSO_`)0JF3$H:E^5LN)XL\_9
MB;PH_FGTU/V:H)/JH7UU0-R`7GXJQ=B=0(CP:>GH6=9"'$?`:?B@BTU'C=0V
MT<5-@\!&N09I"/XBB,PO`J:7/4ROQ"KOKG<9#?T0"Y]6>\^IKSSMW(Q^0_-2
MV4]2&!O$AI8N8C;<_,Z?F@DNK)61_JU/#1P[<26P/R']U">XU)&9]17>3>ZS
M\+#\2CLIZ5K@\1R5,G)TIS6^>@^"EAE5,0`>&T<FBY^:"ODI)1']9+#0P]&`
M%WS.GX%8+M-00T%7'5T4D\Y<;F206`=ZD+U%E!#&[B2N;FZN[SOQV47%H<.J
MZ=]/)2/F!'BYA!GNS]94UD;)75'"AF`#N`+`2#2Q)V)\EJX:*F8"9&,:\[O<
M<SS\2O*/:Y\&Q@T],_B,<^QA8X.SMZ&V@*VM%+C$M(&0004\;'6SU;\T@'0M
M'-!J9Y*6CIG3S3,;$S=\CLH'Q67J^V5-G,6%T=37/V#HVED?S._R17X;!*[C
M8E--B#F:W=]7$SXFP0G]H,,HG"&FFPIC[:-@)G?IS-K`(*X?\9XW<27HX7'W
M<-QIYNW5G0]D6TQXV(U(!YOD?_=9W$OI(PB!SHWUN*5KKVX=,UL#?GNJ/%.W
M\U+`)X<*@IY)-8Q4/,TI'4WT"#V&E.'4,),`DG`&KHF%P^>RIL6[=X10,>T5
M]#`\6!#G\5XO^ZW3\5\\8UVK[0XV<N(8I/)'RB#LK!\`J)!ZI]*W:2F[085A
MIIL5%28GG/$YF6]QXV^7*R\QI0&U4.?8/%T(N<0`3H-D:D8V6H8R0NRN.N47
M*"Z?253\/S%@X+LTC0T7)U-KK/+:.E?A9;:7-'P[ACQH6D<EC="\FVA-T',;
M<K4]GI[/;"7`+/0D%UK:<[JPB!8X/:ZQ\D&VFI@T"1P!<T\ANCM:UP$@M8[`
M;+.T^-3!G#EL[3=2(<98TECV=WE;D@M7,&:Y!)&WDC=UXS#F+.]4&%\53&)(
MI+@A&C:P7!)`=I?S0"=$UU]+Z*)+3$$.:-E,&CBTW!!L4[D0#H@JI(9`#W?@
MALXC7"[2.6VZNK$\@FN8"-0@@M$A-R#9$8US77UTZJ3E%MK),H\1(`\T$JFE
M-P#=7=+(.[8ZK/QNL[N-)OS*LJ61S2"[T0)V^CXV`15(!+Z><7/0.%C_`$7G
M+9NZ=5ZGC,?M/9K$H]R(2\6ZC5>0M=<((LQM6,-_M+14S2_AEKM;%9R=I=4-
M#=3=:#"SDDIQ*#W@19!(:YPS!VX1Z9AED:!S*)54XSVB!NX@`;DE7N%]FL>C
M!,F!X@'#:].[^R#JLAC(XF[-%DZC98"_,V4U^`XZ1_@U?>__`$'?V4NCP'&A
M(S/A%:!>^L+D`68_5X55F&`C(UHTNK*/MQ7#Q,OZ%5=;V<QJ6NED&$5Q!=H>
M`[^RJY:22"9T$\;XI6Z%CVEI'P*#8P]NIK]^$J6SMTS[<3ODL)P,N[E*;A&)
M/IO:V4%2ZEREW&$1++#<WZ(-U'VYI#XF$?!2&]M,/.[@/5>?4>%5M;G%'2S5
M!8`7")A=E];(-123TTKH:F*2&5N[)&Y2/@@]-9VOPQV\K1\5)9VGPM__`*AG
MS7F!P;%!3>U'#:KV?+GXO".7+UOT4'*+H/9&8]AK_P#U#?FC-Q>@=M4-/Q7B
MH8ZV8$V20MJ9I6Q0<5\CC9K&7))\@$'N#:^D=X9V?-%94P/VE:?BO$&NK62<
M-LLPDS9<FM[]+=5.@J,4IIG1RRSQ2,\3)`01Z@H/9@0X7!N$JRW8[$9ZN)S)
MM2W2ZU2!$J7DN"#Y'F($K_5,S))B.*\>:9;6Z`F9-)NN3<NJ!Y=R2)`+)""2
M@(P(C2A,V1`/-`I.ALF@$BY7;)P\*`)YJ-AVE6Y27#<*+0Z5B#7!WU3;=%O?
MHP)]IF;FMJ%@V-^J:5L?H\CSUTMGECA:S@4'L5AZI00-E!9/4,!;)%F(V+>:
M:^6<@ESHXAYZE!8$@:D@#S0'54320TEY_=5!78Y@]&?UBO$C_N--S\@JJ7M1
M5S]W"<*E?^^\90@V)FE=X69!U=JJ[$JZ&EN^HQ&)K`-6.-EC:V7&J@9L3Q>.
MAB^Y&ZQ_NJ\4="^_LU%5XE*?\QQ(;?U*#3O[8X<!EH**:IF.EFM_JHD^,]I:
MMEQ[-AL/WI""?Q5?3X?CSB./P\+I]KQM!^94^/"\!IK25M8^ODW[[B\(*>5]
M'4/M4U]=BLWW(;Y/[*TP[#L3?8X?A%-A[/\`J2C._P#LIGZ8IH1P\-H&,`V(
M8"H<V*U\Q^LG#!TOF/P`06KL'IW#-C&)2U+A_EM=9H^`T315X/0@QX=0-?(-
MK-S%5\5-6U(N*6:6_P!N<Y&_)3685.6@3U.1O-D#;#YH!56)XC(RTD\5&SF+
M@N^0T41L7M6O"J*LC=\KLK/EH/S5S!A\$9^I@:7#F1F=\RK*"AD=J\`?Q:E!
M014=00&NE9%&/L0MM^)_LID%#2M?F$1E?R+SF_-78HXF>,%SO-<YA#;1@-00
MPR<Z:,;Z)1##?O/+W?-.F[@N\EU^31=0Y)V0-+IGPTS!SF?<_P`H06;'QL`R
M1@GSU09ZQS76<_)ST6,Q'M,YDQI\.C?72GPN:[AQ_$;K)]H<=Q]HR#%VQR$=
MZ.E8`&#IFW)0>IS5EV_5-??F\MT'Q.BSV,]H^S$3_9\3Q%U0]FI8PEX]+-L%
MY#6U^*530VJQ"IF`%K/D)'R51."&ZH-[B?;K!X9G?HKL[3#+HV286!\\H5%7
M_2/VEJ&/B@J8Z2)WV:>(-/SW6.D=?GJK;!<(%4#5UC^#1Q^-YY^0',^2`U)+
MCF.R\.IQ&I?3L&9[YI3D8.9*-65<<+!AF$M?PY#9SK=^;S/0=`B5^(/JRS#,
M,I^%3WLR%NI)^\X\S^2G/;%V1HR9!'/C<HL2ZSA2CE?]X]$"4N&0X68VSQ-J
M<9F&9D!\,`/VG_#DLWCH)J(YGO>^65F9[GGQ&Y%P.0\E>X'&^J?(^H>]TT^A
ME<;GJX_DLUB,W'KI7:90[(VW)HT""=V?IZ66KA,SV6#LSL^@`3NUE##0XP]E
M.^-T<D;90(S<-S<D?`I:/](MH^"&1R-+722:NT%_3=5N(0,;65(808F&S2T:
M%!`<US;7&XNK7#&14E315M1?@A_UFFP.@4JDPSBY)96.X1BL'<KBUQZKJYCI
M(WT\8!+K96H)':)X=#AY;('AE*T$C;<_TLLU&+NZ!7,\>>..)X-FM#;WZ*HG
M9PI7,Z'1!-C#&-N=443#E8JL$CASN$AD-[@D(+,3BYY=24V2H;S/Q5?FY\TK
MKBX0:'L]7.94!N8Y7&UBM5QVD%I<`>BQ.`19Y'D:N;8Z<EIR[BM`([^UT$^6
M2SHYF:YNZ[U&WX)62@Z:`J'3MEEBGISXB,S+]1JEC<7-:[8V03LQO_9(76\T
M$.-AU">T]WGIH@<"\DZ@`IV1OBYVWO=,OOL;^:<''0D(#,.AY*7$ZVO0*"SS
MV*D1DW/F$%_26FI:J$?;A>+?^)7BXO<CIHO7\(E`J&`FV;NKR6MC=!75,)%B
MR5S;?$H'4T+2XRN/D%:Q-O4Q,%KAEP@T](U]&P$V>3>RD4L(+WEQ-V"P(06#
M9)(ZJGDX=RQ[7D7WL;_T7KD?TO.?<G!8V@:ZU/\`_E>14<;I:J)C7W+W!@ON
M+FW]5]$55'V-['X12LQ"CI6QDB)KY*<2OD=:Y)-B3U09;_ZN/+\HP1FUS^L[
M?_BIE)])[Z@C_D[&BU[^T7_HIQ[6?1TW4PT@OI^P?_Y4BG[3]@Y`XPQTO=%S
M:CM8?)!3T?TIFHK8*=V#`,DE;&7-GN1<VOMYHOTOTU.V+#:WA@3E[HR\;EMK
MV/Q6/[15F%5_;"EJ<&:QM(70`"./AC,':Z6"VOTQFV&8;_\`?=_^J#RV-CZF
M>."$7DD<&,'F38+W/"'1B6I[*FF>*6EHXXQ+E(;)<$/%]CN/FO*^P1P:#%FX
MEC&)1TPI7!T43VD\0V.MQM9:C#,?:SM3-45';#BX8T\1K"QV1^:_<`Y9=-4%
M;V)CJ<-[;QX=Q7L#7R1RL!L'Y6FUQSZJ_P`7[/8+CG:O$:67$:AF).C;(&L8
M,C``!;7<\^6Z!4UW9MO;6D[04^-0ECKMGC#3W3D(S7MST"D4F(]FV]J:OM)^
MFH@Q\7#$#F$.S"P)'4$`6]4$K`J69G8O&,-Q&L=:GDGIW2F[LC`!L.EM@L=B
MW9.@/9N''\!JJF>)Q:UT4[0':NR\MB#R6AH>TV!U&#8S!6UGL[J^JERLRDN:
MQP`#B!\RHU1B^%8-V,AP>AQ&&NJ\X<YT0.4=_,3^%D$.;LE@F&/P[#L9Q"K&
M(5YLWV=HR1G;6_*YM=6W93LK0X1VKDIZJ22:KIV<>F<&V8YATS']X$D60<3Q
M+L]VAQ/!L9=C,-&:,WFIY@<^X=8==0GP=L\*E[<NK))N'0"E--',X$`G,'7/
M0'9!'P7#^RM5VU+8ZNOFK65$DO"DC#8\[23OT!59](4>'-QVI=333NKGR#C,
M>T!C1E%LIY\E:T.)]GL*QFB?%6T]4]]74335,,?NV/!RM)W-EW:"3!:JIJGT
M];3U=1654<C2QFL+&ML07>9Y()79&B]FP]CR+.<+K0J/0\(4T;(W`@#DI-CT
M0(E%DB</1!\ARV,K_5,22NM*^^AOLFM?<70.%[F^R6X29@=EP`*#@;E<767&
MS1=#=(-=-4!X]44A!B.ETXO<#N@YUPE:Z[4PNS+A>VB!7-T*A49M6V4W-?10
MZ<?KMT&QB!,(UTLM!V.Q%N'USW&)\A-K!JH:<_JX]%>=CC/^DR*>.-SK#5^P
M0;^3%,?KAEHZ-E.P_;DU*K:K#9I'9\:QUUC_`)<9M^`5W+"]S?UW$K`_Y<`L
M@L.&TQO%2A[Q]N4W*"MHZ6A8;8;@\E0[E+*+#\59/P[$IF?K5=%10_<A%C\T
M^3$:E[;1W:W]P91\U#=*Y[K.DS./)@S'YE`6*@P.B)>8WU<HW?(?ZE$DQ<AI
M91P1Q@#9K;_B@QT$TQS&.PZS.O\`@K"+#J>P,SW/_=;W6H,[7/JJP$33.)/+
MQ'Y(.%894R2.B=&6B]V\?N_(+:Q0PQ:00M9Y@:H-?123L;-$<LT1NTG\D%?'
M@].W6HJ'/_=C&4*;!#!``*2D:T]0W7YJ12/I96@NUE;XF'<%3#*&-T:UC?-!
M%;!4OU<0P>>I18Z5C7`R.+SSNF.K&DV8XR'HW95V)X]34#'&>IBB(^R.\X_!
M!?M#(QW&@#S375$8^T3_``KRFO[<8M-7-CHJ9C:8.!+I1JX>G)!J^TN+37`F
M$0.F6,6"#T^MQBAI&9Y9XF?Q.N5EL4[8TW#<VCB?+)R>\Y6CX<U@'R2/.9[B
MYQU))0GRAOB03:C$,5J9I'U.*5'#<=(HW96M701U%:[*PG*W1TLAT;\2FT=$
M9HG558_@4K=?WG^BC5^).DC]FIV\*F;LP;GS*`U9B,-+$ZEH+YCI)4'=WHJ"
M5US<F]^J4WN7;)A+;C,;`Z(`2CKI=5-7(7-+&"Y)T4RKF<ZT;3>V@"6*F;!%
MQ91WN0.Z"'2T#`T2U)LT;@<_(*>\U.(U,-!1,+GZ,C8W5L8_OYKJ2EK,7JFT
M='&7R/.6P&RM<2Q&B[,P2X9A#VRXD1EJ:P:AAYM9_=!U7-1=D87T])+'4XV]
MMGS-[S::^X!YN_)9J&1U13S.D)>21Q;ZF_)_]"JQSG/<7.)).I)4RC+(JL1&
M3/!,,CG:BX//X%!J@78:V&-V6[J4/81U+;K%P-=)/&VURYP^.JO)I'2&".Y+
MX@Z$V.X&WX*/!1-CFB=Q&L>TWMF00\2C=!72-.A!Y<E9-I_^1QR$"[B+#XJK
M$;ZBJ==Y<77<X[E73I'.HZ&C:RS6.+C?G;5`ZF8^G>6NGF=&T9C&3H+\Q\$U
MT4CR'#NCSW4[%JV*2HIIHXVL:UK(7$#Q=2?G9+5QY)"UOA&WH@KI;9FQ@=Y0
ML8I)(60S.80'=TFW-7>&OI36PB<ML9`#?D.JN_I%;A=/!3X;A\[)B&9Y'CFZ
M_)!YHN3@W77?HBM8`+Z>B!K&EQ1^&+6.EN:?`PC3*--5*8WJVVFJ"7@>2GK&
M$VRO[KEIGP,;(1MJLRQM@"W0[A6[JF1\<<H/B&NG-!/:713ME8X&QN0N<T1U
M4L3=&N.9H\CJJIU7*2;;J<9G34=/4#Q,/#</Q']4$RUQMJD)(/\`9,SE[;W^
M"XDNV0*QX%NO-%!(]"@`"X\PB@]T$WN@>'>:D,=<@`Z649HUVT18W;'35!.H
MY2U[26ZAUUC.UU&8>TE0&^&=XE;I]X7_`+K5Q$AR@]KX@Y^'UPU[CHR?,&X_
M`H*KAL[EM"!R2T4;G-DD`)#G<D%C[022'Q;!6-(P14K1?8?B@DX>P,KZ7E:9
ME_Y@O9OIGIZF?!L/=3TTT^2I)=PV%V6[3:]EX?Q79KAQ:0;@CD5ZMAOTO<*B
MBBQ#"7S5#&@.EAE#0_SL=D'F$E)BCM/T=6?Z#_[*TP2AQ%E-5%]#5@D6%X7?
MV7HO_P!8Z*]OT%5?Z[5.'TITGLK:@X/4`.-@WC-0><85AV(?I*B:*"JOQX_\
MEWWAY+TCZ9?\-PS_`.^[_P#5"_\`JQ1__P#&J?\`6:L;VN[65'::HA+H!3TL
M%^'$#F-SN2>J"CH*.>OJV4E/EXCP3=SK``#F42CIY)GR1\1D(B87O=*2`T#0
M[`ZW*ZAKA215(9!&^68-;GD%PUH-R+=20W7R4EF*.&(5=;$SA25$;F]VUFN=
M:Y'E<'3S0#FHZF$L+1QXY&A[)(07-<#H.6]QLAY*KOM;!,2TV<`P]T]#T5A#
MC$S6L;4232V<\N<)+&SF!@MR!')([&GCNPB9K&QNC!,G>=>/('.MN>:"`R"H
M)`$3W/.:[&M)<VV]QR2R<1L#7&-X8_1KBT@'T*M(<<B#_K892T@AP:\=ZY:=
M;_P[@W3*O%F5M*RE;"YA`C#MLO<%A;G_`/W-!"J*"IIXX@Z)[G21"8AK'=QI
MVOHH\%+/-40PM86NF\!>"`?/\%<-QMK>$)(Y[PF-S,DELQ:TBSOW3?\`/JH+
M,0OBE/6R1N<R(,'##N0;EL.B`N#T<M9(UL-LQ-M;Z:$WTY:)\I?2TIG<UPSD
MY'$$`^BFT%534<;64D=1E<YKCQ'B^C7#E_%^"#VEQ055)3T+8RUP+"_;+W6Y
M1;GJ@F]CL7JFU+8IY2Z-QTNO3V.S-#AS7C-&#!%'(-"""O5\(GX]#$^_)!8V
M2@)!LN"#Y`F:.(_U0L@*+,\\5X\T.^MT"&(6W2",#<E.S@[)+H%>WXH)99WH
MBYB.:&YUP@.T]W1*A0^'5$*!#ILGM0R;IXMS0(=+E1X#>K^"DNL!HHD.E6$&
MOIS]18]%;]FG9<2%N8ZJII`'4]_)6O9L7Q9C;`W0>C-&:P%W>3!;\4=E)*[4
M!D8\]2I<4$I:`!8>2DQTSAN=>I00&T45\TA?,>A.BF11Y6VCC:P>04IL;&[F
MY225$,0U<!Z(!MA=?,3\T0-8.I*"^ID<+PP.=^\[0*OJL2AIFN-?6,C_`'&;
MH+9TK6`YG-:!\T!U8TWX;'R>9T"R57VOHJ<%M%3.E?\`?>LY6]I<5JC9T^1I
MY,%D&_K*RA@E;/4UL5.\;AAN3Y*CK^U=*QQ]CB?.3LZ70!8ASW.<7N<;G<G4
MI"\'9!<UW:+$:D%O$$;3NV,65/F<]Q>_4\R=2A&8--K7*:^6^^GD@-Q-;`)C
MIM;`*,Z<'0!+34\]7)PH&EQ)U/(('.G<YPCC9G>=@%9T])#0-%1B)SR_9A!Y
M^:,SV7!V%D8$U818NY-5-+)))(Y[W%SCN4!,0K9:N3,\V:-FC8*OD-A?DGO?
M9199-W..@0)J07.(#6A1'/DG/#A;<[7"+&R:MD$$3"XN/)6[C!@<>49)J\C4
MC5L?]R@A>R187"):VQJ"+MB)V\RH5'35.+U@CCYW+G'9HY_!$BIZC$IGSRO.
M3=TCD#$\29%3.HL-)9"[NR2C0R^7H@L<7QJ#"\+.&8!(.^[)4UC?$\_=;S`\
M^:Q.I/FE-]KW2('QQN?*(VB[B;*ZK,+]GHH9"`R>0ET<8-W%HW-NBE]D<+,\
MDE9/$\P1BYRC4ZZ`>9.BT%9)%`R:>5K)*ZI`;PQJR&/DT'H.?WCY(,S%3U$.
M'?I&1X#'V=&+:EVQ521('7<Y[I#X1OKT6F[0U5W14HN&Q,`R\LQ&_P":I64O
M%E:-;`7)\R@+A[AA4GM$F7BR-[D;]7-(/,)#4S/S.G%YG,-G#D>BK71\*KM*
M<S6NUOKF5\Z)OM;@US/J\M[&X#CK^""+C(,%/10F]P`=>?57DS?JA(X=XL%O
MDJG&P<0QBGB:?';O'ES*M*UKP]MSH[D@RU8]T57EN6D&]_-$Q@R.EAF>;N<S
M7U28A%?%^!]YS6_-&QRUF@<GD((U13F*1O(/:'`A=PKL+ARW"GS-XU!25`;<
M,;E<?R40'N.OSU02(RT.(`ULCBQ)4.G).XUTU"F@$6-D!HQHI>&#C&6E<[4#
M.W116FQUV74TY@Q&%][`FQ/D4%FVG;8%^4>:DTD;#3U5.#XF%P'F-5%G<]CW
MMUM>X0Z2K$51&YW)PO?IS03*8G*"=K([@!_5!B`CGGIC]AW=\VG92'`%NEM$
M#&7L#:_)&;;2]D-@O8WN"4]IMIJ@(T`7N4C#8^2ZY-S8;)HY\T$Q@N00EQ>+
MVC`J@!O>A<)`/+8_@5U,;LTUU5A`P/+XG:LE:6&_F+(,-`,[X(C:Q=F/P5G,
MX9;!0J9HCJI1(/=]WXHY<3<@:(&GFD"5Q\CHD',(%8W,\#JKNMNR"GB')MS\
M54T@SU$;1U5OB#@:HM'V0&H(K6WLC`6%@G,:`$K1=VB!``!JGQCFD([P:I#6
M!HU0`?<:)";(A:+[II;=WH@0G*TW3X`61%QW*&\%\C8PI$U@0T;`(`W.I2P@
MND%QHEMHBTX`N[H@GTYO+?[+`JY[O:*Q[MQ>P4J9YIZ!S_M/4;#&&]]^:"UA
M9>T?+1>FX#"(L/C'D%Y[A<7%J&-(W*]/HHQ'3L:!;1`=<"N7!!\;SR_72#]Y
M<)!;5`F`XS]_%U26TY_-!)#FG8>JYI!<HX`M_NE;O>Y^:"2XMZJ.\`'0E.MZ
M_--+1KZ]4!J?:Z.AT;19R,6C-_N@:E`3\K>B5K1T0#^TH8_;`0K$M;;90@QO
MM8TY=4&KH-:<>BM,#JHJ'%8YIB`PZ7/)0,,:.!MR3*]C2T@C\4'M<&+03M;P
M'M=I]G5&XU0_9F4=7+Q_LI55%),6T\KF`ZD`W5IBN*8A)4\-U7)DML#9!Z'6
MU]#2QYJFM;INUI66Q+MC'&<F%TC7'[\FRQDQ+GG,XGU-TCF@#9!<5':7%Y@6
MR5.6^[8Q95<LKY7%TKR7=7&Y2-`#+@)H`+A=`,FY[OS2YFL/4HLC0!H%'RC,
M$#P2XW<ZP3'DWLTI"`38[)"`+V0,<<NVIZH3B_Q$H@:-5*HHHY:R-LC;MOM=
M`F%X5-6N+WG)"-W%6DU7#1Q&EH&Y1LZ3FY6./G@P0PQ=R/[K=%F@!J@8]Q+M
M=RFQSB)[CE#KBVJ5P%D%S1F&G-!%J9FQASSSY(=#25&)3Y&`@7UOL`DD8UU3
M9PN+VW6AQ;]5PFFCI_JVR#OY=W?%!"JJNGPN,TM`0^7[<_\`0*LI*.6O=)43
M.X=,SO22NT0::-DM4QL@S-)U%U+[:O?&^GHHW%M,&@B,&PN@KL5Q4U-L.PJ,
MQT;3;-LZ3S)557<*)K(V->7V[SW;?!:G!J6G9A_%;$W.6ZDZ_FJ;'HHVF+*T
M`6O8(*!*T7<!UT1,C>B5K&W&B#6-Q=]/1QT5!`Z-D>KG7OQ"!8:=-3\U7LEE
M+&3.OQ9)+G,;@V3Z5H]E8[F>:CYG&HI[DZ9K("%QJY)Y7CO%^WY([&G.6C<]
M%U,T-XK0+#12J9C1-%8;DW09K%6EE<_SL0KFFI1^@8)H2'R22$R`[WOM\D+M
M%$SB-=EUS$7\E+P![FX75-#C8-T\KD(!4[0R>!TC'9HV.N/)6E1WXH97"SB`
M[0^$<E7.8UD=5EN-6MW.REU8#>"T:#+L@SV*/X.-&:V;*YK@.J-VBDBDE8Z%
MI:QUW`'S5G[/"^8O?&'.:TV)5/B[098[_=0;GLE00U_T?8G&Z)IFSE\;R.\"
MT7M=8-V@RV7I_P!'P`[.1@;&1UUY]6QL;53M:VP$CK#XH`4P:-MO-6&30:Z*
M#2M:2+A6.5N7;\4#<IRZZ@<T.IB-FO!U&J.WF.29897(+IS6U-/%4--\S=;<
MBH,M+8D==BI.&DG"P"=G$!#F]V#<W]4$F9IO23F^9S#&_P!1_LBY^[?9#C[V
M'N)));*TC79&+6BQMN$'-ON-N2>+Z6(3F`62/:`TV"#A<.-@NU#K=4L8!;JE
M+1M;F@E4;B#IS"MJ8ZAW(*II6C./16N'@<2R#,8G%%!C%;&3:\I>/0BZ;%D?
M=NBD=KXH_P!+M=EU,3;ZJ%$T`Z!`=\4?5##&7(WLI3&@@7')#E:T'0("X:P&
MJ:<N@U1+YIGOWN2CX:QO>-M<A3(FC71`I.P1F@-;<#YH;0,R*X:H!LN7WLI+
MR`T`H;`+A+(+E`(FPNG7L/,II`SA=*!E<@=3"Y?,>6R7<DHK&@4C``FY1EV0
M"*EL99K&#=Q0&-&8:*?2M!J!<;!!%Q5^9T<`\+1=%PYEOBHU0+U,A.][*;``
E&BR#4]FZ835P(M9NJWP!%FC8+"=D26UAL=UO^2!JY*Y<-D'_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g519019.jpg
<DESCRIPTION>G519019.JPG
<TEXT>
begin 644 g519019.jpg
M_]C_X``02D9)1@`!`0$`2`!(``#__@!'35),3%]&3TY44SI;1D].5%-?3$]'
M3UU+34524DE,3$Q/1T\N4%-4"D9O;G0@4VEZ93H@-#8@("`@(%-T<FEN9SH@
M*&@I_]L`0P`'!08&!@4'!@8&"`@'"0L2#`L*"@L7$!$-$AL7'!P:%QH9'2$J
M)!T?*"`9&B4R)2@L+2\P+QTC-#@T+C<J+B\N_]L`0P$("`@+"@L6#`P6+AX:
M'BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN
M+BXN+BXN_\``$0@`)0`P`P$B``(1`0,1`?_$`!@``0`#`0``````````````
M```$!@<%_\0`-A```0($`0D%!@<``````````0(#``0%$082%A<A56&2D]('
M%$%1T14C,3)4D24T-G%S=;/_Q``:`0`!!0$````````````````%``(#!`8!
M_\0`)A$``0,#`P,%`0```````````0`"`P0%$1,441)!D2$Q4^'PT?_:``P#
M`0`"$0,1`#\`GYM8@V-.\DPS:Q!L:=Y)C4<0X[IM(G%R3<N[-3#9LYD$)2D^
M5S\3^PCCZ3V-C.<\=,:R.NN$C0YL0P?W*Q<EOMD;BQTQR/W"HV;6(-C3W),,
MVL0;&GN28O.D]C8SG/'3#2>QL9SGCIA^ZN7PCS]IFTM?S'Q]*BJPY7TI*E4:
M>`&L^Y,2\(5R=H]7ED-NJ[JZZE#S)^4@FU[>8C7L+5M.(*:J>3+%@)=+>059
M7P`-[VWQC=2`3C"9"0`!438#^2.053ZO4@G8!@)5%&RCTJBG>3U%0J7+*JE8
ME91QTI,R\E"G+7(N=9C41V:T2WYN?XT],9C0)IJ1K<A./DAEE]"UD"]@#KC:
MAB[#=A^,2WW/I$=VDJF/:(,XQV"ELL5')&XU&,Y[E</1K1/JY_C3TPT:T3ZN
M?XT],=S.[#>V);B/I#.[#>V);B/I`G<7'EW@HUM;7PWR/ZI.'J)+4&15)2CC
MJVE.%R[I!-R`/`#RC%ZI^LIK^Q/^D:^<78;`O[8EON?2,;F'VYS%"YEBZFWI
M[+1<6)!<N-47[2R;4D?*#ZCNAUY?#IQ1PD8!]@5WNT/#\O3)_ODJYDMS)*RS
MDZD'QL?+=%,MOA""5LE>^F:7'*$W:%D=6X,&`EM\+;X0B_U%#>D);?%U[.*$
HQ4:EW^8<)3)J2M+63\RO`D[CKM"$4+G*]E,XM.$2M,+'U;`X97__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g426392.jpg
<DESCRIPTION>G426392.JPG
<TEXT>
begin 644 g426392.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`]35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU23UA!3DY%7T%54U1)3E]02$]43RY%4%/_VP!#``<%
M!@8&!0<&!@8("`<)"Q(,"PH*"Q<0$0T2&Q<<'!H7&AD=(2HD'1\H(!D:)3(E
M*"PM+S`O'2,T.#0N-RHN+R[_VP!#`0@("`L*"Q8,#!8N'AH>+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+B[_P``1
M"`"'`(<#`2(``A$!`Q$!_\0`'`````<!`0````````````````(#!08'"`$$
M_\0`/!```@$#`@,%!@()`P4``````0(#``01!2$&$C$'$T%182(R<8&1L13!
M%2-"4F*AT>'P)#-#%E-R@O'_Q``6`0$!`0```````````````````0+_Q``7
M$0$!`0$``````````````````3$1_]H`#`,!``(1`Q$`/P"X?*ABCXS7>7_[
M0$`P?3UKG44?!S_6N8PN*`H&-J!VW.U"62.")I97"HHRS$["J6X\[0+B],NG
MZ07AM`>5I`<--YX\EH)QQ'Q[HNC%X4D%U<+L51O94^1-5]J7:7JUTY6W<01G
M]B)=_J:@\=M$JBZU%R"WN+XGX#PI&2X9R8[:$1I^ZN_U-!(9N.>(&;"ZA<HO
MCR,`33E9]H_$-HZ%Y/Q<>PPRX^1VJ`.LH.?:7X?UI(W+P-A)&=OCTH-%<)\?
MZ?K=RME<PFRNW_VU<Y60^0/GZ&IN!64+2]9XEE5RDR'*L-C\<U<G9WQ^NI]W
MI6K2_P"M&T<Q_P"7T/\`%]Z"S#TP37/,'?XT88/ECJ*&,=!F@+TSB@,4?&VU
M`#SH"8_PT*,1G;R\J%`J.N<YHV-JX!BC`>)H"E<T7EI;&13'Q9JJ:1I$DH.)
MI?8C]#XGY"@@/:%Q`;N5M,M),0(<.0?>/^?:JU6WCB62\FCR`<(I\_*I%W1N
M!WA7+S/T]/+[4A<VW/=1P8S'%N1USB@8%M9IG[R<YF<>/1%I29(K>!1$@P>C
M$;M\!7MU1TMVC27(63,K@=6`.%7YG/TJ0\*<+W6KS"^NHBJ'W01LHH(+'I-_
M?.6=2J$]!7J_Z3FY20F<^=7@G#T%M&%"#/PKS7.G1HI`4"@H#4-+N;)B0K*>
MFXIML[N2"=65RCJ<AE/0U</$.G12HRE1\:J/7K%K*[<`8WR-O"@T=V:<4CB#
M21!<R#](6_LN#U<>#5-@-NGTK*G`^N2Z-JUGJ08]VCA9U_>0G<_*M60NLT22
M1L&1U#*0=B#0<P=LB@12O*:X10)8&^U"E!]Z%`;&WE71BE"#0`]*`HR,54':
M3J@OM=73XGS%`.1ONWY5;US(EO;RS.W*D:%V/E@9K-JW;7EU=W\@)+LQ'PSF
M@>K62/\`$-M_M(3\,_X*Y;JH<R,=RP7\C3!'=&.&XD8^W)CKZFO5)?A`AYA[
MV?G0%F@34.+["W?>)(5)'_L36AM-MH;6RB6*-54+CI6=^$[VS;B>WN+V<1(%
M4%B"1UK0D>H64T""TNHI5(ZJV:#DX#$M3%J"L1MXT\2RJD;,34>U?6=.L8"U
MS,`V,\HW-!&=37+-S8VJLN-(>8=X!T\:F-_K,U^SMI]C(5S[S[9J-ZN6N8)X
M9X&BD*$@'H?@:"%Z3O'.FQVSCUK1G8SKK:MPTUE.Y:?3W[O?J8R,J?N/E6;]
M&?DN6'\/VJU.Q:^_1_%<UH6Q%=(4.?'&X^]$C0/RHI!Z4;'G0Q11,8]*%*8\
MJ%`?&=J`6CX\,?.C<M!&^/)FMN#M9E7WA;,!Z9VK.D$A2W6-=V_/^U7?VPZQ
M'IW#+V'><LU[['KRCK5$1%RAY<`GQSX>7]Z!._N0G,H.=P2?A3?=7KDHH;P4
M?:DM4?DYESD],CQ)I33=-N]4ODM[*%I)"```,X]:!WT35+*&,QS6O?E02Q$?
M-@>._A4]X=N=/N)8[JWDEB9",CF(Q\CX4XZ1V4B'1.2>9EDDW=>G-GJ,CPV&
MQI^X<X.2"_3F7OA&`"S=%&<_.@?-8BDCT<7,>Z\O/D>-4UJ=^+NZ=G4O("%1
M1U)\!6@=?5%TAX%4`<A`%4[I.F6TEZXD@1\-D%EZ&@AD]_JT%RUK";="J@NN
M&]D[^R3YC&^,]:Y!=7%[;EKF,JU6G></6LH[X6]N'_>"U%-7T]+7F5=R:"G[
M=3!J4R?N%A4JX9OOP'$.EW><*)5#'T.Q^]1_4$Y->NU`_:Q]<5Z9&,30N#[F
M_P`\YHD;'P!MU]:!'AFBVCF6TMY=B6B1OJHI7'2BDG9%&6('Q-"E2/'&:%`J
M!UH_+7!Z[4H-]_M047VS-*G$]H"S=VUL.7;8'F/RJ"L7,3<T,1QX@D#[5I3B
M+A^PUV&-+HR))'GDEB.&7/QV(]#6=>+-*O\`3M6NM-O+IF$3%5*CE5QX''P-
M!"M3>(S^U*KGP"#85I+LJT'3M.X<TZ^MXU:XNX5EEE;<Y/A\!69+R`0WK`$L
MK=&/D15[]DFN3MP0L85I#9S/#CJ0.H^YH+BOQ"X!>7EC`W"TTV6MVL^I#3+*
M->1`2[^51#5-8NI\6T*/WD@V'3`\S3YP5HRPV4TEUAI)R>8YWQ^5`[Z^\:VS
MLQV&00*I:^U"6PU":>-AA6'L_O"I]QAID\,7=66H.2>O>3`\HJJ+F&"WG83W
ML3MXD/F@GD&M)<6P<9&1N#3#K%RD@+4U07:E>[MV$G_B<TE=][S-WFW+U%!7
MVH.LW$5SR=.?&?4#%>ZUM9+S4[2SC4EI940#XM3/II[S49)2207))^=6'V6Z
M>^I\<V+"/F2U7O7/@#C^]$C2MK"(K6&-1[J`?04J5\>E*@44BBB8Z8Q0HW+X
M\N:%`<#/6C#/0^%=*CQWQ7<>E`4^54=VTVOX?7;:YY<)/$3S>H(!^U7DWNDX
M.U45VUZ]IVHV]@EG+WG=%PS8QOCI04W,.^LUEQS,GLGY';^7VJP.PO5XX-5O
M]'F;`N@)HP>A9>H^A_E4'T:+\5;WZ8W54DQY#<'[TV+<76DZE%=6SF*>!@R,
M/`B@UI?V4#ABHPS#EYAX#-,JZ#^#E[Z\O]0O-.8>U;&<J(VSU&/#T->;@SBV
MRXFTR.5'"7*`+/$?V6]/0^%3<)S0X1@=OK00;5-)X9[ABNGWH8A>7+['SWSC
M>H'K'X""9DTVPA&3[)<\Q&Q'Y^=6;K'#IF+,H5`WD>45$;[08[8$AE!'7%!%
M](MH;`F5D7O96YG..M>'B._6VTZXF)]MAA?B:]VI2+`6P?=VJ$:Q=)?3`3/_
M`*=#T!]XT#=I2=W;R3N,+TSYUH_L.T`V7#[ZW/'RSWYRF?",=*S==W"NT<48
M"P+C"C\ZT]V0<4:=J'"MEI\EW%'=VJ]UW;-@D#QH+%Z]:YCSH,\:@,TBJK;`
MD[&C#?H1\J`N!FA1^7Z4*`X&^]#!S1\#PH8\J"-\<7LNG\/SW,3JNX5L^(-9
M2XFO%NKPQPC;))&<Y)K5/:)`)^$[V,PM*N`2%&2!GJ*R_)I]MWS,UQ'G.&Y0
M0?GF@]_`-EE[NYE7$3)W>_[7G49XMMA!>G!!P`#C[_.I5^E8+2T$,.(XT'^&
MH)JVH/?79FR1X`9Z"B5->QNXQK=W;-NLL(.,^(;^]7O#+>V)S&6GA.X4]1_6
ML^=D^W%(.<?J3]Q6D;<<\:L-R*$PS:KQ1&D?*R,CCJ&!%0G6=?[\'N]SBIOQ
M!9)*N\8W]*KS5K/NV;E7`%%1+4A+=Y5F95SN`>M175[<VZIRY"\V*L0668RY
M%0GC!E#Q0J/'-$J..Q88'05[M*U">RE$D;$$>M>`9(]?O7HMG(.R!OX#U^55
M)J7MQ?K4YC[R\D58SE%#$[YZXJ[>QKB35M5BDTVYMU-K`I?OG8\X)/0^9)R?
M2L\V,]J90)(WB'BV!M6G.QO28;+ALW:SP32W3\Q$3!BBCH"?.HTL'8;T*/\`
M>A0&/G]*&*9>)N)]$X7LUNM9O5@5]HT`YGD/DJC<U6O$O;?IUOS0\/:<]Y)_
MW[G,<8^"CVC_`"H+CQDXQGTJINU+3NS:.-IM6G2TU/'LKIQ!F;XH-OFV/C52
M<0]I'%^N\T<^JR6T#=8;/]4N/4C<_6H8S%F/4Y]X^)-!Y]2<R2R"`R=QS'D#
MD<V/#.-J\:1$`LU.;1@CIM2$H`&<;>`HG#GP7J2:3Q'9W4NT.>1_13MFM/Z1
M,LD:LK!D89!%9*A3.6/6KP[*]=>;3X;:=BQ3"@DT58NJ][C(7(\Q4'U:SE<G
MG&!_.K`O(V9,TR7UE)*0%7)-!!+U5CA6(#!Q50Z_="\U"62,YB7V5]1YU9O:
M#,^E6\L8)$LH[I/3;VC]/O53$9'2@\>X.*7A5G*JJ\Q\*3Y"7Y0"3G``\:F^
ME:;;VML6:XCY&1B3)$P9G4#]6"-QYCS`;RJLR&2'1+ZZ[U%'ZY"%$>"2Q)``
M'U'7:EOT;K.CWC_@)[J.>`9F[IFB:-M\CKOC!WJ32Z[9IJ4MK>)>7$\]NL)D
M#%RLA`!;).6/EUQX4\ZMI.F)IS7&GRF2RDF$1%V.4HQ3>0NHR$!.`#U8[C>H
MT8-+[5N.["(1IKC7$8&WXJ)93]2,_P`Z%1O6([<+%=)/#WK'NWBCB*>T.K8^
M.V?&A0/?'O$,_$O%ESJ$C/W)<K!&W_'&HV'Y_&H^:%"@*>GQKL8H4*#KML0.
MGC7D;+OO0H4"ZKA=JG/9=(?Q+("?9DQ^="A0:)@B[T*&;]D4[0:;#&"Y4$^%
M"A09<[8=1%YQA>VT61#9MW`]6ZL?KM\J@('LT*%`6Q9XM0@D0\KI(&4^1!J?
MQ7AOH#;QVZAX@99+B60^VQD)[U%&RMRL$Z=!0H42%[J*UM=3M]1LCW-X'=2N
M<HK;`N`5V)W\_3%)7-_';VWX=)I)K909KIH4`9\>[N_P&1TV^5"A14;X@<O;
:6Z+/'*DLA<D0A"K8R0#UY06(W\A0H4*(_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g173968.jpg
<DESCRIPTION>G173968.JPG
<TEXT>
begin 644 g173968.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`\35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU724Q,24%-7T1!3$597U!(3U1/+D504__;`$,`!P4&
M!@8%!P8&!@@(!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE,B4H
M+"TO,"\=(S0X-"XW*BXO+O_;`$,!"`@("PH+%@P,%BX>&AXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+O_``!$(
M`(<`AP,!(@`"$0$#$0'_Q``=```"`@,!`0$``````````````P4&!`<(`0()
M_\0`.A```0,#`@,&`P8%!`,``````0`"`P01$@4&(3%!!Q,B46%Q%(&1"",R
M0J&Q,V)RP=$6)422HN'P_\0`%`$!`````````````````````/_$`!01`0``
M``````````````````#_V@`,`P$``A$#$0`_`-Q8HQ3+(L@7BC%,Q19`O%&*
M998]550TS"7N!</R@\;H/MUF@N<0`.9*CJK4X(;A@+SY\@HVKK9)W7<>`Y-'
M(+!>,KWN2@D#K^)XQ,`]UF4FM450<7/[MQY7/!5&KB=Q`%E$39Q._$;(-LM`
M<`6D$'J%[BM<Z3N&IH2UA=WD75I/[*]Z7J=-J++Q.`?:^-T&7BC%,LBR!>*,
M4RR+(%XH3+(0-Q1BFV]$8H%8HQ3;(L@@MR:F=*HFNA9G53O[N%O\WG\E7V,<
MQN#I'/<.+WN/%SCS*=N*=E9N:"G8Z[:&(N</YS_C@F0L`%B+E`IL9XK[<P6O
MBLTQ-[OD+I;VV'#)P*",FA#KV^2A=0A&'$$'CQLK*]K21X;^7%0VI@!I!R:?
M,"Z"IEQ:\C_XK[BUJ?31\13R8N8;@\U[7AK6O>PAW#Q-(L;^RK55(7T\PO>[
M39!N[96YH-RT4KP&MJ82!(T=0>1"LV*Y^[$JUPW5#&UQM-%)%(V_ID#_`.*Z
M&Q0*Q19-Q1B@5BA-Q0@?BC%-Q1B4"L4!O$)N*,4&L8HRW7-0>\EQ>]W$]?$I
M6-F5C?GR4;J\KJ;6M0G>PXLN;-\R>2PZ34ZQP$S[1M)_#;(CZ(+$62M`M:R4
MZ[G%CAQLL0ZO,9`TM`B//)ANL^&1DI$A')OD@QV0ES"23<'A91.HLLPY/+1_
M4I*OU!E/2W81D7&RIFI1ZMJ[\&4\,45[ESG"Z".UF5K'/:9`X'UXCU"J]7.U
MD4CS8`-)61K^D:Y1R,D:R`TL9N\B0EV/IPX_5156YKJ4R-=X1R<@L?8^P1[N
MT^3$G)SFD=07-/Z+I+%<V=F5>VDW%3ROA?@)F<`.G(?NNF2VQ(\D"<48IMD8
MH%8H3<4('X^B,4[$(Q"!.*,4[$(Q""A[BI(SJ-0R1I(E&7)5Z7X]CY(*8QT\
M38R8Y,<G.?T!)X`*T;K)&J\.C6\O913PX6+`+>B"GT$FKNK'R5%4_`RAK&/:
M/$WJ2!R(]%<8GB.F?D.(;S"6*2)[N]>T%PY72*SA`XWL`@J=+7/EU*IBE!?B
M3W;!QXWM_P"T_<;M2I(:=M":>1DO%]LKL%C<'CSO;H!:_DJ[WA&L2/!(M)P(
M5ZCB?41-ROR%['@@I&E5-=/45.GUP!:0"WK91.J4`IG.IR.!'(J_5M%34L4D
ML3,97'+/K=436YS)4![C=UN*#)VG7:9%N?1:".0.G96QF1I'X`'#@?/FNF\>
M*Y5T6B%1O739H;"43Q@D<R,FV_<KK%S?$[W*!&*,4[%&*!.*$[!"!V/HC%.L
MBR!./HC%-LBR"@[N&&JN('.)I43`X.:;GBK=O6D:^BCJFM&<;L7$#CB1_E4B
M(N[HAO/H@=WQ.8AZ'&Y\TFLC!I'/<1QOP2VMPC[JYM>Y(ZE8];#.^`012`%_
M++B@U[J5XM1EGB-@P7]"5L+0JIE7IL52P8AS02T]%29M%DI9914SOF<XW-Q8
M?13>@UX@<:=_\.UN"#[W)4X12&]AR6N*IY?+<GF;A7C?#3$R)D9OWSPT*C3,
MPFL?-!;.S6DDJM\Z9;Q!KVR.'D&@F_Z!=+XJF=E.C4E%M6AK_A8FUE2PN=,&
M#,L)X"_.UE><0@3BC%.Q1B@1BA/Q0@]0A"`0A"#$U2G^+T^HI^KV&WOT6K(_
M"\@\#;BMO+6FZ:0T.K2AHM%+]XSY\Q]4%<U"&OL9J29C7GDUS+A+,]8UK7U(
M<7@>$QV/UN%,M`+!=8U3&2VQDMP\[(*5K<]=+*X1NX<\W@?V^:R]LT`+\I97
M.=*[B2+"RRZVD9)(&AXL!Y\TM]5'0-+G.#>[:2`@QMP.CK=P.A'&"@CR/O:P
M"H51)WU86,L3>W#]%8GUHI=NU>ISO'Q%:XO/H.@^BING5K*6*?5YQ>"F&?'\
M\A_`T?/C[!!UQL+4M-U3:FG2Z5*'P11-@<.K'L`#FGUO^ZL:XL[&NTN?9.L2
M4]<'3:-72`U#&B[HW<N\;Z^8ZA=FT=33UM+#5TLS9J>9@?'(PW#FD7!"!R$(
M0"$(0""0`238!:YWOVL;;VPQ\,$K=2K@/X4#Q@S^I_(>PN5SGO?M<W+N1TD#
MJPTU&[_CTY+&$>1/-WS0=3:QVA;.TB1T57KM,9FFQCA)E</?&]E3]5[=MH4;
M;4T%=5/Z>!L;?J3_`&7(<U?42NOWCF^@*QGO<\W<2?=!TEJOVC7MR&FZ%`#T
M,TSG_H`/W41LW?\`NC?.Z#3UTD<L?PTTH@8P,;"U@!N`.IY<2M!+>'V7:3OM
MXZG.;$0Z>1_V>T?V0;1I*ALC,'&QY63'B*..V0]KIFX-)-!J<L47@8?'$?Y3
M_CDJY6QU0X=Z2@7J$L<$W?.(P:";76M]Q:]\;4_"4Y<[,V<6\K*YR:-5:D[N
MK2RWY-%^/T4[HW929'B:O:(8NL;>9]R@U++3ZGN>H@TRB8Z.@IS>HJ2/`/0>
M952W;J5--.S2],/^VTA(8;_Q7_F>?/T6W>V3<>E[8T]VSMOM8RMD9C4OC%A3
MQG\O]3NOD/=<_H!;G['NV.7:%/'H.N0OJ=&S)9*PWDI[\[#JWK;W6F$(/T,V
M[N30MRT?QFAZG3UL/YNZ=XF>CF\VGW"EU^=VA:YJVW]0CU'1Z^:DJF'@^)UK
M^A'4>A7479[V\Z%J\<%#N>VEZC8--01]Q(?._P"3Y\/5!N]"7!-#41,F@E9+
M$\9->QP<UP\P1S0@_.RJK'S@!SN'4+$)!]T$W7B`0A"`71_V3Z#Q[BU,\K14
MX^I<?[+G!=7?9GTV:/8-;.R0Q/KJUY#QS#&M#;CUO=!L3=.J:)/+\"]CZFJA
M=9QA<`8;\[D\#YXI6A[?TC4(W3FJEJ6M=B6%O=D>XYJFU%/%2[FUF&GC+(89
MK-NZ_-H)O[GBHG_5U9HNOT$U!]Y&\X30M-VR@FUO0CSZ(-Y4>FT-$S"FIHXQ
MZ!:U[<.T5FRM&90Z<]IUVM:>X%KB!G(R$?H!U/LM@ZSKM!H^WZK7:V7NZ2FA
M,KR>?+@WW)L/<K@S>&XJ_=>XJW7-1>3-4/NUE[B-@_"P>@'!!$5,\U3/)45$
MKY9I7%[Y'F[G./$DGJ4M"$`A"$`A"$%JVIO[=FU/#HNL30PV/W#[21?]77`^
M2%54(!"$(!"$(!=E_9Z@-+V9TD[^(>YY;QY#(G]W%"$&#N&LI-.W5J\%7+B^
MH<V9GA)O=@'3R*KNQ=.96;[I8JJ,/A!+VAW(V!/^$(01OVG]V/$]%LJBO'!&
AUM55V%@]QO@WV`N?<CR7.R$(!"$(!"$(!"$(!"$(/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g243310.jpg
<DESCRIPTION>G243310.JPG
<TEXT>
begin 644 g243310.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`K35),3%]'4D%02$E#4SI;04)"3U14
M75=?2D%-15-?1D%24D5,3"Y%4%/_VP!#``<%!@8&!0<&!@8("`<)"Q(,"PH*
M"Q<0$0T2&Q<<'!H7&AD=(2HD'1\H(!D:)3(E*"PM+S`O'2,T.#0N-RHN+R[_
MVP!#`0@("`L*"Q8,#!8N'AH>+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+B[_P``1"`"'`(<#`2(``A$!`Q$!_\0`
M'`````<!`0````````````````(#!`4&!P$(_\0`/1```@$#`@0#!04'`@<!
M`````0(#``01!2$&$C%!$U&!!R)A<9$4,J&QP14C0E)BT>&#DB0S0U-R@O#Q
M_\0`%@$!`0$```````````````````$"_\0`%1$!`0``````````````````
M``'_V@`,`P$``A$#$0`_`'X6C@4?EKO+B@+BABCA<]J-R9H$PM'5*45/A2-W
M=VMFC&>4!E&>0;M]*!4+CM7<5!RZW*_*;>W$:9W9SS,!Y\H_S4?/K-[R\\=V
MICZ<P0#\<8]*"VA,UWPS5(.OW@B"_:6$G\P<9]0:8/Q?K-I)_P`V*=/)P#F@
MT3D-`(:J^B\=6-W-';ZE;FRD<X$A.4S\?+Y]*NXA&Q&]`P\,T4QFI$Q8[41H
MQ0,.0UPK3IHZ(4P>E`A@T*6Y:%`EBC!:"TH!0<"4JB;=*"+GM3;6[T:9IDUU
MC+C"H,9RQV%`VU/43#)]EM$\2?\`B(_@_N?A5'O[KP%?]XZN7PQ)YBQ.^^1G
MTHW[=BYP]US*<GF8R8W/7Y_YHDT8N81+#SF)\YYD)4_KZB@B5O)N=40GQ,X7
ME8GTI66>52&\/$G\08XS\"#^9I*Y1HR'$3-V(P"K>AI!Y+R>(0);,RC8<V2!
M0$N)U5<_9W#+G;H"#U\\?C43<K(55X3(JG^'\]O.I/\`9&INI00<JG?`4[?V
MKKZ;?(G+-;A_,L#D>M!"^)*B<Q;*]P]6SA7CW5-.BCM[A$N;*)B`)#[P'8!N
MV.V:K-]8RR''*%`[YS381&(\I!5#NH_,'R.:(]%Z'K6G:[;-/82Y9,>)$^SQ
MD^8\OB-J>NA\J\ZZ5JUYIE]#?6$WAW,9V;LP[JP[@]Q7H30]2@US1[;4[<`"
M5??3.\;C9E/R/Z44&3X4F4IZT9I-DH&96A3ADH4#-5I55HP44HHH.QQBJG[2
M&9=-L(5)Y9KG!51NV%R-^PWJZQIYUG?M0EE;4=&LD^[R/+C^HL%_(&@A.&.'
M(]:XI99<-;6B\[J,X)Z`;_7TZ5M$&DVR1"%8E4$>55OV:Z6UGI\]Q(`9)92#
MY@#M5Y&2V=\T$'-PM8,2S1(<]PH%%_8EA;1XBMXP?EO4_<2@`!E]::D^)'LN
M_6@K-]9PQH>5%SUVJGZA&K,W+@`5==4+*KY.,#SJK/!(_.S8Y.Y-!4-2M@4P
M%`'YBJGJI8A<^ZZ[%AW(VSZ@#Z5?;X`,0:JVKV@8<V#DC;;K05J,8PV=CUK5
MO8YJ3"ZOM*=CX<D8GC![,#@_@1]*RP1D'^G.U73V62K#QC8QLX7Q!)$/CE#M
M]0*)&Z,GPI)HQ4@R4BR_"BF+1[4*<LGPH4$4!3F).E<CC^%.8T[4!D7:JIQY
M8>*NFWXPOV>;D=\=%;_('UJYQI2=[817UK):S#W)!CY'J#Z&@8Z+-!8Z&)GR
ML6[;#)Z_CFF*\=Z0C\DB3JW9>3<BI!;;.GVT/+LC893ZYJ"UKB7A^W+VL.G-
MJ-S$>4F&,%5.<8+]/SH)N#BS2;UTCBE(+G`YUQ1M1UFWT^/F<CWC@`?G66VN
MN1WU[!(ND75J3(`J2+CF/D!CK5LX[MN;1+>X#L@Y=P%P<_I01>H\475Y.UII
M%D)YV;^4N0*C[S3^*3;^/?,T6WW,@8]!0X"_:*CP[0QP*\G-)<-]['^/+O4A
MQ/I_$DEVWA<0M-9$>[&Z*6/7K@`>6V#\Z"HRO<Q,JS-S8[UV15FB*N-ORI=M
M.U)"%NWBE'FJ\I%$E4QX7I05BXM&29@.^=O+RIUHD@TO6;"](9C'.O(.Q(/0
MGY4_G0!V8#+,,&D]!C?4)[>UDMU\<W$95@,9;G``_&@](N@!*C&VU(LM/I%'
M,V.F33=EH&C+0I9EH4#%%IQ&@ZT6-?.G*+0&1*6""@BTX5101S1*LD\1SRR#
MFZ^?6F4ENUI;"WM$2*)!A`H`Q4K?D1O#(1L<J?S_`+TA<3P"VYV8`"@K5AP_
MRW/VZXE)D!S[IW-,>/89I-%'(I)#Y(ST%3-EK,=]J#6=H%98AS22'Z`#_P"[
M5WB-8AI+N[+RD'K04+A157PE.5YCC8X.:OR:;`\?BN&D8#^:L9N+RTADDF%P
MPE&\)#8*MYX%7G0N*'N+,17)Y9\;^3?&@0XBD19#$BA`O854)G]_![5+Z]="
M2=FSG?M4)R\P)ZG\Q0)QG,P9CC&XJV^S?2TNN);1T7:S4W,^^0K`81?]S9_]
M:J&<2*"-AM6U^RW2UM=!?4!"$^WR>(AQNT8&%/R)YB/0T%K=*0=:?NM-Y$H&
M3`4*4=:%`T04NO6DT%+H*!5!3E!M22"G"#:@9:PF=/D;NA##Z_YK+.,M7N[>
M**PM07N+@\L:*?Q/PK89H5FADA;HZE3ZUF&O:1'<R/XL96=`5!'5&W!H&O#>
MDI;:8UO<\DLMP0TV6.6/S'3';%1W%MM?36\5C;RRR`Y`4'/S_P#VB6FFZ^VD
MM)I&I(L\+%&2:%7S@=1FI_2[G3YHX(=5N]6MKUH5,L:VX=.?!#!6"X(R`?D:
M#+DX>GMIN>]"\XW`Z^M/I'C@0*V1R],=JLVNV]EB%[>/5=0F"^^)0(49@1GN
M,#J*J!TDW5]+<WB_9K;G)2V20L0,[`M_:@<6Y;48YS'EO!7F+?#.,?.D,F.*
M,GNI_.K3IBV]OI%\J1JA*@``=`*J6IS)''"@(RJ;^M`S:53+G`QD;>8S7K&)
M%2)41`B*`%4#`4=ABO(EIF>ZCC&Y=U&/F17HGA;BQYN([WA/62B7\0$MC*-A
M=0D9`_\`-=_F`3U!H+@XI!UIVPI%Q0,I%^%"E9%H4$;&,TY04A&M.D6@4C&3
M3N,4@B]*=1B@,!5;XKTF:1#J%E&TDJC$T*C)=1_$!Y@=NX^5661XX8S--(D4
M0ZN[!5'J=JI.O>U7@_1RT<-X^IW"_P#3L5YE!^,APOT)H(C0`<2F(!HW/-D4
M\O'N(XV$2)N<XY!5(TGVC)J7&'.FD16-G=^[X<;EV+[GG;;&3WP!T[UI@GMB
MOB<R,A&0P.:"F:JU])$REBJ_RJ,"JF\4O.7;)Q6AZO?6QC8\RA0.E9[J^L6L
M8<Q$>6U`C<W<=IIT_._[V3W5453+V8RR%L^Z-A7;J[DNIBY)Y>M%L[6XU"\C
MM+6/GE<[#L!W)/8#SH)_@/3WO]?MCRGPH&$TA[`#H/KBB^U/4\\:H]K(4FM(
M8AXB'#*X)<$'L1S"K]HEK9<.Z3-AO<BC,MU<$8+X&3CR'8"L*U.^EU+4KK4)
MMI+F5I2/+)Z>@P/2B6O0W`GM>T_4UBL.)S'8WN,"]SB"8_U?]LG_`&_*M5)5
ME5E(*L,JP.01Y@]Q7AV.0KWJV\*<<\0\-E(]/OV:T4Y-G/\`O(3\E/W?FI%"
M5ZN<4*S;A[VN</ZB@CU>-]*N`-V;,D+'X,!D>H]:%%7A!3C*)&TCLJ(@RS,<
M!1\3VK(-=]K42#PN'[`R$]9[P<H]$!R?4CY5G&N<2:WKSDZKJ4TZ=H<\L2_)
M!@4&ZZW[3^%M*YX[>XDU.X7^"T&4S\9#[OTS6?:Q[8.([K*:;!::;'V*KXTG
M^YMAZ+69%C7,T#_5]6U/6)O'U;4+F^DZ@W$A<#Y`[#T%1VY^5=-`4$KPO<FS
MXDT>Z`R8[Z`X_P!11^M;AQIHE[I%]*NGR&.UD+-`IW`&=U'ECR\L5AO#D+7/
M$6CVZD`R7T"Y_P!1:]G:GI=IJMH]M=)E&/,K#9D/8@]C0>4=>FUI2PF=O#_I
M&U5J2.1O>?.#YUL'&5G#IE]<V!N+>\:(^_X4J!DR,@.K$$'':H;2N"+_`(DM
M8M0CFMH-.<D!HI5E<D;%=LA2/C]*"@:7IEWJMS]EM$!Q@R2-]U!YD_IU-:CH
M.@0:7;>%`I+-@RS,/>D/Z#X5;-)X6LM$LU@AC``W\R3YD]S\:)J(6VB>1V"1
MHI9F/10-R:#,_:GK'V/2HM$MCB2[]^;':-3T]3CT!K).IJ3U_4I=8U6XOYB?
MWC>XO\J#[H^GZU'8WJL5T;493[YK@%=0?O6'RH0Y4GJ#0H#K0J-G9H=:%"@*
M3V%"A0HCM=VH4**L'`40FXYX=C/0ZA#^#9_2O4'M(XBDX:X5FN;8XO;@_9[9
ML9".P)YO0`GY@4*%!Y5NUDD4R2EF,A)+.^2S]V/G]ZG?`G&E]PQK)>+Q)M-F
M;_C+;(_>?U+GHPSL>_0_`4*)7I2*XAO[:"Z@;GAE021M@C*D9&QZ5F7MEU,V
M&A)8QDB6_<QDCM&N"WURH]30H45@_+DFBNN#0H54=1<FN@`3CXK0H5`L*%"A
$17__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g616240.jpg
<DESCRIPTION>G616240.JPG
<TEXT>
begin 644 g616240.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@!`35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU(7TQ!55)!3D-%7T953$Q%4E]02$]43RY%4%/_VP!#
M``<%!@8&!0<&!@8("`<)"Q(,"PH*"Q<0$0T2&Q<<'!H7&AD=(2HD'1\H(!D:
M)3(E*"PM+S`O'2,T.#0N-RHN+R[_VP!#`0@("`L*"Q8,#!8N'AH>+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+B[_
MP``1"`"'`(<#`2(``A$!`Q$!_\0`'`````<!`0````````````````$"`P0%
M!@<(_\0`.A```0,#`@0$`P8$!@,``````0`"`P0%$1(A!C%!41,B87$'@9$4
M,D)2H;%#P='P"!4C8H*2)'+A_\0`%@$!`0$```````````````````$"_\0`
M%A$!`0$```````````````````$1_]H`#`,!``(1`Q$`/P#L(SN2@!T2P.R,
MCL@;&?T0QUW2])SS1EOR0(P0<818Z[I>DE'A`C&#Z(B-T)7LB:7R/:UHZE09
M:]ATMCF:SW&H_3D@G$$#8($<@JBIN,T?W!K'N!G]$B#B"#4&U,;F`_B&X""Z
MQUZH8V1L<R1H?&]KVGJ#D)8:@0!Z<D70E+(/1&!_80-@=,(QG?*60BP>Z!&.
MNZ"<TXZ800+`V2L(#*,`($@<T>$#S*/&$"<;JHJ;W!',88(C.0<$@X&?3NK"
MZ'105$AR&M9@X/?HLU;J8F,2N;@N^Z.P0/3F:NE\6?RC\+!R:$ET;8@6Q,PX
M]<95C'#C<#..:C5.1GIE!GJ]\N<`GWV5+4U;V;'<=QS5_6$@.QME9BXM+03C
MV*"TM%ZJ*.3Q(R2W\37<G#U_JN@6BZ4EU@,E,_SLP)(R?,P^OIZKC5-6.BE'
M;D1W5A3W&6S7:"ZTI+H3M(S\S#S']/5!V7'/9$`BIIHJB&.>!X?%(T.:X'F"
ME#F@&/1$`E@!)/WD`Q[((]@@@&-]T8&?1+`W2@![(&B""@!D<DLCW1AOI@H(
M-UA=/0M@U8:^4$_^H"CT\33LT#`V"E53M-+%ODZ<`!%2`%NK(0.MB`4*MBC(
MQC?HITCB`<]`JRL+FX=JR,?1!GZV+#G`_)9RXQAP(ZK4UK'.!.505,9,NXY`
MDE!C:QCHGZL<RI\+FS4)CQY@,^Z*\-&P`ZJM@J70/VZ%!U3X:U1FM$U$Y^32
MR>7)_"[<?KE;$]<KF?PNES>*Z/.-5/G'LX?U73\'/=`G&?1$1@IT-&VV$G&_
M5`@`'H@G`WT00++<C=&`4L#.3C&>B,-[(&B,HV@]`EX\RI^+!5LL51-1.`EA
MQ)CHYH.XV01:RI#FPM'(=<^J6*A\49$<>L@<LJ@H:V.KM\+M)8XMSI<<X^?4
M)4MX^P.;$*>6>5W1C<^P_OEU064M^@PUO@S%Y&""WD?55\E>]\<CW;!KAMV6
M7N'%KZFJ?3FRU#"S=SR1@'MC',+0<*@UD-4ZKCD:W`T9VU;(&JN[1-;(#^%W
MU"S53<9ZI\C*:G?CJ_&RB<32/@N4<<;"]FH9;GF,INN;Q+441=0R-@R<,A9I
M&!^8D_MS01*YSVO#9#N.8*IGN<3\^:EU4%QC`;42&9^,NR-P?=0:@.8,9&XR
M@O>'N*IN')ZB>FH8JE\K`TNE>0&M!R<8W)*[U1S"JHZ>J#=(FC;)CMD97EI\
M[9XY(H\ZV@@YZE>J+=#X-OI8B,:(6-(]F@('0"B(SE.AJ(#?*!`!Z()P-[`%
M!`Z!V1X&,(-QOU2\(&\;HI(HY(WQ2-#F/:6N:>H2]@Y*QL@YA5T3K7=OL^"*
M=@+8QW'3]%=4T9\1[HH@\.`)R=^73*L>(Z:*2H<`T>(^$Y//?H53VRJ'A,U<
MR`2@756J>MF:^0""%O,ZRXG'MLGYO"IHQ3TS,-8T\_W53>N(7NJH+=2NP^5^
M"X#.@=3]$])5TL43]<FKR8#LY)08&_'%U$DAPWNKBBKI7TSFPF,D#!RLYQ/5
M1SSL;&[<<R%$LM<^"HDA:=3"`02>2"SND,KP9:APY[-9NLM6.#2`!@#HM/<*
MC5%OL5EJ[).KH4#W!EL?=.+[?`69BEG8'`?E;NX_0%>I,9)]=UQCX)VZ::[U
MMU<&_9J>'P6G_>[!V^0_5=I';F@+2.2+&Z<PD[`GJ@+2$$O&R"`@,#(2@"C#
M1[H8]$",<SU2ADH\;[[H8]$%==;?]OB`9,8)F[-D#=6!U&.JP-1#+2SS48<=
M<3BS/<+IY;U(^2P_%40@N[IL$"1K7_R/[(,?:&!EYJZN1VI\6(VD]#C)_DI=
M\ML-7&ZHBC/B8_AG&ZAMMU8Y]1X$S(WRS%X<6Z@!@;8^2136N^Y.NN=4-&<F
M(A@]-B@QUSL[XRU[BXN.Q!.5'A_\?((QZA65WI+P)I!*V1H!PW5*W]<!4LM'
M6:O]6L=I)/E:-_3<H+5DQJ8R,;M'/"@-@=5S0TC/ORS-B'N2!_-3H964M!*2
M<G(;D]@KCX;4L=5QG:V3-R6"2I(/<-)'[CZ(.\4=%34,/@TE/#"S/F$;`T$]
MSCJG@,#(2\;H!H'3*`@$G',]4O'HAI&<[E`0WYX01X]$$"\;;(`>N<I>.:+&
MR!('9`#?.4O'HBQT0)`PL?\`$.NM5!14;[A4B*IEF$4#>K\\]ORC;?IMW5AQ
M-QEP[PU&?\SKV"?&6TT7GE=_Q'+W.%YEXZXDJ^+;_)7R:XHW'13PZL^%&.0]
M^I/=!V&DUASR'`Z>7<IFL9-K+PYT,G=IQ]4W545=8HJ$53WR&6ECD9)C&HEH
MU-/J"I5-<*4:II`-;1R=N0@QMW^T:LOJG/)/NJAD3W%S_,X-YN<MI<KMXC7/
M>[2UVS1G)PLG77!K6F*+?)RY!5U+P961./D:=3@JJZ5]TH(VWVV5#Z>>CJ(W
M-D;S!.?J.X[%3F1RU,NB-I=)*[2T=_\`XKOB"U10<'5U)D.+83(YW=PWS^B#
MLWPRXXH^-[%]I:&PW&GPRKI@?N.Z.;_M/3MN%M,;;+PAPUQ%=^&;FRY6:L?3
M5#=G8W:]OY7#DX>A7<.'O\0<9:R+B*Q.#M@Z>A?D>^AW\BKB2N_ANR,<MEC;
M)\3>!KUH;3<04T4KOX55F%V>WFP/H5L8I(IHQ)$]LD9'WF.#@?F%%`#KE!*Q
ML@@7C?"@7:[VJSP&>ZW"FHXP.<\@;GV',_)>:>)?B_Q=>2Z&ADCM-,=M-+O(
M1ZO._P!,+`3/J*J9U35SRU$SCN^5Y>XGW.Z#TA?/C5PM0AS+9%5724<BQOA1
M_P#9V_T"Y5Q-\5^+KVV2"&H9;*1XQX5(,.(]9#YOIA8/2/IS2F-R_)Q@;H%L
M:1JD<2Z1YRYQ.2?=2[7&Z2[4\;6[^JC^^59<.@"^TQQODH/7%9:Z.^6.&FJ&
M^5T371O'-AT[$+CO%'#M?9I'_:03%OHE;]UP_OHNL0WJ@LW#=/5UTI;&UH:T
M-&ISNH`'LLG>.,[C?*5]'PY:Z77)ENNY#4W_`*#(S[E!QFXSPN<!'*^1P&/*
M"<*O@,]35,I6^&R1Y\K'/&2FN([9?;5<IZ&]R21U9:)=,<@T:79((T[`<]EB
M*Z!XJ&D.>7D['.3E$=OM%M@M^99I/$J7#!.-FCL%$XUJ?#X<K=((,K1$W/4N
M/],JIX+BN,%&/$JIYI7;N\9Y>UH[`%3^-8I)[C1VY[=.AK9)&#\+B,X^G[HK
MB]5$8*B2%W-IPFE><34I@OM:PC`U`_5H*I'`M.ZTP`5Q9K]>[+)XMHNM71.!
M_@2EH/N.1^BIVG!4@#;'7H@ZG:/CAQM1-#:M]#<6@8'VB#2[ZL(07+0/38H*
M&U?Z!DCJ2C.!OTZ((*-DY`.GH$ZW#6\]SZ(((`<;\]E:<,2!O$5M+FAP>\M(
M/J,(((/5`L-#=K3!!4!P;$#H+3RR,'W3W#MH@H8I:3PXM43L:XVZ=0.XS\D$
M$'"/CM41Q<<.PPD14432!W\Q_8KEMB?'5WND?(SRO#C&#OYAW_5!!$=KLM((
M8?$CC;EC2X>XY*RL'"L=TNDLM7(YT@&IQSODH((KC?Q1I64W%UTB8,!A8`/^
?`6'(U#&>B""K-,'&<*1`=3>>[4$%0Z`.?0H((*#_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g785559.jpg
<DESCRIPTION>G785559.JPG
<TEXT>
begin 644 g785559.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`R35),3%]'4D%02$E#4SI;04)"3U14
M75))0TA!4D1?1T].6D%,15I?4$A/5$\N15!3_]L`0P`'!08&!@4'!@8&"`@'
M"0L2#`L*"@L7$!$-$AL7'!P:%QH9'2$J)!T?*"`9&B4R)2@L+2\P+QTC-#@T
M+C<J+B\N_]L`0P$("`@+"@L6#`P6+AX:'BXN+BXN+BXN+BXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN_\``$0@`AP"'`P$B``(1
M`0,1`?_$`!T```$$`P$!```````````````!!08'`@0(`PG_Q``_$``!`P,"
M`P8$`P8""P`````!`@,$``41!B$2,4$'$R)187$4@9&Q(S)""!4D4J'!,]$6
M-$-B8X*BLL+A\/_$`!8!`0$!```````````````````!`O_$`!81`0$!````
M```````````````!$?_:``P#`0`"$0,1`#\`O:BBDH"BDS10&:2FS4%]M.G;
M>JX7B8W&CC8%1W6K^5(YD^E4+K/MINMQ6N!IACX&.H%)DK'$_P`N@Y(_J:"Y
M-5:\TQI<+3=+DCXE(S\,UXW3GEX1R^>*KUSM^LN5B/I^X.$;#B<0D'RKGQIN
M1*DJ?DEUTO.#O5N94HDJ&2?,UZJM[ZE'NT$)4<)V]`55478G]H%1</%I<%K.
MQ3+WQ\TT[6[M[L3SJ43K-/CH/-QLI<`^QJCA:\9XO$7"%)&#L#DDGUVY>E;I
MM"<A(8XW3DA!&=^I5]@-N6345T_8>T/1U^<2U;K['+ZN3+V6EGY*QGY5+,Y&
M:X:OEL1$?;3WP4^L9X4D%7IL-AFI7H/M2U'I)UIB8X[<;03@L/*)4@=>[4>1
M].5!UU13%I75%EU5;_CK-+2\@'#C9V6V?)2>E/E`M%)10+1244&9I#124!6M
M<IK-N@2)TC/=,H*U8&2?05LU%NT-U;>GE)2XA`<<"5%7+&#_`'WZ^U!S]KR\
MW;6=R2N=EF*V2&&D9(;&>H&Y/F>=,,.R267DI6HMG(`).,[\C_[%3!Z+(+Y2
M$%"2"HJX2E2O8#G]*F&B=$KNW\;<N^:C?H:4L+XA_:@@T2U-KD*=4T`#E#J5
M(.SF0,_,?8'K3I^X%I?&6UJ'"O\`*.($9RG^AJ]8VFK:S'0PAH$(PD$[G`Y5
MO_N6(DH4TRD8\AO04@_:H[*([SS*>\;2EI*",`E*,`GR&<_0CK3/.BM1G%M-
ME/>J"@5G;A'ETVV/SJ[[KIEN2XEQ!">#=(J*W31K!)6"%$'/BWR?7-!0-TBB
M-Q/O)!<=W(.^WKY9\N9]!FHA/DE]PE8)(P$D]!Z#I5WZHTR&`XXX0I1R>615
M:W6TI4#L$J!V.*#2T1JJYZ3O35SM[F4CPO,G/"ZCJD_YUV1I:^P]26*)>()/
M=2$9X5<T*&Q2?4&N-8,)M!_%"`H?SCG5Y]A-U<8FR["MU!86V7V4`$<*@?%C
MW'VH+NS1244"T4E%!E1110%1W78*=-RGT,AU;&%I221ORZ;\C4AIMU&DKL4\
M!03ADG)Z8WH*OC,J1%R^XRMUX!7=,-^%(SS4I65*.=AY]!UJTK*T&+=&;P0>
M`$Y.^:KYEM+LIN,AP)9(4Z258XAYGY#'I5AVMQ+L5E8&$D>&@=6QM@UZ*7@8
MKR3T-([G&?+>@PDK_")'.F&62XAP\6%8Y4\J4%$H/,BFB8WW25@\E9/M0075
M`RE0(RE7(>55+>8Y;)!'ZJMG4#G?*#39XB#GERJMM1I.>(CD=Z"'&1P.EOB`
M'D3L?>IMV69':%:.X7C/><0"L^'@.=CO5<3'`'WRHX*0",U:G[/%O<G:DG7A
M:"6(,;NFUGHMP\A[)!^M$=%T44444444&5%%)0%->IF),K3]QC1$I4^ZPI"0
M3C.:=*Q6D+0I!)`4,9',4%$6ZZ%,^X-O%U#K"%DH7S22K!R>A'"1CS)JXK,2
MW;H8<'"M325*3Y$@'%0#4NEIB);-S)<F.OI^'=6D8PKBYD#TWSYDU/;B`F`K
M@4$J"0$D[8V\Z#9F:AM4`J3(DI21S\@:UHNH[7<U.MQ):%+2C/#U%0UZ]S1"
M<-@TN[<TY(,A2DH0M7^Z%$%8R,;8'J:A$!O4DZX,/RK3$A3GUD%M@E)9\BK!
M(P>5!=K\YMIQM97X20G/OM4?U)?H<!M2Y,A*`D';J:>K59$,VE*;AE;Q0`I)
M5D(]!Y^]47KZ!+E:M>MS3J>Z1@^-6VZ<@$]-^M![.:R=F27(UJ@*?R3Q*".+
M;U-1N]7)\)<;F,=RXHC"<8VJ5.Z6O$.Q,*L][0P^4A4D!SC"2"<\"4C&",#?
M?;UVKR]":J<(KCYED#)=[O@.?4#;%!'+V%!QMQ)(*LIVZ]15W?LV.2(Z[U;%
M+):#;;ZD]$K)Q]L54<UAO*._1^18.,\JO7L`AMIMUYN2-UOO(9]@E.?_`"H+
MAHI<4E`4444"T4E%`4444#1<T.=YP\:NZ"5.#'(J'0_7-;D(=XE0(!2>AZUZ
M2&RM"VOTN@I]B1SIMBW!F'&#CZTI&PR?.@]IUF1(2I/?O-)5T8/":U[1IZT6
MA_OF6RJ0>3CZ^-0SY=`?EFO.XZH9:@N26CQ)`V*1S/3%8Z?8N2V'+M<>)R0Z
M,MQ`0`VCR]5'K]*"025_@.;9PG:N?K]_!ZS=?F.$=Z>(<(R<"KAG:J@18CBY
M\23$*.29#12H_3(_K7/.I]1N76^NRV&%H`XDH!'(&@M^+:K-<8S;JXC;H4G.
M<$'^E,NKH%KMUJ<$.(TV3DXWQ42T/?9%K!:><6MM:L\!)./:MK6]^8DL%MM1
MR1UH*XN9R_CGE0KH/L(MI@Z'2XK.9,A;F_D,)_L:H>SVB=?[M&MT%I3CSBLD
M@;(3U4?("NM;);F+3:8=MC##49I+:?7`Y_,[T&]1BEI*!**6B@QHI<4N*!,4
MN*7%&*#$I!&#4>D1F7'78[S84D*X@%;YZY^M2(FFB]M.I:,UE)464DK0!DE'
M4CVYT&C,@P"!+,;ODQT_A,)&R2.N/.O:R7SXF"W(?MLJ"V<A(=;))`VY)R1R
MY'!KSB.E;8=;/&@C.1U'0BGAM*'64J3G?<'&]`WW:7;)3*6WX\UQ&<^&*HC/
MTWJH];18;,A<AFQ3FDG<*6VE(_[JMV[I>[C>0ZVA/+N\_:JMU3$<DMA+*9"N
M?$IPDDGYT%>V)J?.OK;3#*4M;E7$K=(QSVVK=U<W;&'F&(_XCJ?$MS.<@\A_
M?YUDMU5CCR2G*7G,)</4)_E]ZCT:/<;U-8A1&B]-E+PA&?N>@`ZT%J=@-J2O
M]ZWMQ.Y6F,T?3\RL?]-7=BH]HC3S&F]/P[8R>(MIXG%_SN'=1]L\O2I'B@QQ
M12T4&.**6B@,48K+%'*@2L37G,EQH;)?ER&F&D[E;JPD#ZU6^I^U_3%K0ZS;
M7_WG-"3PI9_PP?57E[4%ASID2!&7*FR6H\=L94XXK`%1/2/:'9=4:MDZ=M[;
MBF!$6M,E?A#I!`(2GGC!SD^5<Y:EU=?-5.][=9JEM`Y1'0.%I'LD?<[UZ]F]
M\1I[7%HN;B^%E+X:>/0-K\"OIG/RHCI*4'++)4X$9BK40Z@#_"7U('D>?I3C
M"N<9TD(=3@[\\4^7V`'V%.A/$0,+&.8'7_[I4`EVX(4L(&$GR.**>[K>(T<$
M+D)2!S)Y"JWU5JIE2Q&MRVP5#QK3SQZ4SZJ@R6EGBE/J3ZJ-0B>R&&CPDA2N
M>#0:^H[G\4_W*592WS(ZG.33MV:ZEAZ:U%&N=U2GX!]1AN.D94P%#(6/3(P?
M2HDZ@)&!S/\`6O.ZMJ_T9[PC"3,\/J`D@GZD_2@[?:+:VD+:4E;:DA25).0H
M$9!!ZBLB*Y`[/.UW4&D&F[?(`NEH0,)C/+PID?\`#7N0/0Y'M5]:8[8]#WX(
M;=GJM4I7^QG#A3GT<'A/SQ06)BC%9M*;>;2ZTXAQM7Y5H4%)/L1M67#0>.**
M]>&B@@FJNU#1VFBMF1<A+F)'^K0_Q59\B1L/F:IS47;Q?YO>M6*W1[<TH82Z
MX>]='K_*#]:IQ+7ASR]*]T->6.0^]7$ULWB]7J]OJD7:Y2ICGFZX2/D.0K6:
M3PA?Z3P\Q621X32NY0PI65`D@;'%5'NPL*2$\1/N:]"G'/;.V>1%:4-63GO%
M8]Q_G6Z>`8SOGUS]J@[2[+]0(U+H>TW'CXGTM!B1ODAU'A5GWQGYTXW:RAT*
M>BI'$?S-\L^H\CZ51W[-.H4Q[G=-+O*"4R0)4<'.ZTC"P/=.#_RFNCZC2E-3
M6\.)7X/$D\*DGF/>JHU#%*5X`/+:NK+W9(=V9(=XFGA^5YO'$/?.Q'H:JM6B
M95UN<R$Q)MJTQUE"Y`65<)Z@MC<$9&V?G043"M,NY3TPXR?'PE:UG\K+8YK/
MMT\R0*SU\TQ$LK$6.DI90XE"`>9`!.3ZU=>H=-0-'V!,&&HOS)C@5*E*3A3Q
M'(8_2@=$_,Y-41VER/QH44'8)4X?GL/L:""T444$ATOK'4FE7P]8[L_&3GQ,
MYXFE^Z#E)^E7IHS]H*$^$1=76\Q7-A\9#25(/JIOF/D3[5S510?0&R7JSW^*
MF59;E&G,D9RPX%$>Z>8/N!17`D65)B.AZ+(=8=`QQM+*5?444#MP#@Y8Y?>E
MP`-^N/O1158($^`[;UK3=TH`SMN=Z**+&$<\*A^+CT(K=<(*T$ND@;["BBBT
M[:6NDC3E\M]]C*R[&>#Q'+B3R4GYIR/G7=$"4U-A1YC!)9?;2X@D8\*AD?>B
MBH1HZIO#=AL$Z[.(*_AV\H0/U+.R1\R17+";Q+MU^3?H\_X>XA:GOB.`E+BC
MS2I(_2K<'WHHHJWKA=(NL-/VF^QVRAJ2T7`VKFA6X4GUP01FN=NTQC@N*%=4
4(`'MDT44$$HHHH"BBB@****#_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g509192.jpg
<DESCRIPTION>G509192.JPG
<TEXT>
begin 644 g509192.jpg
M_]C_X``02D9)1@`!`0$!J0&I``#__@`_35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU*04-+7TU?1U)%14Y"15)'7U!(3U1/+D504__;`$,`
M!P4&!@8%!P8&!@@(!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE
M,B4H+"TO,"\=(S0X-"XW*BXO+O_;`$,!"`@("PH+%@P,%BX>&AXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+O_`
M`!$(`(4`A0,!(@`"$0$#$0'_Q``<```!!`,!```````````````"``4&!P$#
M!`C_Q``Z$``!`P($!`0#!P,#!0`````!``(#!!$%!A(A,4%181,B<8$'D:$4
M(S)BL<'10E+Q%7+P,S6BLN'_Q``6`0$!`0```````````````````0+_Q``7
M$0$!`0$``````````````````1%!_]H`#`,!``(1`Q$`/P"XNBQ;=':_;V6=
M/-`%K'@L<D>GC?ZK!X60`!8)NQ?%Z/"H#+4R#7;:.^Y_A%C.*1X;#L/$J'@Z
M&<O4]E6]125V+5<M372@-D?L#_4>P_8('6ISW/*\MH:8`==.I<,N;L:;YG2Z
M/R$#]$YT67RR$,L(6'BYH\Q_A=`P6BAL&Q:W?W.W*!C&>L59M(UKSR)8/X4E
MR_G3#<0:(:^5E'5`VM(=+7^AX#T*:JJAA=MX+;>BCN)X;!<^4#J@N-CF/8'L
M<'-<+AP-P?19`-]ME15'B6,9>E\7#:MQAO<PN\S'>W_"K4RGFFCS%`0T>!6,
M;>2`F_NWJ/T02$\MTK=D0'5*W3@@'E8<$MO=&04@`@``?Y21$7WW^:2#:-S?
MBBMLL`(AU*`2V^RU3.;#"^60>1C2XKIM<)JS(\1X5(T?BD<UC;=;H*^QVOJJ
MB=W@1EU14/TL'(#HI+E[!6TD(?-][5.'F>?T'0+5@]!']H?4EMRS[N._#N5*
M*:+2[2#YB-ST"`&TS#OH-CSZ+EK*-I%Q\D^QPD--KKAKAHC+K7ZA!&:F%I?:
M,BW91[%86AIZVY%2BK($AZ64=Q3S,-Q>_(((36$@D<EPT-?58+B<5?0O#'BX
M)(N-^H3G7,N]R9ZJ/4PL(-B$%YY4QR/'\,^TAHCJ(G>'/'R:[MV(W"?+=E3O
MPJK719@%.XG150.8X7VULW!^5U<X%R@U6ZI6]RMNE"=N5D&NW8I+;8I("L?\
M+(MT1D;+-N/!``%K)@S<\,I:3<;S[`];%2.UCQV47SVW3AD$K1YV2W!MV0:<
M%>UT+6AE@WJI-%9HU$#@H=EJH9-'(]IO=U^*D[:HMC(;$9G`_A!`0.)D(!N+
M-Z!-N(2LU,8;D.W)Y!:Y,:IHK>(QT9.Q#AP3968G#,[1'NXD`(.>H#W/?8&P
MX=TP8FQP=8;FQ4D%5&VJ#7<W$"_H4P8Q)&USBV1@ORN@B-2RU]29:T:7@!/E
M7+'I):\./#8J/5,FMQ+MB-D#Q\.PYF;L,:#L9G\?]CE?@%@O/>0)I)<UX2V$
M:GB>Y'Y;&_TNO0Y'(H,6Y(;7/!%;99MU0:^'^4ELM?H$D!@7V2`LMEK[<D6F
M_#B@U@'FHOG$%\E'`Z,/A?J#P;C;L>14L(L;\;)HQZ!CXZ=Y;<LDL#ZH('ER
M5T<LL=-#+]D;*8G^)N]GEXGW/LI+BF*MPEI:VA?5RO`,<;6@W[D\@F^D8:>>
M:9D>ED\KG-!X'E?YA2&)T=0USS&`0T#S[7].R"K,:QW'ZC%/LC\%IH&VU.+6
M'RCE9W/;>Z=LO,E,T%0^%XB=MYC;<]RI%BN'-F?IAB<7]```/4KOH,.C!IZ0
M'6`"Z1QYH(?FJLDH:N)[M)C%W@Q@[[=U%ZRHEJ8YJQU(^:.%MW@D@-^6ZEV?
MFL:\,TC\5@.@4>PZH>(',,EP!:SN2".#%&U$+":!U)J;M8W'HN>ICD-.9"?,
M'`#T-_X3U6-U:F:0;\+<DWUP\.!L(==SGZG#H`+`7]R@ZOA/2D9QI'Q2.8Z[
MR[?BT--Q[KT*!U^BI#X3TPDS=%,SA%!*YWJ;#]U>8"#7;E:R5KK9;IP2`L4`
M6/HDCM;ND@V`+8`A&UKK9ZH-;AS7%B46NAFL-VC6.Q&Z<'#9<U7&Z6FF8S\;
MV.:/6R"(U#1]IB877:&@MMR!W3U2EKJ=VJVGA8[IAE>XSGQ(GQR-LUS7"QX(
MI,4BI*22:5Q$8W.R!5\P9)H9:U^`">,+:Z&$25%HW.:+DG<+EPJ.-[14U,>F
M:1MPTC\`/[KEK<%CB=/5TM7*V5X)+2\ECO4';9!&<_OB,0+7ZG$[*+85.TDQ
M2`:]B.X6O,--BU0[[V=C6&Y&D^:W[)OPV-]*X.D>2\"PN;H)#5-$,;G`WO\`
M11*M>7S'4=[I\JZS7%M[J.O=K>7=4%E_!>D=]HQ:L<.#&1W[DEQ_0*V0-E7G
MP<IYX\+Q)\L4C(Y)F%A>TB]F[V^BL<`]$`EJ$BQ6TBW)"18@(`]TD>_(!)`8
M_P"760/DCTV)L$B+(`(W6"$=OGZ+("")9G;X6(4\MO)*RQ/<'_ZFN6FIYX3'
M,T$,=J`Y&VZDV:J0SX89&CSP.UBW3@?Y]E$VRAX:UYMR(0#14^*PT'C13B4F
M1Q`D.]B>%UP8S68FR`B6GJFM<+78W6/HI;$YH@#0-K6V4=Q=^)\*47B[\0@A
M%=6,=MHJ)'B^WAFWS4>GJ9`\D02>XL`IC6SXN^,QNA))ZG9,%53R1-+Y[:B-
M^@0<WAN91NEEV+^`Z+ACC,TS8F[N>X,'J3;]ULJZDRAK+^5O).V1Z5M9FW"(
M'VTFH#W`GB&^;]D'HF"(0Q1P@6$;`T>PLMED9!)+C9(`(`XA(!$`$@.J`=NB
M2,-"2`@+):1=';LE9`/+@L`;\D7`7/`;WZ*`9P^)^`8"R2"AF9B6(#810NNQ
MA_,_A[#=`[9_S+1Y9R]4U$KV.JYF.CI82=Y'D6O;H+W*@M%)45N&4%5(##)4
M4\<Q:?S-XA5#F7'\3S)B,V)8G-XDSFEK&MV9&WDUHY!>G:S`&U.7<.;2,`J:
M2EC9&W@'M#1Y?X01:GKGTL8$^[!P?;]4-1BT+H#I(/:Z;*FJEB+X7L((V+'#
MZ*/U;FN):PEI/$`VN@=<8Q6.(G2YM[6%BH;BU>:IVW`<UBIA.O22XA<<C';`
M-0<VD@$N0UHJ8\-J<2I9713T19-%(S8M>'`W'LN^DH9JR80Q-[N<>`"<LU14
MV&Y4K81L#$6@GBYQ06_\,,\4V=,$\5VB+%::S:N`'GRD:/[3OZ'938#8V*\+
M8#CF*9?Q*/$L)K)*:ICX.9S',$<"#T*]`Y.^.>$UC&4^:*<T%1:QJ8&E\3CW
M;Q;]0B2KH`Z)67+A6*8=B]**O"ZV"KISPDA>'`>MN"[+=D4._()(C=)`P9AS
MCEK+S3_JF+4\4MKB%AUR'T:-_FJJS!\<GDOCR]A``MM/6'?U#&_N51P;<DG<
M\^ZV,;J-N7-!)\=SQFO,33#B6+S?9C^*&`")A[$-X^Z86C8`"P6``!862)Y#
MYH#C:7O:T<2;+VCA+A)A5$\?U01G_P`0O'&"1";%:*$\'S-;\RO8673?`<.Z
MBG8/D+(.7'<MT.+!TCF^'46VD;S]0JNS+EM^$#Q*YC_"<ZS)F'4PGH3R]U=J
MX<8J,/IL/FEQ-T0I--GB07#NUN=^B#SC-3MU:VGR^J=<(RU4XJTS@^'1M-G2
MVO<]!U*>*23),F*Z:O#JRDHS)]V/%U1@?G'$#L"5:51#2&BB%&(OLP8/"$5M
M&GE:W)!5_P!@IL/C,5/'I',G<GU*K/XH59,$%(T^75=WJK=Q.,OFD`'!4I\2
M["MIHB?,0YY';@/W00!P6`MSF70$6V*K..["<8Q7!Z@5&%XA4T<P_J@D++^M
MN/NK0RU\<<RX?:+&8(<6A_N=]U*!_N:+'W"I\+:W<(L>K<*^-.2*VF$E745.
M'RBVJ*:$NW[%MP4EY4LDHIV.PVY(H';EMN]TDD&]VUNZ$[!))`XX`XLQS#GC
MB*F/_P!@O8&7_P#L]*`+#0DD@<51F>\PUF(9CK:)XTTU#*88XP;@D<7'N;^P
M2201/&9#&UNG^H'GP3C\/<TXG0XY!@SG^/A]6[3X+S_TG$_B:>7<<#]4DD%E
MU].QLDCN>Z\Y?$:0R9HJFGA$UC&CM8']24DD$4YH2`0DD@TEMN:*(7N[Z))*
)IUM`22245__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g916736.jpg
<DESCRIPTION>G916736.JPG
<TEXT>
begin 644 g916736.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`Y35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU$059)1%]/5T5.7U!(3U1/+D504__;`$,`!P4&!@8%
M!P8&!@@(!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE,B4H+"TO
M,"\=(S0X-"XW*BXO+O_;`$,!"`@("PH+%@P,%BX>&AXN+BXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+O_``!$(`(<`
MAP,!(@`"$0$#$0'_Q``<````!P$!`````````````````0(#!08'!`C_Q``Y
M$``!`P,"!`0#!0@"`P`````!``(#!`41$B$&,4%1$R)A<0>!D10R4J'!(T)#
M4V)RL?`6DJ+1X?_$`!0!`0````````````````````#_Q``4$0$`````````
M````````````_]H`#`,!``(1`Q$`/P#81G<E`#HE@=D9'9`V,_DACKNEZ3GF
MC+?D@;P0<+AJ;I;J67PYZN-L@_=!R1]%'5]?5U53)249\-C"6ND',KDI;#')
M*<>;;47G_>J`5W%C6/<R@HC,T'>25VAOT&ZCQQC7AQU45,X#LYP4A<;(8(6E
MH&^X';LJE>**2/[K2>ND(+#%QPP./VFC:&]XY<G\PI>BXML%8]L0KF12']R;
MR_F=EC592UKLAY<!V!T__5'FDF`P-`^>3^:#TFPAS0]A#@>1!RCQLO/UIXAO
MMB=BDK7^%_*>`YA^71:?P?QU27R9E#5PFEKW##1GR2'T/?T07,#TY(NA*61V
M1@?Z$#8'3",9WRED(L'N@1CKN@G-..F$$"P-DK"`RC`"!('-15=+-/5-H:8D
M8WD</\*5>=.7'INH:DD<(JJL<T$Y(!/<\D#4S(J>7[-"-\^<D\TO,\;=$1(:
M<9]4BGA+R';EQW)4JSR-WP?1!7KA550(DF)V[#8*JW2NJ'DMAA$>>9YD*_7-
ML<L3-31W5:K:5CLN:T<\904"M?5S.TN&&#H/U4/40S$DM?\`+"O-93-#79`5
M?GA&O;D@KL<<P)#RTM]EW04X#FR0N<Q[""US#NTIX,#92UPV*>8`TYQ^>$&J
M<"\0R7:F?1UQ;]N@&=0V\5OXO?NK:`L'HJV6UW*EN,!\T,@+AW;U!]QE;O$]
MLC&/:?*\`CV*!6/1$`E@!)/WD`Q[((]@@@&-]T8&?1+`W2@![(.2LRVGD_M*
MK]/+JH_"'(R-5DJF%U/*!DDL/^%3J.0AN_X@4$]3X:>W0)Z1P:!ZE-4_F`VY
M?FEU#M(S@\T')52%[@W'E`ZJ,JF$-&!MS7?*<-SGS9PFZ^,-B))05"XG!<,8
M]%7IP`XNZ!3UU`+R03L-^RK]6<$C!&0@C)<ZB[KE.O!CB;)I!;R(/1,R'?V4
MA"&RTV@]00$'+4`.I?&CY8P1^BVOA&I-7PS:YW')-.T$]R-OT6(T3L.EISU&
M<'H5N?"=*VDX<MU.PY#80<]\[_J@E<9]$1&"G0T;;82<;]4"``>B"<#?1!`L
MMR-T8!2P,Y.,9Z(PWL@9>W4TCN,*C$?9<1R@C!(.W8J_8W5)KX75%Q>'DZ,.
MR.YSR0/07BD#</)8WD"1A":X0Z"Z.5KP>6"JG76^H;-)%!"]^C^(92QF>V>9
M57IG7UT\C)Z?P(]>&@9S_O-!H%3</V/BDZ0XD#)]<)NY7(R!FIX;EHSD]4Q;
M[>^:QR"X-`DC.D'GJ',%4*NGN,MR+()7!C'%NY^@06:LD\./+HW'U=LH&MF9
M(XX?SY$\DJ:V75EN\<$FJ<[;Q,N8UOICJHR>&H9@2,9J//&?U0(>=SN#D]%V
M6EY,#XSS:<A<)B<QOFV[975;,`2$]T'6(!45,7V=FJ=[M+0.I*W>VTII;=2T
MSCDQ1-83[!8CP<#5<96V*-VS)R7CV!*WP-[CGT0(`*(C.4Z&H@-\H$`'H@G`
MWL`4$#H'9'@8P@W&_5+P@;QNJW>Z`Q53:MF[)#I<.Q5FV#DS7,#J*<.`QH)W
M'+&Z"JSL<8],>GS#!'0J,-D?/+XM6]C(_P`$(W(4FV5A;JSTW7#)>&"L92MD
M;'&`7/<X]`/_`&@1=?V5N>(1@`Z0WTPLUIVN97DNT[N.<GFM'O%73"V`MG:[
M4"X8.05E,U=2FK?)+,T$'9J"^P4S9XVLUO82.0=C*C+G:J6%Q=EY=_45'<.W
MB7+F3$F-KCH=Z+ONE:UVHDA!6[B2&G887#%4&-A#6Y/3U/1.5DWB%P!V7"\D
M,)Z@(-!^#=I>^^U5P=DMIXCJ<?QOY#Z96U@+,/@FZ;P+M&X_L0Z-P_NP?TPM
M1';F@+2.2+&Z<PD[`GJ@+2$$O&R"`@,#(2@"C#1[H8]$",<SU3=5":FEF@U:
M3*PMSVRG\;[[H8[!!D5PGK*$RQ2M)#"1D>BZ>%H"8I*^L83)4-PUKAR9T^JF
M;Y`V&[5(E:`QQU;]6E0>FX/J2VDJF>$P8#-/3IN@C>*;7&RE+Z69T9&0R(;M
M.?1466R/@>))3JU;\L*_U$=VE#G/%(QC>KW.<?IA0-R@JYFESZUF!MAD.!]2
M@A&O9!&<D-'4Y1PN=6R1QTDID802XG?``[KG%"V60ZGN>T<R=@I>DDCH;?.V
M-H!=L$$*^(MEF!W#<+KX9HC<>([=0B,/;+4M#FD9!;G)SZ8!7,YSO#>YW-QR
M5>_@Q;(ZF]5ET>[)HXPUC?ZGY!/R`/U0:W:K3;K13N@ME'%2PN<7%L8YGN5V
M`8&0EXW0#0.F4!`)..9ZI>/1#2,YW*`AOSP@CQZ((%XVV0`]<Y2\<T6-D"0.
MR`&^<I>/1%C;T05SBZ@=-1BKA;F2#.L`;EAY_3G]53K>#'*X`8SR*TZKGIJ6
MEEGK)8XJ=C2Z1\APT-ZY*Q9E\I:N2LK+0RHDMT%1X+99&8!R,CZCEE!8JJD,
MP.=B>H.%7[E;W`'4X8QU*DX[W3R1M=K`/4'JH.]WJ)X(#P/9!%2T@8T@.&&\
M\*&KIAXOAM/EV3L]R\CVL))<=R5#N>]\H(^J#HJ7@[#NKK\)KW26>\U45=.(
M::K9'$'N^Z)-6&`GIG)&>Y"H3CYL#<J:GLSCPQ613#1-,PO]6Z=V_P"$'IO'
M0H8VV6+?"?XKP5T5-8.)IQ'6@".GK9#Y9NS7GH[UY'W6UC#FAP(+7<CT*!(;
MLC'+9*PACT0(`ZY02L=$$"\;X060W?XW6J$.9:K14U+QL'3N$;?RR5G]]^*W
M%UU#HX:J.VPG]VC;AW_<Y/TP@]&7B]VFR0>-=;A!2,Z"1WF/L.96:<0_&>UT
MP,5BHI*V3^;.#&P?+F?R6"U-34U<SIZNHEGF=SDE>7./S*;:,G*"S\4<9W_B
M;#+E6$TX=J%/&-,8/L.?N5KOP,HJ:HX*N#:B)LL=36O;(QPR"`QH7GT%>B_@
M+C_A4P!W%;(3_P!6H([B[A*2TS&>D#I*"0[$[F,_A/Z%4*ZT+VC7D8.XP,+T
MS-%%/"^&:-KXWC#FN&00LRX[X5;1VZ:MI)!]F;]YKSYF9.-N^_S08NYF_-+C
MB<XAD;2YSM@`-R5VV^B?<;@VWT>)ZEV2&-/(#F2M!M/"\5LB\:<!]2!N[HWT
M""MV2P"G+:NM:#,-VQ]&>I[E=/$+]%GKGC8B%^/HIV4;D*O\3Q/?:IX6CS2C
M2$&%C885EL'''%?#X8RUWNJBA;R@>[Q(QZ:'9`^2K9YH80;EP]\>JR/3%Q!9
MXZAH&\U&[0[/?2[;Z$+2[#\5."KRYL;+J*.=W\.M;X7_`)'R_FO(8"5Z(/>,
M$L-1$V:GE9-&[</C<'`^Q""\-T%UNEM)-ON-729Y^!.YF?H4$':_`>[W2,H(
M(!E*"""`\X&5Z.^`XQP<\X^].XH((--61\:\0FZ<2S66/4*2A!!Z:Y>I^0.!
M\SU0009U?*M]JJ*>HIG^'41.,D;VMQ@C_0M1H;HV\6:CN,;=`J8@\M_"[DX?
M4%!!!PNC!E*C+C3^.VX.SY:2D>X?W%IW^B""#SV\8Q[)(000&$H(((%80000
#?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g993219.jpg
<DESCRIPTION>G993219.JPG
<TEXT>
begin 644 g993219.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`^35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU"3T].15]03U=%3$Q?2E)?4$A/5$\N15!3_]L`0P`'
M!08&!@4'!@8&"`@'"0L2#`L*"@L7$!$-$AL7'!P:%QH9'2$J)!T?*"`9&B4R
M)2@L+2\P+QTC-#@T+C<J+B\N_]L`0P$("`@+"@L6#`P6+AX:'BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN_\``
M$0@`AP"'`P$B``(1`0,1`?_$`!P````'`0$````````````````"`P0%!@<!
M"/_$`#H0``$#`P,"!`,&!`4%``````$"`Q$`!`42(3$&01-187$'(H$4,D*1
MH;%2DL'1"!6"X?`6(V)D\?_$`!8!`0$!```````````````````!`O_$`!<1
M`0$!`0`````````````````!$0+_V@`,`P$``A$#$0`_`-A\J$4>)KNG_P"T
M!`(/IZUSD4>#/]Z$0F*`@$;>=$=4AM.MQQ*`.ZCM4)U=U"U@+#6D!V[<V;;G
M]3Z5C>2R69S+Y=N[AUP$[(3.E/L*#7LCUAT_8*\-=\'7>-#(U?[4TM^MK6Y)
M2Q9/1S+BDI%9*BT*-WW$-CO)C].:GL/EL/C02W:*O;D<*6(;2?;O0:>C.RE*
MU6YTJC[A)^G%)N]48]A6FY2XP`))7M`J@?Y_FKQQ2FO":2H0/E4=/UXGV%+6
M^`OGT&Y<47U<B`2!0:A97]E?-AVTN6W4G@I53D"L:NF+NW65)=6TL#9+:P#^
ME2F"ZRR-FX&;U*KFW'*E*^=/]Z#4CQ!-<\QS[TWL+VVR%JBZM'$N-J[^1\CZ
MTZ`'830%XF*`CTH\;;4`/.@)'_#0HQ$[>7E0H%1S,S1HVK@$48#N:`I3-).J
M;8;+KRPAM(DJ4=A3F)%9Q\1\DMR]M\,PH@`:W8/<\"@HG6M\N]S[[C;WB(*C
MX?MV]JBD6EP^K0M]PI_A"B!5DO,*VTPBY`B=P!Y>=-K1)#A2>30$L>GVUQKW
M]*G6<`VVT"AL`]C3G'I&H)_*K$PC4V(WGTH*RYTVZ_!"EF/6CVF&R-@O6PX^
MDCLVX15XL$:0)$5)-MI484G:>PH*.;AUQ)1=M/.*B#X@2L'V,34!D\,7@7;9
MDD#E(7']JV!>.MG1"VTF?.F#F$8D^"M20KM09?B\CE,`L.VUBK[-,O-[G4//
MT-:MCKMB_LVKNW.IIP2/,>E-^G,9IN[RVOF]>T(<V,@^E)8&U..>O\6-D,OE
M38_\3_O02T':10(I72:X10)0-]J%*#]Z%`:-O*NB*4(-`#TH"3I$GCO6)*>5
MD\Y=WRS(>>5IGLD&!6UWA4BTN%(^\&E$#U@U@V.N`BW\4['>/4^=!8,R^DLM
MLIX2*B+9(\35Y"F2KW[0O4%2`-J6M'2H[;D?K03UI\BT`&(.]6*R6=0'.]5^
MP;TK275`;<5.,/MM.#[L']Z"Q,A8E)Y&_%.V7"%CD[[U'I>0L(=0J)D'U@4X
MM2T@)*E@R.]!,)<!`!['N)HR].F1S':D&G&H^0C4?6@XXLH)B4\30+,:6U&Z
MF83"AYBH1%T'>HRI)E+B")]*4OW5HM'2VHIT_-J!B(J+P90]>)NE*&WZ'RH+
M9]**0>*-$[_O0B@)$>E"E(\J%`>)VH!-'CM'UHVF@:7JDMV=RXXK2E+2B3Y;
M&O,YN'%-J:2)WT[&8]Z]']4,./\`3^29:!+AMU:0GDP)_I7FBU"+9MTN*Y6H
M@]XH']N2E"9Y(I]9.Z(@D+)F8J.:6E;J"DR@@0?2K`O'D6R%I2%2(B3-`X2X
M708N&T@;23`2?<F*;W+E_:%$/I=;!^4R""?<$TU9Z>9OY;NW%*^;8B1`]/*I
M[*XJW_R]`,*4VF-0V*O4^9H'G3F47?W+-M"DE,D[\FIG+7;]LYX!4A!2G[ZC
ML*JGP]EK)):6..)W,5;>KL4S=ZKI2%*TD),'8#VH&=C?6UR^DKZA8#Z1`;[5
M8[95RE&E%R+E*E"2.WTJIX;H[&*OOMJT`J4!J2#\JO($5;L?B+2P41;N.!"I
ME"E$CZ=Q0+784MAY*>2@B#Q]:9]*-VBEN(8O4N^&=P@;)([;]J=N.>%=AL$%
M+@T[4ZZ=Q35DVXZE,..*5)_U<_\`/*@EX'ES0([32A'D-ZY'%`2/3]:%*1]:
M%`H!S1X[UP>NU*#??]J!,CN!7F?X@XAS'YJ_LFD$)0\5M@?P*W'[UZ;($5E7
MQ@Q4&SS;2/\`UWH'U23^HH,CLE0ALQ$)`CRJ]X9].A)6-4C@U14P%&.QJQXR
MX*5($["@O35M:NI*@V0KT,5#Y]UFT82B1\TB.]+#(I8MB1Y3MWJCY/(7+]\M
MUV5)@A*0>*"V]&-:[[QAM)XK2$J3K5XJ0$GD'B*RKI+--,+&J$D=C5\1D[J\
MN&FVK`K:6/F<U!*4C^M!)V]M9/*AA(3!D:3'>G[S1;:AN"?,U0G;F\P>5T.$
MJME*_P"VOM[5<1D1<VR5`[D4#127%WR'`G4&AJ4KRJT6"5"R8U#YB@$^_/\`
M6JV@RBZ5(DZ1S[U;FTZ$)1_"`*#FG:0*X4]^*5CTHI%`2.(BA1M/?3-"@4`G
MGM71/![4;2-YWBA'I0%.VU,LOC;;+8]_'WB"IAY.E6DP0>00?,&G\2./UK@'
M%!A'7W15OTRQ:7=D_</M/.*0ZIV/E5$IX'E-5O'H*G$)!Y->A>J<,C.X*[QB
MH"W$ZFE'\*QND_G^]>>;4.6[RD.H*'V%E*T'D$&"*"R.LD(C[T"JFNZL_'4T
MZN%`\0:MK-VAW'`ZH<"B#42];@+UZ`I',$3%`ZP:<2M.EPIU<SM5\M<QC;9A
MMLND*B``)G\JK&&5;-0M%H@E0B0!5NL_LSZDN)MDI<&VL[D#RH(?.9%J\9+1
MLG2TI,H<4V0)[$33G!E:;30L\';SJ6RZ6UVR6BD;J'/E3-I/B7"&V-/B.J#;
M8)@306'`V%O<(-Z\A2E^(=(4HZ=N\<<U8X,4E9VJ;6U9MV]TMIB?,]S^=+QW
MWH"\BN1YT?3OOM0C?RH"0)H4?3^5"@.!OO0@S54Z@^(?1N`!3?9NW4[$AFW/
MC+/T3Q]:SG+_`.('%M%:,1@;FX5/RKN70VD_02:&MQ('>A!W.\>=>4<O\<>L
M[W4+-RTQZ#V89U*'^I4U1\KUEU1E@4Y'/9"X0?P*?5I_(;5<37L?,=7]*X8K
M&3S]@PM/+9="E?RB37GO-]16V>ZDR.9L6?"M'WR&Y$%82`-9'F8FL@"U$E1,
MDU>L(UX6'M"?Q))/U,T)5G1>!LA)(TJJP8UQIQHAPR`*HRU'2-_:G=MD'F4\
M$[1([U%:=A+:W<0%*)`![5<6VF&T2V8$<>?M608OJ/P4E*TN3Z"K!;=4NJ1\
MK2D^J]A06?*O(U):!!5.\'BJ)\0LH]C['')M75MW+EQXS:TG[H;@@_S$?E4[
MB&KK*78G4O6=_(_[52OB_<)_ZG:QB%`IL+5*%1QK6=1_330:/T[\8L)<M,,Y
MMA^QN2`E;R4ZVBKN=MP/I6CXK*XS+M%[%W]M>-CDL.!4>XY%>-5@^"3P0)!H
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M?!*5*4K>"=O?VIATY:.YJ^3:@+2RR`HDC:3W_H*UK$XQJR0E#:-I^8^=`[Q=
MI;8JR6ZO9+:"MU<<A(D_2!Q7ES*Y)S,Y6_RKWW[M]3OL"=A^45NGQ9ZNML%T
MZ_C6'`K(7[:F4)'*$$0I1^D@>]>?;<$-)$<"@45$`3S39(C;TI9T[C;]:3_&
M>-C0<Y!'UKOX8\C74QK@G;B@!R/.@X4Z@-4;;;T*,B#MYT*"&T[4D0#L*%"J
ME!:(%-R"3-"A1FNMC>KWT+=A*[FR7N`0H?44*%%Y7[P$I2%3S5"SO6=V77,=
MB'BW:ZH=<@@ND=O,#]Z%"HM2?2V:=;N$WK#KOVQK<AQ95*>Z)_A/KN($5NR<
MXV_A;?(VB3IN&0X@*[`CO0H45YTZ^N7;[J'Q'EE:RH[GTJ-;"@FA0H"K*C29
9F9/E0H4!9E4TOPOZT*%!P?*KCBA0H4'_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g521797.jpg
<DESCRIPTION>G521797.JPG
<TEXT>
begin 644 g521797.jpg
M_]C_X``02D9)1@`!`0$!K@&N``#__@!!35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU77T%.3E]215E.3TQ$4U]02$1?4$A/5$\N15!3_]L`
M0P`'!08&!@4'!@8&"`@'"0L2#`L*"@L7$!$-$AL7'!P:%QH9'2$J)!T?*"`9
M&B4R)2@L+2\P+QTC-#@T+C<J+B\N_]L`0P$("`@+"@L6#`P6+AX:'BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN
M_\``$0@`A@"%`P$B``(1`0,1`?_$`!L```$%`0$```````````````8``P0%
M!P$"_\0`.Q```@$#`P,"`P8#"`$%`````0(#``01!1(A,4%1!A,B87$4(S*!
MD;$'0M$5%C-28J'!\>$D-'*"\/_$`!0!`0````````````````````#_Q``4
M$0$`````````````````````_]H`#`,!``(1`Q$`/P#2X57VUX!X\5)15ZD?
M[5&A)]M?I7JZN/8MG/.XCX0.I-`W?7\-I"[E-Q`R/K0[-J3F>,WGP[L[<#A<
M8_K3-[=PO#[QE^%5(<%3TW9(QYJCUC6";A+F&#[J)@6D/*J#@<_6@(;N\56C
MC##VVRWPM@C`R?VJ3/K-O!92;)D+K@9(S@]L^1VXK+_5E\ZWDC0QXB$@W*W9
M3T_[^=4B:OO7%S[BE251L_&/(\'%!H=SZOCN[N*)X9L<;RN`I'.`2>@SR?I1
M+IQ%];F:*/*'AA(ARP_T]B/G6%S-8VK07MKJ(GD5PS)AQQ^?TZ5;MZE]0WKW
M6HV\C10;1$65CE4Z8`^9'./VH-@N8[2*1IIY(DFD4I;V\C`/C_,/F.OR'%,V
M<^@RHB:5=VQ=B6$K1,\DY/5LG@#Z"LCT#U!J-G>,T;BZ)7XE=0Q`\ECT\4YJ
M_J:>34@(K.*W,9*L000['K].H%!M#W[V-W';HS3W6!(F!M`^G]*LCJ'VK<)8
M0QSS&C#=GZ]OSH5]*:O%J^G2V>H6\,=V%)C<$B.3CH<$@4UIWJ.VM;M]/F"6
M]S"VUEPS#M^(XQ^=!I4MM&;11&WW8_!N'*_*J^6W,85^"C?A(Z5!AU26WB4V
MK">-FRZ'H!_I-7#$3",@GV7&03_*3Y_:@A;5!'%>-J_04_)&4+*W!4X--+CI
M0<*CIBE7KC`I4$:/\*C'-5NHZA;I$9)&^#<1D<\@XXJ8['VUQT;BL_U36U6T
M=?9=GAE/P-C:P4^>U!$U,F*Y)Q$L;,&R)#Q@YR!TZ$9%.7$MO:Z!]M:W`,N4
M(9F9<X/7'0']\4,:]JMQ?P0LR1)(796BCCX=?Y3D_H:AZ787.H7":=/*XE&=
MKYR@(/*D?D<4%A=ZC;7<3>_&R2Q$PJ63<)$(X#CKD#N*K)-)N;NV]W2MLC1C
MX88\-[@ZG`\_*C:[T.VAA2RO[=`@4,LRG:R\9Z^?K4#7((X;*&72X;:<ERKL
MF`2>/C/?B@#]%O4L[F&74MT-LK\QO`0Q\KM.*-6]<Z9*1"MM$4"[55;?8JJ?
M)\]J%9;.6[8_:V,EQ,&*&1R3D<#GJ.M-G0KB'>&;9&I'WC*2ISTX^?/%!K&E
MQ:)=Z8]Q%!:@,`%";<9`X/D_3%4NO>G=.;39[J")H[A`9"HQDK_F*$8_;K0U
MI!-BP>]BG$"$;9DE)13D[20!E1\QT[T2:7+;C4(V_MPM<.V^.)F92R^`P&UO
M_B10`FB:QJ.EWR0P2QNC95"R@HWCQ_6M3TK5+@^[-J8A@C+#:-N-W'09R?UH
M>]7^G=)C#7UA(;42,2\:_#&LF.&)(R,GCQS3&AF"6W^R/K3Z?>_A(N=K1O\`
M_8?]T!A!/9Q*0]Q,\,AW`,W)7/.!V%&EO<QV^DR!RTBJ00!UP>E9D]N^FRS1
M7NV1)%7_`-5M_'GN#SV[U*3U7'%/)(D@]K8=V5(#'L`:#2Q)'=V8N(6#@GKW
M![@C\JAGD\5%](ZOIU^DJ64JLX`8@?S'/_=65Q"(Y&*G`W$$'J*!DXP*5=*`
M@=_I2H*Q,-&`Q'(YK.M7GM;_`%+V),?=`INB(&2&)&?SK0)7]NV0<XZ9%9;J
MMM*+9RS);W,;,"2,%CQM8?7/ZYH):Z;%<6VGW\3NZ1-[LF>JJ@S@G'D5+@LE
MMYWN(74_&"C9`R9.Y/0<XY^=1HM4%E:0(`KV\D`$D;<$\'G]Z[87DL>TPC[5
M;LN`4.X%?#CJI'DT!9>))/9*ESMBF"!&W'EUQR#V[D?D*$]2].6L,37%I,JN
MN1M)VD]\@#O1?I<IO;6-)83A<?%S@^.M6.I6)ELV*V.Z->22`<'Y4&46VG.\
MJ8]P87*.1_,<?OY^E:1I5M=R62(D=L\CH>)H_B0X."01@G/'-*R@M3<2)-$/
M=*AE/D>#4RYGM_;CM8]R.I^&0')4^:"JTT_8KJ7^T;9521?:E25<KO'';@9'
M;&#QBE'H&C%9[2YC?V0Q:,-U`Z[D8<C'CY5<>T\LLI.U9,X)&<,/%,W=U9-:
M_9VN"+B,9SNP>/\`GF@H-C:3+LN[JYO+%R%BF0[MG@/@=#YZ5"UCTW#>3"^T
MN$01QHP=64*IY_%QD'J:N%`*A-2A@>7:5,I1@LJGH05X!\@UYN]*N880=&CM
MXWC&"O*AAU/G.>!S0`[:=>+-;Q6BS/;.1]T6)3=W..P[U7:];70]V15F,4+A
M0$CP.GXL?\UI>C/JUQ=F2XMH;=XOA;WHF4A>X&#@G_:INM:3;7,;R/$LDQ)/
M+8QD8Y_*@S3T)KMUI^I`1P%F+H"N[XBI(!^G7-;]9:C:3SB*1%)E'!QSGYUF
MVE:!I]O<+<6\.)MPS)_,<'Y4<PVWM21JG!4[@P[9[4$B52CE2>AI5(U!0)\@
M]1GIBE0"E^RG3\'!`QR?/6@'U$\M]-_[<^ZJ`%2QVYZ\41^I+FYCAM8;>;VS
MC>Q_S=JH)[TR!_<&P[>/;.0?IXH!NZW6T4;OAG4E'#+P/R_\T1?PRM(Y+[49
M2$=5V(`/S)H<O/\`#.Q3@$D!>@/G%7W\)KV-+O6!<R@;I(V!/\V`P./]OUH-
MNTZUB**=G;K5E);H\1CV\8-5NCZGITR[8;N%V'PE1(,_I5XC(>010!6K:'<+
M()+0*648'4''BJ:[T^^5!<BW:WG3)P4+@\<@8[UJ.Q?`KT%4\%0<T&8:'J<,
MMHWO03/-C'"$$M5;;:%J"ZX^JW$3Q6DR^VL+J/A(/#`^#SP1WK8EMX5;>(8P
MY_F"`&N3013J4F17![$4`1'91&+V9%4#&!D]OG0_>)=Z??)#;D_9WX#A=RJ?
MGW'[5J$=C:PD>W$H/G%9Q_$,7>GS?:+*:1`2"R(VTGGL:!HW=_=1-#<6IB`_
M#-'@AQCKCKGKP:EZ>D4SNK2E)#@[7)QCZ=J!_3]WJ`N(Y7NII(BQW+)(6;(!
MZGS6C[[>Y@60QJLH`ZC!%!'EAV3QI'\'\I8#]JMK5UF#!MH(7C-0<IN4/N*Y
MX)\XJ39N8IPOPE5...2:"7>E?NCDYV\XI5YNMLK+)$^5([]12H`37H%?3HIG
M&/989;N`>#_Q0;);!IB)IRRKVVD'Z&M'FMTNK&2VE&4D0J3X^=!.NV5WII5W
MN5]IAC+8)';KW%`/:D\8E]D.VP`ON!P`!X'SJ9_#"PL=0U#5C?-((X-A41R;
M1\6[.?TH;U"X]IOB(+<X&>O]://X,6BW%MKA&<M)$N2/DQP/UH/=RWI6.:>X
MTM-12*V/WUTGN-%%\R0#@=O-%7IOU4]L8H9Y#+9RLL:R$G=$S?AWJP#*#QU'
M?O5_;Z%;0Z9/IR1(MI-_BQ;?A?YGYU7R^GK&QLOL]K`L41_$!EBV.G)YH-!A
MR\:GBJ'U')+&@19GC#=U/)^E76G`K90JW78,YZYQ4?4;-;GE@"1T)%!F"7DZ
M:HON>I4@!)"QR1R,#@<_$`1_U6D:/>;T2.24NS#<D@D#I(.^UA^W6H=YH=M?
MQ6\-]`DJ0$&/:2FW!R,8J;::1:6K[K:)81QA5Z<=_KSU[T%L`2,]101_$!4%
MHCL!N]Q<'QS1L.G'Z4#?Q6MI9?3YN(<DPMDCRIX(H`.RL!.FWWC#<.[/&Y`V
MA@>,X[>?D:-5]V.WB!4*<#(!#=NF>XK---O1J>R`2-')-AK:3?@$KRRG'1NH
M^>`:/+&5IK4BYB9)<X)5CR/..Q\XH+-5/M;CL$K<+QR!7%E:WB:22,`[2.#R
M:9L9(EE<[B77JN<_2I5S=6TRBWD1`TA/P]R!U-`XCGVHV4X)&3BE7#M5548`
M`P`*5!6P_P"$HSV%4OJ+3KR\^.!8)(BFQXI1GKW^=7%N?NDSXYQ4E3GI081K
M_INXTLB1P@B?E73/P^5Y\4?_`,"I@D&IVT@Q*+E68,.2"O&?THEUC0K?55C$
MC!-C[QQGGS7?2WI^ST'4)IK>1W>Y8&0L0,D9Z`=.IH-)*H5R%&[%4VI;6*HH
MY9@#FK(7"[.HJG@GCN]03:X.#T/RH">$8B4=L5[V@\TEX`Q2;*J2!SVH&R`3
M@CG-.*,"HPN$:0IG#*<,I_>I0.1CKVH/!.!_6J#UB0=&E5EW!N,$9S\JOW&[
MI^=5FMVRSV+`H7"_$%7J<=!08=9Z(9KDM;J(ANRN3RWG'T\T3G6)+.&&W=5N
M&`P[,<L.@Y\T_P"HO[/T#2H%GN"E_?G;';GF3:>K`=E'<FLW_O#J&G7%Q8OI
MHANE9OQG.Y?(R/ITH-.@U&3VV]J/W#D;Q&`"OUJ;I44V)+B<`N6PG!^%?SH)
M]&7YU:^CN6MI+>>-MD@&=DO'!_*M'Z9QS0-.<8I5USX`I4%3!GVU\XY(Z5+7
MG'&#WJ);'[E<C!QTSG%24Z=*!\?K7B0'X<=FXKH/'-<SG(/2@>O/M"0(2S>T
M?Q,.<4S::5%J'L75K<,CJ0T<L3=OV(J]TYUEMGCP,`9%9W=:7=:=ZOAN+34;
MJUTNX=S>0PMP"5.R11@@8;KYH-6MK>^2-$N;H2\8)"[34VWMXXB63<2>N6)_
M>JG2;6X]B*1=8DGC<9!91G'RJR,80?>W<K'!X!QG]*!K4;%K@+-&^R9.C`?O
M36F7;R'VI0-Z]U/!IK4-,BU3[BYWBU#!B-Y#2$'."<\#Y5-M[6*`XB0*H&,"
M@E$#%>0,MS71P.M)>^<T&3?QGL7EN]*O%C]Q$BDC9=O/X@00>OFJ#[%_>/1;
M:<0E;NS=45@OXT\#YCQ6F?Q%M9)?3TMQ"@>2W^(C_1W_`*T'>FX)X[186DQ$
M""`>#DCQ0>?1UJ#//>0[%LMJI#MZNPSN9AV(Z8[<T5GC&*\:5IL.F:1#!$[2
M$NSN[=68G->V/F@:D/2E7)!SV_6E05L2E50`]OUI]<YIF)LJG`'`X\4\G/\`
MYH'-V3G'-+.:0&..E<XYH)5A<>S+@G"MQFN7T#&[CE#[6'1O/UJ-C(QYJPLY
MU<+%,`2.Y[T%O9JSQ(2J;EYXJXA0XR<`_*F+*.)8E(5?RJ<%&.!Q0><+XKR>
M`33C$"H,URAD]I&!;O@]*!_))ZG`_P!Z]BFXL[0",4Z!QTH.2(LL;1.`5=2I
M'RH7FTM;.))'$:HSG:J]5\<]Z*B,ML[D<_2O%S;174)BE&1V(_E-`)R2;@$&
M`HYXI@^:FWVG3VC?%EHNSC_]Q4(CQ0-.,XP`?K2KK]NII4%2CC8N1SBG%<$9
M&>.*5*@D1O\`"#YKNX<G'>E2H.JP)QCGO7H`,`1D$="#R*5*@L;75+FV0*P5
MU\YYJ=#ZE5YD@%JP=ER#NXI4J!R>\GF#_$5'3"G%,Z<^^;`7`'SI4J`@C4@4
MZ3M4M2I4'I5P#WS7<<@>:5*@ZRJRD,H(/!!H;U?35M\2PMA&;!4]J5*@II(V
))[?K2I4J#__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g633815.jpg
<DESCRIPTION>G633815.JPG
<TEXT>
begin 644 g633815.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`\35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU23UE?4U]23T)%4E137U!(3U1/+D504__;`$,`!P4&
M!@8%!P8&!@@(!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE,B4H
M+"TO,"\=(S0X-"XW*BXO+O_;`$,!"`@("PH+%@P,%BX>&AXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+O_``!$(
M`(<`AP,!(@`"$0$#$0'_Q``<````!P$!`````````````````@,$!08'"`'_
MQ``[$``!`P(%`@4"!`0#"0`````!`@,1``0%!A(A,4%1!Q,B88%QH10CD;$5
M0L'1,C-3)$-$4F)RX?#Q_\0`%0$!`0````````````````````'_Q``4$0$`
M````````````````````_]H`#`,!``(1`Q$`/P#8>U"*/$U[I_\`M`0"#[>]
M><BCP9_O0CTQ0$`C:O#`!4HQ`W)X%>7+S-K;.W-PX$--)*EJ/05CF:<Y7&+7
M3C-HXXWA\0EN=U$<E5!=\9SM86#Q8MFQ=*&Q7JTH![=S56N<ZX^XZKR'FV43
M_@0T#]S5>L&@M&M:`93,GH9Z>]+(4C4I;K9G@)C95!+MYIS,M#BE8D9$F"@"
M-^.*<VOB%B5H^EF]MFKA$1J)TKGXVJ`.(VR04Q_/$]SW^_2HF^4D("U-I)5(
M]0]/M0;3@.:\&QM*1;W`:?/^Y>])^#P:GH^*Y7=NW+4J<87Y8)V`Z3O6D9#\
M1G_.M\+QDA;).A+ZSZD=!)ZB@V$\037G<'?ZT80>((Y!H1'`F@+Q,4!%'C;:
M@!WH"1_Z:%&(G;MVH4"HYF9HT;5X!%&`ZF@*4S10C<")I:)%(7MR+"PN[TC_
M`"&%N?H*#*/$K'W<0Q(9<P]2PRRK_:%#8+5_857K3!6$D:9U<FDL&)?=N;MT
MR\XLE2C]ZLK"`-$#G?:@:-X<$)&Y`'045UM*&SI1(ZU8$,@-DJ)`CCM3%]"-
M"MC%!3KRV25E0$3)J*OFRI!!4KZ$U:KEI.J8'TFH'$&QJ)`H*TY;[$$^_-1S
M[2V5^:E1VYJ9?V)BF;R0001,B@WSPEQQ6-9:\MYY3EQ:+#9*COI(]/\`45>@
M-N/TKG;P8Q!=IFUJTUG1<ZFE)U0#MM^U=&@;`4"<'8$4(I72:\(H$H&^U"E!
M^]"@-&W:O1%*$&@![4!1(J`STHIRABVGE36G]2*L40>=J@<\6RKC*>)MH2%$
M-A>YZ`@T&'9=6G26SSWJWV@C0O2#TJF8.RIIU4S/V'M5WPT(2TDON)0CW-`_
MW6C>2:8/MG224D">(J81>8.ALC\6%+`Z=*B7KE+KR4-G\L@^KVB@@+W8D@&)
MWJ#Q"5'@Q5M=+!94%*'I-0.(O6*6=1<'OO051Y)))Z4P?D$FI5]ZU=GRE[U&
M/C??K0&RE<FVS1AKZ21IN4;CIZA77$0HUR'EUM9S#AZ&CZR^B#''J%=?@$"#
M]*#SXHI!XHT4(H"1'M0I2.U"@/$[4`FCQTCYHVF@)'>D+UD/V=PPK9+C2D'Y
M$4Z(@_2D+YEI^SN&7E%+3C2DK(,$`@S0<_,-I;2ZI*`/+)$C?49YIP/X:M!_
MBF)>23P)Y]NYKVQ:<;=?9*TK<#D3$`]J-8-85AM\Y?7:RJZ*5()(D"=B(_K0
M5Z^O,):?4FP><)'^H@@FG.#WSUV]Y30U$;1VIDZWAPNW5M^;<K>4)#GYBEQ$
M"/CO5SRSA#-FAHMLZ'%J!4F)(Z\_:@J..7+UB%L+D*/.]0*2W<:?,6I9/"!N
M:M7B!;ZKE2DIWU3M4/@;UM8)4]^'4;E/^%1/I`(YXH(]:\,:6IO1#B#"O2?2
M?>F=RI*E2@RF)!IZIYDJ>0BV@.SK`63J_6F*[8M'9)2B>*!UE0LHS9A*GU^6
M@73<KZ#U"NMU<D*'6N1<">;M<Q89<.!)2W<M+@]86-JZ]@%1(ZT!(':@1TFE
M".PWKR.*`D>WWH4I'S0H%`.:/'6O![[4H-]_VH$U)["FUTT7;9YI.Q6@I'U(
MIX0(HA[T&!AARTQ1]A]$*\PF.^]7)NRM;JU1K::5M)UI!FHKQ&PVXPS$DW\J
M5;W"E:#.R5<E-0]IF0^4&@?5$106%=OA-I<`-6K8<(/J`B*5P[6\ZVA(]7`$
M<"JU;-.XA>!URX"8Z=)[4^7F:VPK$@T[:7+3R-M2T^@CV(YH(GQ`M5?BE.!,
M`<BJ;9.AET+5LD]")!J>SEF5A]3CBBD^PJC'%OQ;>@(2T`1!F307$*8!UI0F
M?I43B:@I)4J*8L7ZD@))!]YI.ZN?.!`ZT"N6\+_C&:L(PXDA#URD*4.B9W_:
MNN4I`$`;<"L+\"L"9O<3N\;>62;`A#3<?SJ2?4?H/WK>`(VB@+IVD"O"GKQ2
ML>U%(H"1Q$4*-IZZ9H4"@$\]*]$\'I1M(WG>*$>U`4[;44BE(D<?>O`.*"A>
M+MJ7<KHN4@S:W*5&.R@4G]Q6(),N>:DZ5`&NHL5P]C$\-N</N4RR^V4*]O?X
MYKF/%;&ZP;%;G#[M&E^W64*[*'0CV(@_-!*V5XYNTBZ80`>"H$QW^M*X@\FY
M;2GS/,4Y*6Y$E(GD_;[U$X#A5M<W3MRZ@+GOR/I5TPW+5BC4;ERZ\D00MIWU
M1/;KM/%!FF)X7YZU^8V4G@0#I$=)/-1+]@PT@AM/KTR2%;@S,Q6M7V"8`D7`
M8%W<%(_+#JS$[\S'M5,Q]>I3K+(;9MU`!3;8Z0-B>O%!3+=Y*W@V$ZAON.I_
MM3ETA!T)YX_O1VVTL^M(CM2386XZ-"2I:C"0!))H.@/`2S4SE>]NU)C\3>'2
M3U"$@?N36IP8JD^$F*X1B>2\/M\*.A5DV&KAA1]2'.23[*))!J\`=:`O(KR.
M]'T[[[4(W[4!($T*/I_2A0'`WWH09H\#I2%W<VUDPJYN[AIAE.ZG'5A*1\F@
M4('6O#M*B=@))/`K,,R>+F&6@<M\"ME7SXV#[@T-#XY5]JR?',V9BQU2V[_%
M'U,K,EAM6AL#MI']9H-RQ_Q(RUA0=;8N3B%VB0&K82F?=?`^)K%;RYQ;.&-W
MV(*;2Y<EE3Q9;Z-H`]*1U@'YWJO#9/:K9X87PL,]80M7^!Y:F"3_`-:2!]XH
M&N"O)2F4GU#8$'FG%WB.(6@4AITAN9T\@5=\]Y%NL*Q!W',"MR[8.$K?MFQ*
MF3U*1U3U@<?2JB,2M2QJ4TVMSCU`4%7N<9O%;+<!)YJ-<??N%0OCKMS4MB#M
MLMS=IL2)V`W-1[KS2$J5L(V`%!'7BXE/Q5P\.L$+JU8S<)_+;E#`(Y5U5\<5
M$99R\_C]Z'%A2+)!EQS_`)O8>]:IB!M\(P&X6TVEIFV85I2G@0-J#$<%S'B>
M5LPNXA@]R6EH=6DH.Z'$:CZ5#J*Z#RAXQY;Q=E#>,K3A-[_,')+*CW"^GT-<
MM*45**CRHS0$@\T1W?:7-K>VZ;FSN&KAA>X<:6%I/R*<`<BN',&QW&,&>\["
M\2N;18_T7"F?J.#6NY2\<;ZV2FWS-9"]1P+FWA#@^J>#\1170NPWH5`Y;SAE
MS,C*5X3B;+KL2IA9T.I^J3O^E"@S_-'B^D!3&6[343_Q5RF(_P"U']_TK*,9
MQO%<;N/Q&*WKURYR-9]*?HD;#XJ/VHI)Z4!I/;<T8".>:(D0032J1UF#0"?3
M1V+A=G<LWC1AQAQ+J3V*2"/VHBM_BO%00?<4'8F'W2+ZQMKUK_+?:2ZGZ*`/
M]:JF:/#O+V87'+EQI=I>+'J>MCIU'NI/!_?WI+PAQ+^(Y(LDJ5+EJ56ZOH#M
M]C5XH.4,ZY*QC+-P?/MW'K8F$7#4J0L>^T@^QH97R1>XJ3<XBCR+-LB6]0#B
MS'!'*=N^]:UFG$;3,-Q>,.WT6;#9-NS;H+CATR%.D`P!.P)Z5GBL5NLNWIO$
MMM.VI@D(D*>1UU;<C>#TH+S9V;-JPBWMV@TRV(2E(X%5#Q3OA;9=<M4F%/D)
M/TFM`2XP_:-7=LL+8>0'$+'5)$BL7\4KLOW*6Y]*3`_<_P!*#-HKV*4T30"=
MZ`FF-^]*!-&T2(HS8F0>10!M2T*!0HI4."#!%"E(%"B+%WHHYF*%"B@E04O3
M$$=.]*G8;\FA0H/)W`%&`$$=J%"@V+P`OSY>)X<HF-0<'[5HF?,8.#Y?>6U/
MXFX_)9(Z$C<_`FA0H*!AV5VV,!L,:<#[I<4&7+=IP)\U*U:8))XF*S[';9>)
MXBEAM2VFFX;\@D0@@D<]>WQ0H4&BX-:.8;E5+*S*&BH(WX!WC]:Q7/"_,Q!(
E/1.KY)_\4*%!5$#>*44CM0H4`B*(82Z`?YAQ0H4"X%"A0H/_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g304005.jpg
<DESCRIPTION>G304005.JPG
<TEXT>
begin 644 g304005.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@!"35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU724Q,24%-7T1?4TU)5$A"55)'7U!(3U1/+D504__;
M`$,`!P4&!@8%!P8&!@@(!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@
M&1HE,B4H+"TO,"\=(S0X-"XW*BXO+O_```L(`(<`AP$!$0#_Q``<```!!`,!
M```````````````'``$%!@(#!`C_Q``Z$``!`P,"!`,&!0,"!P`````!`@,1
M``0%$B$&,4%1$R)A!S)Q@9&A%".QP=%"4F*2\#-3<H*RX?'_V@`(`0$``#\`
M,/:E%.!!]/6FYBDD=*Q5I&ZB!\:C+[.8JQ)2_>M)4![LR:JV4]HV.M3HM6%W
M/4D;"H17M?M`LI.*=,;'\P`_I4SB?:;@KT`/^+:KY$.)D#YBKG892POT!=I=
MLO2)\B@:[`-NU.>1FEW'/XTN4Q2$4H_V:SB:?3_]IH,_S31M'2-Z@>(>(;7$
M,0E0<N"-D_V^IH7YGBZYOUJ;7<*2V?Z0HIJ%:6V]J+BW%?XGS>G.N9X)0U*6
M"C2=E`[DUQW+%N^A3CZ0IR0"KD?K_OK7&]9I9$H*H`D;ULL\A?8MX.6[[K+@
MZI5%%7A#VCH>#-GFTZ'%&$W"8TF>6H=/C1.;4E:0M,%)W!K+2.@FGC;:D!WI
MB)V[=JVCG,S64;4Q3-<>4NVK"Q>?4H%:$E03/,]!]:#G$*EI4Y=7BBMQPZB#
MR^'J*K.,QMQF\@BW8;"4$SLG8#THJ8[@JT9LR$R5Z8)CG4+D^'5-J4TEO4VD
M2!&]52XPCKBB`V05'85JOL<ZEE32&X1"1,;P*K.6M;D*+^D[&8ZUR6SRG$J6
MD01S,T7?9IQJ5K;P^0<F=F5D_:BX.0VVI0=I%(BF@;[5L`BL@.IK(<J&W'-\
MM629M]10TWYU`<BKI\Z&/$-\N[N=`G2%;2>=$[V9X?P,<+MU!\1T[`CD*)#3
M/E!(KEN6F]4%*3,Q(J"NL9;AS4E(Y;[5$WF.9*5#0`*H^<L6QK`2(Z4/'[?\
M%DT]&73!VY4\FTNBME12IM6I*AT->F.#\NG.8"TO@1K4B%@'DH<ZGM)-,13#
M]:RC;M3B*?D-^76@EQ2ZI_)W*P%I`6H@J,Q%5K#8YS(Y0!R4HD;=:]`X:T:M
MK5FW0`$H2(J6Z0/O7'=>4@SRWJ*>4"E?;]*B;HD)(G:JAETA4S'.:H^>M):6
M4QJ2=234`ZL/)"S[Q$'O-%7V(W2@B]M-8VTK`Y<]C1D&XF*8@\J:(]*V$&D!
MZ5D`)@\NM!'BM"6N(;Y"U:$3(_RG<`338%3!O&$-(@%P;CKOSHQ,E(3Y3O-;
MT/H*BD*2I0Y@&2*T7F@H))@@$U#H4E3A;7R4T5_I_-0U\]J=+0,Z!*HJL9'4
MX5$"JME0"A2.X-5"0F6U$`'K1(]B04G,Y!!,CPDDCY]*.0'>E%/':LXG:D$U
ME'>@W[3,>\GB`7GADMJ2E*O#,E//S1\_M47PBTXO.VR%`@)A9%$S*7+Z6V[2
MV64O.[:I]T=35$SEHJQUO,\2(2^=RF23]17)B,SQ`I?@KO57"#_2K?;N.M7O
M*^-CD6]ZX0$FV*#Z$@?Q0OO^++I;BVK-`4L\R!S^-1:[S+WG.Y;!_M#F]:O&
M?7J:N/?3Z557ED.K"C!22*+/L0MKIQ^[O$G\E*0@COO-&^!VYTB.DTH]/O6<
M=(^=9::1$'X53.(,<S=9Y27I_-;$'J`.U16+P#%CF1>-.J*H*%MJZ$=9JRWN
M,:N6]"Y`6(4H'<"J_E>$,>MIM272`D@J&H0L@D@GN1)IL)P[;I>_&3J93LD'
MDHCM67'5R$8K1,DC3':AC@\?;I?475>54[$;&L[G":7'7$J*RLSJZGE_%1R[
M<I4I"U:EH$3,S4$]AUW5TM0<"&RJ28FC!["VW!;Y<E/Y:5H0DQU$_M1:([#>
MFCE3Q\ZV`<ZSCK3*3V%0F;8TJ:O$I$I!23V]:KF/95;M:G#^8Y<+U>GN_P#N
MK+;K"O*0-,5S7S%D"'+A""!N=?*M2+U%RE*6%`M@0%$0-NU4OCNY:6T&0O?O
M5*QK@\?PU1)Y`]:G1:6ZD$DKCJD*BJ[DRV'E):;2VD;".M0P=4W=LP=EDB/W
MH_>S'&IQ_!]FH)A=V57"O^X[?8"K=IVD"F*>O*E'*(K,>NU;!OO^E,0(KGN6
M4O,.-&`%#KWJIWZ?#4AI2D!2-M']0^-;/Q(;//IM59XBOW+N[9L6E$N.*T@=
MAU)I\MCKQNXMC;7;K=LTB"A($*/K0_XC-ZI:D*>&Q("AN?I46VNX6&E*(#C9
M!U#::M#%ZE=L%3YHWJOWSNIQ1%:\9CGLI?VMC;I4I^Y6&A`]T$[GZ5Z>M;=N
MUMF;5H0VRA+:8'0"!6Z/2L2*;3UTS6P">?2G$\CTI';:L2*@>*F$BW:NDMH"
MT.:5+C>".]0QT^&M9$D)D52[2[M;.\7D[UT%Q:"0(G0)Y0/2IQOB!J^MDK:L
MWW&E#RN(02#55RKM@R'6E-.(=U$J*T$$'UJJOO6Z#"%#<]=JZ["73H&X6#'T
MKA>`"W"3L#%'K@/AS'8W$8Z_%DA&1=MDEQX^]YM_EL1-6Z#%+F*:.]*!-9Z1
MO.\4H]*42.7WI@.5:+ZU3=V;UJO8.)(GL>AJB)<6T-#J8=;);6#W&U:N'<>A
MO\0IY`*EJ46S'('I63K-K:!?G=MU3*2T8$_"JOGWOQ(.J_TR=1(0D&?I5%=L
M;=RX22I;Y1LDN&0-Y_>I6Q2W:6[ST>ZDA/QKEP^.?S.5M,8R)<N7()_M3_4?
MD)KTVAM*&T-MB$(2$I'H-A64==Z6G??:E&_:EI^E9@;[TH,TB!UI`&=MZ1`$
MD]JH&>MELY"X>5.ZPM7I(D']JZ<>\VY;@I@$"?@:U7MLW<(.H@'N4\JIN4Q*
M`M2BL*!](J`N[-#+"G$%(_FH3(7`4VW;-*\B>9[T9?9%AK2WP(S90%7EX5)U
MG?2VE4!([21)HA@4HWZ4Q'?K3@<Q3;#>LX'2E':D!2B*K'$V32,ACL$RN%W3
MZ/'*3NEO5R^<?2IC-XI.0:UH@/I!&_):?[3^U#M9?Q=TXW"@`2"@\P:Y;SB1
M*1H("/6.=5G)<1I=5`22GN=JK=_DEOIT@^6HU,K6`!*B8'QH\>RS,V[EBYPT
ML)1=8Y"5I'_-;5OJ^(5(/RH@QTI09I"`>]*.L4NGK61[_2E%+K58XDXJL\4E
MRVME)?OAL$#=+9_R/[4-6;]U.88R=RXI;HN$.K4KKYA-'8;[CE41G\';9=@A
M?Y=PD>1P=/0]Q0CXHP5Y;A:%(TOHY@GWAW!ZU2KG&W"1^8Y]*C'VRC8B#ZU+
M\.XQ9`R%PF$G_@I/_E_%<6;RE[@>*+'*XQ[P;MIK942")(@CJ"-B*-O"'M/X
M=S[;#%T^G'Y)8`4R^80I7^*^1^!@U?\`MZTH^E+X4OG3CE7!E<OC\4SXE]<I
M;)]U'-2_@.M#C.<<9&^#EO8(_"6ZMM<_F$?'I\JJ#3DJ,F3-9O#6VH<Y%&K@
MR_.2X:L+A9EP-^&O_J3Y3^E3E<&7QK&2MO"=2`M.[:XW2?X/44$.(;=&/R-S
M;NJ0%-GW">5<.&X:N\LLY*Y94FR!\I4(\4]AZ=ZF+QGP1IB`-@*%O&.I6<6#
MR2T@#[U!15JX9XWXEX?4D6.2=4P.=N^2XV1V@\OE%%7`^VBS>*6\[BG+975Z
MU/B)_P!)W'WHBX?BGAW,P,=F+5Y9C\O7I7_I,&IN/E0DR''&<NE0PMNT1')I
M,GZFJW<.NOO*?N'5NNJYK6J2?G6C5)/I7.R=^O.NG5Y>M$;V37FJTR./)/Y3
MH=3\%"#]Q]Z(#SJ&&7'G5:6VTE2C$P!03XM]H62RUS^$PGB6^+"M+CC:@A]\
M>A/N`_7UZ57K]IAQ#[C#@6?&UC4G1Y8,JY'<'IR/K71@^-\\G4RZZB\L$**4
MMNI`(3TTJ&Z=AUFI>YO&<BP+IB0A1(A0W21S%#/BIF<R\>NA'Z5!%OI3Z"/-
GVYUN0`1-;0GD>HY'M5KPW'?%>(:2S;99QQA(A+=P`X`/2=_O7__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g583704.jpg
<DESCRIPTION>G583704.JPG
<TEXT>
begin 644 g583704.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`\35),3%]'4D%02$E#4SI;04)"3U14
M7TQ!0D]2051/4DE%4UU*3TA.7U)?5T%,5$527U!(3U1/+D504__;`$,`!P4&
M!@8%!P8&!@@(!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE,B4H
M+"TO,"\=(S0X-"XW*BXO+O_;`$,!"`@("PH+%@P,%BX>&AXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+O_``!$(
M`(<`AP,!(@`"$0$#$0'_Q``<````!P$!`````````````````0(#!08'!`C_
MQ``\$``!`P($!`0$`@@&`P`````!``(#!!$%$B$Q!D%180<3(G$R@9&A%$(5
M(S-2<K'!T18D-6*2X;/P\?_$`!4!`0$````````````````````!_\0`%1$!
M`0````````````````````'_V@`,`P$``A$#$0`_`-AZ(62[71Y?_J!`%CV[
MHMPEV-_[HK6%D"0+:)#W-C89)'90-R4<TK(6^K5QV`W*B*ZO$3;W+I>HUMV:
M/ZH)1ID>-+1#JX7=;V7#7?A1$65<\LH.MB<H/R"8@%1+%<Q.N>3C>RC\0I*B
M0$E@!ZA!!XE5TK)#Y`RD;@IO"^*Y:![62MSP$ZCI[+FQ&BG=?/>_?55^L@<U
MI:^XUW"#9\-Q*CQ.`3TDH>.8YM]PNP!8+A>)8C@U8V:GD(`[Z'L0M2PCBV"K
M;$*J(PR.T+@;M06D[6)1=0=?=!CFO`<PAS3J"-4JUMA=`G:]D!9+MH@!U0(M
M_P"E!*(OITZ(('1O>]TJVB("R4!S*!);=(<&L:7OT:T7)/)/VN%&XN^S(Z?\
MLFKM>0Y?-!!XA7%F:K(=ZSEC%N7*PZIS#*-[RV:K8?-.H9>^7W[IJFA-16R5
MLUGY#EC['L.2L%)&,I)TMS*!Z)H`RC3V49B#;26%]N2FG!HV(7!6AA;ZB`1S
M053$('',X[;W55Q&,6N0-E>*L,<'=.2J.,,&5P&W1!5)V@BW(I=#*^!WE`G*
M=M?LCD81>XYIA^EC]$%QP'BN?#)1350=)3`ZM.[>X6FTE1#54T=1`X/BD&9K
MAS"PNM'^7AJ@.@/=7SPOQ!TD=9ACW$B(^9&">1*"^V.EP@0G<I1$(&K#71!.
M#^:"!5M.B,63A!0`[($BX4)B8,N*,A:;$Q6%^6NJGK6TO8*MXJ\QX]&XW#6Q
M@('Z>)K7MC#?2-5)Q?#<:"ZC*)PD>PWN.JE798HB][FM;?KS0,S2$.!'PCDN
M21GGONT@7WU0JZF$^IKQ<'8'=,4]5%H]SAJ+(.7$HQ'!<6.46M=4G$GA^;>Z
MLV)UXF<Z&.09M[]%`?H]\CKRN-CMH@KD[00=%'RZMZE3V*P"F;HYCCV.ZKKW
M$@D=4'96S-9A;(=W'3Z*9\,*AQXG8T$@/A<'#KHJO*3)N3E`5F\,X#_BR)P'
MI;&]Q^B#:_DDD'9*LA9`BUNR"<MT00+M?1`-2[<K?-*RH$6ZJO\`$\-O(G:"
M7ZL_LK&18^RY<2@;-22-R@N:,[;]1J@@O(?24T43-)0P%Q[G=5_&<5P>)KA5
M35M5)'HYD(<YK3W(L`K6US:J;?*',M<>RYQ%%14P@IPR*(:^IF:Y.Y[E!GE#
MC`JW1NH*>K8#J(IV:N]E<*FC$&$?C+'S'MN0[=IZ)^BHR^I\YH>(P<SY'-RY
MNP"<Q^8,PQPN;6-P@R6"L,]74/GAJ)F,=E8R/2Y7?551I3''^A*HE[2<\;\P
M;MH2=+^W1(PJS*IXL?6;_-3<[*B9N1CW6/4`H*C-5"9Q#&.:=BQVA:N9["TN
M:K7-A4$1;)(`YXUUYJMX@6MJ2!H$'+(VV9PTS*^>$E+*_$JRL<P^3'%Y8?;3
M,3LLXK:TQF&)K<Q.OOJM^\/8FLX0PPM@$3GQES@!\1+CZC[H+#8=$".5TX1T
M&J*VR!%NWW03EOF@@<`W2[<T0[Z)P:Z_R0-N;T";(TU&B?(%D@]4%?GI6T=>
MPL?:*0$M;^Z>?\UT/<P^H:V2L>81%!/;2.2Q]B%!XI7"CHG3.Y(.V:OC_8L-
MW@7-SL%#<3.(PHN;:]KFQ35#A\LV'RRU,DD=54^H.;O&.04!CF%8I34(BDKG
MS7%B2/B""K0U#J>0U.8%@=\'4*W4,\,\(FB<'-<%0AAU0Q\N=[[.W:3M_96+
M"GBG@$0T;;5`[B-46.RDFQ.AZ*LUSLTUU,8J2Z[@#INH2<@DDG0(.GAO!QBF
M,TE*`2ZHD#7']U@U<?H"O1D$,<$3(H6!D;`&L:-@!L%3O#KA>'"Z&'%)SYE;
M4Q!S>D3':V'<\RKR!R0(RZ7`1%O/9.V[))"!%MK602LO/+=!`X!??DC%]CR2
MLHUOK9"W9`DZ:))"<M<;?=$!L@YJVG%32RP;%PT/?DJ#C+/Q%)D<W5C@2WK8
MZK2"-%3N)Z%]/,9XV_J9S]'<Q\T$`S$L4GJ)'14)-/'JUY>!F^2*NQ.L?!GF
MPA[RWX<I!(4S1Q&.@9&[7JHC$L-JI0[R9`UO^XH*'B,V(OE?(::*._(N3>%_
MI!\QSOBR'H"IG$L-<QP;-*"1I8%<L;!`?5HT:(%8YE@B$>F9S!<CJJI4.]+A
MS(4OC56)YVM!]+0H9H,E1&T"Y<]H`ZW(0>H:)@924[```V)H`Z>D+HL;(PTY
M6BVPM9';GJ@3N$5NJ7EUUT0MKT0(L+H)>7Z((%@:ZH6-TNPY(6Z($$#F@`;Z
M:I8"*UD"<N^]U#<5P&;!Y`"1E>UVG+7_`+4AB>(X?A5*ZJQ&L@I8&BY?*\-'
MRZ_)9G5^(D'$W$.%<-\.LF$%35L%352-RYXF^IS6MW`(;8D\D#U+B,E/(::K
MY?"\;.".IQ>$!S+@$[ZKIXCP>2FJ'1D>EUW1/Y.'147&8)869W-<T#<A`6*X
MM')/F+A8'8%0==B+I/2W9<UO/<0S/?N%R3!T9LX>J^R`W/<ZY<=TNA8Z2NIF
MM)!,K;'I8WNF0#;U*T\/84YC/Q\[2'N%HFD;#][YH-IX-XCIN)<,DJ(V^554
MTI@JH2;F-X_H1J"K#;7DO)'$>,8QPIQ:ZOP6NEI))XF/>&'TOMI9S=B-.:OW
M#?CW&6,BXCPEP?L:BB.A[ECOZ%!O!'7FC`W"@^&^+.'>)(\^#XI!4.MK$3ED
M;[M.JGK<[($:#5!+Y=T$"MAJN>NK:*@A,]?5P4T0_//(&-^I7G[BCQJQ>N#Z
M?A^D;AL!T\^6TDQ]ORM^ZR^OKJ_$YS48C63U<Q-R^>0O/W0>D\?\7>$L++XZ
M2:7$YQLVE;Z+_P`9T^EUF>-^,?%&(.='AD5/A<&MBQOF26_B=I?V"S$-3K1;
M0(.NOKZ[$ZEU5B%9/53NWDF>7'[[+1O`;!YJSBN3&"VU-00N:'$;R/%@/I=9
M?V`%UZ4\"J)M/P-'4AMGU,[W$]0TY?Z%!H59205M.ZGJ&9F.^H/4="LVXGP:
MIPZX='YU&\V$EOL>A6HI$L4<T;HI6-?&X6<UPN"$&!24M/`]K0UMCLH+%*:-
MM9(\-)9LWN5K&*\/89'BC:6GQ6FB>7-_4U#Q=I=\+1S)/(*4@X6H<./GEOXB
MKM^VD'[/LP<O?=!E>!<,29VUF)19;:QP'^;O[*Q31V!5HJ:=K;V"A:J*Q*##
M/%+_`%NG;S;3B_\`R*HJM_B++Y_%%4`=(PV,?(?]JIEJ)0AEEAD;+%(YDC3=
MKFFQ!['DM0X6\:.*L&$<&(NCQ:D:`,M1Z9`.SQO\P5EMDL"Z#U9@'C-P;BD8
M%;/-A51;5E2S,SY/;<?6R"\J6*"*F@Q*L@@@,=D>PV000!OQ+U1X/"WAU@_M
M)_Y'(((+NJ_QMQ#'PSP]4XFYGF2@9(8^3I#M?MS/L@@@\O8]BE9+42U=1,^2
MLG)D,NSG'U7<#RM\K6%@MV\/>+W\5<-B2I!&(4=H:D\I#;TO'N!J.H*""":>
M,[C=1-9&,KWG9H)*""#R_P`0SFJQFMG/YY7'[J,<VX000(LA^>P000+L@@@@
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g206804.jpg
<DESCRIPTION>G206804.JPG
<TEXT>
begin 644 g206804.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`O35),3%]'4D%02$E#4SI;04)"3U14
M74U)3$537T1?5TA)5$5?4$A/5$\N15!3_]L`0P`'!08&!@4'!@8&"`@'"0L2
M#`L*"@L7$!$-$AL7'!P:%QH9'2$J)!T?*"`9&B4R)2@L+2\P+QTC-#@T+C<J
M+B\N_]L`0P$("`@+"@L6#`P6+AX:'BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN_\``$0@`AP"'`P$B``(1`0,1
M`?_$`!P```$%`0$!```````````````!!`4&!P,(`O_$`#H0``$#`P$&`P8#
M!P4!``````$``@,$!1$A!A(Q05%A$W&!!R(C,I&Q%$*A"!4S8L'A\!92<I+1
M@O_$`!8!`0$!```````````````````!`O_$`!<1`0$!`0``````````````
M```1`2'_V@`,`P$``A$#$0`_`-SU29[)/NE0+TT2:H2X0)ZI)'M8"][@UH&2
M2<`+A<*ZFM]))65DS8H8QDN/V`YE8KMKM=67N;\/%%+!0-.D&1F3'-V/M]T&
MFUVV%LAD\&F/XQW`^$X8"C_]65D[O@4\#>SLD_W]%F-N?*Z-F`?#=P!X>G^9
M5PM;7OB:R<Y</ED(P2X=>_=!:(MJ)6`">D!+C@/:="?Z*1BVAI=W?E8^/!P2
M-0#_`$5;'OTV2!O#1XQC>_S[J/EFEI9R&@.CSC+N8Z(-'I:J"JCWZ>1KVCH>
M"[^OU5`AN4=N@=5T\3G/T^$.Y&BFK7M%/5.S/0B-G\C\D(++JEY=%\1O9(QK
MV.RT\%]>J!>NJ.O-)]4'"!3WX(290@.7'5&O)'V2GH@3/9!X=$>B8WFH-/;Y
M7M.'N]QO7)T09WM?6U%\G^!&X45.XB,$:R.X%Q'(=%3X*.H\8F2-F1TT)5\N
M\.[#%3!Q8#QP=24TIXXLMC`R!U014-`S<<\1_"=_$8.(/4=_NK!;H=!'D.W@
M,.Z]"GT5'$1OM&/)?4-&^$AK&983D?RH"=C63`_DD&Z[L4RJZ-SLMW>V>@4V
M*?>RYYX\1C@E>QGAG`SGF$%==3[T;6NT(XE2UH!:0W)ZX!0(F^+\O'0DI]0P
M-$I&H'(H)FG/AM:X?*?F']4\7&!N8=UP&1H5TC.6#)0?25'DA`FB$>:$!U1Z
MX1W1E`#'-0.T4COQ-#`,[I<7'N>7W4^5`[4PDT\%:T^]"_!'9VB"%O4+0YTQ
MU)&!VPH6A.]*<8XJ8N]1&^BWB_@,#',J`M._XI!&<]4%NIG-.,-P,!/&D`:.
MX<%%TK)L#3ZE2#6.:,D9Y\4'?+=T]4'PPTC3'9-VLD>[)`POO<>!EQ;A!PE8
MUNN.)T(3JE;[P32I.?\`.2?4>'L!:=1R^R"5=((X`[/(#*2E<70-?R))'EE,
MI'^Z6C&,YQT3ZFW131AAT`"#KGHCS0A`%""4(%\DGJE&4F$!ZJ+VDCEDLU2(
M3[S0'XZ@')"E4PODYIK-7U#1ES('N`SSP@RZHJ'2TS)=[+&DY[E1-!772KFW
M[93.>QG!NC0[KDKO).V2&W4@]WQ!XCP#U_LG$^SSZJIBC;(UM*UV]X>N[(>C
ML<D$O0[1U,3W4]5;W->T:^&X.U]"3^BGK;>(*]F8CDC0M(U!Z85$EV2CM3JV
M=G@2&=A:R-D7\+.?EQTSUZ%/=EF?NZ1D>7Y=ESP3G)06^LN%12!N:9SLG`#"
M-569-H;G6U3H(VV^``XQ-6,:1Z9RIVOIXKI3OBD+L@Z8/!14VQM%=74K:QNX
MRF&ZT,:T9&"->IPXZ]T'8&Y4!9)+N302X+A'(7@'J-%.4-1A_P`V-,>>4UI;
M)!02O;2S%L3R7/8=6Y/,#@WR&`N5P<VFJ?<X<<=4$Q657A'<:,O=J`.94Q:B
M#01.:,;P+N.>)54_'0U7BQL>&U#6,=@CAG4:^:GMF9Q46]Y`<&ME<`".`SG"
M"9]4).^.*`@"<(1GLA`8QT1PXH2]^B!`HK:>-TNSMS8PDN,#B!UQJI7."$.:
MUX+",M<-TCL4&!/$L%W;)O8:[#V:?*W'!72S5$LH`B;D'BYRIUW<]M8P;I^&
MPL'?#B%8-FZJ04N1HT<T$[=Y&_ARZ2;=&-<JMVR037-@#\Z'!`_SHG-Z:ZM;
ME\XA:W7=YN\U#VB6II+E'(VF\9@!!<W4X/9!<Z>:."8M><`Z@'FI2FGII@X1
MO(=G4$\"H"JJ!4/:]L(:UH#'#&N?_4CH8Y=V>"5U/.S0/&N1T(YA!9)XI&P^
M+O#34*O5SS+*PGYN"<4]7/-"^GG]V5@WA@Y:]IY@^:X.C<Z(DG4'()0,HX)J
MBLADIY/#C@:/Q>!DO`<2QH5_V?A\&V1DLW7/)>1CJJU9G!^[3.`+'SX=N\0"
M`?Z*\#`P`,#&B`*!A&J.71`:(0A`N,HT2#@E0(ETSHDZ(*#,O:':::DN%%64
M\&XVJ<]LV''!?H>'+.2OG9>..1DU(X8D;P^JN^U=K_>UDJ*<#XS/BPG^=NH^
MNH]5G%@J3'5Q5`)#7-PY`PVG;6TMP:Z.#?IG?,6N(<S7IS"FK125D\!$%(*A
MH&2^&5I!&G+((XIQ=(F5L;P1J"2".2C[:)*25P(<'@8\2-Y82.AQQ06**BJ:
M:G+JJ.&EB>0,U4H;J>PST5;JC<KA.8+3*R&#@ZJ?%J[_`(`_<_12K&1U)8^2
M#Q).3Y7EY'UX*9H*1L(+N)(0<:2C--;8XI'F25K0PN/$]45+6Q4^"<9!3Z4;
MQ:QO$:E1US)<!&-<:GR02.QC(7LJYC$WQ6RAN_SQN\%:.BKNQ+"VURO(P9)W
M'(''``5C\T"=?)*CB@#J@,E"3*$`>8"`<H2X0&OHD/FA'H@74>BR;:FC_<]_
MGB:-VEJOCPG_`&D_,/K]UI5WNUMLMODN%UK8J2DC'O22NP/(#B3V&JSNDN<W
MM%L]UNU)3/CH:6I#+<Q[,22-8WXKCW<7#`Y;O5`EMKHW`LE.O=/(,5`(C@R!
MS*JK(9&G>8X@J;M]U=$P1398X:9P@GH&R0-),+<<3GBGK)P&[SAC70!1M-<1
M*7!NZ\)RW><0YVIY('#9,`N/S'BF<5-/7U7X>'YWG5Q_*.OD$]HZ2>KE\*)N
M<\3R;W*MMNM\-!#N1C>>[YY"-7?V09'M[>*WV=;6VFZ4OBS62O@%/5TA=D%T
M>`'LZ/W2#WQJM+LMWM]\ML-RM=2RHI91[KF\0>8<.1',%99^TJTFU6$;V@J)
MB6]?=;JL=V6VHO6REP_&6>I+6.QXU/)[T4P')P^Q&H1'L1+S[E9_LQ[5-E+Y
M'%'/6"UUS@-Z"K]UN]T;)\I'G@]E?F2,DC$D;VO8>#VG(/J$4N.NJ$80@7''
M`)ZJ"O&UFS%ER+K?J"F>/R.F!?\`]1D_HO*FT.V>UFT3S^]+U4&(Z>!`[PH@
M/^+<9]<JM>"UN<`9//"L2O35U]M^Q=$'"C%?<'@Z>#!X;3_]/(^RH5Z]OMZF
MWF6:S4E&W@)*AYF>.^-&_=8S,=2&_5<4A4UM#M'?MJ:YM3>;A+62C2-IT9'G
MDUHT'HO5_LFM3K3L!9J5XQ(Z,SN\WN+OL0O._LAV8.T>T,C'M+HJ6FDG=I^;
M&ZP?]B#Z+US24[*:FAIXQAD3&L:.@`P/LFBJW[9DR2R5M`W)<2Z2$<SS+?\`
MQ0E/01R\L%:8%7=I39[8UMRK;C3T!E?N?&)#978SIC7>\@5%1$-"(0"3IA2M
MNMDU:ULC/AP$_P`1PU</Y1S\^'FNFSS;;?(C6P7&&MI(W[GAPM(;O`9]XG4\
M1IH/-6H::#@@XTM-#2Q"*%FZT<>I/4KLE32Y5;*.CEG<X-W6DY/+N@\]?M!7
MB.MVEH[9$\%M#"0_7\[CD_H`%DQX<L*3VCN,EWOM=<"<MFE<6DZ^[G3]%&/)
MYX0,JD>\TM)!X*0LVTE_L,GB6BYU-*>.[&\AI\V\#]$RF((`W>!"^=SA@*LM
M/M'MOVII1NW&@H+BT?FP87_5NGZ(69-;H=4(=(.O)-YI"XB&,X)XE"$#-[2T
MD8QCBEB8Y[@!P'%"%1Z&_9II`*B^U.!@0Q1_5Q/]%NY"$++3Y/0+S?[2[@[:
MG;Z:UR5H@HJ',4!DW@QI&CCAH)+G.T]!R0A`]]E>T4FS>U\%A,T=3;Z]WA.?
M$PC#\X:[4`Z'(\BO1R$(!9/[;KU-2;./IH'%KZN00`CDW&7?4#'JA"#S?'O:
CXP>R)?=T(&4(0<'#(()&HZ+Z;'J.B$(C[8PGN3W0A"*__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g733421.jpg
<DESCRIPTION>G733421.JPG
<TEXT>
begin 644 g733421.jpg
M_]C_X``02D9)1@`!`0$!KP&O``#__@`V1$E32S$S,CI;,#9#2$DQ+C`V0TA)
M,3$Q,2Y/5510551=,3$Q,5]015)&7T-(05)4+D504__;`$,`!P4&!@8%!P8&
M!@@(!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE,B4H+"TO,"\=
M(S0X-"XW*BXO+O_;`$,!"`@("PH+%@P,%BX>&AXN+BXN+BXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+O_``!$(`<T"G@,!
M(@`"$0$#$0'_Q``<``$``P$!`0$!````````````!08'!`$#`@C_Q`!8$```
M!0,!!`4&"0D%!08%!0$``0(#!`4&$0<2(3&4$Q=15M(4%18B0=$R55=A<8&1
MDJ$V0D94=7:3P<,C,U)BL0@D-4-R)3=SHK*S-%."X>(G8V=T\/'_Q``8`0$!
M`0$!`````````````````P(!!/_$`"T1`0`"`0$%!P,%`0`````````!`@,1
M!!(4(3(3,3-1<9&A(F'105.!L>'!_]H`#`,!``(1`Q$`/P#^D0``````````
M`````````!XHR2DU*,B(MYF?L'HX*]$>GT2HPHZR0](C.M-J/\U2D&1']I@,
MQ1J)>-SRY[FGUL1)M(A+-HYT]\VRDK+B39$9?SXEG&<#I9U>@HT^1=$ZE2&J
M@J2<%-,29FMV219V4F9?!P9'G&[AO/C2M.]1:;85CG:M9I%08N2`X\A$(HRC
M.2M2C-)DHMV,F19["R6=P[=1/2M^DV#>]>H9*72IQRJC`B(49LH4I!H,TJ,S
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MTXM)9,O6,\%[5=I&8ZH,^Y+6U!O>3<+,%N=+MXY:3IB5]`:VTDELD[6_.XRP
M`LM(U$ONXX]8J5N6O2I%+@RGF$N/3%(6X2-^<<-Y&7VC]R=8'5Z<4>Z(-(;.
MHU&>4!,-UPS3MY/)DHBR9;B^T4&+8<J#H6Y7D7%<,64Y%5)53V9&S'7MK(L*
M;(LGE.,Y/\!-NQ$U.OZ/6]'@(CQ6(B:K(:::-*$JV27O^E2%<=_K`+M5+XNB
M?>52M.SJ33'Y-*:0N6_49"D)4I1$>RA*=Y\2WG^&[/R>U3DTJS_.=PVQ-AUY
M4PX#%+(CS*=+&%-J,MZ#SQ(CW[BSDLT2Z:K8U8J=2=OBFU*V+PBN*:9=I_2F
MN2DBPA25$G95GAO(MV-_9Q3&[OB6_IM>ESP:A/;H\MY4M*T&I]#*EI-MQ9'O
MSA)[S[$Y/>`O,O46^+7=ILV^+4@Q*+.?2P;T.2:W(RE;RVR,S(]Q'PQP/?[!
M(7AJHFW-1Z7:RH33D!]+/E4LUF1L*<49)^;'P3//:*G>MP-:NRJ-:=HQI<BG
M(F(E5*H.L*;;90G);.5%QP9G\YX(L[\>,VVN^ZGJQ(4VK;<6W!IZU)P1+8+*
M<'\YH1O^<P&G>EDIW4_T-C0FEQF:;Y;)DFH]I"C5A*2+A[4_:/AJ'??HL[3J
M33*8Y5KAJ:C3#@H5LY(N*U'[$E_(^!$9BD:`.5.O5>YKNK3*VYCR8T$B4DR_
MNVR)7'MPDS^?(_6H;[MIZPT.^*G#DOT#R!4-<AELW/)5^OO,B_ZB^DC/&<8`
M2\'4"ZZ/=-'H-^6_"A-UA1MQ)<%\UH)S<6RHC,_:9%Q]I<1Y/OZ\9MZUVW;0
MMF#4FJ0;:7GGY71'M*3G&_=QVB^H0$JJ'JGJ);<NBQ)*;8MUTYC]0?:-M+KF
MXR2G.\_@)+''B>-Q9XM++&A7I&K]V5IZJ1WZC57E-E&E+8RWG)9(N.]1EO[`
M&SVC*N.72U/713(U.G=*HDL1WNE3L8+!FKM,\[OH''J!>4"RJ'YRELN27W7"
M9BQ&OAR'3X)+L+M/_4\$+!3H;-/@1H,?;Z&.TEI!K4:E&22P63/>9[N(RC7:
M).8FV==35/>GTZAU#IIC+*=I1),T&2L?-L&6>TR`>.Z@W[09-*EWA9\2-1J@
M^E@UQ'S<>C&KAMEDR/!9R6[@?`]PM-,O*54=4*M9[$-GR*F0T//2ML]KI%;.
M$XX?G?@(*!J@NZKFI='L>GKF1#5MU.=*CK;1&:W;BWEZY[RW[LXX[\5&W[LI
MMAZC7\[>#$R-)J,Q+D-Q,93A/,D:]DDF7S&GYOL`7B7J.\Q=-XTU,)@Z=;E-
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M[<HCCJ0B*RV19VE'NW&1<-VX_F`7J+J)5GZU8E&.DQTR[@B'-E$2U?[NW@U%
ML]NXCXC2*A-C4Z!(GS7DLQH[:G77%<$I(LF8_GV7<E&M[7*;.JC<WS?2*8BG
M0^@C*<PK93GAPQM+(=]]7-,U33`LVR6W4,R25(J#TUM;"$MH/U4*,B,\*/?N
M_P`OS@+3IUJ54KPFUV*JAIBNQHR9=/:4X9*D-KVM@U9W%GU-_#UA"KU%U*1=
M35J'9E*.KN1O*2:*?DB;W[S5G!<.&>P<EJL7+0]<(C5PQZ8TNHT4V&RI1.>3
MI0W\`O7WD9$WC[!+V&T[5]:[ZN!Q"NBA-MTYA2DF1>PE8^ML_M`=#NHER1[@
M3;LFAPDU)FB/5*:A#REDTXDEFALC+B1X;R?^8\#L1J<VUI&Q?<R*VF5(2I#,
M1"CPX_MJ0E!'QQZN3^8C$/I]$57]3M1Z[(0KH<II;!J3N-!$:58S[/[-/VBA
MZ,4:I7//HU)J<13="M-UZ0I+B3Q(DK<,T9(RW[.,_5_F`:!-U#O;TBIUKTRU
MX$JMN4Q,Z8RN2;:6%*,_4R?81IS\YBYV=4+XFR9*;KM^#2V$((V51Y73&XK.
M\CP>XB(8)4*C:\[5*\:G=CE=;;)],:$JFI<3M);]1633[/4+'TC=M+4T$[8Z
M>W5514%Z0M1*J2EJ=-182?PM^-W^H"W2WVXL5Z2\K9::0IQ9]A$63_T&.6U?
MVIUT4ANLT6R:6[`=4LFUN3]@U;)F1[C/M(7/6"HN4S3:X7V=HW7(IQT$DC,\
MN&2-V/F49_4*UIYI91J?0[>J4B15"G-,LR7&O+5I9)PR)9D:.&,GP`)6I-;9
MJMTTU-(AK=M^C)FR#2XHR.1L(4ILL?FEE6__`"COJFI90-,J5=GD2':G5$-(
MBP$J/^T>6>#27MP6#/[.T5?2Z`[7J3J77GVC)5<E2&&]M.#-LD*V<9]G]H1?
M4*_H;2ZA=,VB3:O%4U1[3CJ:BM.$>'92UJ4:\'_A29?09)`7-S4"^I=U3;8H
M5KTV=-IL9ER<:I9MH0ZM"34E)F>\B-6/GP9B]6;-NZ:U+5=E$ATM:5))A$:3
MTVV6#VC,\[O9^(_FZAU&SYM?NBLW:Y<34J=45KCE3B=01LY/9R:>/'&_A@;=
M3*-4*E:%$585U3J'`_M737.AE*>?)2MVUTAY3@R/'S&0"2U`O"9:$^WG5PF7
M://F%$ER%*,E1S5\%1>PRQM<>P<+U_R9E]2K>H4%F13J2T;M9J+JC)+&,F:$
M8XJW&6_VY_PF([6.*]%T8G1*Q*55:BA#*2DDR3:G7ND3A9)3N3[=Q>P1\^E,
MV+H%.:AL*14)<!/E*B(S<=D/$E*C/V[MHR+L(@'YMB_]3;II+=9HMDTMV`ZM
M:6UN3]@SV3P>XS[1<;DN^=;%CL5:L4]HJ_(V&6:<PYMDY)6>$MI/V]IF78?S
M#$+++39-+HU.E/7<546EM#K;"GFVNF499(B(\$6T8M<WTOO_`%"57[99IATB
MV7CCP2JQNI9>>QZ[I$@LF9'C!YX$D!>K8O\`75-,YMXSH;4>1";DF]&0LS22
MVLX3D^WU?M%27J7J"Q9C=ZO6C2548T)=4:9RB<V#5LYV3+M^GB,]7,J](TRO
MVU9+'_:*JZAG982HT'TBLJ)&=^S_`&)_49"PZB6*NUZ':B4URMU6.=1BQ7J9
M->-V)L8R9$A)$1$1ECZ#`;W`JBZG;<>LT^,:URH:9+#"U$DS-2-I*3/@7$BR
M,F7J-J4BZFK4.S*4=7<C>4DT4_)$WOWFK."X<,]@VII"&FDM-(2AM!;*4I+!
M)(MQ$1#(;#:=J^M=]5]Q"NAA-MTY@U),B]A*Q];9_:`Z)FHEU+J$2U*/;,69
M=Q,]/46_*/\`=8!&>XE+_./9-)\?:1%D]P[+6OZNRK@J=H7'06(=R1HARHR8
M[^TS*3C<1&?`]Y>WMX8%/@UV-IMJI>4FZXLIJ%6EH?AU!#"G$&DC,]C<1G^=
MCYMGYR$MI\W/O'4ZI:BN4^1"HS4,H--\H1L+?+VKQV?"^\1;\&`^*]1M2D74
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M873(;R:CQ\'<9X(MXV'6I_S?H[YNIC<@_+"C0F$KRIW9/!X5[<[*<'GM`<U,
MU&OARUWKNJ=K4Z+0DP7)3;R99FMQ1$9-IV>);2L%G'`6A=[2XFDY7Q/@LMRC
M@E**,E1[!J4>&TY/?ORG[17]6J%4HNB)T*CQG'U1&(K3K;*<J-MLT[1D1<=Y
M$9_-D5"[+KI^H%I4:P++CSGI,A<=N41QU(1%9;(L[2CW;C(N&[<?S`+;.U(N
M8WK.I5+H$%^M5Z`<U;+SZD(93C:3O^@E<>P2%M7_`%Q=[OV?=M#BT^64(YC;
MT60;J#07'.?K^SAOR*>5LG=>LU8CM5*JTR#0*8S#CR*>YT3A'LD6R2C(]WK+
MSCL$324.6W'U>><7)J$V$VF+&J,PE.25DX2D;)K/B1'LGN[,\,`-`THU3*]W
MZQ'FPFX+D-)/L[*C/I6,F1JW^TC(L_2+)IC=,R\K837I4)N*EZ0ZAA#:C/:;
M2K9)1Y]N2/[!B=W4&I698MGW-1XZO*RI*Z9/0E)YV7VU+(SQO]5:E?7LC<],
MJ4=%L"WZ:I)I<;A-J<(RQA:BVU?BHP%I````````````````````````````
M`````>&E)F1F19+VCT``>$E*>!$7T#T````````````>&E)GDR+(]P``/"2E
M/`B+Z!Z```&1'N,@`!X1$18(L$/0`````>$E*>!$7T`:4GQ(C^D>@`````\)
M*2X$1?0/0`````````````````````````````````````!X:25N,B/Z1Z18
M````````````````'A)27`B+Z!Z````````````````````````8#,Z]'K%,
MHKM<GW!/9N-U]10H3#^U'<<-9]%'2SC"R-."49EM?"5DL;I9F+*NBHUE]RLU
M*#'A2E0HK4%_HB2:$IVG%;O7,U*,B)64X26[>8CZ5!NV+4':M4;:@5"KN*61
M2UU7!,MF>YMI!M&3:<8SC>H]YF8DU1;DH53JBJ+38E1AU)_RI!.RN@.*\:4I
M62O5/:09I)62WD9J+'`P$70YU4NYV)`FU"3$;B02=F*@N&RN0^;SK)>L6]*"
MZ!:L),LFHM^"P=CM&1*0[6*-,ENS%TR633<AW'2+:6VAQ&T9<5%MFG/MV2,]
M^1"0;=KEL*@3J4AJJ.^1>2U!A;O0FZOI%.DZA1D9?#<<]4_8KCDL'8+5ITZ*
MFHU"JI914*E)\H=:96:T,I)"4(;)1D6UA*"R>"WF8"?``/@`J-0U'L>FSI$"
M=<L%B5'6;;K2U'E"BXD>X<W6II[WLIWWS]PI.F]!H=9OK4I57H\">IJKD39R
MHZ731DUYQM$>.!#2?0:R^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@U
ME]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@
MUX0]!K+[I43D&O"`C.M33WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R
M^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:
M\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@UX0]!K+[I43D&O"`C.M3
M3WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R^Z5$Y!KP@(SK4T][V4[[
MY^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N#K4T
M][V4[[Y^X2?H-9?=*B<@UX0]!K+[I43D&O"`C.M33WO93OOG[@ZU-/>]E.^^
M?N$GZ#67W2HG(->$/0:R^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@U
ME]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@
MUX0]!K+[I43D&O"`C.M33WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R
M^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:
M\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@UX0]!K+[I43D&O"`C.M3
M3WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R^Z5$Y!KP@(SK4T][V4[[
MY^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N#K4T
M][V4[[Y^X2?H-9?=*B<@UX0]!K+[I43D&O"`C.M33WO93OOG[@ZU-/>]E.^^
M?N$GZ#67W2HG(->$/0:R^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@U
ME]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@
MUX0]!K+[I43D&O"`C.M33WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R
M^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:
M\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@UX0]!K+[I43D&O"`C.M3
M3WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R^Z5$Y!KP@(SK4T][V4[[
MY^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N#K4T
M][V4[[Y^X2?H-9?=*B<@UX0]!K+[I43D&O"`C.M33WO93OOG[@ZU-/>]E.^^
M?N$GZ#67W2HG(->$/0:R^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@U
ME]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@
MUX0]!K+[I43D&O"`C.M33WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R
M^Z5$Y!KP@(SK4T][V4[[Y^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:
M\(",ZU-/>]E.^^?N#K4T][V4[[Y^X2?H-9?=*B<@UX0]!K+[I43D&O"`C.M3
M3WO93OOG[@ZU-/>]E.^^?N$GZ#67W2HG(->$/0:R^Z5$Y!KP@(SK4T][V4[[
MY^X.M33WO93OOG[A)^@UE]TJ)R#7A#T&LONE1.0:\(",ZU-/>]E.^^?N%AMZ
MXJ)<D9V50ZDQ.8:7T:ULF9DE6"/'V&0X?0:RRW^B5$Y!KPBB:`--,,WHPRVE
MMINX9"$(06$I21$1$1>PB(!KX`````````````````?``/@`R72'\N-3OVNG
M^H-:&2Z0_EQJ=^UT_P!0:T``````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````!C(]!OTX_>.3_(:X8R/0;]./WCD_R`:X````````````
M`````'P`#X`,ETA_+C4[]KI_J#6ADND/Y<:G?M=/]0:T````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````!C(]!OTX_>.3_(:X8R/0;]
M./WCD_R`:X`````````````````'P`#X`,ETA_+C4[]KI_J#6ADND/Y<:G?M
M=/\`4&M`````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``8R/0;]./WCD_R&N&,CT&_3C]XY/\@&N```````````/PIUI+J&E.()Q>32
M@U%E6.."]N,CEFU6F07":FU&)&<46T27GDH,R[<&8#M`<4BJTR+"3/DU&(S#
M7C9D./)2V>>&%&>-XZ6'FI#*'V'4.M++:0M"B4E1=I&7$!]`/@`'P`9+I#^7
M&IW[73_4&M#)=(?RXU._:Z?Z@UH`````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````#&1Z#?IQ^\<G^0UPQD>@WZ<?O')_D`UP```````
M``%)FT]$74FARRDRW5R(D[*'GU+0@LLGA"3W)X^SYNP<M2H=<F7)6:E'IU`D
MMGT+3'G-)NFM*$9-);/]WZRU;SR?#U1;Y5+9DUF!55.+)V&T\VA!8V5$YL9S
M]&P7VF(F=;,M52ES*1<$NEHG*)4MEIIMQ*EDDD](C;(]A9I(B,]Y'@CQG>`@
M[;?I]R7&Q)=@-M,PJ2T<:$XE)IC.K>>;>V2QC)&R2<E[.S(F+.;:AU2YZ7%;
M)N%&J"5,M)W);Z1AMQ:4EP(MM2E8_P`QCQVS6(R*>N@SWZ7,@L'&0\E*7NE:
M,]HTN)7\(]KUMK<>3,\[S(Y>WZ.W1HCK7E+TJ3(>5(DR7L;;SJL949)(B(L$
M1$1%@B(B`2H'P`#X`,ETA_+C4[]KI_J#6ADND/Y<:G?M=/\`4&M`````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````8R/0;]./WCD_R&
MN&,CT&_3C]XY/\@&N`````````````````!\``^`#)=(?RXU._:Z?Z@UH9+I
M#^7&IW[73_4&M```````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````8R/0;]./WCD_R&N&,CT&_3C]XY/\@&N`````````````````!\``
M^`#)=(?RXU._:Z?Z@UH9+I#^7&IW[73_`%!K0``````````````````````\
MR6<>T>@`````````````````````````````````````````````````````
M`````````````````````````````````````!C(]!OTX_>.3_(:X8R/0;].
M/WCD_P`@&N```,HUEDME6;-@5:J/TVVI4M[S@^V[T1&I*"4TA2O81GG_`/Q;
MJ%4JM7:C1+BU68NBH1$1*D35&A$[LQWV$K))I4WP5M9/ZR/.?9IVKE:G16J)
M;]+H--K$^M25--LU)!+822$[1FI.[)[_`*L&*!)N2#5WX$.K:45&=4K9<4T[
M'IJ<Q8KIJ+&RE.Y1&2241&6"^?B`_H&.X;K#3JD[)K22C3V9+@/H/$GDB/&,
MCT````````#X`!\`&2Z0_EQJ=^UT_P!0:T,ETA_+C4[]KI_J#6@`````````
M>*4E"34HR))<3,]Q`/0%8JU\VS2]I+U3;>=3_P`N/_:G^&XOK,5A>H=8JRS:
MM>VGW_83SQ&9%]2=Q?6H7ILV2T:Z<OOR0OM.*LZ:ZS]N;3A$U6XJ)2"/SA4X
M[*B_,->5_=+)_@**5N:@5[?6JZFGQU<66#WX^A&"^U1B6I6F5N0S)R6EZ>[Q
M,WUX29_]*<?CD:[+%3KOKZ?ECM<U^BFGK^'#-U0AN.^34*DS*B^>XO5V2S]!
M95^!#G__`%.N`^+-$C*_^E6/Q5_H-'A08<!HF845F.V7YK2"27X#I#MZ5\.G
MOS_P[#)?Q+^W+_65NV!<E.Q5*3<CK]6+>OI#-).%V9,SS]"MWT#KH^H;L.45
M+N^`Y`EIW=.2#V#^<T^POG+)?0-)$?5Z/3:S&.-4HC<AOV;1;TGVD9;R/Z!W
MB(ORS1K]XY2YPTTYX9T^T\XEUQI#$MA$B,\V\RLLI6VHE)47S&0^HRR3:%R6
MJ^N=9\]<B,9[2X3ID9G]7!7X'](E[=U%ITUWR&M-*I502>RI+N2;-79D]Z3^
M97VF.6V>9C>QSO1\^S5=IB)W<L;L_'NO@#Q*B41&DR,CWD9>T>CS/2``````
M`````````````````````````````````````````````````.&95J9!(_+*
MC%CX_P#FO)3_`*F.Q$SW.3,1WNX!49NH=IQ2/_M+IU%[&&U+_'&/Q$&]JI$>
M7T=)H<^8KV9PG\$[1BU=ES6[JRA;:L->^T-*`9CZ1ZBU+=3K8;BH/@M])Y+[
MQI_T'GI%J'13S5[>1.9+>;D=.\B^E&?Q(:X6_=K&OEK#/%T[])T\]):>`H%-
MU1H$A1-3VI4!W\XG$;:2^M._[2%OIM9I5422J?4(TGYFW",R^KB)WPY*=4:*
MTSX\G3;5(``"2H`````````````&,CT&_3C]XY/\AKAC(]!OTX_>.3_(!K@`
M`"AZDVG7;ADT*IVY6(]-J=(===:6^STB5&M))^?&XC]A\10Z8C5FR:E6*G+H
M%&K3=2?3(DNQI:6#VDI).4DK&-Q9/U3WBZZOT"[ZY289VC5GXCT9Q2I$9F2<
M=4I!D7JDLMQ&6#QG=O&(T*B6C6M1Z11:XU767#CN^6Q*[+/I"D$9;!)66SM$
M?LQC/8`_K!)Y21XQDAZ!$1$1%P(``!"^DM'5<3-NLS&WZBMMUU3;2TJZ(D&D
MCV\'ZIY41$7S'V#GJ5SHB3Y,*'2*G5'(B25*.$V@R8R622>TI.TK&_93D\&6
M[>60L0"NR;J@DU3SID>35GJ@SY1'9ADG:-K=EQ1K4E*$[R+UC(\G@BXB0H=7
MC5J&J3';>:4VXIEYA].RXRXD]Z%%D]_`]QF1D9&1F1@)(#X`!\`&2Z0_EQJ=
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M5@OL(QZFP*]6%$Y<]S/.)XFRR9J+\<)+[HT\`XF:^'6*_P!^\G"Q;Q+3;^O:
M%5I-AVQ2]E3=.1(=3P<DGTA_8>XOJ(6A"$-H)"$I2DBP22+!$/T`A>]KSK:=
M5Z8ZTC2L:```RV```````(*XK7H]PM;-0BETQ%A+[?JN)^OVE\QY(3H#5;36
M=:SI+-JUM&EHUAE"J=>=C*-RENG5Z,G>;"B,U(+_`*>*?I3DOF%KMB^J+7]A
MDG/))Q\8[QD1F?\`E5P5_K\PM@J=SV+1:_MO&WY)./>4ADB(S/\`S%P5_K\X
M]':X\OBQI/G'_8>;L<F+PIUCRG_DK8`R=-2O.QE$W56CJ]'2>"?(S-2"_P"K
MB7T*R7SB^6[=%&N!K:I\HC>(LJ8<]5Q/U>WZ2R0QDP6I&]'./.%,>T5O.[/*
M?*4X``(+@``````````````````````````````#AJ-7IE-3M5"?&C%_^ZX2
M3/ZN(K4W4FU(N=F:Y(,O8PRH_P`3P0I3%>_3$RG?-CIU6B%S`9FO5`Y2C11K
M<G2S]AG[DDH?GSUJ;4MT.@,04'^<\DB,OOJ_D*\)DCJTCUF$>+QSTZSZ1+3A
M\WGV6$;;[J&D%^<M1)+\1FOHUJ'4M]1NE$5)\4,*/=]TD_ZCZLZ5PG5])5:U
M/F*]O!.?K/:,.QQ1U7]HU.VRVZ<?O,0M,V\;8A&9/UJ(:B_-;7TA_8G(KTS5
M2W6C-,5F;*7["2V2"/[QD?X"4A:>VG$(O^S"?47M?<4O\,X_`6"'2Z;!(BAP
M(L?'_P`II*?]"#79Z]T3/P:;3;OF(^6?>GMRU#_@MGR%)/@M[;,OP(B_$,:J
MU+B<*FH5_P!!&7_J,:<`<16.FD?SS.'M/5>?XY,R]`;CJ'_&;PD+(^*&MLR_
M$R+\!VP]*[<9,E27)DI?MVW"21_=(C_$:``Y.UY>Z)T].3L;)A[YC7UYJ_"L
M^V81D;%%B9+\YQ'2']JLB<99:902&6D-I+\U"2(OP'T`1M>UNJ=5ZTK7IC0`
M`&6D?4J-2JHDTU"G1I.?:XV1F7U\13ZEI=0)"C=@/2H#OL-M>VDOJ5O_`!&@
M`*TS9*=,Z)7P8\G575E_H]J'1-])KZ*@RG@T^>_'T+S^"B'I7[<=(42+DM=U
M""W&\P1I+Z=^4G]HT\>&1&1D9;C]@IQ$6\2L3\3\)<--?#O,?,?*GTO46UI^
MR2IQQ%G^;)1L%]XLI_$6N-)CRFR=BOM/-GP6VLE$?UD(:J6A;E4RJ728_2'_
M`,QM/1J^U.!5).F#49PWZ!7)D!TMY$9Y+[4X/_4-W!;NF:^O,WMHIWQ%O3DT
MH!E^SJA0N"H]9CI[<*4?_I5_J/K'U/3$<)BX:%,@N\#-)9+/T*P?V9#A;ST3
M%O23BZ1RO$U]8:6`KU+O&VZILIBU9@G#_P"6Z?1J^Q6,_4)\G$&1'M)P?#?Q
M$+4M6=+1H]%;UM&M9U?H!QE4Z<<E44I\4Y"<[31/)VRP63W9SN$0W>UI/,3G
MX]Q4Y]N"UTTE3#Y.=$C_`!'LYW;QEI8S&1Z#?IQ^\<G^0LK^J%DMT%ZOMU@G
MZ<S(3'<<99<4:7%%DB,L9X%QX"I?[.TMJ?!N^='VNADUUYYO:+![*DD99+V;
MC`;(```AZ[<E"M]<5%;JD:!Y4:DLJD+V$J-.,[SW%Q+B,WUV<M^I:=2:S':I
MM3>CNLI8DH42S;)3A$>RM!Y+CVX^8QI-P4"@W`RW%KM,B3D),U-ID-DHTG[3
M3[2]G`8UJGICIY;=N2;@;I=0CI;=:0IJ%,-.=I9)SAPE%NSG&[Z@&]-?W:/H
M(?H?EO&PG'#!#]`*K5TI*_+;V4D1G$GF>"X_W`^5H/LQY]V19+J&Y#%47(=)
M:B+#2VT*0L\_F[)8SP]0R]@M2X\=R0U)6RVI]HE);<-)&I!*QM$1^S."S]!"
M.J]N4&LOM2*M1X4UUHME"WV4K,BSG&_V9WXX`*%IJZVQ5XY/H-KSC22>@[98
MVVRER%F2?H0\R>.PR%IM):9%;NR6PHE15U%#:%$>Y2T1VD.8^A1&D_G2?8)F
MJT6DUB*B)4Z=&EL-J)2$.MDHD&18R78>-VX=,&'$I\1J'!C,QHS1;+;+*"0A
M!=A$6X@'0!\``^`#^8X\2\9-VZBG:S+\A*:L?3L,RDL*5O7C>>,^W=D5.3/O
M"@3U.UZS.A9SO<FQGW&R^<U(4DE?:-NTA_+C4[]KI_J#6<%PQN%J[1DK7=K.
MD(VV?':V]:-9?SO;FHU06EF/2+CTZ@F[@B:<A2XYD?89G@L_68O\:1JM+VCB
MU6PG]D\*Z)$A6/IPH6JKV9:E9;<14[=ILCI/A+5'22_O$1*(_G(Q1Y>AUJ-O
MM3+>EU6@3FE;27X4I1G_`.;)_89"4S,\Y5B(CE"6Z/6+];LG^!*\0='K%^MV
M3_`E>(5UVS-5Z`X^JV+[35(ZT8)FM$:UH/M2HR46?L+YAR^G.KMNQ'$W#IX5
M46E9&F13G/5V/;E*-O?\^[Z!QU;.CUB_6[)_@2O$'1ZQ?K=D_P`"5XA7X6O5
MK]"UYWIE7ITG>4AM48UICGG=E6XSS[-WL,7JGW]9E0E,1(ES4QR2^E!MM>4)
M)2MK@1%_B_R\<@(7H]8OUNR?X$KQ!T>L7ZW9/\"5XAH)*(^!Y'H#/>CUB_6[
M)_@2O$'1ZQ?K=D_P)7B&A``SWH]8OUNR?X$KQ!T>L7ZW9/\``E>(:$`#/>CU
MB_6[)_@2O$'1ZQ?K=D_P)7B&A``SWH]8OUNR?X$KQ!T>L7ZW9/\``E>(:$`#
M/>CUB_6[)_@2O$'1ZQ?K=D_P)7B&A``SQ3.L*B-*I-D&1E@R-B5O_P#,*J_I
MU?$JJ(GK>M>"HCR9TTI#)DK_`!%G)$?T8&V@*8\M\<ZUG1/)BIDC2T:L4K-U
M:CVPVU"EM4]2B5LIES&%N(<+_J0HLF7T9$U2*GJA6(WE--JUBR&O;LLRLI^8
MR-62/Z1IDJ,Q+87'DLMO,K+"D.))25%\Y&,[J^GCT*4=4L^>Y`EIW]`:SV%?
M,2O87S'DOH%M<67O^F?C_$-,V'N^J/G_`%]^CUB_6[)_@2O$'1ZQ?K=D_P`"
M5XAS4K4"7392:7>5/<AR"W%)0CU5%VFDO9\Z<E\Q#1(<N--CHDQ)#;[*RREQ
MM1*2?UD)9,-\?5'X6Q9J9.F>?E^JB='K%^MV3_`E>(.CUB_6[)_@2O$-"`25
M9[T>L7ZW9/\``E>(.CUB_6[)_@2O$-"`!GO1ZQ?K=D_P)7B#H]8OUNR?X$KQ
M#0@`9[T>L7ZW9/\``E>(.CUB_6[)_@2O$-"`!GO1ZQ?K=D_P)7B#H]8OUNR?
MX$KQ#0APU&JTVF-])4)T>,G&?[5PDF?T%Q,=B)F=(<F8B-94OH]8OUNR?X$K
MQ!T>L7ZW9/\``E>(?NIZH4",HVH#<FH/?FDVC82?UJW_`&$8CO/VHM=_X51$
M4UA7!U]._'TK_DD7C9<FFMN4??D\\[7CUTKSG[<W8I.KZ$FI<VR$I+>9FS*(
MB_\`,*Y5+SOJFFI+]P6(XXG\R/'E.G_Y58+ZS$RC3RL551.7/<TA_P!ILLF9
MD7UJW%]219*58=L4W94W34/N)_/DGTA_8>XOL'=S!7JM,^GYES?SWZ:Q'K^(
M9O1;_P!1JD[LM4ZERR(^$2$\9?6HUX(3SU)U.KC2U2JG'IJ#+<RASH\_,>P1
MG^(U)MMMI!-MH2A!;B2DL$7U#]!Q%:^'2(]><G#VMXEYGTY0P=&E][HEG(5(
MMF27^&2J2K/TFG9,Q.0[3O\`A8\FI^GB%%^<<.2I7VFHS&N`)WSY+]5I4IL^
M*G36&=H8U@0DDHD60E)<"*/*(O\`U#]=%K%^M63_``)7B&A`)+,]Z/6+]:LG
M^!*\0='K%^MV3_`E>(:$`#/>CUB_6[)_@2O$'1ZQ?K=D_P`"5XAH0`,]Z/6+
M];LG^!*\0='K%^MV3_`E>(:"9D7$\",](*$=0534UF`J>DE&<5,A)NELEE7J
M$>=Q$>=P"H]'K%^MV3_`E>(.CUB_6[)_@2O$/M'U4LZ=%JLBDSGJEYLC>4OH
MC1U;1HSCU=HDYWF.5O4.JU2V7JQ;MD5>5(1+3'*'+(HZU(-.>E(]Y&DCP0#Z
M='K%^MV3_`E>(.CUB_6[)_@2O$/C5)FJ]0HM(=HM*HU+GOI=\O:G.&X<<R5A
M&R:3,CRG>>X]XZI]MWS/N"GU`KU\WT]E#"GX$>,2TNN)QTA;1X/94>>/;P`?
M(T:PEQEV21?^!*\0X5534M,MN&JOZ>%*</90R9O[:CQG!)V\GN$S"T[@Q[O?
MNA^M5F6^XXZI$5^3M,-I<(R-!)QG!$H\;]VX?2GZ9633ZG$JL>BEY?$)HF7U
M/N*4GHTDE!_"P9D1$7#?C>`J+-W7Q(D3(T>ZM.7WX;3CK[;)25J;0CX9F1*/
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MH`#*BINM[L60RY7[59<<(B0ZW'<4IK?G*<IQ\WK$8B:A9NLE1HJZ3+O.C+);
M_2JDDVXEW&,='DD$G8]O#.?;[!M8`/Y[/22_CC1&/.UN9CH4E;AH>-<C)YVG
M#,N)<"QC<.QG26YE+8D3)5&7(C*)QA3:G3V5I,C(RVD[MY$-X`>BNU9:QIKK
M'WYO/;9<5IUTTG[<OZ?S^JW+EMRO/W,5JQ)%:6XMU51)+C_K+(R4>PAPB+)&
M?YI<1!T*KU"F/R8\2C6-2NG0;+QNTR2?2(,\FE9$M1XS[#'].#AJ-(IE31L5
M"!'DEC']JV1F7T'Q(=[7%;KI[<F>QRUZ+Z^O/Y9903O9^.;-#E::="M1+4S&
MBOIR?::2,M_U#S_9Y*042\2F&T<DJ^_TW0D9(V\%M;.=^,YQGV"R5+3"WI"N
MEA+DP'2/*3:7M)(_H5O^PR%:_P!GA@XL*\(RG#<-FO/-FL^*L$19^L3R1CCG
M2?=7';)/+)'LV,``259KK5"LQVB0ZA>%1FP4Q75%$<@N8>-Q1;R26#SN3]6.
M(QF-#B7@@[6I.I]824A23:I=Q1U%TNR>4DEPE&6<EN(B(S[!K&M#4B!4[0N]
M=/=J%+H<QQ<YAI.TI"%DDB=Q_E-.?IP*EJU>]DWG:\:%;DCSC<SDAGS<349:
M7F5[99]8TEC=DL9XX[,@/Z$06$)+L(>CYQR<)ALGC(W=DMLR[<;_`,1]````
M`````/@`'P`9+I#^7&IW[73_`%!K0R72'\N-3OVNG^H-:```````!\946-+C
MNQI3#;S#R30XVXDE)6D^)&1\2%&K6DEAU2(U&30V8"FG.D0]`(F7"/\`ZB+>
M7S'P]@OX`,=JVD=3A7"_<-CW8_1Y3VT:V7T&^A2E9VCR9GQS[2/'L$-%9U[M
M2/+;Q$N9"D$3+BGR6IHR/>>%;"E9+=@\C>P`8A3M6[NBTN0JOZ=U0ZA$4;DK
MH&5,M-QR+^\RO:,SR1Y]F-^188^M5C'"I<J;,?B%/:-PB4PI9-&2MDTJ-)'O
MSV#3%(2M)I6DE),L&1EDC(0%=LVV*]2$T>IT>.Y`2[TR66R-HDKWY46Q@R/>
M?V@.UNX*&Y4E4I-7@G4$[.8O3I)TMHB47J9SO(R,2F1EUX:04NN7`S<=+JLN
MBU9E+9(=C(2I.T@L)69'@]K&"SG@1"FP].=5K1G3)]N7+$JOE#;B%-RG7&_6
M7O-PD&9HVR/>1F?U`/Z#`?SBS=NM]H0'*C<M):J,)EY+*T.MI-TR,C/:2IG=
MLEL[U'G>9"_4#6RQJS5VZ4B7(C/.&E+;DADT-+69?!)7LP>[*B(@&H`.>%.A
MSFNFA2V)+1&:=MEPEIR7$LD8Z```````````'%5:73ZO%.)48C<AD_8LN!]I
M'Q(_G(9U,LNOVU(74+-J#BVS/*X3ID>T79OW*^O!_.-2`6QY[X^4=WE^B.7!
M3)SGO\_U4"W]18<A_P`WW!'52IZ3V5=(1DV9_7O3]>[YQ?4+2XA*T*)25%DC
M(\D9"(N"VZ/7V>CJ,1*UD6$/)]5Q'T*+_0]PH*Z->-D*4]0I"JK24GM*C++)
MI+_IX_6G[!3<Q9>CZ9\I[OXG\I;^7%UQO1YQW_S#5P%*H.HE`J3*O+'BILEL
MC-;4@\%NX[*O;]&X_F'-5-3[?C*-J"B34'>"2:1LI,_I5O\`L(QCALN]N[LJ
M<5AW=[>A?AXI24)-2C(DEO,S/<0S#T@U#KO_``BA(IS"N#KY;\?2O'X),>IT
M^KE643ES7.^\7$V63-1?C@B^Z-</%?$M$?,_#'$S;PZ3/Q'RM56O:V:7M)?J
MC3KA?\N/_:J_#<7UF*L[J3.J+ALVS;DF6K."<=(S+[$_S,A8Z58-KTW9---3
M(<3^?)/I/P/=^`M#33;+9-M-I0@MQ)26"+Z@WL%>ZLSZ_P"&YM%^JT5].?\`
M;,O-6I5=WSZHU28ZN+;)X5CZ$;_M4.ZG:749I9/527+J+Q[S-:]A)_9O_$:$
M`3M63NK],?;D[&R8]=;?5/WYHZF42DTI)%3Z=&C_`.9MLB4?TGQ,2(`//,S,
MZR]$5B(T@``''0!XI1)(S,R(BXF?L%-O#4:V+4A194R2Y+\L-:8S<%'3&\:#
M(E$1EZN2,R+>9`+F`S2XJGJ=5JBS&LZF4Z#27F&GDU.H*ROUDY-/1\4J+@9;
M)_4/HU:%[U"VI--KU^/HGNRD/)ETUGH5-MD6#:+&SDCXY_U`:(ZZTT@UNN)0
MDO:H\%^(AJG=EM4N<S3ZA7(,>:\:$MQUO%TBMH\)]7CO[15Y>E-OU6BTBE7!
M+J56\V=+T;\B29..$M6T9+,N.,$1=A"P+LBTW9466_0(3\B*RVPRZ^WTBD(;
M+U"(U9X=O$!'L:D6M)NY=HQI,AVKH6XVILF%$E*T$9FG:/!9]4\>P1M'U`K=
M>C59=,L2L,.Q8QNQBJ*>@3)<(\=&1XP1^WC[!H+4:.TXXZTPVA;A[2U)01&H
M^TS]H^H#-VY>J]6MI]2:72*%6O*T$R3[G3(\GV?6,\&KUR5\W#V#]U*T;WK=
M#I,:=?;U-GL)=*<[3&=E,G:5ZAEO2:3(MWSY&B@`H-2TQHU6K=/K=4J55D3(
M3;"4%Y1LMJ6UP<-./A&99/>)N'95K0K@>N*-18Z*NZXMQ<K>:]I1&2C+)X+.
M3X=HL8`.2#3*=3TFF!`BQ4GQ)AE+>?L(AUX`````````````````?AQUMI)K
M<6E"2WF:CP1?:.9ZITUB8Q">J$5N6^66F%O));A=J4F>3X'P`=@""3=ENK=J
MS+56CNO4EM3DUMHS6IA*<[62(L[L'N+>*2_KG8*5FB)*J$Y1>R-"6>?O8`:F
M`R?K@5*42:1I_=LS/!1P]A/''')_,+)*N.ZUQK;?IEFNN^<3(YZ'Y!-*IY93
MG)&1;1[U?=^<!=`%:9?O!5WRH[T*G(ME+!]!(2LSD*=PGX19P19VO9["%,.@
MZTS-TB]J)`2>X_)(/2&1;_\`$DO]0&KF9#)-!OTX_>.3_(?3JXO:5OJ>K%95
MGB4-DF/Q)7\AR?[.\=42#=\53[CZF:\\V;KIY6X9)(MI1^TSQDP&Q@``,]U7
MN2O4ENAT2V$QTUBN2SC,OR"VD,I(LJ5CAG>7$CW9W&*83EW::56%6;F;H57H
M\Q],:3.A0$1Y$92^"CV4IRG[<_,>!?\`46QW;P.E2(E=D4B?3'5NQY#+9+,E
M*(BX9+L[1G5XV/K!4J`_0W[BI5=I[BD*/I6R8?\`542BP>,>SVF8#>P'Y01D
MA)'Q(B'Z`````````^``?`!DND/Y<:G?M=/]0:T,ETA_+C4[]KI_J#6@````
M`````````````````5FX+$M"XMHZO;\&0XKB\3>PY]].%?B+,`#'4Z)QZ/,<
MG65=E7H#[B32I*5$\@R]A8W&99QQ,Q]4U75NSX;BZS2HEW1D&DDN4[+<C9WY
M4I.SOX%N))\>(UT`&<,:MVS&I]/?N<I-OS9J36B%,96;B4$HTDL]E.Y)F1X,
M\=N,"YT6X*'7&>FH]6ASD8R?D[R5F7TD1Y+ZQ\J];%O7"E":W1X<[8,C0IYH
MC4G!YW*XE]&1F-8T%M^5<#E9IE2FTU*S6X<6-LMI0LR/9Z-1%ZB2/!XP>X!L
MX#^>K>:U?LAV3/N>IOSK?II(<>;093')235C9:,RVR,MQF:C3@A;[4U<C5>G
MUZMU*F'3Z'!<4B')6Z723#(C/HTMGQ<V2(\$9\0&K`*U2KUMRHT.!6_.+<.'
M/6IN.<XR8-:RSE)$H^/JG]@L;;C;J$N-K2M"BR2DGDC+Z0'Z``````%>K5GV
M]6I*94Z`DWR/*G&U&V:_F5CB.ZET*CTHB*GTV-',OSD-EM'_`/5Q$F`W.2\Q
MNS/)B,5(G>B(U``!AL`````<LNH089[,F4TVO84X2#5ZZDI+*C)/$\%V$`Z@
M&;,:GQKAI5:>L:G/5693TMF@I)>3-/[2L'LJ5_A+>9'LBH7#7TUJW(D>]-1*
M?;<Y#[IRHU"D=,IYDR+90>P9FE1'GM+[=P:U6KOMJB3HU/JE:B1YLE:&VHZE
MY<,U&1)RDLF1&9\3P0KL2\Z]6;EJ5!I=I5")&C)?9\[34X9)])'L83^<@S+V
M'G!EN(5.V[GTTK%QT>/3J'4JY4FVVH3=7D0.DV$H+U5K4K&#_P`VSG>+[%K%
MVSJA<4$K:1`:B-K339TA\EMRG-^R9I+!DD]Q_;O`05/L:XZY0:G3M1KB*HIG
MJ:6EB"GH2C&@S,R2K!9(]Q&6S[!<*!;=!MJF1Z?2X+<>+%-2V]M1K-!J^$>T
MHS,L_2*Z_1+_`*S:,6'/N:-1:YY2:Y$FF,](A3._"")6#(]Y;\^P0B-%:5-4
M3ES7+<-=<SDRDS#2@_J+)E]H"YU2^[-I*MB?<U+9<S@T>4I4HOI(LF(=>KNG
M"%FA5TQ3,MWJMN&7VDD==)TQL&DFE42UJ>:BX*?1TY_:LS$QZ)VOW;I')->$
M!6^N#3?O3&_A.^$3,R^+7A/4-F14R2NN$DZ?AI:B?)1I(MY%NSM)XXXB0:MN
MWF2,F:%3&R/>9(B-EG\!V+I\!9QS7"CJ./@F3-I)]'CAL[MW`N`"(C7A;TFX
M:A;C$_:JM/:-Z2QT2RV$$23,]K&#^$G@?M%1>URTV;41%7'7",LY1#=Q^*1I
M9,,DXITFD$XHL*422R?TF/CY!!_4X_\`"3[@&<)UTTY4>$U:29_-"=\(F:AJ
M;:L&WJ7<3C\E=-J3JFF'41U&>T1F1[1'@T_!/CV"XMQ(K2MIN,R@\8RE!$/K
ML)P1;)8+V8`5]R[J2W=[5I**251=:Z5"NA/HC3LFKX?#.",5&?K5:4*0['7%
MK3KC3BFUDW!/<:3P>\S+L&H``R=&N=IN+)"*7<*E'N)*8&3/_P`PGUZCTLK1
M<NE%'K:XJ)/DQQRB8?-6[>2#5\'?QR+R&`%1FWQ"B5.WJ>NDU9:ZVVAQIQ#!
M&A@E8P3IY]4RSOXB(N#5!BC5.932L^Z9CD9S8Z6-`VFG.&]*L[RW]@T4,`,C
MZY?_`./;PY'_`.X^JM3KGD&94S2JXW>PY1=`7XI,:O@,$`RIFY]7IKR.AT\@
M0F361*5*J*5&2<[]Q&7L^87(T7?Z8$LG:4=K&UO09+\J)S9]A_!QM8^H6,`%
M*@4&\W*16X58O`E29;A'!E1(J4+AH(\XQN)6=Q?;O%</2>IRU%YVU+NJ4GVI
M:D=$1_5D_88U@`&4MZ&66HR.>]6*@KVG*G*/.['YI$+R[:=O/5.FU5ZF-.3Z
M:TEF(\M2C4T@N!%OQ[3WGO$Z`"/C46CQ94R7&I4-J3,SY2ZAA)+?SQVSQE7'
MVCJCQ8T9!(CL--)+@3:"27X#[``8```````QD>@WZ<?O')_D-<,9'H-^G'[Q
MR?Y`-<`````````````````#X`!\`&2Z0_EQJ=^UT_U!K0R72'\N-3OVNG^H
M-:```````````````````````````````!6KKLFVKK@)A5BG)<;0M3C:FE&T
MI"U<5$:<;_IR+*`#(;TTLJ=431(-)JL)5#IK+<8J;4&#66R1X6Z3A;]LR[-G
MAQ(4ENTJE1KQETB@INJTH9*=7'J")'E,%3:$FK;<2>-G)%P-2CWEN']*#Q24
MJ2:5)(TJ+!D9;C(!C>FEU7I6*K'CE7K;N6C9,Y$N/M,2F$X/!J:,DF63+'P3
M^D72EWW"D%<#E4IE1H\>B+,GI$YDT-N(RHB6CVF1[.>'M+CD?NK:?VU.I=5@
M1(94DZF2"D/TTDL.*V%;2=Y%CCQW;Q6ZI;U]6_:L6F6]+CW2:7G%2VZZ>TIY
MHR+8;3D\8+'M,M_V`-$I56IM7@1ZA3)K,J)((S:=;5DEX/!X^@R/[!W##KU?
MLV2[;=H7;2:I0I:&6UQ':2DTQX[[NXVD&DL*,CP6229;_9O'5%MN_J4X^U9F
MID:LHBK-MV!5B)U3:B_-4LMHR/[H#9P&2M7UJ32S5&KVF<B6]CU'Z2^2VUG\
MY>MLE])_4/RNXM9*JA2X%GTBA1\9Z:IR^D-)=IDDRQ]9`-<'X>>:8:4Z\XAM
MM!94M9[)$7SF8PQVZJ[:%PTN3>]^-U`Y#>VU1Z13MM#Z%Y22ND+9+!'O]IGC
M@.JE6E<YW)7;>E4MV79M1>/RR74J@;CCR-DS0;.,&C!J3N,C^#C(#1[AO>UK
M=@1JA5JRPU%E;7D[B"-TG<<=G8(\\2%&>UPHLO::MFW:]77]K81Y/%-*#5["
M,]YE]T=-GZ.TJD4YZ%7ZE(N!EUGH4QY*<,L)VMHNC+)J0>\]Y&7$]PT:CT>E
M42&4*D4^-!C$>>BCMDA)GVGCB?SF`R4JCK)==;@>3T@K2H9+0;ZG5-O.J(CR
M>2/"L'C&"(OI'92])Y/I/=%QU2JI*HU!;OFR5$4X3D$E[19P9D1GLJ(L;RW'
MCB-=`!05:8T*;:E)MJNO2ZG'IKBG&W%N=&I9GG<>QC=A6,?,0D*3IS8U),C@
MVO34K+@MUDG5%]:\F+<`#\---,MI;:;2VA/!*2P1?40_8```````````````
M`````````````````````````````````````&,CT&_3C]XY/\AKAC(]!OTX
M_>.3_(!K@```````````*+7KJEQKAE4V/6;>IC,=+2=JJ;6TZZLC49)PXG<2
M=CM^$`O0"JRJE7W:A%H5/<IZ:@F(4J=,<86MELC4:4DALED9FHTJXJW$GVY'
M?;-4F3VYT2IM,MU*GR3CR.@ST:_52M"TD>\B4E:3P><'DLGC(";`^``?`!DN
MD/Y<:G?M=/\`4&M#)=(?RXU._:Z?Z@UH````````````````````````````
M````````````!^'&FW223C:5DE1*(E%G!EO(_I%,ZM[<C7!*N:D,KIU:?:>3
MY0VLU()QPC(W#09X-1&>=V"%V`!GE!HNI%(HE;BR[F@5B83:2I+\F.:3(RSG
MI<=N[&]7;D^`YV[`J]R6UYKU$KRJ@]Y84HO-_P#8)0G9QT1F1>LCV\"/YQI8
M`(FC6]1J+#A1*=`::;A-="PHRVUH1G)D2U95C._B)8``````````````````
M````````````````````````````````````````````````QD>@WZ<?O')_
MD-<,9'H-^G'[QR?Y`-<``````````%(EU"ETRKUMFL6Z\;DU23;=CT]R250;
MZ-);)FE*B)1&1I-"L%C!\#,Q=P`9A;J9]H.P)E9A2DP9-,1%6;+:I"H2FWG5
MM-K)!&>.C>)&T1&648SO+-GLY#\B17*X[&?C-U*82X[3[9H7T2&D-I4I)[TF
MHTJ/!X/!EDB%H```^``?`!DND/Y<:G?M=/\`4&M#)=(?RXU._:Z?Z@UH````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````````#&1Z#?IQ^\
M<G^0UPQD>@WZ<?O')_D`UP`````````````````/@`'P`9+I#^7&IW[73_4&
MM#)=(?RXU._:Z?Z@UH``````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````#&1Z#?IQ^\<G^0UPQD>@WZ<?O')_D`UP````````````````
M`/@`'P`9+I#^7&IW[73_`%!K0R72'\N-3OVNG^H-:```````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````QD>@WZ<?O')_D-<,9'H-^G'[
MQR?Y`-<`````````````````#X`!\`&2Z0_EQJ=^UT_U!K0R72'\N-3OVNG^
MH-:`````````````````````````````````````````````````````````
M``````````````````````````````````````````````````````````QD
M>@WZ<?O')_D-<,9'H-^G'[QR?Y`-<``````````````%1JD8Z]=KE&E2)"*;
M!@MR%LL/K9-]QU:TIVE(,C-*2:/=G&59/."'WL]QYB16Z([)?DMTV82&''UF
MM?1+:0XE*E'O4:36HLGOP1;S`6<#X`!\`&2Z0_EQJ=^UT_U!K0PW3ZYK?M^^
MM2$5NLPJ>IZKY;*2\2-LB-><9XXR7VC1.LBPN]]'YI("W`*CUD6%WOH_-)#K
M(L+O?1^:2`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/6187>^C\TD.LBPN]]'Y
MI("W`*CUD6%WOH_-)#K(L+O?1^:2`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/
M6187>^C\TD.LBPN]]'YI("W`*CUD6%WOH_-)#K(L+O?1^:2`MP"H]9%A=[Z/
MS20ZR+"[WT?FD@+<`J/6187>^C\TD.LBPN]]'YI("W`*CUD6%WOH_-)#K(L+
MO?1^:2`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/6187>^C\TD.LBPN]]'YI("
MW`*CUD6%WOH_-)#K(L+O?1^:2`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/618
M7>^C\TD.LBPN]]'YI("W`*CUD6%WOH_-)#K(L+O?1^:2`MP"H]9%A=[Z/S20
MZR+"[WT?FD@+<`J/6187>^C\TD.LBPN]]'YI("W`*CUD6%WOH_-)#K(L+O?1
M^:2`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/6187>^C\TD.LBPN]]'YI("W`*
MCUD6%WOH_-)#K(L+O?1^:2`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/6187>^
MC\TD.LBPN]]'YI("W`*CUD6%WOH_-)#K(L+O?1^:2`MP"H]9%A=[Z/S20ZR+
M"[WT?FD@+<`J/6187>^C\TD.LBPN]]'YI("W`*CUD6%WOH_-)#K(L+O?1^:2
M`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/6187>^C\TD.LBPN]]'YI("W`*CUD
M6%WOH_-)#K(L+O?1^:2`MP"H]9%A=[Z/S20ZR+"[WT?FD@+<`J/6187>^C\T
MD.LBPN]]'YI("W`*CUD6%WOH_-)#K(L+O?1^:2`MQC(]!OTX_>.3_(6[K'L(
M_P!+Z/S2?>*;_L_/-26+SDL.)<9=N!];:TGDE),B,C(^PR`;````````````
M``K59I=7:KS5?H7DKKZHWDDF)+<4VAU!*-2%)6E*C2I)J5Q29&2CX8'1:]*F
M0&YTNINLN5*HR3D2#8ST:/52A"$F>\R2E"2R>,GD\%G`G0````%8G6%9D^8]
M-FVQ2WY+ZS6ZZY&2I2U'Q,S]ICX=6]A=T*/RJ1;@`5'JWL+NA1^52'5O87="
MC\JD6X`%1ZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ%'Y5(=6]A=T*/RJ1;@`
M5'JWL+NA1^52'5O87="C\JD6X`%1ZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ
M%'Y5(=6]A=T*/RJ1;@`5'JWL+NA1^52'5O87="C\JD6X`%1ZM["[H4?E4AU;
MV%W0H_*I%N`!4>K>PNZ%'Y5(=6]A=T*/RJ1;@`5'JWL+NA1^52'5O87="C\J
MD6X`%1ZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ%'Y5(=6]A=T*/RJ1;@`5'J
MWL+NA1^52'5O87="C\JD6X`%1ZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ%'Y
M5(=6]A=T*/RJ1;@`5'JWL+NA1^52'5O87="C\JD6X`%1ZM["[H4?E4AU;V%W
M0H_*I%N`!4>K>PNZ%'Y5(=6]A=T*/RJ1;@`5'JWL+NA1^52'5O87="C\JD6X
M`%1ZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ%'Y5(=6]A=T*/RJ1;@`5'JWL+
MNA1^52'5O87="C\JD6X`%1ZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ%'Y5(=
M6]A=T*/RJ1;@`5'JWL+NA1^52'5O87="C\JD6X`%1ZM["[H4?E4AU;V%W0H_
M*I%N`!4>K>PNZ%'Y5(=6]A=T*/RJ1;@`5'JWL+NA1^52'5O87="C\JD6X`%1
MZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ%'Y5(=6]A=T*/RJ1;@`5'JWL+NA1
M^52'5O87="C\JD6X`%1ZM["[H4?E4AU;V%W0H_*I%N`!4>K>PNZ%'Y5(=6]A
M=T*/RJ1;@`5'JWL+NA1^52'5O87="C\JD6X`%1ZM["[H4?E4B;H=!HU`CN1Z
M+3(L!EQ>VM$=LD$I6,9,B]N"(28``````````````````I\N[*@;M1=I-NO5
M"GTYU3,A\I*&UK6C^\)I!EZ^SPWFG)D9%D?=ZZ7I;[4>VZ9YU6J,W+<6J03#
M;;;A&;9&9D9FI1$9DG&XBWF62S7JI<5,K<RHT5%P4NB4AAYQB8ZJ4VW*E+(\
M.);(S+HTYR1N'E1[]DBW*'=1ZA2*%<]:C2I42%$FLQI4!U;B4-.LI9)LR0HS
MP>SL$9D1\%D?M`2)W<3\&GG3:6_(JDU;K:8#BTMJ94T>R]TBMY))"L$9EG)F
MG!'D>%>"684WSA3'F*K$>;CG`;<2XIY;N.BZ->XE)5OWGC&RK.,&*K;TZ/`K
MT*XICI,4BK/5)$:2X>RV6V\TIHS4>XB<2TLTYQG=VD/S6I\>3<<JYXJDOT:F
MS*>W(DM'MM^H4@G5Y+B3?E"#499QLGV'@+O2*]->JA4FLTCS=+<9-^.:)!/M
MO(29$LB41%A2=I.2,N"B,C/?BPBE.SX-:OFAII,QB6F!&DOR5L.$M+:5DA"$
MF9;LJ/)D78@S%U``````````````%<JUP3FJNNCT6CG49;+"7Y"ER"8::2HU
M$@MHR49J5L*W$7`LF9;L\J;P.1!@E`I,AZK2W7F?-[CB4&RIE6R\;B]Y$E)X
M+)9SM)P1Y')<UT1XU;=H,"ITFES>A0Y+J$]U">A0K.P2$&9&XO<HR(S)*>)Y
MSLGP0W*)0*W;TV/4VWZ,]$EP_.*Y!.(5)6ZVX9N._!VEFESL]8L=A`)LKP2S
M"F^<*8\Q58CS<<X#;B7%/+=QT71KW$I*M^\\8V59Q@QU4FO37JIYJK-(\W2W
M&5/L&B03[;R$F1+(E$184G:3DC+@HC(SWXI-:GQY-QRKGBJ2_1J;,I[<B2T>
MVWZA2"=7DN)-^4(-1EG&R?8>+&[/@UJ^:&FDS(\Q,"-)?DK8<):6TK)"$),R
MW94>3(NQ!F`EJ)<\&M5FHTV$V\90F67%NN-*;)1N&LL))1$9XV./#?CV&)\5
MF!_W@UK]EP?_`'9(LP``````````````A+AKCE,>@P84!<^I3E+)A@G";3LH
M+*UK6>=E)$9>PSR9$1",1>/019Z*G27XU5B.M,^0MNI=-]3IX:Z->XC)1D99
M/&-E62(BR/I>=R1J$Y`CI.`FIS.D3&<G/$RRTDB+;6M9[\%E/JEO49D6[>95
M>65,BP8M?:KD>MO1JO'EU>8PXE9-M["VR/909[#:"7DBWX(E&9F>3`6J-=#T
M>0_&N.F%25MQ7)B'"D$^TXTWCI/6(B,E)RDS+'`RP9[\?.)=,_RB`JJV^]3Z
M?4'":COKD)6M*U%E!.MD7J;7`L&K!F1'C(K=]O,W/(5!M^0U4'XU'G..^2N$
MX1&XA*6VS,MV5F1X+L29B3KEQ4BX(%"B4B<Q)ESJC$>;9;<(W&T-NI=<4I/%
M.RE!D><8/!<3`=,B\YJ6)M5B6Z])H,)QQ#TPI*$N*2VHTN+;:,O62DTJXJ(S
MV3P1[LW)MQ#K:7&U$I"B)23+VD8S.3<-&N54BGN7!2:3;B'EM.M'+;;DSME1
MDM)EDNB:-1&1_G++/P2/?IC>QL)Z/9V,%L[/#'S`/T`````````````C+AJ[
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MT-H2MM@VVNB2XRE:DMN$C\W:0258^<!90````````````'PG2F(,.1-E+V(\
M=M3KB\?!2DC,S^PA5H=V5`W*:_4K<>@TRHN(:CR#DH6XA2_[LG6R+U-K<6XU
M8,R(\"RU65$@TN9-J!I*&PRMQ\U%DM@DF:MWMW$>X42D5:G7+4Z=.JE>I+#3
M;J7*?16)C:U])C"%/&1^LLL[D)+92?M49$9!*2+QDI9DU6/0G9%OQ7%I=G)D
M))9I0HTN.(:QE2$F2M^2,R29D1[L]D^XIRJC(@T&BG5%1$H5)<.4EA"5*3M)
M;29D>TLTF2L;B(E)R>\5*#6Z93M,IE#F266ZO#C/T]<!2R)YQ_UDH2E'$]O*
M33@CR2LB3M:H0+9F5NDUZ?'A2$K9E)<DNDVEYKR9I!J2:CWDE;:DGCAN[2`6
MB+<--?MU-PJ<4S"-HW%]*G"T&6Y2#+_$2B-."]NXLA:E9.X*%&JQPG8:GC<2
MJ.ZHC6V:5J09'CVY3]0HM(BW%*@4:7%I#$JE^42:DB,_+\G4;CDA;C)J+85E
M*4*)1%N]8R/\TA/:5O3W;7Q-A-1B3+E=&:'^DV\R'#5GU2QA62]N<9W<`%T`
M````````````!2Y-Y34L3:I$MUZ30H3CB'IA24)<4EM1I=6VT9>LE)I5Q41G
MLG@CW9N@S"5<-&N4Y-/<N"DTFW$/+:=:.6VW)G;*C):3+)=$T:B,C_.66?@D
M>\+-,N6>Y-E1Z#0UU1$,D^4.^4I93MJ22R;1M$>TO94D]^R1;1;^./RN[2F-
MTY%O4]51E38WE9-N.DPEEK.,N*,C,CVLI))$9Y)7L(S$?0:S2:#/N:'6*C&@
MK*<J<VJ0X39.QW$(-*TF?PB(R4G=G!IQV"%LB6U0JC$>K.S`9JU,)<9<DR;2
M2BDR'>B,SW$K8?0>SQ]4^PP%J5=QE1ERBI3WG-$U%/73E.I)1/J,L%M\#3LJ
M)9*_PG[.`E*).K$Q;Q52A^;DI(C0?E2'MOCGX);L;OM%!?=H%1DSZO5G'3H$
MRNH)B8V]L,&IN*36VM9'_=J62D$9'@S(LG@]\S:::9%NZ=!MAY*Z&F&E<EIA
MSI&&).WZI(/)DE1HVC4E.[<DS(C/>%\`````````````<JZ?`6HUKA1U*4>3
M,VDF9_@/9,&%+:0S*B,/-(,C2AQLE)29<#(C+<.D`'R?88D,*COLMNLK+"FU
MI)23+L,CW#UEAEAE+#+2&V4EA*$))*2+L(B'TR7:09+M(!SPX<2$V;4.*S';
M,]HTM-D@C/MP0Z`R7:09+M(``,EVD&2[2``#)=I!DNT@``R7:09+M(``,EVD
M&2[2`<[T*&^OI'HK#B^&TMLC/\2'JH<1494145DXRBPIHVRV#^DN`^^2[2#)
M=I`/FRPRPREAEI#;*2PE"$DE)%V$1#YPX<2$V;4.*S';,]HTM-D@C/MP0Z,E
MVD&2[2`>;*24:MDMHRP9XWF0]#)=I!DNT@``R7:09+M(``,EVD&2[2``#)=I
M!DNT@``R7:09+M(!\7XT>1CIV&G=GAMH)6/M!F+&8)26([39*^$2$$G/TX'V
MR7:09+M(!SQ(<2$V;4.*S';,]HTM-D@C/MP0,PH;$AV2S%8;?>_O'$-D2E_2
M9%D_K'1DNT@R7:0#D.FT]1F:H,8S/B9M)W_@.LB(BP7`,EVD&2[2``#)=I!D
MNT@``R7:09+M(``,EVD&2[2``#)=I!DNT@'S>9:?1T;S2'$<=E:2,OQ'S9AQ
M&%[;,5EM>,;2&R2>/J(=&2[2#)=I`.=F%#8D.R68K#;[W]XXALB4OZ3(LG]8
M+A0URT3%Q6%2D%LI>-LC6DNPE8R1#HR7:09+M(!SRH,*8;9RXC#YM'M(-ULE
M;!]I9+<8Z`R7:09+M(``,EVD&2[2``#)=I!DNT@``R7:09+M(``,EVD&2[2`
M>+2E:30M)*298,C+)&.9%/@MK2M$*.E:3R2DM)(R/[!U9+M(,EVD`YUPH:Y:
M)BXK"I2"V4O&V1K2782L9(@E0H<PVSEQ6'S;5M(Z5LE;!]I9+<8Z,EVD&2[2
M`!XE*4%LI222["+`]R7:09+M(``,EVD&2[2``#)=I!DNT@``R7:09+M(``,E
MVD&2[2`!R'3:>HS-4&,9GQ,VD[_P'7DNT@R7:0#GD08<I3*I,1AY3)[39N-D
MHT'VEDMWU#]2HL:8R;$N.T^R>\T.H):3^HQ]LEVD`#YFPR;'DYM(-G9V.C-)
M;.SV8X8^8>1HT>(REB*PVRRGX+;:"2DOH(MP^H```````````````,\URK%3
MH6G-0J5(F.Q)C;K))=:/"B(W"(_P&AC+?]HW_NIJG_C1_P#W4@.*-8&H3\=I
M[K<J*>D0E6/(BW9+/^,?7J[U"^5VH\B7C&H4S_AT7_P4?^DAU`,EZN]0OE=J
M/(EXPZN]0OE=J/(EXQK0`,EZN]0OE=J/(EXPZN]0OE=J/(EXQK0`,EZN]0OE
M=J/(EXPZN]0OE=J/(EXQ?KRN*+:ENS*Y+;6ZW'))):;^$ZM2B2E)?.9F(%[4
M:EHL2!=S460\B<M##$1)I)PWU*-/1F9G@L*(\F?8`K_5WJ%\KM1Y$O&'5WJ%
M\KM1Y$O&)E>HR:;3*[*N:WYU)E4=IMUUC;2^EY*SV4=&XG"5&:C(C+=C(]8O
M^6PW5$UVU9M,D0Z:Y4VD],AYN0R@LF1.)W$O_*8"%ZN]0OE=J/(EXPZN]0OE
M=J/(EXQ:IE\18M#M2KJ@O*;N&3%CM()999-].T1J[<>W`X[9U)I-<N*Y:&<=
MV(]0E.=*XZLC2XA"S2I98X$6"X]I`('J[U"^5VH\B7C#J[U"^5VH\B7C'WHN
ML%-JU!;K+-'EH:75V:4E"W$YVG"(R7]&#X"5I^I=(FU2[*3Y.ZW-M]+KBFU*
M+_>4-D>TI'UD1;^T@$'U=ZA?*[4>1+QAU=ZA?*[4>1+QB8>U'2]"H*:+09=4
MK-8A%.:IS;J&S:9_QN.*]5)9W%VF+!9]SM7+#DK5`E4^=#?./+AR2+;9<+?C
M);E$9'DC+B`H_5WJ%\KM1Y$O&'5WJ%\KM1Y$O&.Z!J<N=<+L:-;D]ZAI?\E*
M>R1+42^D-LUFV1[1-[18SC/MP)^!?MOU&[I=KP)/E$F'%7(DOMF1M-&E9)-!
MG_B+.3QN(!4NKO4+Y7:CR)>,.KO4+Y7:CR)>,2M)U2IDZ5%.32JA`I4]#ZZ?
M49!(Z.23)&:]Q&:D;DF9;1;R(==KZAQ:[5(,!ZC3Z:FIQURJ8])V#3,:3Q,B
M29FD\'G!^S?V`*_U=ZA?*[4>1+QAU=ZA?*[4>1+QBU5Z]XM&KM2H[L%YQR%1
M'*RIQ*B(E(0HTF@OGW<>`C8.J%'J%NV]7(<5YU%8J;5+-G;(E1GEY^']&"/=
MQ(R,!#]7>H7RNU'D2\8=7>H7RNU'D2\8F%:G4Y%E5"YG*?(2]"FJ@.0-M)N]
M.2R3L$?#?G/T#\*U"JKU7JM,I-D5*I*ICQ,/N,R64I)9I)6/6,C]H"*ZN]0O
ME=J/(EXPZN]0OE=J/(EXQ+U/428Q4IM.IEISJC(ID5J35$(D-H5%):=HD)(_
M[Q1%G<G[1\:_J7(I7FQ]FT:G+@513#4.23K;?2NNIREO84>TE7$CS[2`1W5W
MJ%\KM1Y$O&'5WJ%\KM1Y$O&)6;J'5(U1IU(19-2=JTN&N8J&F2R2F4)<-&\S
M/9/@1[C]I#]5/4&I4]5#B/6743JU77(2S`*0UMI)HDF9FK.SO(S/C[`$1U=Z
MA?*[4>1+QAU=ZA?*[4>1+QBY6=>$6Y5U"&N#+IE5IRTHEP)9$3C>T64J(RW*
M299P9>X1=9OR6U6YU'MNUYU?>IQ).>MAY#2&#46201K^&O&_9(!`]7>H7RNU
M'D2\8=7>H7RNU'D2\8D:AJ[;D*FVW5%MR/(:R^MA3BB)*H:D&1*)Q)]AGOQV
M9WBT4RYH]0NRLVXW'6ERF,L.J>VB-+A.D9E@OFP`HW5WJ%\KM1Y$O&'5WJ%\
MKM1Y$O&+?4KZH,&[J;:)/F_5YCAH4RU@_)R)!K(U]F2X%QWB'GZGTZ'5);7F
MF>[1X,Y-/F59!HZ)F0K!;.SM;1D1F1&9%N/ZLA$=7>H7RNU'D2\8=7>H7RNU
M'D2\8LMSW_!MZH5&*_"?D-P(K+KJV#(U&\\X:&F$I/BI6%*SG!$0_%.U%HYQ
M*PNOM.T&51W&VYL>6I*C0;B34WLJ09DO:(CQC?N`5WJ[U"^5VH\B7C#J[U"^
M5VH\B7C%NAWO396GZKX)EYJ`49R033N"69)-1$G=DLF98+Z2$'+U1CPGGO*Z
M!4"AP#8:JTQM2%-0'G2(]@]Y*7LFHB4:2W`(WJ[U"^5VH\B7C#J[U"^5VH\B
M7C$S(U-IS-6>9*E3ET>//33'ZNG8Z%N2>"V<9VC21F1&K&",6"O7,S1:];])
MD1'%HK#SC")"5%LM+2G:(E%Q];@6`%&ZN]0OE=J/(EXPZN]0OE=J/(EXQVMZ
MN4=ZA7)5F($APJ-,3$)E*BVI)K7L(4GL(S(^/8.R=J&^R5=.#;$R?YEDFQ+Z
M)]M.PDFND-?K8W<2P6_<`ANKO4+Y7:CR)>,.KO4+Y7:CR)>,2$;4UY5NLW#,
MM2?#@278S<5;C[:NG)Y6"46#,RQN/?CB+5+N5F->-.M=45Q3TV*[)2\2BV4D
M@R(R,N._("B]7>H7RNU'D2\8=7>H7RNU'D2\8LETWM)HUS1K<IUMS*Q.?AG,
MV8[S:-E!*V3^&9>W_4<;>I]+=I$:>5/F-R559JDR83Y$V[%>6>/6]AD7'=Q`
M0_5WJ%\KM1Y$O&'5WJ%\KM1Y$O&)I>I=-9M.NW!)@OM.4>8N"_#-9&X;Q*))
M$1_YMHC+ZQ\:IJ='IL2X7GZ+*-VBO1&'64NIRM;Y$9$1\"V3/!_0`B^KO4+Y
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MC<2Z_'EE*I4JESX3YQY,61A6RK&<I66Y:3(]QD`HW5WJ%\KM1Y$O&'5WJ%\K
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M68*4K>A2R+:-M7!:5),R4GV9(6T!DO5WJ%\KM1Y$O&'5WJ%\KM1Y$O&-:`!D
MO5WJ%\KM1Y$O&'5WJ%\KM1Y$O&-:`!DO5WJ%[=7:CC_^B7C'7H15:S5;<K!U
MNJ/5&3%JST9+SO'92E&/HWF9_6-/,9+_`+/7_`+E_>"3_H@!K0``````````
M``````#+?]HW_NIJG_C1_P#W4C4AEO\`M&?]U-4_\:/_`.ZD!I%,_P"'1?\`
MP4?^DAU#,(6L^FS4..TNXR):&TI,O)'MQD1?Y!]^NO33O&7*/>`!I`#-^NO3
M3O&7*/>`.NO33O&7*/>`!I`#-^NO33O&7*/>`.NO33O&7*/>`!^M2J'<5S5R
MVJ92E)B4^(^=0D3G6B=;2ZW_`'2#;VB-6\S/'#@*@U:EVTFE7!;<N@0[EI"J
MHW.PM),E):<++R6")?\`9.)5@RR>/A8%MZZ]-.\9<H]X`ZZ]-.\9<H]X`%-I
M]N74W&KR*#;TWT;=B-H:H5RR2<Z=PG"-?1D2SZ/U"W&:OA8^KZ46T*Q)F5*!
M0*57+>MV729,61$J\HG&U/K0:6S:02UF1$9Y-786!;>NO33O&7*/>`.NO33O
M&7*/>`!6X5-NNM0;$MB9:TNFE;LV+(F3GW6S96EA)I(F]DS-1JW>S=^(@*KI
M[>"W:Q/I<)4>94:[/BO&:D>O3I))_M./`C29XX[^`T/KKTT[QERCW@'O77II
MWC+E'O``I[EC5Z/#G0X5'6EA-XQYD=!*3_\`"((BV^/`B+AQ^8>5;3VX)4:\
MJK`AG&KI5B3(IRC-/^]QG6R0XV>_@HC/&<;R+@+CUUZ:=XRY1[P!UUZ:=XRY
M1[P`*W2*'=%J.6W<#=`D5%/H\U2:C"C.H*1'4E6T2T9,B5V&1'\XL6DM/NF%
M)N!5P-51J&\XRNGM5&><M;;>RK);1F>#X9+M^@>]=>FG>,N4>\`]ZZ]-.\9<
MH]X`&>2+=NI5\N'2[<=H]P=.EURHTZ034%YKIU9=6@UGM;2-QHQDSR>!HTVV
M9TC5:74T0S:I4BVUP3DIV2+IE/&>,<<[)YX#Y]=>FG>,N4>\`]ZZ]-.\9<H]
MX`%'9LZZ:[1K:LV=0WZ<W0F9:)-0<<0;+RE-K0UT6#,U$>T1GDBQO$Y:%%N.
M;7K'\YT&32V+2I[L=]Y]:#3)=4VEHB:V5&9IPG:R>.SZ9SKKTT[QERCW@#KK
MTT[QERCW@`<-[6W6ZA>5P3X=/6[%DV=(IS3A*21+D*<,R;WGG)D?'A\XJDC3
MFXH4FPY5+AJ*,;U.?K4,E)_L)#"22;Q;\;TFHE8XF1'OR+SUUZ:=XRY1[P!U
MUZ:=XRY1[P`*W4+$KSVK);,;:L^1/:K;Z\IP4E#:D[.,YWJP9[O;\PCY]K3V
M[PNJ;4+"K-79FSNEBOPJKY,G8V"+>27$YW]I"Z==>FG>,N4>\`\ZZM-.\9<H
M]X`%7NRA3I]8E3:C8E37+<8:\UU*A2B:D->I_=R%&X1;25;MK!E@A-5BWKMF
M6GI[&J*%3ZO3ZS#DU%PEI,TH1M;2C,S];!&1&99R>_>.[KJTT[QERCW@'O77
MIIWC+E'O``A=3+<J$_4&G5?T6J%;IC=+5'6F%-\F4ETW#,O6):3QCV<-XYIE
M.KT2H6'6:18]42Q1ESTNT]R:AUY!.)(DF;BUGG)FH^)XQCL%BZZ]-.\9<H]X
M`ZZM-.\9<H]X`'18U)KLBZZ]>->II4I<]EF+&@FZEU:&V\Y4M2=V3,RW%P$6
MPBY;(N:Y7(EKRZ[3JS+\NCNPW4$IITTD2FW"498+);E%G=^';UUZ:=XRY1[P
M#SKKTT[QERCW@`52'IS5UG:+=:IK<EM^HU&96&D*)3<<I#>"1G._V%DL[Q-:
M3VI<EMW;<WGHEOPR8C18,U1IS(:;VB3DB/.T2321Y+B0DNNO33O&7*/>`.NO
M33O&7*/>`!VWC0YTV^K'JD*#TD>#*D+F/)V2Z-*FME)G[3W[O:*C4HMQ5>[)
M)URS*JY;L6<3L*%`..AJ0M)__$/F;A*6?`R3PX9R+#UUZ:=XRY1[P#SKJTT[
MQERCW@`?BFQKKIUNU6XX=(;?KU4JARY$&3@G/)25T:&DGM$1+)I)&63QDS'+
MIU;T^-(N^2=$ETVC5%2%PH52<2[)-PFS):UJ-2C+)XP2E']0[NNO33O&7*/>
M`.NO33O&7*/>`!#6_;-=.QK#M"H4UUEE$DY%6VME24-LK4XAM6#_`#UFWP]A
M&(ZY;9N8F[UM6%0GY3-S5%$N/4DK03#"%&@W.DR9*(T[.XB(\Y%JZZ]-.\9<
MH]X`ZZ]-.\9<H]X`%-?M"Y6J94[!:HLAR+.KY5!%7VT$PB,:TK/:W[72%LXV
M<;Q?M7J+5JO:S3]OL]+6Z9-9G0DD9$9K2K!ED\?FJ/[!Q]=>FG>,N4>\`==>
MFG>,N4>\`"DQM-:[$KME1&8AE1CC1':THE)W2(YN.%G?D\J<QNR+A3;>K#1:
MG$Y!6GSL\ZJ%E2?[<C8-)8W[M^[?@?;KKTT[QERCW@#KKTT[QERCW@`0U>M*
MLS]&[:MPZ8XY.85!3*CDLB4A*#+I-^?86>!CLINGT6W=4*14K?I3S-*3`D(D
MO*DK=(G#,MDO749\.S<.WKKTT[QERCW@#KKTT[QERCW@`?"[F+AI^I]/N6EV
MU+K$-%'7$64=UM!I6IW:_/,O87XBMS+-NJ?'>KDNDDS4:I<T*>[`:>2OR6,T
M1IRI6XC5@\G@6KKKTT[QERCW@'O77IIWC+E'O``K=PV'79>JJ/)X^U:51EQJ
MI.7DL)?90LMC&<^L>,[M^2[!SWA:-RRT:AJATAU\ZC4J<_#2E:"Z=#>SMF63
MW8Q[<"V==>FG>,N4>\`\ZZ]-.\9<H]X`'&Y$NJ[KMH]6J%LN42GT1J2M"9$A
MMQV2\ZWL$DB09D22XY/B*OIE;4^AE0&:EI[6TU".ZDG9_G;^P1E9^OT1.XP2
M3WEL[\"Z]=>FG>,N4>\`\ZZM-.\9<H]X`&=U336YSL:;*I<%3%?.5,8>C93F
M9"==VB(SSC)&1++)]OS"TQH]V6W>LFKQ;/F55A^C0XI=#(:;)+C:?6(S4KMW
M"<ZZ]-.\9<H]X!YUU::=XRY1[P`*FY9E:C4!E5?M./6F*E5953J<&([_`+U"
M6X1=&;"]I)'C&%%G?NQVBX:34NO4U-9\O14XU%=>;.E0ZI()Z0P@DGM[1D9X
M(SQA.=V/K/\`'77IIWC+E'O`'77IIWC+E'O``J#FFM8FT*_WG7*Q%GRZG,?@
M1&9QH8E(/"D&ILCV5;1D9>M[,9P/G6[9K$FZX-7J%CU&HQ54"+'4Q3YI0^@?
M(\J3ZKB=Q<,;RX"Y]=>FG>,N4>\`\ZZM-.\9<H]X`$-Z.U>36:#-BV[,I\-B
MA3HBF)$DGELK49DA*EFHS4:N.<GQWBJ3--;HC6S:KU)@J1)=**U6X!&DC,V7
M#4V]G.-I)92>#X&7SC1.NO33O&7*/>`>]=>FG>,N4>\`"MWA8E>J&IJ#A1MJ
MUJP_$EU5>4X2Y'VL)P9Y]8MG@7M^8<MQ6O/5J/=%5FV15JU!F^3>2NP:EY*1
M;#1)7DB<29[]V_A@^T6[KKTT[QERCW@'G75IIWC+E'O``K=RT)^=/C2JMI_4
MGF$P&44^31Y6S/AJ).%-/K-PB5@]Y*WE].3'94K<O*9I30Z754/3ZZS4([SY
M*=2M:6DO&HMI><*-*,9/V_.)CKJTT[QERCW@'O77IIWC+E'O``C-6+>J%4NR
MVJBU;<ZM4Z(Q*1(:AR_)UDI>SL^OMI/B6=Q^P1DZDUIJ):<VCV-56$TFKNON
M0'YZ7G5(-LO7):UGN,S,L9]ABR]=>FG>,N4>\`==6FG>,N4>\`#]VC3*_4[\
MG7K7*/YF;\W)IL2&M]+KJTDYMJ<7L[BW[B+/_P!]&&;]=>FG>,N4>\`==>FG
M>,N4>\`#2`&;]=>FG>,N4>\`==>FG>,N4>\`#2`&;]=>FG>,N4>\`==>FG>,
MN4>\`#2#&2_[/7_`+E_>"3_H@2775IH>"])"Y1[P"(_V<GVI-L7!)85M-.UV
M0M"L8RDTH,C^P!KX````````````````#Y28T>4R;,IAMYH\&:'$$I)X^8Q]
M0`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1O
MF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?
M$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#E
MD>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/
M,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^
M)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+
M(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD
M@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1O
MF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?
M$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#E
MD>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/
M,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^
M)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+
M(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD
M@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1O
MF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X/,-$^)X'+(]PD@`1OF&B?
M$\#ED>X/,-$^)X'+(]PD@`1OF&B?$\#ED>X=<2)%AMFU$C,QVS/:-+2"01GV
MX(?<``````````````````!&7%*J,.CR)-)AE,FHV>C9/\[*B(_:7LR8DP'8
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M%49COU6HLSU^4GTY*9(C;B^4)/U]QD9J(]^<%P&QSK`LV?#@P95NP7(L%*D1
MFMC"6B4>58(C]I[S'V>LBTWJ$W0%T&%YL:7TB&$HV20O_$1EO)7SYR`S>##E
M2)]\VN5P5Q=-H)-RH4EJH.)>;6ME1J94Z1Y6DC+.#/<(V+193NC"KP5=-T>=
M2I2Y6T58>V.D(C,O5SC&[@-FH]N4.BTI=)I5,8BP7-K;:07P]HL&:C/>HS+=
MDSR/VB@TA%!]'TP&BI70FQY+OV.C/BGMP`K-L0G*;IRJ6FIU.5)E4XI:W9DM
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MU5FUFKSHK<IIZ8IQJ83Q_P!HT31^JG9WD6"+&!6F:I<3=/.KHJ-T-.IN`XQ5
M1VI&N`VWT^SLK9VC,RP>/@XX;QO-,L*SZ75_/,"WX;$\C-27$I/#9GQ-*3/9
M2?SI(AV^BMO>:7:/YJC^;W7_`"A;&#V3<VMO:X\=HL@,6O34%V)J@N0W6WV:
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M!QZJXIV:V9'A]:B(C-7S[B`8/=]:N#RJY8\:L5%Q15VDL-%&F*8VDN,*-24*
MS_9DL\'V<#$Q5H-S1:"S!Z6J4V;,JC24P9]R&^[46TI4:F6GR+^Q,S,NS../
ML/5)ED6I-9DL2Z)%>;E+:<>2HC/;4VG809[_`&)W$.5K3BR&J?*IS=MPD192
MD*=0E)EM*3G9,CSDC+:/>1EQ,!#:0SS>9KE*><J[<FGRR2[!J;Q/KB;2<DA+
MQ&9N)W&9&>\AHXB;>MVBVW#5"HE/9AL+6;BR1DS6H_:I1Y,S^<S$L`""O"HU
MNET94JWZ)YXG$XE)1>F)K*3XGM'V"=`!G4RZ=06K?ILZ/I]TU3?<=3)A>7)+
MR=*3]0]KV[1?8/W6KGOZ([2DTZP?+42(C3LM7EJ4>3/*,]MO_-L[M_M&A8(,
M`*0[<%Z)O0J2BS-J@],E'G7RM/P#3DU;''<>X<U(N:_)51J3$^P_)(K##RXS
M_EJ5>4.)_NT8]FUV^P:`&`%1L6MW76/+?2>U/,71;'0?[R3W39SM<.&,%]HH
M^II5B9>#C<*3-J,*)3-MVF4RJ'"DQ5&H_P#><;B=+&"(L_5V[,*]<EF6Q<SS
M+]<H[$MYE)H0XHU)42?\)FDR,R^8]P#"[FNR;6*=1I-$K59>ATVG-+J-16HV
M#A+==23<A:&U9>41(61IP:=^<\1,W76Y=>ONG>1E=[E-F6VB:S"H\DX[J5J=
M427%IVR(BQC/'B7$:I-L&S9TB#(E6[!<<A-I:8+8PE*$_!2:2W*(O81D8[J5
M;%!I$EF53J8S'?8C'$;6G.4,FO;V"R?P=H\X`4F9Z81-%4L56H-QKH<82P<A
MZ8ADT*6Z24Y=,R(ED@R+)'DU<,F*>B?445R/8;U1K%/?<K#34^2BLN2S4TIA
M3C:&GE$E3>T:<&6"/=\XW6J4Z#5H#].J45J5#?3LN,NIVDJ+Z!`-Z?V<W0W:
M$F@QBISKI/K;,U&I3A<%[>=K:+AG/#<`QBD5:O5R=6*!.NFK1H5`@U!^'-9D
M&V[*-I\T(6XLO[PDD6#+@?M%TNFO5E_2:U:R<M^-4)C].4^XPHVC7MJ3M<,;
ME=G#>+E,T^LR;3J?39-OQ%Q*>1E&;(C3T9&>5%DCR9&>\R/.3XB;J-&I=3A-
M09T%EZ*RM#C;1EA*%(/*3(B[,`/YYK=V7-1J=?KTFIS5TR=4Y\*#(2XO;@26
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MO)@T:*R3T;R5PB29[3._^SWF?J[SW`.^@QV8M%@,1ICLUE#""1)>=-U;Q8^&
M:CXF?'/SB0')2J="I-/8IU.CICQ&$[+323/""SG!9'6`"%NRK3:)1'JA3Z+)
MK$E"D$F'&/"UD:B(S+<?`M_`30`,EZSKO^22X/O_`/X#TM3KO,R+JEN`M_';
M_P#P&LX+L#!=@"LR+AJC5Y0Z`BV9KE/?9Z1=52?]BTK"CV3W<?5(N/YQ#A@W
M;6Y$>Y'7;+J3"Z5M>2H6>^HX-6.C]7V[)=OPB%T#!`,EZSKO^22X/O\`_P"`
MO%EUZI7!2W9E4MV90WD/&V4:6>5*21$>V6XMV\R^H6+!=@`,&U$?JQW5<=01
M/J4ZETV.T9E1ZIY.]1C).TI:V3P3NUC/$]V[Z(VY[RD/U^#<4.IU55O4U$)J
M34$J4VEIXR-U9=`@\.&Z@TH/:+92HRWX&RUZQ;2N"H)J-8H<:5+2DDFXK:2:
MR+@2L&1*+_JR/Q4+`LVHU,ZI-MV"_+-LFS4M'JJ22=DLI^"9DG<1F62+@`R6
MZ9M;J]]7/&IY7BXM-/B.0(]+F&RB*ZMK)&ZDUD1%G&=Q\#%]NXKG3IG38#U1
M9C7%*.''??*:F+EPU)-PD.;O6,B47JY,\G@C%QI5OT>DR')%/@-L/.,M,+6G
M)FIMLL(29F?`BW$/M6J13:Y3G:;5H34N&[C::=+);N!]I&7L,MY`,-ILV;4[
MJB6#(JU;I:&9,Q4]UNL.2%NN(:0;:6Y"B)1((E&HT8+>1Y$13KBN2XK>J-0G
MW-4H4BAV^4R(J,Z;)2W2==(G7"_YA&3:$X/);^TQMKNGMF.T1JAKH$8Z>TZ;
MR&R-1&3A[C5MD>T9F6XSSO+`^E2L.T*H5/3.H$-U-/;)J,G9-)-H(\DC!&1&
MG)<#R0"G:BUVN,VK8=3@].FH3*M`Z:,R]T'3FMM2E-*/@23/=OW"E7?<MV&Q
MJ6]*.=19<6+3#8BM3^D\FVG4DHT*1@B-1<<=N\;_`%*DTVJ%$*?#;?*)(1)8
MVR_NW4_!47SEDQQ5&U;>J2JBJ=2H[ZJDAM$LUD?]LEL\H)6_V&6X!F34^L65
M:MR5ZJ0:S%=;B)1$*H5[SBEQY1F2=E/YIY-)GVE]`IL6\*DC3NX:.W<TV;/I
MLZ$ZS4>D<0ZZRZXC:(C5A6$KVTG\QD7`;7"TXL>"\A^);<)IQ"T.)-*3W*2>
M4GQ]A[Q(UNTK;KLA<BKTB-+>6R3"UN$>5-DK;))X/>1*W@*/KE%?CVZY<$"M
MUB%,9<CQR1$GN--&E3I$9FA)X-6%'O\`F+L$>](N&V-4V*'06JI<$9-!-XXL
MVJX,E'(/+AK<R1F6Y)>W!]A"^P[`LZ%!E0(MOPVHLI3:WVDD>'%-GE!GO]AF
M9B;\TT[SSY[\D;\Y>3^3>48]?HMK:V/HSO`9OIQ7*R>C<RMNN/S:HPB>ZV3[
MANJ4I"UFE.3WF18(L"/M**TQ3+*NE^^JDFIU9Q'E")+RY#4Y3B3-3)-9V6]D
M]Q*(B).-XUBD4FG4:"4"F1&XT4E*6339;B-1F:C^LS,0<+3^S8%0>J,.WXC,
MIU*TFM)'A)+(R5LEG",D9D>R1<0&3V?J&[-U33+>K;S]*K<I^"Q!,U]'%2C9
M\G<+/JY<-*R/';O%>H55N(J;0ZP=0NAIYZNICKJ4FHFY`-!O&G8-K:,^'J[T
MD6?:/Z+7;5"52X-).F,>0P7&W(S)$9$RM!Y2I/89#\%:UOE244<J5'*GH?\`
M*$L8/9)S;V]HM_':W@,:MUNYJS==Q/='<,V'%N-^.3S-QG&:CMI<+U.A/X1)
K(\[N);A_0`J$O3BQYE0>J,FVX3DQYTWG'5)/:4LSR:CW\<[Q;P```!__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g674535.jpg
<DESCRIPTION>G674535.JPG
<TEXT>
begin 644 g674535.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`P35),3%]'4D%02$E#4SI;04)"3U14
M75)%0UE#3$5$7S-0245#15],3T=/+D504__;`$,`!P4&!@8%!P8&!@@(!PD+
M$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE,B4H+"TO,"\=(S0X-"XW
M*BXO+O_```L(`%<`D`$!$0#_Q``<``$``P$``P$`````````````!`4&!P$"
M`PC_Q``Z$``!`P0!`P(%`P`&"P`````!`@,$``4&$1(3(3$'010B,E%A%2-Q
M%C,V0F*A0U)35')T@8*1L;/_V@`(`0$``#\`_2-*4I62]2\NBX9B4V[.K3\2
M4EJ(T3W=>(^4?P/)_`-1O2/*!EF"6RXNR`].;1T)G^L'4=B3^2-*_P"ZMMNF
MZ;INFZ;I2E*4I2E<\RY-M7EC[U\?DIMD"QKEK2U*=9`(=[JTA2=G0UWK\QKS
M!^\RKP(^-KG2)22U;T.NO2Q`;5V6$H45;4I/E7G?C53_`$Q8DXYFEMMF3LRH
MD6Z+#3D(R'8[B.79#JDH4"GOH#EY"B=:[UUR[0'8N3R+3:+;)N!7<U-!MZYR
M1TF$1XJU:4'AH;>6=GE[#1W67C9*E=F1-<L)^(45J2U^IS$\T<&%HU^\?/64
M-[[Z'8=Q4YV>XNV,W6-!CICR(\5Y#;L^;S3UY*F0"3(">W'9V0.^MC6ZO;*W
M'N-]O]G1#0^["AO.Q^C<YFPX@I2D.#K'LLJV-$=@>Y\UG,>O[.0O-MQ+*J,E
MQY+*5OW&:?K:?=;5H/#8XLC?\U(AST2Q$B/VUQM<RWHE?$Q[C+`:+D%^0E("
MGB>0+:1X(UR\=J[SC3BW<=M3KJU+<7#94I2CLDE`V35G2E*4I2N7>H\.-/N&
M019;ZV6%8NZ5.)&RG3V]_P"5?GVU7RX1(2+<YZAR,;BA((8CV];>_;8+/U=O
M<G9]Z^+3=E+SB,9D7&ZR4+2_.ODQOI:TK:&VD;)Y+6$C:B5$]@`-UVS,LPNV
M$QKS.@PXSTEZ]LQWI,I"UM1A\#'Y*5P[]S_Z/8^*@1?4O)[RBR6G';)CTB^R
MX[TE]PK*HP;;)">(!VE1X_2H[';[[%"/6S)'(@#F+VYPW)D-VMM#"E)4^ET)
M6A?S?,.Y(`T=E/WW6]]0\TOV#HQIIJ%:53;A%D*G$,*"0XTTE0"-*!X[)'??
M:L-`]<+G+A03&M=H1,3"F/2VRPK276FU*;*/F[)*=>=_W@#6@PK/;SGUMOKA
MAVF';K=:2)`2V2^X^IE8VCYOD;'?6P3H:WW.NPXM_9FS_P#),_\`S35K2E*4
MI2L=>V;O%R]%VA6-VYQ7+:8JTM/M(*5=7EW#BAL$?:L5>\*9N3B78N!W6U.<
M0E7P<V$6W-#0Y-.*4@G7;>@=:&Z]\?Q%VSW"/<'<0OMQ?BJYQDRI\)++"]:Y
MH:;4E`5KW()I?;#DUZ<N2EV2^VY3]Q3-9<@W"*#H,--E#B2YQ6-M[T?Q^16=
M;]+GHD2`+99LEM]QBEWE<&)\-+CH<^I)`<``]AKV)WNKF-A;T2/B4:'B5X:;
MQR2J2SN;#4J0M1!5S/4[;(]JGY[CUTS23;)$S%[Q%,!#Z$!F7$5SZJ0D[VY[
M:K,.^EI48;C>-7MIUBVKMRUHDPOWTJ0I'44.IV4`K7YT*FVO`[E8Y3DRRXY>
M67'+2JW/L&5##4H],I#B].=E;XDZ]Q^374\95?8R8EJGV=IF'&AH0)B)07R6
MD!/'AK8\$[WJM)2E*4I2E*53Y5?8N-V*7=Y:5.)93IME'UO.$Z0VD>ZE*(`_
MFLJQC&2W&+^J9%FUVMDIQ/47$M:VFH\1.M\-J0HJX^ZB>_>LSA=GR?)HTR_0
M/42^L6E;RT6KJ])Y;B4'B77`4@$%0.D:!UK9K48IZ@Q'WXV-Y&XW%RU,E<-Z
M&TA1ZBTIY=5.O#:DZ4">W?7M70*4I2E*4I2E*5R[-;DF%G]JFY5$E,8K;D=6
M)+0CJ,&:KMS>*=E'$'2=C6R3NIV7ST9;-@X79I:78<UH2[K*CN!240M]D!0_
MO.GY1_A"C6<PV]3<>O\`D+3.%Y'%QN2\E^''3;5J4V[K3A2E/9*%:!`WY_FK
MRU&$K(KIZC9+&198S+8@P/U!L,.);'UNKWWY+4>*1Y"4_FNDI(4`I)!![@CW
MKS2E*4I2E*4KG'J@[>_U+'8&.Y'+@W*X2@S\(RAM25LCYG725))3P3[]_(&J
M^65-7C"XD?(7,EN=XM+#P1<X<\,J"HR_E4M'!M)*DDA6N^P#6PQC'\=LC,A_
M';?%BLW!29#ACC27.W8CV`UX`[=S]ZMY0>^&>^%Z8D<#TRZ"4\M=MZ[ZWK=<
MRP>Q6_+[<N]Y:IZ[WE"W8<J),`#-O<&TN--M#Y4]M:6=J((.ZN/3R;(M[L[!
M[HZIR=90GX9Y?F5"5_5.?R-<%?E(^];JE*4I2E*4I6"RTIL.<V'+)"0J`\TJ
MT2G%#?PQ<6%-.#[`K'!1_P`0K*9O<&\LRM5K?QN\WW%[.5MR&[<A)2_.*=<5
M$K3V;2H^#]1_%6=KS&+AF,QH3F%YA'M4%*6A(F-,JZ:2O2>2@[X!4`.WC56?
MJO>[\Q;VL>P]MQW))Z%NH#1`4RPWKFYL]@22E(WY*OQ5+"N.4V[,YEZA8%?!
M;[E&2)T93L??Q"-!#J/W-=T_*KQX2>]3,8N<S+O4=V["SR+5'L,1VWR.NM"E
MO/NJ0OI[02G2`@$]]@J%=0I2E*4I2E*5!O=KA7NTS+3<&@[$EM*:<3^#[C[$
M>0?N!7-\.O$?T]LHQC)K;<8ZH;CG3N3$%R0Q.2I94'.3840L@_,%=^U0O4G.
M,=R#"[C:+2Y/?G2"R&FS;)*.1#R"?F4V`.P/DU<WVYP\(SJ=D-^6?TJ\0T--
M2R@J,9UD*/0&O[JP2H?=0(^U?6[9\[<(2X&(V>[OWJ3^U&5*MKS#+)/^E<6M
M(`2D=_N>P]ZU6(8_'QFP1;3'6IU38*WGU_4^ZH[6XK\E1)_\#VJ[I2E*5S+*
M?4Q^PWJ\POT:*_$M/PQ?<5<0T^X'0#^TT4'F1OQR&ZNY>>6@W)%MMSZ'I+=T
M:MTH.MNMI;6HD%*5<"E2^WC>O?8JNN?JQBL>RS[C;GGK@[%CJ?2PF.ZWU4I6
M$**5*1H@*.B1O7O5XWG.,KNC5J5<%-3'"E/%V.XA*5E',-J64A*7./?@2%?B
MH5B]0+1D&5-V.SA4AA4!R8910ML?*XE`"4J2.23R)"@2.U3V\VQER\KLR+D#
M-0XMK71<Z:G$#:VTN<>"E@>4@D_BO.-9KC>32%1K-/4^\&$R`E<=QKDT3H+3
MS2.0WVV-Z-9%OU1>7>UP3:(*F$WA5JX-70*F$ASAU!'X`E/O]78;/M6D9]0L
M.>3-6F](2W#:4^XXMIQ"%MI7P*VU%.G$\OEVC?<C[U5WS(<`S"S/V:YS%*BN
MI>6M#K#K*VBP$N+/S)!0I(*5:/<@]MC=6\;/,5?N$.V,W)1E2@V&4JCN)3R6
MCFA"E%/%*RGOQ)"OQ5=9_4RP2;39)=T<5;Y-T9;=2P&W'4M<UE".3B4<4[4-
M`JU7QA>IUHD1+HEQLLW6%\<40U\P'Q&*M\7"@))(2"4C92#5G9\_QVXNVV$Y
M+Z%QFMM'HEM9;0ZXV'`UU>/#GQ/T[V?M51F?J))QR\7&"U:84ABWP&YSSC]Q
M$=:TJ*P4MH*#S4.![;&]@5?LYSCCEV9LYENMSW4[#2X[@'+I]0HY\>',)[E.
M]U#B>I>%RXKTEF\'IM--O:7&=0IQ"U<4EM)2"YM7R_*#W[5)1GV*N?I@;N*U
MKN3SC$9M,9TK+C9`6E2>.T%)4-\@-#OXKZ1\.M"<HN>1RH[$N7,+!07V$*,8
MM(X@H41L;\_]*A?T$B?[^]_:#]=^@?UG^S_X?SYJK<]++>Y8X]G5=)/29MTJ
M`%A"=D/.I<*OY!2!KW%>4^EUO7D:KW,N+D@O.)D2&51FOW'^GP*PO7)`/GB#
MY\'53L2P,X[=HD]=_F7!$*WJML5E]IM(:8YI4!M(!41P`V:]6/3UAJ[)D?K$
MQ=L9F/7"/;5)1P9DN!04OGKD0.:R$DZV?>IF,X5&L$ZVRVISSRH-G1:DI6D`
M*0E?/F?S[:J&?3JU]/DA[4L7LW@2NBGJ!1=YEK?GCW*?/BJ:)Z-V6/%FQ/U&
M267&BU%4EEI#D8=5+@/,)Y+(4A/GMH=Q[UYS+`[O>K9:;8_<I=UD*N?6EW%Y
M;;/P\=2"AU"4)`^52"4\1[G9-:.)ARX.12KG!OTZ-;Y4D2W[:VE'3<>"`C?+
M7()(2-IWK8%9I?I##5'ML;];D*:@QX[*`Y';64EIPN`H)[M\C]7'SH=_:IR?
M3%E4B0J3?YKT8F>Y&C=)M*8[DH+2XK8&U:"R`":];5Z56RVWZ)=6[@ZXAA;+
MQ87':/)YML("@L@J2#Q!*0?/OKM6C>P^T2LHDY%.C,3'G8S+#;<AA"PSTU+4
M%))!()Y_Y"J&1Z<MJRES)1=7GI`E.2VVW64*4"MHM]/J_5TQOY4^!^?-4%F]
M)%S,8M[.27:6;DQ`8C,("6BF#P6'"D:&G/F2!\V]CM^:U>/8!"LLVT36YJW'
7H'Q:E:80VEY;_#D>*0`G73`'^9-?_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
